| Acarbose Tablets IP | Each uncoated tablet contains : |
| Acarbose IP 25 mg |
| |
| Acarbose Tablets IP | Each uncoated tablet contains : |
| Acarbose IP 50 mg |
| |
| Acebrophyline (SR), Montelukast sodium and Desloratidine | Each film coated tablet contains: |
| Acebrophylline (Sustained released) 200 mg |
| Montelukast sodium IP |
| Eq. to Montelukast 10 mg |
| Desloratidine 5 mg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Acebrophylline (SR) and montelukast Tablets | Each uncoated billayer tablet contains : |
| Acebrophylline 200mg |
| Montelukast Sodium IP |
| Eq. to Montelukast 10mg |
| Approved colour to be use |
| |
| Acebrophylline and N-Acetylcysteine Tablets | Each film coated tablet contains : |
| Acebrophylline 100mg |
| N-Acetylcysteine BP 600mg |
| Approved colour to used |
| Acebrophylline Capsules | Each hard gelatin capsule : |
| Acebrophylline 200 mg |
| Approved colour used in empty capsule shell |
| |
| Acebrophylline Capsules | Each hard gelatin capsule contains |
| Acebrophylline 100 mg |
| Approved colour used in empty capsule shell |
| |
| Acebrophylline Sustained Release Tablets 200 mg | Each uncoated Sustained Release tablet contains : |
| Acebrophylline 200 mg |
| Approved colour to be use |
| |
| Acebrophylline Syrup 29.04.2022 | Each ml contains : |
| Acebrophylline 10 mg |
| Approved colour used in flavoured syrupy base |
| |
| ACECLOFENAC & PARACETAMOL SUSPENSION | Each 5 ml contains : |
| Aceclofenac IP 50 mg |
| Paracetamol IP 125 mg |
| Approved colour used in flavoured syrupy base |
| |
| Aceclofenac & Paracetamol Suspension | Each 5 ml contains : |
| Aceclofenac IP 50 mg |
| Paracetamol IP 250 mg |
| Approved colour used in flavoured syrupy base |
| |
| Aceclofenac & Paracetamol Tablets | Each film coated tablet contains : |
| Aceclofenac IP 100 mg |
| Paracetamol IP 325 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Aceclofenac & Paracetamol Tablets | Each uncoated tablet contains: |
| Aceclofenac IP 100 mg |
| Paracetamol IP 325 mg |
| Approved Color to be use in Tablet |
| |
| Aceclofenac & Serratiopeptidase Tablets | Each film coated tablet contains : |
| Aceclofenac IP 100 mg |
| Serratiopeptidase IP 10 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| |
| Aceclofenac & Thiocochicoside Tablets | Each film coated tablet contains : |
| Aceclofenac IP 100 mg |
| Thiocochicoside IP 4 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yelley |
| or Titanium Dioxide ip /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Aceclofenac & Thiocochicoside Tablets | Each film coated tablet contains : |
| Aceclofenac IP 100 mg |
| Thiocochicoside IP 8 mg |
| Colour: Brilliant Blue / Crythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Aceclofenac & Tizanidine Tablets | Each sustain release tablet contains |
| Aceclofenac IP 100 mg |
| Tizanidine Hydrochloride 2 mg |
| Colour: Brilliant Blue / Erythrosine /Tartrazine |
| or Titanium Dioxide IP / Sunset Yellow |
| |
| Aceclofenac & Trypsin Chymotrypsin Tablets | Each enteric coated tablet contains : |
| Aceclofenac IP 100 mg |
| 5000 Armour units of enzymatic activity |
| (Supplied by a purified concentrate which |
| specific Trypsin & Chymotrypsin IP activity |
| in a ratio of approximate six to one) |
| Approved colour to be used |
| |
| Aceclofenac (SR) &, Pregabalin (SR) Tablets | Each uncoated biylayered tablet contains : |
| Aceclofenac (As sustained release) IP 200 mg |
| Pregabalin (As sustained release) IP 75 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Aceclofenac , Paracetamol & Chlorzoxazone Tablets | Each uncoated tablet contains : |
| Aceclofenac IP 100 mg |
| Paracetamol IP 325 mg |
| Chlorzoxazone USP 250 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine I Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Aceclofenac , Paracetamol & Serratiopeptidas Tablets | Each film coated tablet contains : |
| Aceclofenac IP 100 mg |
| Paracetamol IP 325 mg |
| Serratiopeptidase (An enteric coated) IP 10 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Aceclofenac , Paracetamol & Serratiopeptidas Tablets | Each film coated tablet contains : |
| Aceclofenac IP 100 mg |
| Paracetamol IP 325 mg |
| Serratiopeptidase (An enteric coated) IP 15 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Aceclofenac and Paraceamol Tablets | Each film coated tablet contains : |
| Aceclofenac IP 50 mg |
| Paracetamol IP 250 mg |
| Approved colour to used |
| |
| Aceclofenac and Tizanidine Tablets | Each film coated tablet contains : |
| Aceclofenac IP 100 mg |
| Tizanidine Hydrochloride IP |
| Equivalent to Tizanidine 2 mg |
| Excipients q.s. |
| Approved color to be use |
| |
| Aceclofenac Sustained Release Tablets | Each sustained release tablet contains : |
| Aceclofenac IP 200 mg |
| Permitted Color Used |
| |
| Aceclofenac Tablets | Each film coated tablet contains : |
| Aceclofenac IP 100 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline |
| Yellow/Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron Oxide red Iron oxide Yellow |
| |
| Aceclofenac Tablets IP | Each uncoated tablet contains : |
| Aceclofenac IP 100 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / |
| Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| |
| Aceclofenac, Paracetamol & Thiocolchicoside Tablets | Each film coated tablet contains |
| Aceclofenac IP 100 mg |
| Paracetamol IP 325 mg |
| Thiocolchicoside 4 mg |
| Colour:Sunset yellow or Apple Green / Titanium Dioxide IP |
| |
| Aceclofenac, Paracetamol & Tramadol Tablets | Each film coated tablet contains : |
| Aceclofenac IP 100 mg |
| Paracetamol IP 325 mg |
| Tramadol Hydrochloride IP 37.5 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Aceclofenac, Paracetamol & Trypsin Chymotrypsin Tablets | Each enteric coated tablet contains : |
| Aceclofenac IP 100 mg |
| Paracetmol IP 325 mg |
| 5000 Armour units of enzymatic activity |
| (Supplied by a purified concentrate which |
| specific Trypsin & Chymotrypsin IP activity |
| in a ratio of approximate six to one) |
| Approved colour to be used |
| |
| Aceclofenac, Paracetamol, Cetirizine HCI,Phenylephrine HCL | Each flim coated tablet contains : |
| Aceclofenac IP 100 mg |
| Paracetamol IP 325 mg |
| Cetirizine HCI IP 10 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Approved colour to be used |
| |
| Aceclofenac, Paracetamol, Tolperisone Hydrochloride | Each film coated tablet contains |
| Aceclofenac IP 100 mg |
| Paracetamol IP 325 mg |
| Tolperisone Hydrochloride JP 150 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Aceclofenac, Paracetamol, Cetirizine HCI,Phenylephrine HCL and Caffeine | Each flim coated tablet contains : |
| Aceclofenac IP 100 mg |
| Paracetamol IP 325 mg |
| Cetirizine HCI IP 10 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Caffeine (Anhydrous) IP 25 mg |
| Approved colour to be used |
| |
| Acetaminophen, Phenylephrine, Caffeine and Dexchlorpheniramine | Each uncoated tablet contains : |
| Acetaminophen IP 500 mg |
| Phenylephrine Hydrochloride IP 10 mg |
| Caffeine (Anhydrous) IP 30 mg |
| Dexchlorpheniramine maleate IP 2 mg |
| Approved colour to used |
| |
| Acetylcysteine 600 mg Effervescent Tablets | Each Effervescent tablet contains : |
| Acetylcysteine BP 600 mg |
| Excipients q.s. |
| |
| |
| Acetylcysteine and Ambroxol HCl Tablets | Each film coated tablet contains : |
| Acetylcysteine BP 200 mg |
| Ambroxol Hydrochloride IP 30 mg |
| Excipients q.s. |
| Approved colour to used |
| |
| Acetylcysteine and Ambroxol HCl Tablets | Each film coated tablet contains : |
| Acetylcysteine BP 300 mg |
| Ambroxol Hydrochloride IP 30 mg |
| Excipients q.s. |
| Approved colour to used |
| |
| Acetylsalicylic Acid Tablets IP | Each uncoated tablet contains: |
| Acetylsalicylic Acid IP 300 mg |
| |
| Activated Charcoal & Simethicone Tablets | Each film coated tablets contains : |
| Activated Charcoal IP 250 mg |
| Simethicone IP 80 mg |
| Excipients q.s. |
| Approved colour to used |
| |
| Activated Charcoal & Simethicone Tablets | Each Dual coated tablets contains : |
| Outer layer (Sugar Coated for Gastric release) |
| Simethicone IP 80 mg |
| Inner layer (Enteric Coated for Intestinal release) |
| Activated Charcoal IP 250 mg |
| Excipients q.s. |
| Approved colour to used |
| |
| |
| Activated Dimethicone & Domperidone | Each 5 ml contains: |
| Activated Dimethicone IP 40 mg |
| Domperidone Maleate IP |
| Eq. to Domperidone 5 mg |
| Dicyclomine Hydrochloride IP 10 mg |
| Approved colour used in flavoured syrupy base |
| |
| Acyclovir Tablets IP | Each uncoated tablet contains |
| Acyclovir IP 200 mg |
| |
| Acyclovir Tablets IP | Each uncoated tablet contains |
| Acyclovir IP 400 mg |
| |
| ALBENDAZOLE & IVERMECTIN SUSPENSION | Each 5 ml contains : |
| Albendazole IP 200 mg |
| Ivermectin IP 1.5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Albendazole and Ivermectin Tablets | Each uncoated tablet contains : |
| Albendazole IP 400 mg |
| lvermectin IP 6 mg |
| Approved coloured used |
| |
| Albendazole Bolus For Veterinary Use | Each uncoated bolus contains |
| Albendazole IP 3000 mg |
| |
| |
| Albendazole Chewable Tablets IP | Each uncoated chewable tablet contains : |
| Albendazole IP 400 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / |
| Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| ALBENDAZOLE SUSPENSION IP | Each ml contains : |
| Albendazole IP 25 mg |
| Approved colour used in flavoured syrupy base |
| |
| |
| ALBENDAZOLE SUSPENSION IP | Each 5 ml contains : |
| Albendazole IP 200 mg |
| Approved colour used in flavoured syrupy base |
| |
| |
| Allopurinol Tablets IP 100 mg | Each uncoated tablets contains |
| Allopurinol IP 100 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Allopurinol Tablets IP 300 mg | Each uncoated tablets contains |
| Allopurinol IP 300 mg |
| Approved colour to be used |
| |
| Allylestrenol Tablets | Each film coated tablet contains: |
| Allylestrenol IP 5mg |
| Approved colour to used |
| |
| Alpha Lipoic Acid, Mecobalamin, Pyridoxine, Foilc Acid and Vitamin B1 | Each hard gelatin capsule : |
| Alpha Lipoic Acid USP 10 mg |
| Mecobalamin IP 1500 mcg |
| Pyridoxine Hydrochloride IP 3 mg |
| Foilc Acid IP 1.5 mg |
| Vitamin B1 (Mono) IP 10 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Alpha Lipoic Acid, Mecobalamin, Pyridoxine, Foilc Acid,BENFOTIAMINE,BIOTIN,CHROMUIM PICOLINATE AND CHROMUIM | Each hard gelatin capsule : |
| Alpha Lipoic Acid USP 100 mg |
| Mecobalamine IP 1500 mcg |
| Pyridoxine Hydrochloride IP 3 mg |
| Foilc Acid IP 2 mg |
| Benfotiamine 50 mg |
| Biotin USP 5 mg |
| Chromuim Picolinate USP |
| Chromuim 200 mcg |
| Excipients q.s. |
| Permitted Color Used |
| |
| Alprazolam (PR) Tablets IP | Each uncoated prolonged-release tablet contains : |
| Alprazolam IP 0.5 mg |
| Approved colour to be used |
| |
| Alprazolam and Propranolol Hydrochloride Tablets | Each uncoated tablet contains : |
| Alprazolam IP 0.25 mg |
| Propranolo Hydrochloride IP 10 mg |
| Excipients q.s. |
| Approved colour to used |
| |
| Alprazolam and Propranolol Hydrochloride Tablets | Each uncoated tablet contains : |
| Alprazolam IP 0.25 mg |
| Propranolo Hydrochloride IP 20 mg |
| Excipients q.s. |
| Approved colour to used |
| |
| Alprazolam Sustained Released and Sertraline Tablets | Each uncoated bilayered tablet contains : |
| Alprazolam (Sustained Released) IP 0.25 mg |
| Sertraline Hydrochloride IP |
| Eq. to Sertraline 50 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Alprazolam Sustained Released Tablets | Each uncoated sustained released tablet contains : |
| Alprazolam (Sustained Released) IP 1.5 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Alprazolam Tablets IP 0.25 mg | Each uncoated tablet contains : |
| Alprazolam IP 0.25 mg |
| Approved colour to be used |
| |
| Alprazolam Tablets IP 0.5 mg | Each uncoated tablet contains : |
| Alprazolam IP 0.5 mg |
| Approved colour to be used |
| |
| Alprazolam Tablets IP 1 mg | Each uncoated tablet contains : |
| Alprazolam IP 1 mg |
| Excipients q.s. |
| Approved colour to used |
| |
| Ambroxol Hcl, Guaiphenesin, Phenylephrine Hcl and Menthol | Each 5 ml contains : |
| Ambroxol Hcl IP 15 mg |
| Guaiphenesin IP 50 mg |
| Phenylephrine Hcl IP 2.5 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Menthol IP qs |
| Approved colour used in flavoured syrupy base |
| |
| AMBROXOL HYDROCHLORIDE, GUAIPHENESIN,CHLORPHENIRAMINE MALEATE AND MENTHOL | Each 5 ml contains : |
| Ambroxol Hydrochloride IP 10 mg |
| Guaiphenesin IP 50 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Menthol q.s |
| Approved colour used in flavoured syrupy base |
| |
| Amiloride Hydrochloride and Hydrochlorothiazide Tablets IP | Each uncoated tablet contains : |
| Amiloride Hydrochloride IP |
| Eq. to Anhydrous Amiloride Hydrochloride 2.5 mg |
| Hydrochlorothiazide 25 mg |
| Approved colour to used |
| |
| Amiloride Hydrochloride and Hydrochlorothiazide Tablets IP | Each uncoated tablet contains : |
| Amiloride Hydrochloride IP |
| Eq. to Anhydrous Amiloride Hydrochloride 5 mg |
| Hydrochlorothiazide IP 50 mg |
| Approved colour to used |
| |
| Amiloride Hydrochloride Tablets IP | Each uncoated tablet contains : |
| Amiloride Hydrochloride IP |
| Eq. to Anhydrous Amiloride Hydrochloride 5 mg |
| Approved colour to used |
| |
| Aminophylline Tablets IP | Each uncoated tablet contains: |
| Aminophylline |
| Eq, to Anhydrous Aminophylline IP 100 mg |
| |
| Amiodarone Hydrochloride Tablets | Each uncoated tablet contains : |
| Amiodarone Hydrochloride IP 100 mg |
| |
| Amisulpride (Sustained Release) Tablets | Each uncoated sustained released tablet contains: |
| Amisulpride IP 200 mg |
| Approved colour to used |
| |
| Amisulpride (Sustained Release) Tablets | Each uncoated sustained released tablet contains: |
| Amisulpride IP 400 mg |
| Approved colour to used |
| |
| Amisulpride Tablets IP | Each uncoated tablet contains : |
| Amisulpride IP 50 mg |
| Approved colour to used |
| |
| Amisulpride Tablets IP | Each uncoated tablet contains : |
| Amisulpride IP 100 mg |
| Approved colour to used |
| |
| Amisulpride Tablets IP | Each uncoated tablet contains : |
| Amisulpride IP 200 mg |
| Approved colour to used |
| |
| Amisulpride Tablets IP | Each uncoated tablet contains : |
| Amisulpride IP 400 mg |
| Approved colour to used |
| |
| Amitriptyline and Methylcobalamin Tablets | Each film coated tablet contains : |
| Amitriptyline Hydrochloride IP 5 mg |
| Methylcobalamin IP 1500 mcg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Amitriptyline Hydrochloride Tablets | Each film coated tablet contains : |
| Amitriptyline Hydrochloride IP 75 mg |
| Approved colour to be used |
| |
| Amitriptyline Hydrochloride Tablets IP | Each film coated tablet contains : |
| Amitriptyline Hydrochloride IP 10 mg |
| Approved colour to be used |
| |
| Amitriptyline Hydrochloride Tablets IP | Each film coated tablet contains : |
| Amitriptyline Hydrochloride IP 25 mg |
| Approved colour to be used |
| |
| Amitriptyline Hydrochloride Tablets IP | Each film coated tablet contains : |
| Amitriptyline Hydrochloride IP 50 mg |
| Approved colour to be used |
| |
| Amlodipine and Nebivolol Tablets IP | Each uncoated tablet contains : |
| Amlodipine Besylate IP |
| Eq. to Amlodipine 5 mg |
| Nebivolol Hydrochloride IP |
| Eq. to Nebivolol 5 mg |
| Approved colour to be used |
| |
| Amlodipine Besiylate & Atenolol Tablets | Each uncoated tablet contains : |
| Amlodipine Besiylate BP |
| Eq. to Amlodipine 5 mg |
| Atenolol IP 50 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine/Quinoline Yellow / Sunsel yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| |
| Amlodipine Besiylate Tablets | Each uncoated tablet contains : |
| Amlodipine Besiylate BP |
| Eq. to Amlodipine 2.5 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Amlodipine Besiylate Tablets | Each uncoated tablet contains : |
| Amlodipine Besiylate BP |
| Eq. to Amlodipine 5 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Amlodipine Besiylate Tablets | Each uncoated tablet contains : |
| Amlodipine Besiylate BP |
| Eq. to Amlodipine 10 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Amlodipine Besylate and Hydrochlorothizide tablets | Each uncoated tablet contains |
| Amlodipine Besylate |
| Eq. to Amlodipine IP 5 mg |
| Hydrochlorothizide IP 12.5 mg |
| Excipients q.s. |
| Approved coloured used |
| |
| Amlodipine Besylate and Metoprolol Succinate | Each uncoated bilayred tablet contains : |
| Amlodipine Besylate |
| Eq. to Amlodipine IP 5 mg |
| Metoprolol Succinate IP 47.5 mg |
| Eq. to Metoprolol Tartrate 50.0 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Amlodipine Besylate and Metoprolol Succinate | Each uncoated bilayred tablet contains : |
| Amlodipine Besylate |
| Eq. to Amlodipine IP 5 mg |
| Metoprolol Succinate IP 23.75 mg |
| Eq. to Metoprolol Tartrate 25.0 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| AMMONIUM CHLORIDE, SODIUM CITRATE,CHLORPHENIRAMINE MALEATE AND MENTHOL | Each 5 ml contains : |
| Ammonium Chloride IP 125 mg |
| Sodium Citrate IP 55 mg |
| Chlorpheniramine Maleate IP 2.5 mg |
| Menthol IP 1 mg |
| Approved colour used in flavoured syrupy base |
| |
| Amodiaquine Hydrochloride Tablets IP | Each uncoated tablet contains : |
| Amodiaquine Hydrochloride IP |
| Eq. to Amodiaquine 200 mg |
| Approved colour to used |
| |
| Analgin Tablets IP | Each uncoated tablet contains : |
| Analgin IP 500 mg |
| |
| ANTIOXIDANT, MULTIVITAMINS & MULTIMINERALS CAPSULES | Each hard gelatin capsule contains |
| Pyridoxine Hydrochloride IP 3 mg |
| Niacinamide IP 50 mg |
| Cyanocobalamin IP 5 mcg |
| Folic Acid IP 1 mcg |
| Copper Sulphate USP 2.5 mg |
| Calcium Panthothenate IP 12.5 mg |
| Zinc Sulphate Monohydrate IP 15 mg |
| Chromium Chloride Hexahydrate USP 65 mcg |
| Manganese Chloride IP 1 mcg |
| Lactic Acid Bacillus 60 mill. spor |
| Selenium Dioxide Monohydrate USP 60 mcg |
| Calcium Ascorbate BP 25 mg |
| Di Basic Calcium Phosphate IP 200 mg |
| Containing: |
| Calcium 45.0 mg |
| Phosphorous 36.2 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| ANTIOXIDANT, MULTIVITAMINS & MULTIMINERALS CAPSULES | Each hard gelatin capsule contains |
| Calcium Ascorbate BP 50 mg |
| Lycopene 6% USP 5000 mcg |
| Mix Carotene 10% 10.33 mg |
| Wheat Germ Oil BP 25 mg |
| Zinc Sulphate Monohydrate IP 24.5 mg |
| Selenium Dioxide Monohydrate USP 75 mcg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| ANTIOXIDANT, MULTIVITAMINS & MULTIMINERALS CAPSULES | Each hard gelatin capsule contains |
| Calcium Ascorbate BP 50 mg |
| Lycopene 6 % USP 5000 mcg |
| Mix Carotene 10% 10.33 mg |
| Wheat Germ Oil BP 25 mg |
| Zinc Sulphate Monohydrate IP 24.5 mg |
| Selenium Dioxide Monohydrate USP 75 mcg |
| L-Cartnitine L-Tartrate USP 125 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Antioxident, Multivitamins, With Multiminerals Tablets | Each film coated tablet contains : |
| Vitamin A Acetate IP 5000 IU |
| Folic Acid IP 1 mg |
| Vitamin E Acetate IP 25 mg |
| Thiamine Monoitrate IP 10 mg |
| Riboflavine IP 10 mg |
| Pyridoxine Hydrochloride IP 3 mg |
| Nicotinamide IP 50 mg |
| Cyanocobalamin IP 5 mcg |
| Calcium Pantothenate IP 12.5 mg |
| Vitamin C IP 100 mg |
| Zinc Sulphate IP |
| Eq. to. Elemental Zinc 15 mg |
| Copper Sulphate IP |
| Eq. to. Elemental Copper 1.6 mg |
| Manganese Gluconate USP 1.4 mg |
| Selenium Selenite USP |
| Eq. to Selenium 60 mcg |
| Approved Color used in Tablet |
| |
| Apixaban Tablets 2.5 mg | Each film coated tablet contains : |
| Apixaban IP 2.5 mg |
| Approved colour to used |
| |
| Apixaban Tablets 5 mg | Each film coated tablet contains : |
| Apixaban IP 5 mg |
| Approved colour to used |
| |
| Apixaban Tablets | Each film coated tablet contains : |
| Apixaban 2.5 mg |
| Approved colour to used |
| |
| Apixaban Tablets | Each film coated tablet contains : |
| Apixaban 5 mg |
| Approved colour to used |
| |
| Each uncoated tablet contains: |
| |
| Aripiprazole Tablets IP | Each uncoated tablet contains : |
| Aripiprazole IP 5 mg |
| Approved colour to used |
| |
| Aripiprazole Tablets IP | Each uncoated tablet contains : |
| Aripiprazole IP 10 mg |
| Approved colour to used |
| |
| Aripiprazole Tablets IP | Each uncoated tablet contains : |
| Aripiprazole IP 15 mg |
| Approved colour to used |
| |
| Aripiprazole Tablets IP | Each uncoated tablet contains : |
| Aripiprazole IP 20 mg |
| Approved colour to used |
| |
| Aripiprazole Tablets IP | Each uncoated tablet contains : |
| Aripiprazole IP 30 mg |
| Approved colour to used |
| |
| Armodafinil Tablets | Each uncoated tablet contains : |
| Armodafinil IP 50 mg |
| Approved colour to be used |
| |
| Armodafinil Tablets | Each uncoated tablet contains : |
| Armodafinil IP 150 mg |
| Approved colour to be used |
| |
| Armodafinil Tablets | Each uncoated tablet contains : |
| Armodafinil IP 250 mg |
| Approved colour to be used |
| |
| Artemether & Lumefantrine Suspension | Each 5 ml Reconstituted Suspension contains : |
| Artemether IP 40 mg |
| Lumefantrine 240 mg |
| Approved colour used in flavoured syrupy base |
| |
| Artemether With Lumefantrine Tablets | Each uncoated tablet contains: |
| Artemether IP 20 mg |
| Lumefantrine 120 mg |
| Excipients q . s. |
| |
| Artemether With Lumefantrine Tablets | Each uncoated tablet contains: |
| Artemether IP 60 mg |
| Lumefantrine 360 mg |
| Excipients q.s. |
| |
| Artemether With Lumefantrine Tablets | Each uncoated tablet contains: |
| Artemether IP 40 mg |
| Lumefantrine IP 240 mg |
| Excipients q.s. |
| |
| Artemether With Lumefantrine Tablets | Each uncoated tablet contains: |
| Artemether IP 80 mg |
| Lumefantrine IP 480 mg |
| Excipients q.s. |
| |
| Artesunate Tablets | Each uncoated tablet contains |
| Artesunate IP 100 mg |
| |
| Ascorbic Acid & Cholecalciferol Tablets | Each uncoated chewable tablet contains : |
| Ascorbic acid IP 20 mg |
| Cholecalciferol (Vitamin D3) IP 200 IU |
| Approved colour to be used |
| |
| Ascorbic Acid & Cholecalciferol Tablets | Each uncoated chewable tablet contains : |
| Ascorbic acid IP 40 mg |
| Cholecalciferol (Vitamin D3) IP 400 IU |
| Approved colour to be used |
| |
| Ascorbic Acid & Cholecalciferol with Zinc Tablets | Each uncoated chewable tablet contains : |
| Ascorbic acid IP 40 mg |
| Cholecalciferol (Vitamin D3) IP 400 IU |
| Zinc Sulphate Monohydrate IP |
| eq. to elemental Zinc 10 mg |
| Approved colour to be used |
| |
| Ascorbic Acid & Cholecalciferol with Zinc Tablets | Each uncoated chewable tablet contains : |
| Ascorbic acid IP 500 mg |
| Cholecalciferol (Vitamin D3) IP 400 IU |
| Zinc Sulphate Monohydrate IP |
| eq. to elemental Zinc 5 mg |
| Approved colour to be used |
| |
| Ascorbic Acid & Cholecalciferol with Zinc Tablets | Each uncoated chewable tablet contains : |
| Ascorbic acid IP 1000 mg |
| Cholecalciferol (Vitamin D3) IP 1000 IU |
| Zinc Sulphate Monohydrate IP |
| eq. to elemental Zinc 10 mg |
| Approved colour to be used |
| |
| Ascorbic Acid & Sodium Ascorbate with Zinc Tablets | Each uncoated chewable tablet contains : |
| Ascorbic Acid IP 100 mg |
| Sodium Ascorbate IP 450 mg |
| Eq. to Ascorbic Acid 400 mg |
| Zinc Sulphate IP |
| eq. to elemental Zinc 50 mg |
| Approved colour to be used |
| |
| Ascorbic Acid & Sodium Ascorbate with Zinc Tablets | Each uncoated chewable tablet contains: |
| Ascorbic Acid IP 100 mg |
| Sodium Ascorbate IP 450 mg |
| Eq. to Ascorbic acid 400 mg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Ascorbic Acid & Sodium Ascorbate with Zinc Tablets | Each uncoated chewable tablet contains: |
| Ascorbic Acid IP 100 mg |
| Sodium Ascorbate IP 450 mg |
| Eq. to Ascorbic acid 400 mg |
| Zinc Citrate IP |
| Eq. to elemental Zinc 5 mg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Ascorbic Acid & Sodium Ascorbate with Zinc Tablets | Each uncoated chewable tablet contains: |
| Ascorbic Acid IP 100 mg |
| Sodium Ascorbate IP 450 mg |
| Eq. to Ascorbic acid 400 mg |
| Zinc Sulphate |
| Eq. to elemental Zinc 5 mg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Ascorbic Acid Tablets | Each uncoated chewable tablet contains : |
| Ascorbic acid IP 50 mg |
| Approved colour to be used |
| |
| Ascorbic Acid Tablets IP | Each uncoated tablet contains : |
| Ascorbic Acid IP 100 mg |
| Excipients q.s. |
| |
| Ascorbic Acid with Zinc Tablets | Each uncoated chewable tablet contains : |
| Ascorbic Acid IP 500 mg |
| Zinc Sulphate IP |
| Eq. to elemental Zinc 5 mg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Ascorbic acid, Menadione, Dibasic Calcium Phophate , Cholecalciferol and Rutin | Each film coated tablets contains : |
| Ascorbic acid IP 50 mg |
| Menadione Sodium Bisulphate 20 mg |
| Dibasic Calcium Phosphate IP 150 g |
| Cholecalciferol (Vitamin D3) IP 300 I.U |
| Rutin U.S.S.R.P 100 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Ascorbic Add & Sodium Ascorbate with Zinc Tablets | Each uncoated chewable tablet contains : |
| Ascorbic Acid IP 100 mg |
| Sodium Ascorbate IP 450 mg |
| Eq. to Ascorbic Acid 400 mg |
| Zinc Sulphate IP |
| eq. to elemental Zinc 20 mg |
| Approved colour to be used |
| |
| Atenolol Tablets IP 25 mg | Each uncoated tablet contains : |
| Atenolol IP 25 mg |
| |
| Atenolol Tablets IP 50 mg | Each uncoated tablet contains : |
| Atenolol IP 50 mg |
| |
| Atomoxetine Tablets 10 mg | Each film coated tablet contains: |
| Atomoxetine Hydrochloride IP |
| Equivalent to Atomoxetine 10 mg |
| Approved colour to be used |
| |
| Atorvastatin & Aspirin Capsules | Each hard gelatin capsule: |
| Atorvastatin Calcium IP |
| eq. to Atorvastatin (As pellets) 10 mg |
| Aspirin (As Enteric coated pellets) IP 150 mg. |
| Approved coloured used in empty capsule shell |
| |
| Atorvastatin & Aspirin Capsules | Each hard gelatin capsule: |
| Atorvastatin Calcium IP |
| eq. to Atorvastatin (As pellets) 20 mg |
| Aspirin (As Enteric coated pellets) IP 150 mg. |
| Approved coloured used in empty capsule shell |
| |
| Atorvastatin & Aspirin Capsules | Each hard gelatin capsule: |
| Atorvastatin Calcium IP |
| eq. to Atorvastatin 10 mg |
| Aspirin IP 75 mg |
| |
| Atorvastatin & Clopidogrel Tablets | Each filmcoated tablet contains: |
| Atorvastatin Calcium IP |
| eq. to Atorvastatin 10 mg |
| Clopidogrel Bisulphate BP |
| Eq. to Clopidogrel 75 mg |
| |
| Atorvastatin & Clopidogrel Tablets | Each filmcoated tablet contains: |
| Atorvastatin Calcium IP |
| eq. to Atorvastatin 20 mg |
| Clopidogrel Bisulphate BP |
| Eq. to Clopidogrel 75 mg |
| |
| Atorvastatin & Ezetimibe Tablets | Each film coated tablet contains : |
| Atorvastatin Calcium IP |
| eq. to Atorvastatin 10 mg |
| Ezetimibe IP 10 mg |
| Colour: Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Atorvastatin & Fenofibrate Tablets | Each filmcoated tablet contains : |
| Atorvastatin Calcium IP |
| eq. to Atorvastatin 10 mg |
| Fenofibrate IP 160 mg |
| Colour: Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Atorvastatin & Metformin Hydrochloride (ER) | Each uncoated tablet contains: |
| Atorvastatin Calcium IP |
| Eq. to Atorvastatin 10 mg |
| Metformin HCI IP 500 mg |
| As extand release |
| |
| Atorvastatin and Aspirin tablets | Each Film coated tablet contains |
| Atorvastatin Calcium |
| Eq. to Atorvastatin IP 10 mg |
| Aspirin IP 75 mg |
| Excipients q.s. |
| Approved coloured be used |
| |
| Atorvastatin Tablets IP | Each film coated tablet contains : |
| Atorvastatin Calcium IP |
| eq. to Atorvastatin 20 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green/Iron oxide red, Iron oxide Yellow |
| |
| Atorvastatin Tablets IP | Each filmcoated tablet contains : |
| Atorvastatin Calcium IP |
| eq. to Atorvastatin 10 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Atorvastatin Tablets IP | Each filmcoated tablet contains : |
| Atorvastatin Calcium IP |
| eq. to Atorvastatin 30 mg |
| Colour: Erythrosine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Atorvastatin Tablets IP | Each filmcoated tablet contains : |
| Atorvastatin Calcium IP |
| eq. to Atorvastatin 40 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Titanium Dioxide IP |
| |
| Atorvastatin Tablets IP | Each film coated tablet contains : |
| Atorvastatin Calcium IP |
| eq. to Atorvastatin 80 mg |
| Colour: Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Atorvastatin, Clopidogrel and Aspirin Capsules | Each hard gelatin capsule contains |
| Atorvastatin Calcium IP |
| Eq. to Atorvastatin (As pellets) 10 mg |
| Clopidogrel Bisulphate IP |
| Eq. Clopidogrel (As pellets) 75 mg |
| Aspirin IP 75 mg |
| (As Enteric coated pellets) |
| Approved colour use in empty capsule shell |
| |
| Atorvastatin, Clopidogrel and Aspirin Capsules | Each hard gelatin capsule contains |
| Atorvastatin Calcium IP |
| Eq. to Atorvastatin (As pellets) 20 mg |
| Clopidogrel Bisulphate IP |
| Eq. Clopidogrel (As pellets) 75 mg |
| Aspirin IP 75 mg |
| (As Enteric coated pellets) |
| Approved colour use in empty capsule shell |
| |
| Atorvastatin, Clopidogrel and Aspirin Capsules | Each hard gelatin capsule contains |
| Atorvastatin Calcium IP |
| Eq. to Atorvastatin (As pellets) 20 mg |
| Clopidogrel Bisulphate IP |
| Eq. Clopidogrel (As pellets) 75 mg |
| Aspirin IP 150 mg |
| (As Enteric coated pellets) |
| Approved colour use in empty capsule shell |
| |
| Atorvastatin, Clopidogrel and Aspirin Capsules | Each hard gelatin capsule contains |
| Atorvastatin Calcium IP |
| Eq. to Atorvastatin (As pellets) 40 mg |
| Clopidogrel Bisulphate IP |
| Eq. Clopidogrel (As pellets) 75 mg |
| Aspirin IP 75 mg |
| (As Enteric coated pellets) |
| Approved colour used in empty capsule shell |
| |
| Avanafil and Dapoxetine HCI Tablets | Each film coated tablet contains : |
| Avanafil 50 mg |
| Dapoxetine Hydrochloride IP |
| Eq. to Dapoxetine 30 mg |
| Approved colour to be used |
| |
| Avanafil and Dapoxetine HCI Tablets | Each film coated tablet contains : |
| Avanafil 100 mg |
| Dapoxetine Hydrochloride IP |
| Eq. to Dapoxetine 60 mg |
| Approved colour to be used |
| |
| Avanafil and Dapoxetine HCI Tablets | Each film coated tablet contains : |
| Avanafil 200 mg |
| Dapoxetine Hydrochloride IP |
| Eq. to Dapoxetine 60 mg |
| Approved colour to be used |
| |
| Avanafil Tablets | Each film coated tablet contains : |
| Avanafil 50 mg |
| Approved colour to used |
| |
| Avanafil Tablets | Each filmcoated tablet contains : |
| Avanafil 100 mg |
| Approved colour to used |
| |
| Avanafil Tablets | Each filmcoated tablet contains : |
| Avanafil 200 mg |
| Approved colour to used |
| |
| Azilsartan Medoxomil Tablets | Each film coated tablet contains : |
| Azilsartan Kamedoxomil |
| Eq. Azilsartan Medoxomil 10 mg |
| Approved coloured used |
| |
| Azilsartan Medoxomil Tablets | Each film coated tablet contains : |
| Azilsartan Kamedoxomil |
| Eq. Azilsartan Medoxomil 20 mg |
| Approved coloured used |
| |
| Azilsartan Medoxomil Tablets | Each uncoated tablet contains: |
| Azilsartan Kamedoxomil |
| Eq. to Azilsartan Medoxomil 40 mg |
| Approved colour to used |
| |
| Azilsartan Medoxomil Tablets | Each uncoated tablet contains: |
| Azilsartan Kamedoxomil |
| Eq. to Azilsartan Medoxomil 80 mg |
| Approved colour to used |
| |
| Azithromycin Dispersible Tablets | Each uncoated dispersible tablet contains : |
| Azithromycin Anhydrous IP 100 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| AZITHROMYCIN ORAL SUSPENSION IP | Each 5 ml contains : |
| Azithromycin IP |
| eq. to Anhydrous Azithromycin 200 mg |
| Approved colour used in flavoured syrupy base |
| |
| AZITHROMYCIN ORAL SUSPENSION IP | Each 5 ml contains : |
| Azithromycin IP |
| eq. to Anhydrous Azithromycin 100 mg |
| Approved colour used in flavoured syrupy base |
| |
| AZITHROMYCIN ORAL SUSPENSION IP For Paediatric Use | Each 5 ml contains : |
| Azithromycin IP |
| eq. to Anhydrous Azithromycin 125 mg |
| Approved colour used in flavoured syrupy base |
| |
| Azithromycin Tablets | Each filmcoated tablet contains : |
| Azithromycin (As Di hydratel) IP |
| Eq. to Anhydrous Azithromycin 100 mg |
| Approved colour to be used |
| |
| Azithromycin Tablets IP 250 mg. | Each film coated tablet contains : |
| Azithromycin Anhydrous IP 250 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Azithromycin Tablets IP 500 mg. | Each film coated tablet contains : |
| Azithromycin Anhydrous IP 500 mg |
| Excipients q.s. |
| Approved Color to be use in Tablet |
| |
| Benedipine Hydrochloride & Telmisartan Tablets | Each film coated bilayered tablets contains |
| Benedipine Hydrochloride 4 mg |
| Telmisartan IP 40 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Benidipine Hydrochloride Tablets | Each film coated tablet contains |
| Benidipine Hydrochloride JP 4 mg |
| Excipients q.s. |
| Approved color to be use |
| |
| Benidipine Hydrochloride Tablets | Each film coated tablet contains |
| Benidipine Hydrochloride JP 8 mg |
| Excipients q.s. |
| Approved color to be use |
| |
| Betahistine Hydrochloride tablet IP | Each uncoated tablet contains : |
| Betahistine Hydrochloride IP 8 mg |
| |
| Betahistine Hydrochloride Tablets | Each uncoated tablet contains : |
| Betahistine Hydrochloride IP 16 mg |
| |
| Betahistine Hydrochloride Tablets | Each uncoated tablet contains : |
| Betahistine Hydrochloride IP 24 mg |
| |
| Betahistine Hydrochloride Tablets IP | Each uncoated tablet contains |
| Betahistine Hydrochloride IP 8 mg |
| |
| BETAMETHASONE SODIUM PHOSPHATE ORAL SOLUTION IP | Each ml contains : |
| Betamethasone Sodium Phosphate IP |
| Equivalent to Betamethasone 0.5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Betamethasone Sodium Phosphate Tablets IP | Each uncoated tablet contains : |
| Betamethasone Sodium Phosphate IP |
| Equivalent to Betamethasone 0.50 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Betamethasone Tablets IP | Each uncoated tablet contains : |
| Betamethasone IP 0.50 mg |
| Excipients q.s. |
| |
| Bilastine & Montelukast Tablets | Each film coated tablet contains : |
| Blistine 20 mg |
| Montelukast Sodium IP |
| eq. to Montelukast 10 mg |
| Excipients q.s. |
| Approved colour to used |
| |
| Bilastine Oral Solution | Each ml contains : |
| Bilastine 2.5 mg |
| Approved coloured use in a flavoured syrup base |
| |
| Bilastine Tablets | Each uncoated tablet contains: |
| Bilastine 20mg |
| Approved colour to used |
| |
| Bilastine Tablets | Each uncoated tablet contains: |
| Bilastine 40 mg |
| Approved colour to used |
| |
| Bisacodyl Tablets IP | Each film coated tablet contains : |
| Bisacodyl IP 5 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| |
| Bisacodyl Tablets IP | Each enteric-coated tablet contains |
| Bisacodyl IP 5 mg |
| Colour: Brilliant Blue l Erythrosine / Tartraz ine /Quinoline Yellow/ Sunset yellow |
| or Titaniuin Dioxide IP IApple Green / Iron oxide red,Iron oxide Yeld |
| |
| Brivaracetam Tablets IP 100mg | Each film coated tablets contains : |
| Brivaracetam IP 100 mg |
| Approved colour to be used |
| |
| Brivaracetam Tablets IP 50mg | Each film coated tablets contains : |
| Brivaracetam IP 50 mg |
| Approved colour to be used |
| |
| Brivaracetam Tablets IP 75mg | Each film coated tablets contains : |
| Brivaracetam IP 75 mg |
| Approved colour to be used |
| |
| Bromazepam Tablets | Each Uncoated tablet contains : |
| Bromazepam BP 1.5 mg |
| Excipients q.s. |
| |
| Bromazepam Tablets | Each Uncoated tablet contains : |
| Bromazepam BP 3 mg |
| Excipients q.s. |
| |
| Bromazepam Tablets | Each Uncoated tablet contains : |
| Bromazepam BP 6 mg |
| Excipients q.s. |
| |
| Bromhexine Hydrochloride Tablets IP | Each uncoated tablet contains |
| Bromhexine Hydrochloride IP 4 mg |
| Colour : Erythrosine /Sunset Yellow /Quinoline Yellow |
| |
| Bromhexine Hydrochloride Tablets IP | Each uncoated tablet contains : |
| Bromhexine Hydrochloride IP 8 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine/Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Bromhexine, Guaiphenesin Chlorpheniramine Maleate,Paracetamol and Phenylephrine HCL | Each uncoated tablet contains : |
| Bromhexine Hcl IP 8 mg |
| Guaiphenesin IP 50 mg |
| Chlorpheniramine Maleate IP 4 mg |
| Paracetamol IP 325 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green/Iron oxide red,Iron oxide Yellow |
| |
| Buprenorphine Hydrochloride & Naloxone Sublingual Tablets IP | Each uncoated sublingual tablet contains |
| Buprenorphine Hydrochloride IP |
| Eq. to Buprenorphine 0.4 mg |
| Naloxone Hydrochloride IP |
| Eq. to Naloxone 0.1 mg |
| Approved colour to be use |
| |
| Buprenorphine Hydrochloride & Naloxone Sublingual Tablets IP | Each uncoated sublingual tablet contains |
| Buprenorphine Hydrochloride IP |
| Eq. to Buprenorphine 2 mg |
| Naloxone Hydrochloride IP |
| Eq. to Naloxone 0.5 mg |
| Approved colour to be use |
| |
| Buprenorphine Hydrochloride & Naloxone Tablets | Each uncoated tablet contains : |
| Buprenorphine Hydrochloride IP |
| Eq. to Buprenorphine 2 mg |
| Naloxone Hydrochloride IP |
| Eq. to Naloxone 0.4 mg |
| Approved colour to be use |
| |
| Buprenorphine Hydrochloride & Naloxone Tablets | Each uncoated tablet contains : |
| Buprenorphine Hydrochloride IP |
| Eq. to Buprenorphine 0.5 mg |
| Naloxone Hydrochloride IP |
| Eq. to Naloxone 0.1 mg |
| Approved colour to be use |
| |
| Buprenorphine Hydrochloride & Sublingual Tablets IP | Each uncoated sublingul tablet contains: |
| Buprenorphine Hydrochloride IP |
| Eq. to Buprenorphine 200 ug |
| Approved colour to be use |
| |
| Buprenorphine Hydrochloride & Sublingual Tablets IP | Each uncoated sublingul tablet contains: |
| Buprenorphine Hydrochloride IP |
| Eq. to Buprenorphine 400 ug |
| Approved colour to be use |
| |
| Cabergoline Tablets IP 0.5 mg | Each Uncoated tablet contains: |
| Cabergoline IP 0.5 mg |
| Excipients q.s. |
| |
| |
| Cabergoline Tablets IP 1 mg | Each Uncoated tablet contains: |
| Cabergoline IP 1 mg |
| Excipients q.s. |
| |
| |
| Calcium & Vitamin D 3 Tablets IP | Each uncoated tablet contains: |
| Calcium Carbonate |
| eq. to Elemental Calcium 250 mg |
| Vitamin D 3 IP 200 IU |
| Excipients q.s. |
| Permitted Color Used |
| |
| Calcium & Vitamin D 3 Tablets IP | Each uncoated tablet contains: |
| Calcium Carbonate |
| eq. to Elemental Calcium 500 mg |
| Vitamin D 3 IP 200 IU |
| Excipients q.s. |
| Permitted Color Used |
| |
| Calcium Carbonate and Vitamin D? Syrup | Each 5 ml contains : |
| Calcium Carbonate IP 625 mg |
| Eq. To Elemental Calcium 250 mg |
| Vitamin D? (As Cholecalciferol) IP 125 I.U |
| Approved colour used in flavoured syrupy base |
| |
| Calcium Carbonate and Vitamin D3 Tablets | Each film coated tablet contains: |
| Calcium Carbonate IP 1250 mg |
| Eq. to Elemental Calcium 500 mg |
| Vitamin D3 IP 500 IU |
| Excipients q.s. |
| Approved colour use |
| |
| Calcium Carbonate Tablets | Each film coated tablet contains : |
| Calcium Carbonate IP 1500 mg |
| Eq. to Calcium 600 mg |
| Approved colour to be use q.s. |
| |
| Calcium Carbonate With Vitamin D 3 Tablets | Each film coated tablet contains : |
| 1.25 gm. Of Calcium Carbonate from an Organic |
| Source (Osystershell) eq. to Elemental Calcium 500 mg |
| Vitamin D 3 IP 250 IU |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Calcium Carbonate, Calcitriol, Zinc Sulphate,Methylcobalamin and Magnesium | Each film coated tablet contains: |
| Calcium Carbonate IP 1250 mg |
| Calcitriol IP 0.25 mcg |
| Zinc sulphate IP 7.5 mg |
| Methylcobalamin IP 1500 mcg |
| Magnesium IP 50 mg |
| Excipients q.s. |
| Approved colour use |
| |
| Calcium Carbonate, Vitamin D? and Zinc Sulphate Syrup | Each 5 ml contains : |
| Calcium Carbonate IP 625 mg |
| Eq. To Elemental Calcium IP 250 mg |
| Vitamin D? (As Cholecalciferol) IP 400 I.U |
| Zinc Sulphate IP 7.5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Calcium Carbonate, Vitamin D3, Methylcobalamin, L-Methylfolate | Each film coated tablet contains: |
| Calcium Carbonate IP 1250 mg |
| Eq. to Elemental Calcium 500 mg |
| Vitamin D3 IP 2000 IU |
| Methylcobalamin IP 1500 mcg |
| L-Methylfolate Calcium 1 mg |
| Pyridoxal-5-Phosphate 20 mg |
| Excipients q.s |
| Approved colour use |
| |
| Calcium Citrate Maleate, Calcitriol , Methylcobalamin with Zinc | Each film coated tablet contains: |
| Calcium Citrate Maleate |
| Eq. to Elemental Calcium 250 mg |
| Calcitriol IP 0.5 mcg |
| Methylcobalamin IP 1500 mcg |
| Zinc Sulphate Mononitrate IP |
| Eq. to Elemental Zinc 15 mg |
| Folic Acid IP 1 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Calcium Citrate Maleate, Folic Acid and Vitamin D3 Tablets | Each film coated tablet contains : |
| Calcium Citrate Maleate |
| Eq. to Calcium 250 mg |
| Folic acid IP 50 mcg |
| Vitamin D3 IP 250 IU |
| Approved colour to be use |
| |
| Calcium Citrate Maleate, Vitamin D3 and Folic acid | Each film coated tablet contains: |
| Calcium Citrate Maleate 500 mg |
| Vitamin D3 IP 200 IU |
| Folic acid IP 5 mg |
| Approved colour to be use q.s. |
| |
| Calcium Citrate, Calcitriol with Zinc | Each hard gelatin capsule contains |
| Calcium Citrate Malate 500 mg |
| Calcitriol IP 0.25 mcg |
| Zinc Sulphate IP 7.5 mg |
| Approved colour used in empty capsule shell |
| |
| Calcium Citrate, Calcitriol with Zinc Tablets | Each film coated tablet contains |
| Calcium Citrate Malate 1000 mg |
| Calcitriol IP 0.25 mcg |
| Zinc Sulphate IP 7.5 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red, Iron Oxide Yellow |
| |
| CALCIUM GLUCONATE, VITAMIN B12 & VITAMIN D3 SYRUPS | Each 15 ml contains : |
| Calcium Gluconate IP |
| Eq. To Elemental Calcium 200 mg |
| Vitamin B12 IP 5 mcg |
| Vitamin D3 (As Cholecalciferol) IP 400 IU |
| Approved colour used in flavoured syrupy base |
| |
| Calcium Lactate Tablets IP | Each uncoated tablet contains : |
| Calcium Lactate IP 300 mg |
| |
| Calcium With Cholecalciferol, Suspension | Each 5 ml. contains |
| Calcium Carbonate IP |
| eq. to Calcium 250 mg |
| Cholecalciferol IP 125 IU |
| Colour : Erythrosine / Tartrazine / Sunset Yellow |
| Ponceau-4R or Carmosine |
| In flavoured syrupy base |
| |
| CALCIUM WITH VITAMIN B12 & VITAMIN D3 SUSPENSION | Each 5 ml contains : |
| Tribasic Calcium Phosphate |
| Eq. To Elemental Calcium 82 mg |
| Vitamin B12 IP 2.50 mcg |
| Vitamin D3(As Cholecalciferol) IP 200 I.U |
| Approved colour used in flavoured syrupy base |
| |
| Calcium With Vitamin D3 Tablets | Each uncoated chewable tablet contains : |
| Tribasic Calcium Phosphate IP 380 mg |
| Vitamin D3 IP 400 IU |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| |
| Calcium, Glucosamine, Methylcobalamin & Methyl sulphonylmethane | Each film coated tablet contains |
| Calcim Carbonate IP 250 mg |
| Glucosamine Sulphate Potassium Chloride USP 500 mg |
| Manganese (Maganese Sulphate IP) 20 mg |
| Vitamin E 4 mg |
| Methyl sulphonyl Methane USP 250 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Calcium, Vitamin D3, Mecobalamin and Pyridoxal-5-Phosphate | Each film coated tablet contains : |
| Calcium Carbonate IP 1250 mg |
| Eq. to Elemental Calcium 500 mg |
| Vitamin D3 IP 2000 IU |
| Mecobalamin IP 1500 mcg |
| L-Methylfolate Calcium 1 mg |
| Pyridoxal-5-Phosphate IP 20 mg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Calciumn and Vitamin D3 Tablets | Each film coated tablet contains : |
| Calcium Carbonate IP 1500 mg |
| Eq. to Calcium 600 mg |
| Vitammin D3 IP 200 IU |
| Approved colour to be use q.s. |
| |
| Camylofen Dihydrochloride and Paracetamol Tablets | Each film coated tablet contains : |
| Camylofen Dihydrochloride 50 mg |
| Paracetamol IP 325 mg |
| Approved colour to used |
| |
| Camylofin Dihydrchloride and Paracetamol Tablets | Each film coated tablet contains: |
| Camylofin Dihydrchloride IP 50 mg |
| Paracetamol IP 325 mg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Captopril Tablets IP | Each film coated tablet contains: |
| Captopril IP 25 mg |
| |
| Carisoprodol Capsules | Each hard gelatin capsule contains : |
| Carisoprodol IP 350 mg |
| Excipients q.s. |
| Approved colour to be use in empty capsule shall |
| |
| Carisoprodol Capsules | Each hard gelatin capsule contains : |
| Carisoprodol IP 500 mg |
| Excipients q.s. |
| Approved colour to be use in empty capsule shall |
| |
| Carisoprodol Tablets IP | Each uncoated tablet contains: |
| Carisoprodol IP 350 mg |
| Approved colour to be used |
| |
| Carisoprodol Tablets IP | Each uncoated tablet contains: |
| Carisoprodol IP 500 mg |
| Approved colour to be used |
| |
| Caroverine Hydrochloride Capsules | Each hard gelatin capsule: |
| Caroverine Hydrochloride eq. to Caroverine 20 mg |
| Approved colour used in empty capsule shell |
| |
| Carvedilol Tablets IP | Each uncoated tablet contains |
| Carvedilol IP 3.125 mg |
| |
| Carvedilol Tablets IP | Each uncoated tablet contains |
| Carvedilol IP 6.25 mg |
| |
| Carvedilol Tablets IP | Each uncoated tablet contains |
| Carvedilol IP 12.5 mg |
| |
| Cefdinir Capsules IP 300 mg 02.09.2023 | Each hard gelatin capsule contains |
| Cefdinir IP 300 mg |
| Approved colour used in empty capsule shell |
| |
| Cefdinir dispersible Tablets 125 mg | Each dispersible uncoated tablet contains |
| Cefdinir IP 125 mg |
| Excipients q.s. |
| Approved color to be use |
| |
| Cefdinir Oral Solution IP 02.09.2023 | Each 5 ml of Reconstituted Suspension contains : |
| Cefdinir IP 125 mg |
| Flavoured syrupy base |
| |
| Cefdinir Tablets 300 mg | Each film coated tablet contains : |
| Cefdinir IP 300 mg |
| Excipients q.s. |
| Approved color to be use |
| |
| Cefixime Dispersible Tablets | Each uncoated dispersible tablet contains |
| Cefixime Trihydrate IP |
| eq. to Cefixime 100 mg |
| Colour: Brilliant Blue / Erythrosine /Tartrazine / |
| Ponceau 4R or Titanium Dioxide IP/Sunset Yellow |
| |
| Cefixime Dispersible Tablets | Each uncoated dispersible tablet contains |
| Cefixime Trihydrate IP |
| eq. to Cefixime 200 mg |
| Colour: Brilliant Blue / Erythrosine /Tartrazine / |
| Ponceau 4R or Titanium Dioxide IP/Sunset Yellow |
| |
| Celecoxib and Diacerein Capsules | Each hard gelatin capsule contains |
| Celecoxib IP 100 mg |
| Diacerein IP 50 mg |
| Approved colour use in empty capsule shell |
| |
| Celecoxib and Diacerein Capsules | Each hard gelatin capsule contains |
| Celecoxib IP 200 mg |
| Diacerein IP 50 mg |
| Approved colour use in empty capsule shell |
| |
| Celecoxib Capsules 100 mg | Each hard gelatin capsule contains |
| Celecoxib IP 100 mg |
| Approved colour use in empty capsule shell |
| |
| Celecoxib Capsules 200 mg | Each hard gelatin capsule contains |
| Celecoxib IP 200 mg |
| Approved colour use in empty capsule shell |
| |
| Cetirizine HCI, Paracetamol With Nimesulide Tablets | Each uncoated tablet contains: |
| Cetirizine Hydrochloride IP 5 mg |
| Paracetamol IP 325 mg |
| Nimesulide IP 100 mg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Cetirizine Hydrochloride & Phenylephrine Hydrochloride | Each film coated tablet contains : |
| Cetirizine Hydrochloride IP 5 mg |
| Phenylephrine Hydrochloride IP 10 mg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Cetirizine Hydrochloride & Phenylephrine Hydrochloride | Each film coated tablet contains : |
| Cetirizine Hydrochloride IP 10 mg |
| Phenylephrine Hydrochloride IP 10 mg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Cetirizine Hydrochloride Phenylephrine Hydrochloride With Paracetmol | Each uncoated tablet contains : |
| Cetirizine Hydrochloride IP 5 mg |
| Phenylephrine Hydrochloride IP 10 mg |
| Paracetmol IP 325 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| |
| CETIRIZINE HYDROCHLORIDE SYRUP IP | Each 5 ml contains : |
| Cetirizine Hydrochloride IP 5 mg |
| Approved colour used in flavoured syrupy base |
| |
| |
| Cetirizine Hydrochloride Tablets IP | Each uncoated tablet contains : |
| Cetirizine Hydrochloride IP 10 mg |
| Permitted Color Used |
| |
| Cetirizine Hydrochloride Tablets IP | Each film coated tablet contains : |
| Cetirizine Hydrochloride IP 10 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Cetirizine Hydrochloride With Ambroxol Hydrochloride Tablets | Each film coated tablet contains : |
| Cetirizine Hydrochloride IP 5 mg |
| Ambroxol HCL IP 60 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| CETIRIZINE HYDROCHLORIDE, PHENYLEPHERINE HYDROCHLORIDE AND PARACETAMOL | Each 5 ml contains : |
| Cetirizine Hydrochloride IP 2.5 mg |
| Paracetamol IP 125 mg |
| Phenylephrine Hydrochloride IP 2.5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Cetirizine Hydrochloride, Phenylephrine Hydrochloride AND PARACETAMOL | Each uncoated tablet contains : |
| Cetirizine Hydrochloride IP 5 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Paracetmol IP 325 mg |
| Colour: Brilliant Blue/Erythrosine/Tartrazine/Quinoline Yellow/Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Cetirizine Hydrochloride, Phenylephrine Hydrochloride AND PARACETAMOL | Each uncoated tablet contains : |
| Cetirizine Hydrochloride IP 10 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Paracetmol IP 325 mg |
| Caffeine (Anhydrous) IP 20 mg |
| Colour: Brilliant Blue/Erythrosine/Tartrazine/Quinoline Yellow/Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| CETIRIZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE,PARACETAMOL | Each 5 ml contains : |
| Cetirizine Hydrochloride IP 2.5 mg |
| Paracetamol IP 125 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Cetrizine Hydrochloride Tablets IP | Each uncoated tablet contains |
| Cetirizine Hydrochloride IP 5 mg |
| Excipients q.s. |
| |
| CHLORAMPHENICOL CAPSULES IP | Each hard gelatin capsule contains |
| Chloramphenicol IP 250 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| CHLORAMPHENICOL CAPSULES IP | Each hard gelatin capsule contains |
| Chloramphenicol IP 500 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Chloramphenicol Tablets | Each sugar coated tablet contains : |
| Chloramphenicol IP 250 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green/Iron oxide red, Iror oxide Yellow |
| |
| Chlordiazepoxide & Trifluoperazine Tablets | Each film coated tablet contains : |
| Chlordiazepoxide IP 10 mg |
| Trifluoperazine Hydrochloride IP |
| eq. to Trifluoperazine 1 mg |
| Approved colour to be used |
| |
| Chlordiazepoxide Tablets IP | Each film coated tablet contains : |
| Chlordiazepoxide IP 5 mg |
| Approved colour to be used |
| |
| CHLORMPHENICOL PALMETATE ORAL SUSPENSION IP | Each 5 ml contains : |
| Chloramphenicol Palmetate IP |
| Eq. To Chloramphenicol 125 mg |
| Approved colour used in flavoured syrupy base |
| |
| Chloroquine Phosphate Tablets IP | Each film coated tablet contains : |
| Chloroquine Phosphate IP 250 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / |
| Sunset yellow or Titanium Dioxide IP /Apple Green / |
| Iron oxide red iron oxide Yellow |
| |
| CHLOROQUINE SYRUP IP | Each 5 ml contains : |
| Chloroquine Phosphate IP |
| Equivalent to Chloroquine 50 mg |
| Approved colour used in flavoured syrupy base |
| |
| Chloroquine Tablets IP | Each film coated tablet contains : |
| Chloroquine Sulphate IP 100 mg |
| Approved colour to be use |
| |
| Chloroquine Tablets IP | Each film coated tablet contains : |
| Chloroquine Sulphate IP 500 mg |
| Approved colour to be use |
| |
| Chlorpheniramine Maleate and Codeine Phosphate Syrup | Each 5 ml contains : |
| Codeine Phosphate IP 10 mg |
| Chlorpheniramine Maleate IP 4 mg |
| Approved colour used in flavoured syrupy base |
| |
| CHLORPHENIRAMINE MALEATE CAPSULES IP | Each hard gelatin capsule contains |
| Chlorpheniramine Maleate IP 8 mg |
| Approved colour used in empty capsule shell |
| |
| Chlorpheniramine Maleate Tablets IP | Each uncoated tablet contains : |
| Chlorpheniramine Maleate IP 4 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron Oxide red, Iron Oxide Yellow |
| |
| CHLORPHENRAMINE MALEATE, AMMONIUM CHLORIDE,SODIUM CITRATE AND MENTHOL | Each 5 ml contains : |
| Chlorpheniramine Maleate IP 2 mg |
| Ammonium chloride IP 100 mg |
| Sodium Citrate IP 50 mg |
| Menthol IP qs |
| Approved colour used in flavoured syrupy base |
| |
| Chlorpromazine Hydrochloride Tablets IP | Each film coated tablet contains : |
| Chlorpromazine Hydrochloride IP 10 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Chlorthalidone Tablets | Each uncoated tablet contains |
| Chlorthalidone IP 6.25 mg |
| |
| Chlorthalidone Tablets | Each uncoated tablet contains |
| Chlorthalidone IP 12.50 mg |
| |
| Chlorthalidone Tablets IP | Each uncoated tablet contains : |
| Chlorthalidone IP 50 mg |
| Permitted Color Used |
| |
| CHOLECALCIFEROL (Vitamin D3 ) CAPSULES | Each hard gelatin capsule contains |
| Vitamin D3 (As Cholecalciferol) IP 60000 IU |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| CHOLECALCIFEROL (Vitamin D3) CAPSULES | Each hard gelatin capsule contains |
| Vitamin D3 (As Cholecalciferol) IP 10000 IU |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Cholecalciferol Chewable Tablets | Each uncoated chewable tablet contains : |
| Cholecalciferol (Vitamin D3) IP 600 IU |
| Approved colour to be used |
| |
| Cholecalciferol Chewable Tablets | Each uncoated chewable tablet contains : |
| Cholecalciferol (Vitamin D3) IP 400 IU |
| Approved colour to be used |
| |
| Cholecalciferol Chewable Tablets | Each uncoated chewable tablet contains : |
| Cholecalciferol (Vitamin D3) IP 60000 IU |
| Approved colour to be used |
| |
| CHOLECALCIFEROL ORAL SUSPENSION (DROPS) | Each ml contains : |
| Cholecalciferol (Vitamin D3 ) IP 400 IU |
| (As stabilized) |
| Approved colour used in flavoured syrupy base |
| |
| Cholecalciferol Syrup For Therapeutic Use | Each 5 ml Contains : |
| Cholecalciferol (Vitamin D3) IP 1000 IU |
| Approved colour used in flavoured syrupy base |
| |
| Cilnidipine & Telmisartan Tablets | Each film coated tablet contains : |
| Cilnidipine IP 10 mg |
| Telmisartan IP 40 mg |
| Colour: Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Cilnidipine and Telmisartan Metoprolol Succinate SR Tablets | Each uncoated bilayered tablet contains |
| Cilnidipine IP 10 mg |
| Telmisartan IP 40 mg |
| MetoprololSuccinate IP 23.75 mg |
| Eq.to Metoprolol Tartrate 25 mg |
| (As sustained release) |
| Excipients q.s. |
| Approved color to be use |
| |
| Cilnidipine and Telmisartan Metoprolol Succinate SR Tablets | Each uncoated bilayered tablet contains |
| Cilnidipine IP 10 mg |
| Telmisartan IP 40 mg |
| Metoproioi Succinate IP 47.5 mg |
| Eq.to Metoprolol Tartrate 50 mg |
| (As sustained release) |
| Excipients q.s. |
| Approved color to be use |
| |
| Cilnidipine Tablets IP 10 mg | Each film coated tablets contains: |
| Cilnidipine IP 10 mg |
| Approved colour use |
| |
| Cilnidipine Tablets IP 20 mg | Each film coated tablets contains : |
| Cilnidipine IP 20 mg |
| Approved colour to be used |
| |
| Cilnidipine Tablets IP 5 mg | Each film coated tablets contains: |
| Cilnidipine IP 5 mg |
| Approved colour use |
| |
| Cinitapride Tablets | Each uncoated tablet contains : |
| Cinitapride Hydrogen Tartrate |
| Eq. to Cinitapride 1 mg |
| Approved colour to be used |
| |
| Cinitapride Tablets | Each uncoated tablet contains : |
| Cinitapride Hydrogen Tartrate |
| Eq. to Cinitapride 3 mg |
| Approved colour to be used |
| |
| Cinnarizine & Dimenhydrinate Tablets | Each uncoated tablet contains : |
| Cinnarizine IP 20 mg |
| Dimenhydrinate BP 40 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Cinnarizine and Dimenhydrinate Mouth dissolving Tablets | Each orally disintegrating tablets contains |
| Cinnarizine IP 20 mg |
| Dimenhydrinate IP 40 mg |
| Excipients q.s. |
| Approved color to be use |
| |
| Cinnarizine and Domperidone Tablets | Each uncoated tablets contains |
| Cinnarizine IP 20 mg |
| Domperidone IP 15 mg |
| Excipients q.s. |
| Approved color to be use |
| |
| Cinnarizine Tablets | Each uncoated tablets contains |
| Cinnarizine IP 15 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Cinnarizine Tablets IP | Each film coated tablet contains |
| Cinnarizine Hydrochloride IP 25 mg |
| Colour: Brilliant Blue / Erythrosine /Tartrazine |
| |
| CIPROFLOXACIN & TINIDAZOLE SUSPENSION | Each 5 ml contains : |
| Ciprofloxacin Hydrochloride IP |
| Eq. to Ciprofloxacin 125 mg |
| Tinidazole IP 100 mg |
| Approved colour used in flavoured syrupy base |
| |
| Ciprofloxacin Hydrochloride & Tinidazole Tablets | Each film coated tablet contains : |
| Ciprofloxacin Hydrochloride IP |
| Eq. to Ciprofloxacin 500 mg |
| Tinidazole IP 600 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron Oxide red Iron oxide Yellow |
| |
| Ciprofloxacin Hydrochloride Tablets IP 250 mg | Each film coated tablet contains : |
| Ciprofloxacin Hydrochloride IP |
| Eq. to Ciprofloxacin 250 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| |
| Ciprofloxacin Hydrochloride Tablets IP 500 mg | Each film coated tablet contains : |
| Ciprofloxacin Hydrochloride IP |
| Eq. to Ciprofloxacin 500 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron Oxide Yellow |
| |
| Ciprofloxacin Hydrocloride Bolus For Veterinary Use | Each uncoated bolus contains |
| Ciprofloxacin HCL IP |
| Equivalent to Ciprofloxacin 1500 mg |
| |
| Citalopram Tablets IP | Each uncoated tablet contains: |
| Citalopram Hydrobromide IP |
| Eq. to Citalopram 10 mg |
| Approved colour to be used |
| |
| Citalopram Tablets IP | Each uncoated tablet contains: |
| Citalopram Hydrobromide IP |
| Eq. to Citalopram 20 mg |
| Approved colour to be used |
| |
| Citalopram Tablets IP | Each uncoated tablet contains: |
| Citalopram Hydrobromide IP |
| Eq. to Citalopram 40 mg |
| Approved colour to be used |
| |
| Citicoline & Piracetam Tablets | Each uncoated tablet contains |
| Citicoline IP 500 mg |
| Piracetam IP 800 mg |
| |
| Citicoline Sodium and Piracetam Syrup | Each 5 ml contains : |
| Citicoline Sodium IP |
| Eq. to Citicoline 500 mg |
| Piracetam IP 400 mg |
| Approved colour used in flavoured syrupy base |
| |
| Citicoline Sodium and Piracetam Tablets | Each film coated tablet contains : |
| Citicoline Sodium IP |
| Eq. to Citicoline 500 mg |
| Piracetam IP 800 mg |
| Excipients q.s. |
| Approved colour to used |
| |
| Citicoline Sodium and Piracetam Tablets | Each film coated tablet contains : |
| Citicoline Sodium IP |
| Eq. to Citicoline 500 mg |
| Piracetam IP 400 mg |
| Excipients q.s. |
| Approved colour to used |
| |
| Citicoline Sodium Tablets IP | Each film coated tablet contains : |
| Citicoline Sodium IP |
| Eq. to Citicoline 500 mg |
| Excipients q.s. |
| Approved colour to used |
| |
| Citicoline Tablets IP | Each uncoated tablet contains |
| Citicoline Sodium IP 500 mg |
| |
| Clarithromycin Oral Suspension | Each 5 ml Contains: |
| Clarithromycin IP 125 mg |
| Approved colour used in flavoured syrupy base |
| |
| Clarithromycin Oral Suspension | Each 5 ml Contains: |
| Clarithromycin IP 250 mg |
| Approved colour used in flavoured syrupy base |
| |
| Clarithromycin Tablets IP | Each film coated tablet contains : |
| Clarithromycin IP 250 mg |
| Approved colour to used |
| |
| Clarithromycin Tablets IP | Each film coated tablet contains : |
| Clarithromycin IP 500 mg |
| Approved colour to used |
| |
| Clenbuterol Hydrochioride Tablets | Each uncoated tabiets contains |
| Clenbuterol Hydrochloride BP 0.02 mg |
| Approved colour to be used |
| |
| Clidinium Bromide and Chlordiazepoxide Tablets | Each film coated tablet contains: |
| Clidinium Bromide USP 2.5 mg |
| Chlordiazepoxide IP 5 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Clindamycin Hydrochloride | Each hard gelatin capsule contains |
| Clindamycin Hydrochloride BP |
| Eq. to Clindamycin 150 mg |
| Approved colour used in empty capsule shell |
| |
| Clindamycin Hydrochloride | Each hard gelatin capsule contains |
| Clindamycin Hydrochloride BP |
| Eq. to Clindamycin 300 mg |
| Approved colour used in empty capsule shell |
| |
| Clindamycin Hydrochloride Tablets IP | Each film coated tablet contains : |
| Clindamycin Hydrochloride IP |
| Eq. to Clindamycin 150 mg |
| Colour: Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Clindamycin Hydrochloride Tablets IP | Each film coated tablet contains : |
| Clindamycin Hydrochloride IP |
| Eq. to Clindamycin 300 mg |
| Colour: Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Clobazam Tablets IP | Each uncoated tablet contains : |
| Clonazepam IP 5 mg |
| Excipients q.s. |
| |
| Clobazam Tablets IP | Each uncoated tablet contains : |
| Clonazepam IP 10 mg |
| Excipients q.s. |
| |
| Clobazam Tablets IP | Each uncoated tablet contains : |
| Clonazepam IP 20 mg |
| Excipients q.s. |
| |
| Clomipramine Hydrochloride (sustained relesed) Tablets | Each uncoated tablet contains |
| Clomipramine Hydrochloride IP 75 mg |
| (As sustained release) |
| Excipients q.s. |
| Approved coloured to be used |
| |
| Clomipramine Hydrochloride Tablets IP | Each uncoated tablet contains |
| Clomipramine Hydrochloric IP 50 mg |
| |
| Clonazepam and Escitalopram Oxelate Tablets IP | Each uncoated tablet contains: |
| Clonazepam IP 0.25 mg |
| Escitalopram Oxelate IP |
| Eq. to Escitalopram 10 mg |
| Excipients q.s. |
| |
| Clonazepam and Escitalopram Tablet IP | Each uncoated tablet contains : |
| Clonazepam IP 0.50 mg |
| Escitalopram Oxelate IP |
| Eq. to Escitalopram 10 mg |
| Excipients q.s. |
| |
| Clonazepam and Escitalopram Tablets | Each film coated tablet contains : |
| Clonazepam IP 0.5 mg |
| Escitalopram Oxelate IP |
| Eq. to Escitalopram 10 mg |
| Excipients q.s. |
| |
| Clonazepam and Escitalopram Tablets | Each film coated tablet contains : |
| Clonazepam IP 0.5 mg |
| Escitalopram Oxelate IP |
| Eq. to Escitalopram 5 mg |
| Excipients q.s. |
| |
| Clonazepam and Paroxetine Tablets | Each uncoated bilayer tablet contains: |
| Clonazepam IP 0.25mg |
| Paroxetine Hydrochloride IP |
| Eq. to Paroxetine 12.5 mg |
| Excipients q.s |
| |
| Clonazepam and Propranolol HCI Tablets | Each uncoated tablet contains : |
| Clonazepam IP 0.25 mg |
| Propranolol Hydrochloride IP 10 mg |
| Approved coloured used q.s. |
| |
| Clonazepam and Propranolol HCI Tablets | Each uncoated tablet contains : |
| Clonazepam IP 0.5 mg |
| Propranolol Hydrochloride IP 20 mg |
| Approved coloured used q.s. |
| |
| Clonazepam Mouth Dissoving Tablets | Each orally disintegrating tablets contains |
| Clonazepam IP 0.5 mg |
| Approved color to be use |
| |
| Clonazepam Mouth Dissoving Tablets | Each orally disintegrating tablets contains |
| Clonazepam IP 0.25 mg |
| Approved color to be use |
| |
| Clonazepam Tablets IP | Each Uncoated tablet contains : |
| Clonazepam IP 0.5 mg |
| Excipients q.s. |
| |
| Clonazepam Tablets IP | Each Uncoated tablet contains : |
| Clonazepam IP 1 mg |
| Excipients q.s. |
| |
| Clonazepam Tablets IP | Each Uncoated tablet contains : |
| Clonazepam IP 2 mg |
| Excipients q.s. |
| |
| Clonazepam Tablets IP | Each uncoated tablet contains : |
| Clonazepam IP 0.25 mg |
| Excipients q.s. |
| |
| Clopidogrel Bisulphate Tablets IP | Each film coated tablet contains : |
| Clopidogrel Bisulphate BP |
| Eq. to Clopidogrel 75 mg |
| Colour: Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Clozapine Tablets IP | Each uncoated tablet contains : |
| Clozapine IP 25 mg |
| Excipients q.s. |
| |
| Clozapine Tablets IP | Each uncoated tablet contains : |
| Clozapine IP 50 mg |
| Excipients q.s. |
| |
| Clozapine Tablets IP | Each uncoated tablet contains : |
| Clozapine IP 100 mg |
| Excipients q.s. |
| |
| Codeine Phosphate Tablets IP | Each uncoated tablet contains : |
| Codeine Phosphate IP 10 mg |
| Approved colour to used |
| |
| Codeine Phosphate Tablets IP | Each uncoated tablet contains : |
| Codeine Phosphate IP 30 mg |
| Approved colour to used |
| |
| Codeine Phosphate Tablets IP | Each uncoated tablet contains : |
| Codeine Phosphate IP 60 mg |
| Approved colour to used |
| |
| Colostrum Capsules | Each hard gelatin capsule : |
| Colostrum 500 mg |
| Approved colour used in empty capsule shell |
| |
| CO-TRIMOXAZOLE SUSPENSION IP | Each 5 ml contains : |
| Trimethoprim IP 40 mg |
| Sulphamethoxazole IP 200 mg |
| Approved colour used in flavoured syrupy base |
| |
| Co-Trimoxazole Tablets IP | Each uncoated tablet contains : |
| Trimethoprim IP 80 mg |
| Sulphamethoxazole IP 400 mg |
| |
| Co-Trimoxazole Tablets IP | Each uncoated tablet contains : |
| Trimethoprim IP 160 mg |
| Sulphamethoxazole IP 800 mg |
| |
| Co-Trimoxazole Tablets IP | Each uncoated tablet contains : |
| Trimethoprim IP 40 mg |
| Sulphamethoxazole IP 200 mg |
| |
| Cyanocobalamin Tablets IP | Each uncoated tablet contains : |
| Cyanocobalamin IP 10 mcg |
| Excipients q.s. |
| Colour – Tartrazine & Sunset Yellow FCF. |
| |
| Cyclobenzaprine Hydrochloride & Aceclofenac Tablets | Each film coated sustained release bilayered tablet contains |
| Cyclobenzaprine Hydrochloride IP 15 mg |
| Aceclofenac IP 200 mg |
| Excipients q.s. |
| |
| Cyclobenzaprine Hydrochloride Tablets IP | Each uncoated tablet contains: |
| Cyclobenzaprine Hydrochloride IP 10 mg |
| Excipients q.s. |
| |
| Cyclobenzaprine Hydrochloride Tablets IP | Each uncoated tablet contains: |
| Cyclobenzaprine Hydrochloride IP 5 mg |
| Excipients q.s. |
| |
| Cynocobalamin Tablets IP | Each uncoated tablets contains |
| Cynocobalamin IP 1500 mcg |
| Excipients q.s. |
| Approved colour to be used |
| |
| CYPROHEPTADINE HYDROCHLORIDE & TRICHOLINE CITRATE DROPS | Each ml contains : |
| Cyproheptadine Hydrochloride IP 1.50 mg |
| Tricholine Citrate 55 mg |
| Approved colour used in flavoured syrupy base |
| |
| Cyproheptadine Hydrochloride Capsules | Each hard gelatin capsule contains |
| Cyproheptadine Hydrochloride IP 4 mg |
| Excipients q.s. |
| Approved colour use in empty capsule shell |
| |
| Cyproheptadine Hydrochloride Capsules | Each hard gelatin capsule contains |
| Cyproheptadine Hydrochloride IP 4 mg |
| Colour: Brilliant Blue / Tartrazine / Ponceau 4R |
| Approved colour used in empty capsule shell |
| |
| CYPROHEPTADINE HYDROCHLORIDE SYRUP IP | Each 5 ml contains : |
| Cyproheptadine Hydrochloride IP 2 mg |
| Approved colour used in flavoured syrupy base |
| |
| Cyproheptadine Hydrochloride Tablets IP | Each uncoated tablet contains : |
| Cyproheptadine Hydrochloride IP 4 mg |
| |
| |
| CYPROHEPTADINE HYDROCHLORIDE, TRICHOLINE CITRATE SYRUP | Each 5 ml contains : |
| Cyproheptadine HCl IP 2 mg |
| Tricholine Citrate 275 mg |
| Approved colour used in flavoured syrupy base |
| |
| CYPROHEPTADINE HYDROCHLORIDE, TRICHOLINE CITRATE WITH | Each 5 ml contains : |
| Cyproheptadine Hydrochloride IP 2 mg |
| Tricholine citrate 275 mg |
| Sorbitol Soluion (Non crystallizing 70%) 3.575 gm |
| Approved colour used in flavoured syrupy base |
| |
| CYPROHEPTADINE HYDROCHLORIDE, TRICHOLINE CITRATE WITH | Each 5 ml contains : |
| Cyproheptadine Hydrochloride IP 2 mg |
| Tricholine citrate IP 275 mg |
| Sorbitol Soluion (Non crysatallizing 70%) IP 2 gm |
| Approved colour used in flavoured syrupy base |
| |
| Cyproterone Acetate and Ethinylestradiol Tablets | Each uncoated tablets contains |
| Cyproterone Acetate IP 2 mg |
| Ethinylestradiol IP 0.035 mg |
| Approved colour to be used |
| |
| Cyproterone Acetate Tablets IP | Each uncoated tablets contains |
| Cyproterone Acetate IP 50 mg |
| Approved colour to be used |
| |
| Dabigatran Etexilate Capsules 110 mg | Each hard gelatin capsule contains |
| Dabigatran Etexilate Mesilate |
| Eq.to Dabigatran Etexilate 110 mg |
| Approved colour use in empty capsule shell |
| |
| Dabigatran Etexilate Capsules 150 mg | Each hard gelatin capsule contains |
| Dabigatran Etexilate Mesilate |
| Eq.to Dabigatran Etexilate 150 mg |
| Approved colour use in empty capsule shell |
| |
| Dabigatran Etexilate Mesyalte Capsules | Each hard gelatin capsule contains |
| Dabigatran Etexilate Mesyalte IP 110 mg |
| Eq. to Dabigatran Etexilate |
| Approved colour used in empty capsule shell |
| |
| Dapagliflozin Tablets 10 mg | Each film coated tablet contains : |
| Dipagliflozin IP 10 mg |
| Approved colour to used |
| |
| Dapagliflozin tablets | Each film coated tablet contains: |
| Dapagliflozin Propanediol monohydrate |
| Eq. to Dapagliflozin 5 mg |
| Excipients q.s. |
| Approved colour to used |
| |
| Dapagliflozin tablets | Each film coated tablet contains: |
| Dapagliflozin Propanediol monohydrate |
| Eq. to Dapagliflozin 10 mg |
| Excipients q.s. |
| Approved colour to used |
| |
| Dapoxetine Tablets | Each film coated tablet contains : |
| Dapoxetine Hydrochloride IP |
| eq. to Dapoxetine 60 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Dapoxetine Tablets | Each film coated tablet contains : |
| Dapoxetine Hydrochloride IP |
| eq. to Dapoxetine 30 mg |
| Colour: Brilliant Blue/Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| DEFLAZACORT ORAL SUSPENSION For Paediatric Use | Each 5 ml contains : |
| Deflazcort IP 6 mg |
| Approved colour used in flavoured syrupy base |
| |
| Deflazacort Tablets | Each uncoated tablet contains : |
| Deflazacort IP 6 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Deflazacort Tablets | Each uncoated tablet contains : |
| Deflazacort 12 mg |
| Excipients q.s. |
| |
| Deflazacort Tablets | Each uncoated tablet contains : |
| Deflazacort 18 mg |
| Excipients q.s. |
| |
| Deflazacort Tablets | Each uncoated tablet contains : |
| Deflazacort 24 mg |
| Excipients q.s. |
| |
| Deltiazem Hydrochloride Tablets | Each uncoated tablet contains |
| Deltiazem Hydrochloride IP 30.00 mg |
| |
| Desloratadine Tablets 5 mg | Each film coated tablets contains : |
| Desloratadine BP 5 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Desvenlafaxine Extended Release Tablets | Each uncoated Extended Release tablet contains: |
| Desvenlafaxine Succinate IP |
| Eq. to Desvenlafaxine 50 mg |
| Approved colour to used |
| |
| Desvenlafaxine Extended Release Tablets | Each uncoated Extended Release tablet contains: |
| Desvenlafaxine Succinate IP |
| Eq. to Desvenlafaxine 100 mg |
| Approved colour to used |
| |
| Desvenlafexine Extened Release and clonazepam Tablets | Each Uncoated bilayered tablet contains: |
| Desvenlafexine Succinate USP |
| Eq. to Desvenlafexine 50 mg |
| (As extened release form) |
| Clonazepam IP 0.5 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Dexamethasone tablets | Each uncoated tablet contains : |
| Dexamethasone IP 4 mg |
| |
| Dexamethasone tablets | Each uncoated tablet contains : |
| Dexamethasone IP 8 mg |
| |
| Dexamethasone Tablets | Each uncoated tablet contains: |
| Dexomethasone IP 2 mg |
| |
| Dexamethasone Tablets IP | Each uncoated tablet contains : |
| Dexamethasone IP 0.50 mg |
| Excipients q.s. |
| |
| Dexchlorpheniramine Maleate, Paracetamol, Caffeine & | Each uncoated tablet contains : |
| Paracetamol IP 325 mg |
| Dexchlorpheniramine Maleate IP 2 mg |
| Caffeine (Anhydrous) IP 25 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Dexchlorphenramine Maleate Tablets IP | Each uncoated tablet contains |
| Dexchlorphenramine Maleate IP 2 mg |
| Colour : Tartrazine / Sunset Yellow / Ponceau 4R |
| |
| Dexrabeprazole Sodium and Domperidone Capsules | Each hard gelatin capsule contains |
| Dexrabeprazole Sodium 10 mg |
| (As entric coated pellets) |
| Domperidone IP 30 mg |
| (As sustained release pellets) |
| Approved colour use in empty capsule shell |
| |
| Dexrabeprazole Sodium And Domperidone Capsules | Each hard gelatin capsule contains |
| Dexrabeprazole Sodium 60 mg |
| (As modified release pellets) |
| Domperidone IP 30 mg |
| (As sustained release pellets) |
| Approved colour use in empty capsule shell |
| |
| Dextromethorphan , Guaiphenesin & Chlorpheniramine Maleate With | Each uncoated tablet contains : |
| Dextromethorphan Hbr IP 10 mg |
| Guaiphenesin IP 100 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Bromhexine Hydrochloride IP 8 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / |
| Sunset yellow or |
| Titanium Dioxide IP /Apple Green/Iron oxide red, Iron oxide Yellow |
| |
| DEXTROMETHORPHAN HBr , AMMONIUM CHLORIDE,CHLORPHENIRAMINE MALEATE AND GUAIPHENESIN | Each 5 ml contains : |
| Dextromethorphan Hydrobromide IP 10 mg |
| Ammonium chloride IP 60 mg |
| Chlorpheniramine Maleate IP 2.5 mg |
| Guaiphenesin IP 50 mg |
| Approved colour used in flavoured syrupy base |
| |
| DEXTROMETHORPHAN HBr , PHENYLEPHRINE HYDROCHLORIDE,CHLORPHENIRAMINE MALEATE | Each 5 ml contains : |
| Dextromethorphan Hydrobomide IP 10 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Approved colour used in flavoured syrupy base |
| |
| DEXTROMETHORPHAN HBr , PHENYLEPHRINE HYDROCHLORIDE,PARACETAMOL AND CHLORPHENIRAMINE MALEATE | Each 5 ml contains : |
| Dextromethorphan Hydrobromide IP 5 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Paracetamol IP 125 mg |
| Chlorpheniramine Maleate IP 1 mg |
| Approved colour used in flavoured syrupy base |
| |
| Dextromethorphan HBr and Chlorpheniramine Syrup | Each 5 ml contains : |
| Dextromethorphan HBr IP 10 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Approved coloured use in a flavoured syrup base |
| |
| Dextromethorphan HBr and Chlorpheniramine Syrup | Each 5 ml contains : |
| Dextromethorphan HBr IP 10 mg |
| Chlorpheniramine Maleate IP 4 mg |
| Approved colour used in flavoured syrupy base |
| |
| DEXTROMETHORPHAN HBr BROMHEXINE HYDROCHLORIDE,Ammonium Chloride and Menthol | Each 10 ml contains : |
| Dextromethorphan Hydrobomide IP 10 mg |
| Bromhexine Hydrochloride IP 8 mg |
| Ammonium chloride IP 100 mg |
| Menthol qs |
| Approved colour used in flavoured syrupy base |
| |
| DEXTROMETHORPHAN HBr BROMHEXINE HYDROCHLORIDE,Ammonium Chloride and Menthol | Each 5 ml contains : |
| Dextromethorphan Hydrobomide IP 5 mg |
| Bromhexine Hydrochloride IP 4 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Guaiphenesin IP 50 mg |
| Menthol IP qs |
| Approved colour used in flavoured syrupy base |
| |
| Dextromethorphan HBr, Cetirizine Ambroxol HCl Syrup | Each 5 ml contains : |
| Dextromethorphan HBr IP 10 mg |
| Cetirizine HCl IP 5 mg |
| Ambroxol Hydrochloride IP 15 mg |
| Menthol q.s |
| Approved colour used in flavoured syrupy base |
| |
| Dextromethorphan HBr, Cetirizine Hydrochioride,Phenylephrine HCL and Ambroxol HCL | Each uncoated tablet contains : |
| Dextromethorphan Hydrobromi IP 10 mg |
| Cetirizine Hydrochloride IP 5 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Ambroxol Hydrochloride IP 15 mg |
| Approved colour to be used |
| |
| Dextromethorphan HBr, Cetirizine Phenylephrine, Ambroxol HCl,Guaiphenesin and Sodium Citrate | Each 5 ml contains : |
| Dextromethorphan HBr IP 15 mg |
| Cetirizine HCl IP 5 mg |
| Phenylephrine Hydrochloride IP 8 mg |
| Ambroxol Hydrochloride IP 30 mg |
| Guaiphenesin IP 100 mg |
| Sodium Citrate IP 75 mg |
| Approved colour used in flavoured syrupy base |
| |
| Dextromethorphan HBr, Chlorpheniramine Maleate,Phenylephrine HCL and Ambroxol HCL | Each uncoated tablet contains: |
| Dextromethorphan HBr IP 10 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Ambroxol Hydrochloride IP 30 mg |
| Approved color to be use |
| |
| DEXTROMETHORPHAN Hbr, CHLORPHENRAMINE MALEATE SYRUP | Each 5 ml contains : |
| Dextromethorphan Hydrobomide IP 5 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Approved colour used in flavoured syrupy base |
| |
| Dextromethorphan Hbr, Guaiphenesin & Ambroxol Hcl | Each uncoated tablet contains |
| Dextromethorphan Hbr IP 10 mg |
| Guaiphenesin IP 100 mg |
| Ambroxol Hydrochloride IP 8 mg |
| Chlorpheniramine Maleate IP 2 mg |
| |
| Dextromethorphan HBr, Phenylephrine Hcl, Chlorpheniramine Maleate Syrups | Each 5 ml contains : |
| Dextromethorphan HBr IP 15 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Approved coloured use in a flavoured syrup base |
| |
| Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride & | Each uncoated tablet contains : |
| Dextromethorphan HBO IP 10 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Diacerein Capsules IP 50 mg | Each hard gelatin capsule contains |
| Diacerein IP 50 mg |
| Approved colour use in empty capsule shell |
| |
| Diacerein with Glucosamine Tablets | Each film coated tablet contains : |
| Diacerein IP 50 mg |
| Glucosamine Sulphate Potassium Chloride USP 500 mg |
| Approved colour to be use |
| |
| Diacerein with Glucosamine Tablets | Each film coated tablet contains : |
| Diacerein IP 50 mg |
| Glucosamine Sulphate Potassium Chloride USP 750 mg |
| Approved colour to be use |
| |
| Diacerein, Glucosamine, Methylcobalamin & Methyl sulphonyl Methane | Each film coated tablet contains |
| Diacerein IP 50 mg |
| Glucosamine Sulphate Potassium Chloride IP 750 mg |
| Methylcobalamin 750 mcg |
| Methyl sulphonyl Methane USP 250 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/ |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Diacerein, Glucosamine, Methylsulphonyl Methane | Each film coated tablet contains |
| Diacerein IP 50 mg |
| Glucosamine Sulphate Potassium IP 750 mg |
| Methyl sulphonyl Methane USP 250 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| DIASTASE AND PEPSIN DROPS For Paediatric Use | Each ml contains : |
| Diastase (1:1200) IP 33.33 mg |
| (Digest not less than 40 gm of cooked starch) |
| Pepsin (1:3000) IP 5 mg |
| (Digests not less than 15gm of coagulated egg albumen) |
| Approved Colour used inFlavoured Syrupy Base |
| |
| Diazepam Capsules IP | Each hard gelatin capsule contains |
| Diazepam IP 5 mg |
| Approved colour used in empty capsule shell |
| |
| Diazepam Capsules IP | Each hard gelatin capsule contains |
| Diazepam IP 10 mg |
| Approved colour used in empty capsule shell |
| |
| Diazepam Tablets IP | Each uncoated tablet contains : |
| Diazepam IP 5 mg |
| |
| Diazepam Tablets IP | Each uncoated tablet contains: |
| Diazepam IP 10 mg |
| Approved colour to used |
| |
| Diclofenac Potasium , Paracetamol & Serratiopeptidase Tablets | Each film coated tablet contains : |
| Diclofenac Potasium IP 50 mg |
| Paracetamol IP 325 mg |
| Serratiopeptidase ( An enteric coated) IP 10 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Diclofenac Potasium, Paracetamol & | Each film coated tablet contains : |
| Diclofenac Potasium IP 50 mg |
| Paracetamol IP 250 mg |
| Serratiopeptidase ( An enteric coated) IP 10 mg |
| Excipients q.s. |
| Approved Color to be use in Tablet |
| |
| Diclofenac Potassium & Serratiopeptidase Tablets | Each film coated tablet contains : |
| Diclofenac Potassium IP 50 mg |
| Serratiopeptidase (As Enteric Coated) IP 10 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green/Iron oxide red,Iron oxid IP |
| |
| Diclofenac Potassium & Thiocolchicoside Tablets | Each film coated tablet contains |
| Diclofenac Potassium IP 50 mg |
| Thiocolchicoside 4 mg |
| Colour: Brilliant Blue / Erythrosine (Tartrazine/ |
| Sunset yellow or Apple Green / Titanium Dioxide IP |
| |
| Diclofenac Potassium & Thiocolchicoside Tablets | Each film coated tablet contains |
| Diclofenac Potassium IP 50 mg |
| Thiocolchicoside 8 mg |
| Colour: Erythrosine (Tartrazine/ |
| Sunset yellow / Titanium Dioxide IP |
| |
| Diclofenac Potassium & Tolperisone Tablets | Each film coated tablet contains : |
| Diclofenac Potassium IP 50 mg |
| Tolperisone Hydrochloride JP 150 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Diclofenac Potassium & Trypsin Chymotrypsin Tablets | Each enteric coated tablet contains : |
| Diclofenac Potassium BP 50 mg |
| 5000 Armour units of enzymatic activity |
| (Supplied by a purified concentrate which |
| specific Trypsin & Chymotrypsin IP activity |
| in a ratio of approximate 6:1 ) |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Diclofenac Potassium , Paracetamol With Chlorzoxazone Tablets | Each uncoated tablet contains : |
| Diclofenac Potassium IP 50 Mg |
| Paracetamol IP 325 mg |
| Chlorzoxazone USP 250 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide ip /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Diclofenac Potassium Tablets | Each film coated tablet contains : |
| Diclofenac Potassium BP 50 mg |
| Permitted Color Used |
| |
| Diclofenac Potassium Tablets | Each uncoated tablet contains : |
| Diclofenac Potassium BP 50 mg |
| Permitted Color Used |
| |
| Diclofenac Potassium Tablets Sustained Release Tablets | Each sustained release tablet contains : |
| Diclofenac Potassium IP 100 mg |
| Permitted Color Used |
| |
| Diclofenac Potassium, Paracetamol and Magnesium Trisilicate | Each uncoated tablet contains : |
| Diclofenac Potassium IP 50 mg |
| Paracetarmol IP 325 mg |
| Magnesium Trisilicate IP 100 mg |
| Approved colour to be used |
| |
| Diclofenac Potassium, Paracetamol, Cetirizine Hydrochloride and Magnesium Trisilicate | Each uncoated tablet contains : |
| Diclofenac Potassium IP 50 mg |
| Paracetamol IP 325 mg |
| Cetirizine Hydrochloride IP 5 mg |
| Magnesium Trisilicate IP 100 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Diclofenac Potassium, Trypsin & Bromelain | Each film coated tablet contains |
| Diclofenac Potassium IP 50 mg |
| Trypsin IP 48 mg |
| Bromelain 90 mg |
| Rutoside Trihydrate USP 100 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/ |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Diclofenac Sodium & Paracetamol Tablets | Each uncoated tablet contains : |
| Diclofenac Sodium IP 25 mg |
| Paracetamol IP 250 mg |
| |
| Diclofenac Sodium & Paracetamol Tablets | Each uncoated tablet contains : |
| Diclofenac Sodium IP 25 mg |
| Paracetamol IP 325 mg |
| |
| Diclofenac Sodium & Paracetamol Tablets | Each uncoated tablet contains : |
| Diclofenac Sodium IP 50 mg |
| Paracetamol IP 250 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron Oxide Yellow |
| |
| Diclofenac Sodium & Paracetamol Tablets | Each uncoated tablet contains : |
| Diclofenac Sodium IP 50 mg |
| Paracetamol IP 325 mg |
| Colour: Brilliant Blue/Erythrosine/Tartrazine/Quinoline Yellow/Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron Oxide red,Iron oxide Yellow |
| |
| Diclofenac Sodium & Paracetamol Tablets | Each sugar coated tablet contains : |
| Diclofenac Sodium IP 50 mg |
| Paracetamol IP 325 mg |
| Colour: Brilliant Blue/Erythrosine/Tartrazine/Quinoline Yellow/Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Diclofenac Sodium & Tolperisone Tablets | Each film coated tablet contains : |
| Diclofenac Sodium IP 50 mg |
| Tolperisone Hydrochloride JP 150 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Diclofenac Sodium (SR) & Tolperisone Tablets | Each film coated tablet contains : |
| Diclofenac Sodium IP 100 mg |
| Tolperisone Hydrochloride JP 450 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Diclofenac Sodium (SR) and Eperisone HCI (SR) | Each hard gelatin capsule contains |
| Diclofenac Sodium IP 100 mg |
| As sustained release pellets) |
| Eperisone Hydrochloride JP 150 mg |
| (As sustained release pellets) |
| Approved colour used in empty capsule shell |
| |
| Diclofenac Sodium (SR) and With Tramadol Tablets | Each uncoated tablet contains |
| Diclofenac Sodium IP 75 mg |
| (As Sustained release) |
| Tramadol Hydrochloride IP 50 mg |
| Approved color to be use |
| |
| Diclofenac Sodium Gastro-Resistant Tablets IP | Each gastro-resistant tablet contains : |
| Diclofenac Sodium IP 25 mg |
| Permitted Color Used |
| |
| Diclofenac Sodium Gastro-Resistant Tablets IP | Each gastro-resistant tablet contains : |
| Diclofenac Sodium IP 100 mg |
| Permitted Color Used |
| |
| Diclofenac Sodium Prolonged Release Tablets IP 100 mg | Each film coated prolonged release tablets contains : |
| Diclofenac Sodium IP 100 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Diclofenac Sodium Prolonged release Tablets IP 75 mg | Each sustained release film coated tablets contains : |
| Diclofenac Sodium IP 75 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Diclofenac Sodium Tablets IP | Each enteric coated tablet contains : |
| Diclofenac Sodium IP 50 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Diclofenac Sodium Tablets IP | Each film coated tablet contains : |
| Diclofenac Sodium IP 50 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Diclofenac Sodium Tablets IP | Each uncoated tablet contains : |
| Diclofenac Sodium IP 50 mg |
| |
| Diclofenac Sodium Tablets IP 75 mg | Each film coated tablets contains : |
| Diclofenac Sodium IP 75 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Diclofenac Sodium, Magnesium Trisilicate ,Paracetamol and Chlorpheniramine Maleate | Each uncoated tablet contains : |
| Diclofenac Sodium IP 50 mg |
| Magnesium Trisilicate IP 100 mg |
| Paracetamol IP 325 mg |
| Chlorpheniramine Maleate IP 4 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Diclofenac Sodium, Paracetamol & Chlorzoxazone Tablets | Each uncoated tablet contains : |
| Diclofenac Sodium IP 50 mg |
| Paracetamol IP 325 mg |
| Chlorzoxazone USP 250 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| |
| Diclofenac Sodium, Paracetamol & Magnesium Trisilicate Tablets | Each uncoated tablet contains : |
| Diclofenac Sodium IP 50 mg |
| Paracetamol IP 250 mg |
| Magnesium Trisilicate IP 100 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / iron oxide red, iron oxide Yellow |
| |
| Diclofenac Sodium, Paracetamol With Magnesium Trisilicate Tablets | Each uncoated tablet contains : |
| Diclofenac Sodium IP 50 mg |
| Paracetamol IP 325 mg |
| Magnesium Trisilicate IP 100 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Diclofenac Sodium, Paracetamol, Chlorphenramine Maleate | Each uncoated tablet contains : |
| Diclofenac Sodium IP 50 mg |
| Paracetamol IP 325 mg |
| Chlorphenramine Maleate IP 4 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Dicyclomine HCI , Tramadol HCI And Paracetamol | Each hard gelatin capsule contains |
| Dicyclomine Hydrochloride IP 10 mg |
| Tramadol Hydrochloride IP 50 mg |
| Paracetamol IP 325 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| DICYCLOMINE HYDROCHLORIDE & ACTIVATED DIMETHICONE SUSPENSION | Each ml contains : |
| Dicyclomine Hydrochloride IP 10 mg |
| Activated Dimethicone IP 40 mg |
| Approved colour used in flavoured syrupy base |
| |
| DICYCLOMINE HYDROCHLORIDE & DICLOFENAC SODIUM CAPSULES | Each hard gelatin capsule contains |
| Dicyclomine Hydrochloride IP 20 mg |
| Diclofenac Sodium IP 50 mg |
| Approved colour used in empty capsule shell |
| |
| DICYCLOMINE HYDROCHLORIDE & PARACETAMOL CAPSULES | Each hard gelatin capsule contains |
| Dicyclomine Hydrochloride IP 10 mg |
| Paracetamol IP 325 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Dicyclomine Hydrochloride & Paracetamol Tablets | Each uncoated tablet contains : |
| Dicyclomine Hydrochloride IP 10 mg |
| Paracetamol IP 325 mg |
| |
| Dicyclomine Hydrochloride & Paracetamol Tablets | Each uncoated tablet contains : |
| Dicyclomine Hydrochloride IP 20 mg |
| Paracetamol IP 325 mg |
| |
| Dicyclomine Hydrochloride & Paracetamol Tablets | Each uncoated tablet contains : |
| Dicyclomine Hydrochloride IP 10 mg |
| Paracetamol IP 250 mg |
| |
| Dicyclomine Hydrochloride and Simethicone Suspension | Each 5 ml contains : |
| Dicyclomine Hydrochloride IP 10 mg |
| Simethicone IP 40 mg |
| Approved coloured use in a flavoured syrup base |
| |
| DICYCLOMINE HYDROCHLORIDE PARACETAMOL SUSPENSION | Each 5 ml contains : |
| Dicyclomine Hydrochloride IP 5 mg |
| Paracetamol IP 125 mg |
| Approved colour used in flavoured syrupy base |
| |
| Dicyclomine Hydrochloride Suspension | Each 5 ml contains : |
| Dicyclomine Hydrochloride IP 10 mg |
| Approved coloured use in a flavoured syrup base |
| |
| Dicyclomine Hydrochloride Tablets IP | Each uncoated tablet contains : |
| Dicyclomine Hydrochloride IP 20 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / |
| Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Diethylcarbamazine Citrate Tablets IP 100 mg | Each uncoated tablet contains : |
| Diethylcarbamazine Citrate IP 100 mg |
| |
| |
| Diethylcarbamazine Citrate Tablets IP 50 mg | Each uncoated tablet contains : |
| Diethylcarbamazine Citrate IP 50 mg |
| |
| |
| Dihydrocodeine Tablets | Each uncoated tablet contains : |
| Dihydrocodeine IP 30 mg |
| Approved colour to used |
| |
| Diiodohydroxyquinoline Tablets IP 300 mg | Each uncoated tablet contains : |
| Diiodohydroxyquinoline IP 300 mg |
| Approved colour to used |
| |
| Diiodohydroxyquinoline Tablets IP 600 mg | Each uncoated tablet contains : |
| Diiodohydroxyquinoline IP 600 mg |
| Approved colour to used |
| |
| Diloxanide Furoate and Metronidazole Tablets | Each uncoated tablet contains : |
| Diloxanide Furoate IP 500 mg |
| Metronidazole IP 400 mg |
| Approved colour to used |
| |
| Diloxanide Furoate and Tinidazole Tablets | Each uncoated tablet contains : |
| Diloxanide Furoate IP 150 mg |
| Tinidazole IP 250 mg |
| Approved colour to used |
| |
| Diloxanide Furoate Tablets IP 500 mg | Each uncoated tablet contains : |
| Diloxanide Furoate IP 500 mg |
| Approved colour to used |
| |
| Diltiazem (SR) Tablets | Each sustain release tablet contains |
| Diltiazem IP 90 mg |
| |
| Diltiazem Modified Release Tablets IP | Each modified release film coated tablet contains : |
| Diltiazem Hydrochloride IP 30 mg |
| Approved coloured used |
| |
| Diltiazem Modified Release Tablets IP | Each modified release film coated tablet contains : |
| Diltiazem Hydrochloride IP 60 mg |
| Approved coloured used |
| |
| Diltiazem Modified Release Tablets IP | Each modified release film coated tablet contains : |
| Diltiazem Hydrochloride IP 90 mg |
| Approved coloured used |
| |
| Diltiazem Sustained Release Tablets | Each film coated Sustained Release tablet contains |
| Diltiazem Hydrochloride IP 90 mg |
| Approved colour to be used |
| |
| Diltiazem Sustained Release Tablets | Each film coated Sustained Release tablet contains |
| Diltiazem Hydrochloride IP 120 mg |
| Approved colour to be used |
| |
| Dimenhydrinate TabletsBP 50 mg | Each Uncoated tablet contains: |
| Dimenhydrinate BP 50 mg |
| Excipients q.s. |
| |
| |
| Diosmin Capsules | Each hard gelatin capsule contains |
| Diosmin (Micronised) BP 150 mg |
| Approved coloured used in empty capsule shell |
| |
| Diosmin Tablets | Each film coated lablet contains : |
| Diosmin (Micronised) BP 150 mg |
| Approved colour to be use q.s. |
| |
| Diosmin Tablets | Each film coated lablet contains : |
| Diosmin (Micronised) BP 300 mg |
| Approved colour to be use q.s. |
| |
| Diphenhydramine HCI Tablets | Each uncoated tablet contains : |
| Diphenhydramine Hydrochloride IP 25 mg |
| Approved colour to used |
| |
| Diphenhydramine Hcl, Terpine Hydrate Ammonium chloride, Sodium Citrate | Each 5 ml contains : |
| Diphenyhydramine Hcl IP 12.5 mg |
| Terpine Hydrate IP 7.5 mg |
| Ammonium Chloride IP 125 mg |
| Sodium Citrate IP 55 mg |
| Mentheol IP qs |
| Approved colour used in flavoured syrupy base |
| |
| Diphenhydramine Hydrochloride Ammonium Chloride | Each 5 ml contains : |
| Diphenhydramine Hydrochloride IP 12.5 mg |
| Ammonium Chloride IP 80 mg |
| Sodium Citrate IP 50 mg |
| Menthol IP q.s |
| Approved colour used in flavoured syrupy base |
| |
| Diphenhydramine Hydrochloride Ammonium chloride | Each 5 ml contains : |
| Diphenhydramine Hydrochloride IP 15 mg |
| Ammonium chloride IP 125 mg |
| Sodium citrate IP 60 mg |
| Menthol IP q.s. |
| Approved colour used in flavoured syrupy base |
| |
| DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE IP | Each hard gelatin capsule contains |
| Diphenhydramine Hydrochloride IP 25 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| DIPHENHYDRAMINE HYDROCHLORIDE, AMMONIUM CHLORIDE,Sodium Citrate and Menthol | Each 5 ml contains : |
| Diphenhydramine Hydrochloride IP 14.08 mg |
| Ammonium chloride IP 1.38 mg |
| Sodium citrate IP 57.03 mg |
| Menthol IP qs |
| Approved colour used in flavoured syrupy base |
| |
| Diphenoxylate Hydrochloride & Atropine Tablets IP | Each uncoated tablet contains : |
| Diphenoxylate Hydrochloride IP 2.50 mg |
| Atropine Sulphate IP 0.0250 mg |
| Approved colour to used |
| |
| Disodium Hydrogen Citrate Syrup | Each 5 ml contains |
| Disodium Hydrogen citrate BP 1.53 gm |
| Approved colour used in flavoured syrupy base |
| |
| DISODIUM HYDROGEN CITRATE SYRUP IP | Each 5 ml contains : |
| Disodium Hydrogen citrate BP 1.4 gm |
| Approved colour used in flavoured syrupy base |
| |
| Disulfiram Tablets IP | Each uncoated tablet contains |
| Disulfiram IP 250 mg |
| |
| Disulfiram Tablets IP | Each uncoated tablet contains |
| Disulfiram IP 500 mg |
| |
| Divalproex Sodium Extended-release Tablets IP | Each film coated Extende-release tablet contains: |
| Divalproex sodium IP |
| Eq. to Valproic acid 125 mg |
| Approved colour to be used |
| |
| Divalproex Sodium Extended-release Tablets IP | Each film coated Extende-release tablet contains: |
| Divalproex sodium IP |
| Eq. to Valproic acid 250 mg |
| Approved colour to be used |
| |
| Divalproex Sodium Extended-release Tablets IP | Each film coated Extende-release tablet contains: |
| Divalproex sodium IP |
| Eq. to Valproic acid 500 mg |
| Approved colour to be used |
| |
| Divalproex Sodium Extended-release Tablets IP | Each film coated Extende-release tablet contains: |
| Divalproex sodium IP |
| Eq. to Valproic acid 750 mg |
| Approved colour to be used |
| |
| Divalproex Sodium Extended-release Tablets IP | Each film coated Extende-release tablet contains: |
| Divalproex sodium IP |
| Eq. to Valproic acid 1000 mg |
| Approved colour to be used |
| |
| Divalproex Sodium Gastro-resistant | Each Enteric coated tablet contains: |
| Divalproex sodium IP |
| Eq. to Valproic acid 125 mg |
| Approved colour to be used |
| |
| Divalproex Sodium Gastro-resistant | Each Enteric coated tablet contains: |
| Divalproex sodium IP |
| Eq. to Valproic acid 250 mg |
| Approved colour to be used |
| |
| Divalproex Sodium Gastro-resistant | Each Enteric coated tablet contains: |
| Divalproex sodium IP |
| Eq. to Valproic acid 500 mg |
| Approved colour to be used |
| |
| Domeperdone SR Pellets 10.00% w/w | Each 1 gm of Sustain Release pellets contains |
| Domperidone 100 mg |
| Release Profile 1st hour -Between 15%-40% |
| 4th hour -Between 30%-60% |
| 8th hour -Between 55%-85% |
| 12th hour -NLT-70% |
| |
| Domeperdone SR Pellets 20.00% w/w | Each 1 gm of Sustain Release pellets contains |
| Domperidone 200 mg |
| Release Profile 1st hour -Between 15%-40% |
| 4th hour -Between 30%-60% |
| 8th hour -Between 55%-85% |
| 12th hour -NLT-70% |
| |
| Domeperdone SR Pellets 30.00% w/w | Each 1 gm of Sustain Release pellets contains |
| Domperidone 300 mg |
| Release Profile 1st hour -Between 15%-40% |
| 4th hour -Between 30%-60% |
| 8th hour -Between 55%-85% |
| 12th hour -NLT-70% |
| |
| Domeperdone SR Pellets 40.00% w/w | Each 1 gm of Sustain Release pellets contains |
| Domperidone 400mg |
| Release Profile 1st hour -Between 15%-40% |
| 4th hour -Between 30%-60% |
| 8th hour -Between 55%-85% |
| 12th hour -NLT-70% |
| |
| |
| |
| |
| IHS |
| IP |
| IP |
| |
| |
| |
| |
| |
| |
| IHS |
| IP |
| IP |
| IP |
| IP |
| |
| |
| |
| |
| |
| |
| IP |
| IP |
| IP |
| |
| |
| |
| |
| |
| |
| IP 50mg |
| |
| IP 0.5mg |
| |
| Domperidone Dispersible Tablets IP | Each dispersible tablet contains : |
| Domperidone IP 10 mg |
| Colour: Brilliant Blue/Erythrosine/Tartrazine / Quinoline Yellow / |
| Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| DOMPERIDONE ORAL SUSPENSION IP | Each ml contains : |
| Domperidone IP 1 mg |
| Approved colour used in flavoured syrupy base |
| |
| |
| Domperidone Suspension | Each 5 ml contains : |
| Domperidone IP 5 mg |
| Approved coloured use in a flavoured syrup base |
| |
| Domperidone Tablets IP | Each uncoated tablet contains : |
| Domperidone IP 10 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / |
| Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Domperidone Tablets IP | Each uncoated tablet contains : |
| Domperidone Maleate IP |
| eq.to Domperidone 10 mg |
| Colour: Brilliant Blue/ Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| |
| Doxofylline and Acebrophylline Tablets | Each uncoated tablet contains : |
| Doxofylline IP 400 mg |
| Acebrophylline IP 100 mg |
| Approved colour to be use |
| |
| Doxofylline and Ambroxol HCl Tablets | Each uncoated tablet contains : |
| Doxofylline IP 400 mg |
| Ambroxol Hydrochloride IP 30 mg |
| Approved colour to be use |
| |
| Doxofylline SR and Acebrophylline Tablets | Each uncoated tablet contains |
| Doxofylline (Sustained released) IP 400 mg |
| Acebrophylline IP 100 mg |
| Excipients q.s. |
| |
| Doxofylline Sustained Released and Montelukast Tablets | Each uncoated Sustained Released tablet contains : |
| Doxofylline IP 400 mg |
| Montelukast Sodium IP |
| Eq. to Montelukast 10 mg |
| Approved colour to be use |
| |
| Doxofylline Sustained Released and Montelukast Tablets | Each uncoated Sustained Released tablet contains : |
| Doxofylline IP 800 mg |
| Montelukst Sodium IP |
| Eq. to Montelukast 10 mg |
| Approved colour to be use |
| |
| Doxofylline Syrup 29.04.2022 | Each ml contains : |
| Doxofylline IP 20 mg |
| Approved colour used in flavoured syrupy base |
| |
| Doxofylline Tablets 200 mg | Each uncoated tablet contains : |
| Doxofylline IP 200 mg |
| Approved colour to be use |
| |
| Doxofylline Tablets IP | Each uncoated tablet contains: |
| Doxofylline IP 400 mg |
| Colour: Brilliant Blue / Erythrosine / Tartraz ine /Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide P /Apple Green / Iron oxide red,lron oxide Yellow |
| |
| Doxolyline & Montelukast Tablets | Each film / uncoated tablet contains : |
| Doxofyline IP 400 mg |
| Montelukast Sodium IP |
| eq. to Montelukast 10 mg |
| Approved colour to used |
| |
| Contains : |
| Povidone – lodine IP 7.5 % W/V |
| Permitted Color Used |
| |
| Contains : |
| Povidone – lodine IP 2 % W/V |
| (Available lodine 0.2% w/v) |
| Permitted Color Used |
| |
| Doxycycline and Ambroxol Tablete | Each filin coated tablet contains: |
| Doxycycline Hydrochloride IP |
| Equivalent to Doxycycline 100 mg |
| Ambroxol Hydrochloride IP 75 mg |
| Approved colour to be use |
| |
| Doxycycline and Ambroxol Tablets | Each film coated tablet contains : |
| Doxycycline Hydrochloride IP |
| Equivalent to Doxycycline 100 mg |
| Ambroxol Hydrochloride IP 7.5 mg |
| Approved colour to be use |
| |
| Doxycycline and Bromhexine HCl Tablets | Each film coated tablet contains : |
| Doxycycline Hydrochloride IP |
| Equivalent to Doxycycline 100 mg |
| Bromhexine HCl IP 8 mg |
| Approved colour to be use |
| |
| Doxycycline Hydrochloride & Sarratiopeptidase | Each hard gelatin capsule contains |
| Doxycycline Hydrochloride IP 100 mg |
| Sarratiopeptidase IP 10 mg |
| (As enteric coated granules) |
| Approved colour used in empty capsule shell |
| |
| DOXYCYCLINE HYDROCHLORIDE CAPSULES IP | Each hard gelatin capsule contains |
| Doxycycline Hydrochloride IP |
| Equivalent to Doxycycline 100 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Doxycycline Lactic Acid Bacillus | Each film coated tablet contains : |
| Doxycycline Hyclate IP |
| Equivalent to Doxycycline 100 mg |
| Lactic Acid Bacillus 60 ms |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Doxycycline Tablets IP | Each film coated tablet contains : |
| Doxycycline Hyclate LP |
| Equivalent to Doxycycline 100 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| DOXYCYCLINE WITH LACTIC ACID BACILLUS CAPSULES | Each hard gelatin capsule contains |
| Doxycycline Hyclate IP |
| Equivalent to Doxycycline 100 mg |
| (Coated Pellets) |
| Lactic Acid Bacillus 90 mill.Spor |
| (As Enteric Coated Pellets) |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Doxycycline, Ambroxol and Bromhexine HCI Tablets | Each film coated tablet contains : |
| Doxycycline Hydrochloride IP |
| Equivalent to Doxycycline 100 mg |
| Ambroxol Hydrochloride IP 8 mg |
| Bromhexine HCI IP 4 mg |
| Approved colour to be use |
| |
| Doxycyline Dispersible Tablets IP | Each uncoated dispersible tablet contains : |
| Doxycycline Hyclate IP |
| eq. to Doxycycline 100 mg |
| Approved colour to be used |
| |
| Doxylamine, Pyridoxine HCI and Folic Acid Tablets | Each enteric coated tablet contains : |
| Doxylamine Succinate BP 10 mg |
| Pyridoxine Hydrochloride IP 10 mg |
| Folic acid IP 2.5 mg |
| Approved colour to be use |
| |
| Doxylamine, Pyridoxine HCL and Folic Acid Tablets | Each enteric coated tablet contains : |
| Doxylamine Succinate BP 20 mg |
| Pyridoxine HCI IP 20 mg |
| Folic acid IP 5 mg |
| Approved colour to be use |
| |
| Dried Aluminium Hydroxide Magnesium Hydroxide with | Each 10 ml contains |
| Dried Aluminium Hydroxide Gel IP 250 mg |
| Magnesium Hydroxide IP 250 mg |
| Activated Dimethicone IP 50 mg |
| Approved colour used in flavoured syrupy base |
| |
| DRIED ALUMINIUM HYDROXIDE MAGNESIUM HYDROXIDE and Activated Dimethicone | Each 5 ml contains : |
| Dried Aluminium Hydroxide Gel IP 250 mg |
| Magnesium Hydroxide IP 250 mg |
| Activated Dimethicone IP 25 mg |
| Approved colour used in flavoured syrupy base |
| |
| Dried Aluminium Hydroxide Magnesium Hydroxide, Oxetacaine | Each 5 ml contains : |
| Dried Aluminium Hydroxide Gel IP 300 mg |
| Magnesium Hydroxide IP 250 mg |
| Activated Dimethicone IP 50 mg |
| Oxetacaine BP 10 mg |
| Approved colour used in flavoured syrupy base |
| |
| Dried Aluminium Hydroxide Magnesium Hydroxide, Oxetacaine | Each 5 ml contains : |
| Dried Aluminium Hydroxide Gel IP 300 mg |
| Magnesium Hydroxide IP 150 mg |
| Activated Dimethicone IP 125 mg |
| Oxetacaine BP 10 mg |
| Excipients q.s. |
| Approved colour used in flavoured syrupy base |
| |
| Dried Aluminium Hydroxide, Magnesium Hydroxide and Simethicone | Each 10 ml contains : |
| Aluminuum Hydroxide Past |
| Eq. to Dried Aluminium Hydroxide IP 250 mg |
| Magnesium Hydroxide |
| Eq. to Magnesium Hydroxide IP 250 mg |
| Simethicone IP 50 mg |
| Approved coloured use in a flavoured syrup base |
| |
| Dried Aluminium Hydroxide, Magnesium Hydroxide and Simethicone | Each 5 ml contains : |
| Aluminuum Hydroxide 0.291 gm |
| (Added as Aluminium Hydroxide paste |
| Eq. to 0.380 gm Dried Aluminium Hydroxide IP) |
| Magnesium Hydroxide IP 98 mg |
| (Added as Magnesium Hydroxide paste) |
| Oxetacaine BP 10 mg |
| Approved coloured use in a flavoured syrup base |
| |
| Dried Aluminium Hydroxide, Magnesium Hydroxide and Oxetacaine | Each 5 ml contains: |
| Dried Aluminium Hydroxide Gel IP 291 mg |
| Magnesium Hydroxide IP 98 mg |
| Oxetacaine IP 10 mg |
| Approved colour used in flavoured syrupy base |
| |
| Drospirenone and Ethinylestradiol Tablets | Each uncoated tablets contains |
| Drospirenone IP 3 mg |
| Ethinylestradiol IP 0.035 mg |
| Approved colour to be used |
| |
| Drospirenone and Ethinylestradiol Tablets IP | Each uncoated tablets contains |
| Drospirenone IP 3 mg |
| Ethinylestradiol IP 0.03 mg |
| Approved colour to be used |
| |
| Drospirenone and Ethinylestradiol Tablets IP | Each uncoated tablets contains |
| Drospirenone IP 3 mg |
| Ethinylestradiol IP 0.02 mg |
| Approved colour to be used |
| |
| Drotaverine and Aceclofenac Tablets | Each film coated tablet contains: |
| Drotaverine Hydrochloride IP 80 mg |
| Aceclofenac IP 100 mg |
| Approved coloured used |
| |
| Drotaverine Hydrochloride & Mefenamic Acid Tablets | Each film coated tablet contains : |
| Drotaverine Hydrochloride IP 80 mg |
| Mefenamic Acid IP 250 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| |
| Drotaverine Tablets IP | Each film coated tablet contains : |
| Drotaverine Hydrochloride IP 80 mg |
| Approved coloured used |
| |
| Drotaverine Tablets IP | Each film coated tablet contains : |
| Drotaverine Hydrochloride IP 40 mg |
| Approved coloured used |
| |
| Drotaverine Tablets IP | Each film coated tablet contains : |
| Drotaverine Hydrochloride IP 40 mg |
| Approved coloured used |
| |
| Duloxetine Gastro- resistant Tablets IP | Each entric coated tablet contains |
| Duloxetine Hydrochloride IP 30 mg |
| |
| Duloxetine Gastro- resistant Tablets IP | Each entric coated tablet contains |
| Duloxetine Hydrochloride IP 40 mg |
| |
| Duloxetine Gastro-Resistant Tablets IP | Each enteric coated tablet contains : |
| Duloxetine Hydrochloride IP |
| Eq. to Duloxetine 20 mg |
| Approved color to be use |
| |
| Duloxetine Gastro-Resistant Tablets IP | Each enteric coated tablet contains : |
| Duloxetine Hydrochloride IP |
| Eq. to Duloxetine 30 mg |
| Approved color to be use |
| |
| Duloxetine Gastro-Resistant Tablets IP | Each enteric coated tablet contains : |
| Duloxetine Hydrochloride IP |
| Eq. to Duloxetine 40 mg |
| Approved color to be use |
| |
| Duloxetine Tablets IP | Each uncoated tablet contains |
| Duloxetine Hydrochloride IP 20 mg |
| |
| Dutasteride & Alfuzocin Hydrochloride (ER) Tablets | Each film coated tablet contains: |
| Dutasteride IP 0.5 mg |
| Alfuzocin Hydrochloride IP 10.0 mg |
| (As Modified Release) |
| Excipients q.s. |
| Approved colour to be used |
| |
| Dutasteride & Tamsulosin Hydrochloride (MR) Tablets | Each film coated tablet contains: |
| Dutasteride IP 0.5 mg |
| Tamsulosin hydrochloride IP 0.4 mg |
| (As Modified Release) |
| Excipients q.s. |
| Approved colour to be used |
| |
| Dutasteride & Tamsulosin Hydrochloride Tablets | Each film coated tablet contains: |
| Dutasteride IP 0.5 mg |
| Tamsulosin hydrochloride IP 0.4 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Dutasteride Tablets | Each film coated tablet contains : |
| Dutasteride IP 0.5 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Dydrogesterone Tablets IP 10mg | Each film coated tablet conains: |
| Dydrogesterone IP 10 mg |
| Approved colour to be used |
| |
| Ebastine & Phenylephrine Tablets | Each film coated tablets contains : |
| Ebastine IP 10 mg |
| Phenylephrine Hydrochloride IP 10 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Ebastine and Montelukast Sodium Tablets | Each film coated tablet contains : |
| Ebastine IP 10 mg |
| Montelukast Sodium IP |
| Eq. to Montelukast 10mg |
| Approved colour to used |
| |
| Ebastine Tablets IP 10 mg | Each film coated tablet contains : |
| Ebastine IP 10 mg |
| Approved colour to used |
| |
| Ebastine Tablets IP 20 mg | Each film coated tablet contains : |
| Ebastine IP 20 mg |
| Approved colour to used |
| |
| ELEMENTAL IRON, ZINC SULPHATE WITH FOLIC ACID CAPSULES | Each hard gelatin capsule contains |
| Elemental Iron 50 mg |
| (In the form of Carbonyl Iron) |
| Zinc Sulphate Monohydrate USP 61.8 mg |
| (Equivalent to 22.5 Mg of Elemental Zinc) |
| Folic Acid IP 0.5 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Elemental Iron, Zinc Sulphate, Folic Acid, Vitamin B12 and Vitamin C (Coated) | Each hard gelatin capsule contains |
| Elemental Iron 100 mg |
| (In the form of Carbonyl Iron) |
| Zinc Sulphate Monohydrate USP 61.8 mg |
| (Equivalent to 22.5 Mg of Elemental Zinc) |
| Folic Acid IP 1.5 mg |
| Vitamin B12 IP 15 mcg |
| Vitamin C (Coated) IP 75 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Empagliflozin Tablets | Each film coated tablet contains |
| Empagliflozin 10 mg |
| Approved colour to be used |
| |
| Empagliflozin Tablets | Each film coated tablet contains |
| Empagliflozin 25 mg |
| Approved colour to be used |
| |
| Enalapril Maleate Tablets IP | Each uncoated tablet contains: |
| Enalapril Maleate IP 2.5 mg |
| |
| Enalapril Maleate Tablets IP | Each uncoated tablet contains: |
| Enalapril Maleate IP 5 mg |
| |
| Enalapril Maleate Tablets IP | Each uncoated tablet contains: |
| Enalapril Maleate IP 10 mg |
| |
| Enalapril Maleate Tablets IP | Each uncoated tablet contains: |
| Enalapril Maleate IP 20 mg |
| |
| Eperisone Hydrochloride Sustained Release Capsules | Each hard gelatin capsule contains |
| Eperisone Hydrochloride JP 75 mg |
| (As sustained release pellets) |
| Approved colour use in empty capsule shell |
| |
| Eperisone Hydrochloride Sustained Release Capsules | Each hard gelatin capsule contains |
| Eperisone Hydrochloride JP 150 mg |
| (As sustained release pellets) |
| Approved colour use in empty capsule shell |
| |
| Ephedrine Hydrochloride Tablets IP | Each uncoated tablet contains : |
| Ephedrine Hydrochloride IP 15 mg |
| |
| Erythromycin Estolate Tablets IP | Each film coated tablet contains : |
| Erythromycin Estolate |
| Equivalent to Erythromycin Base IP 500 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green/Iron oxide red,Iron oxide Yellow |
| |
| Erythromycin Estolate Tablets IP 500 mg. | Each uncoated tablet contains : |
| Erythromycin Estolate |
| Eq. to Erythromycin Base IP 500 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Erythromycin Stearate Tablets IP | Each uncoated tablet contains : |
| Erythromycin Stearate |
| Equivalent to Erythromycin IP 250 mg |
| Excipients q.s. |
| |
| Erythromycin Stearate Tablets IP | Each film coated tablet contains : |
| Erythromycin Stearate IP |
| Eq. to Erythromycin 500 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| ERYTHROMYCIN SYRUPS IP For Paediatric Use | Each 5 ml contains : |
| Erythromycin Estolate IP 125 mg |
| Equivalent to Erythromycin Base |
| Approved colour used in flavoured syrupy base |
| |
| Erythromycin Tablets IP | Each film coated tablet contains : |
| Erythromycin Estolate |
| Equivalent to Erythromycin Base IP 333 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/ |
| uinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Erythromycin Tablets IP 250 mg. | Each uncoated tablet contains: |
| Erythromycin Estolate |
| Equivalent to Erythromycin Base IP 250 mg |
| Excipients q.s. |
| |
| Escitalopram and Etizolam Tablets | Each uncoated tablets contains |
| Escitalopram Exalate IP |
| Eq. to Escitalopram 5 mg |
| Etizolam IP 0.5 mg |
| Approved colour to be used |
| |
| Escitalopram Tablets IP | Each uncoated tablet contains |
| Escitalopram Oxalate 10 mg |
| |
| Escitalopram Tablets IP | Each uncoated tablet contains |
| Escitalopram Oxalate 20 mg |
| |
| Escitalopram Tablets IP | Each uncoated tablet contains : |
| Escitalopram Oxalate IP |
| Eq. to Escitalopram 10 mg |
| Approved colour to used |
| |
| Escitalopram Tablets IP | Each uncoated tablet contains : |
| Escitalopram Oxalate IP |
| Eq. to Escitalopram 20 mg |
| Approved colour to used |
| |
| Esomeprazole (EC) and Itopride HCl (SR) Capsules | Each hard gelatin capsule contains |
| Esomeprazole Magnesium Trihydrate IP |
| Eq.to Esomeprazole 40 mg |
| (As enteric coated pellets) |
| Itopride Hydrochloride IP 150 mg |
| (As sustained release pellets) |
| Approved colour use in empty capsule shell |
| |
| Esomeprazole (EC) and Levosulpiride (SR) Capsules | Each hard gelatin capsule contains |
| Esomeprazole Magnesium Trihydrate IP |
| Eq.to Esomeprazole 40 mg |
| (As enteric coated pellets) |
| Levosulpiride 75 mg |
| (As sustained release pellets) |
| Approved colour use in empty capsule shell |
| |
| Esomeprazole and Domperidone Capsules | Each hard gelatin capsule contains |
| Esomeprazole Magnesium Trihydrate IP |
| Eq.to Esomeprazole 40 mg |
| (As enteric coated pellets) |
| Domperidone IP 30 mg |
| (As sustained release pellets) |
| Approved colour use in empty capsule shell |
| |
| Esomeprazole Gastro resistant Capsules IP | Each hard gelatin capsule contains |
| Esomeprazole Magnesium Trihydrate IP |
| Eq.to Esomeprazole 40 mg |
| (As enteric coated pellets) |
| Approved colour use in empty capsule shell |
| |
| Esomeprazole Gastro resistant Capsules IP | Each hard gelatin capsule contains |
| Esomeprazole Magnesium Trihydrate IP |
| Eq.to Esomeprazole 20 mg |
| (As enteric coated pellets) |
| Approved colour use in empty capsule shell |
| |
| Esomeprazole Tablets IP | Each enteric-coated tablet contains :- |
| Esomeprazole magnesium trihydrate IP |
| Eq. to Esomeprazole 40 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / |
| Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Eszopiclone Tablets | Each film coated tablet contains : |
| Eszopiclone IP 1 mg |
| Approved colour to be used |
| |
| Eszopiclone Tablets | Each film coated tablet contains : |
| Eszopiclone IP 2 mg |
| Approved colour to be used |
| |
| Eszopiclone Tablets | Each film coated tablet contains : |
| Eszopiclone IP 3 mg |
| Approved colour to be used |
| |
| Etamsylate Tablets 250 mg | Each uncoated tablet contains : |
| Etamsylate BP 250 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Etamsylate Tablets 250 mg | Each uncoated tablet contains : |
| Etamsylate BP 500 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Ethambutol Hydrochloride Tablets IP 200 mg | Each uncoated tablet contains : |
| Ethambutol Hydrochloride IP 200 mg |
| |
| |
| Ethambutol Hydrochloride Tablets IP 400 mg | Each uncoated tablet contains : |
| Ethambutol Hydrochloride IP 400 mg |
| |
| |
| Ethambutol Hydrochloride Tablets IP 800 mg | Each uncoated tablet contains : |
| Ethambutol Hydrochloride IP 800 mg |
| |
| |
| Ethinylestradiol Tablets IP | Each uncoated tablet contains : |
| Ethinylestradiol IP 10 ug |
| Excipients q.s. |
| |
| Ethinylestradiol Tablets IP | Each uncoated tablet contains : |
| Ethinylestradiol IP 20 ug |
| Excipients q.s. |
| |
| Ethinylestradiol Tablets IP | Each uncoated tablet contains : |
| Ethinylestradiol IP 50 ug |
| Excipients q.s. |
| |
| Ethionamide Tablets IP | Each film coated tablets contains : |
| Ethionamide IP 125 mg |
| Approved colour to be used |
| |
| Ethionamide Tablets IP | Each film coated tablets contains : |
| Ethionamide IP 250 mg |
| Approved colour to be used |
| |
| Etizolam & Escitalopram Tablets | Each uncoated tablet contains |
| Etizolam IP 0.50 mg |
| Escitalopram 10 mg |
| Colour: Brilliant Blue / Erythrosine /Tartrazine |
| or Titanium Dioxide IP |
| |
| Etizolam & Escitalopram Tablets | Each uncoated tablets contains |
| Etizolam IP 0.5 mg |
| Escitalopram Oxalate IP |
| Eq. to Escitalopram 10 mg |
| Approved color to be use |
| |
| Etizolam & Propranolol Hydrochloride Tablets | Each Uncoated tablet contains: |
| Etizolam 0.25 mg |
| Propranolol Hydrochloride IP 20 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Etizolam Mouth Dissoving Tablets | Each uncoated tablets contains |
| Etizolam IP 0.25 mg |
| Approved color to be use |
| |
| Etizolam Mouth Dissoving Tablets | Each uncoated tablets contains |
| Etizolam IP 0.5 mg |
| Approved color to be use |
| |
| Etizolam Mouth Dissoving Tablets | Each uncoated tablets contains |
| Etizolam IP 1 mg |
| Approved color to be use |
| |
| Etizolam Tablets | Each uncoated tablet contains |
| Etizolam I? 0.25 mg |
| Colour: Brilliant Blue /Tartrazine / |
| Sunset yellow or Apple Green |
| |
| Etizolam Tablets | Each uncoated tablet contains |
| Etizolam I? 0.50 mg |
| Colour: Brilliant Blue /Tartrazine / |
| Sunset yellow or Apple Green |
| |
| Etizolam Tablets | Each uncoated tablet contains |
| Etizolam IP 1 mg |
| Colour: Erythrosine /Tartrazine / |
| Sunset yellow / Titanium Dioxide IP |
| |
| Etizolam Tablets | Each film coated tablets contains |
| Etizolam IP 0.25 mg |
| Excipients q.s. |
| Approved color to be use |
| |
| Etizolam Tablets IP | Each film coated tablets contains |
| Etizolam IP 0.5 mg |
| Excipients q.s. |
| Approved color to be use |
| |
| Etodolac & Paracetamol Tablets | Each film coated tablet contains : |
| Etodolac IP 400 mg |
| Paracetamol IP 325 mg |
| Approved coloured used |
| |
| Etodolac and Thiocolchicoside Tablels | Each film coated tablets conlains |
| Etodolac IP 300 mg |
| Thiocolchicoside IP 8 mg |
| Approved color to be use |
| |
| Etodolac and Tolperisone Hydrochloride Tablets | Each film coated tablets contains : |
| Etodolac IP 400 mg |
| Tolperisone Hydrochloride JP 150 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Etodolac Prolonged Relesed Tablets IP | Each film coated (PR) tablet contains : |
| Etodolac IP 200 mg |
| Approved coloured used |
| |
| Etodolac Prolonged Relesed Tablets IP | Each film coated (PR) tablet contains : |
| Etodolac IP 600 mg |
| Approved coloured used |
| |
| Etodolac Tablets IP | Each film coated tablet contains : |
| Etodolac IP 150 mg |
| Approved coloured used |
| |
| Etodolac Tablets IP | Each film coated tablet contains : |
| Etodolac IP 200 mg |
| Approved coloured used |
| |
| Etodolac Tablets IP | Each film coated tablet contains : |
| Etodolac IP 300 mg |
| Approved coloured used |
| |
| Etodolac Tablets IP | Each film coated tablet contains : |
| Etodolac IP 400 mg |
| Approved coloured used |
| |
| Etofylline & Theophylline Tablets | Each uncoated tablet contains : |
| Etofylline IP 85 77 mg |
| Theophylline (Anhydrous) IP 2.3 mg |
| |
| Etoricoxib & THIOCOLCHICOSIDE Tablets | Each film coated tablet contains : |
| Etoricoxib IP 60 mg |
| Thiocochicoside IP 4 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, iron oxide Yellow |
| |
| Etoricoxib & Thiocolchicoside Tablets IP | Each film coated tablet contains |
| Etoricoxib IP 60 mg |
| Thiocolchicoside 4 mg |
| Colour: Brilliant Blue / Erythrosine /Tartrazine / |
| Sunset yellow / Titanium Dioxide IP |
| |
| Etoricoxib & Thiocolchicoside Tablets IP | Each film coated tablet contains |
| Etoricoxib IP 90 mg |
| Thiocolchicoside 4 mg |
| Colour: Brilliant Blue / Erythrosine Tartrazine/ |
| Sunset yellow or Apple Green / Titanium Dioxide IP |
| |
| Etoricoxib Tablets IP 120 mg | Each film coated tablet contains : |
| Etoricoxib IP 120 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red dron oxide Yellow |
| |
| Etoricoxib Tablets IP 90 mg | Each film coated tablet contains |
| Etoricoxib IP 90 mg |
| Colour: Brilliant Blue / Erythrosine/ Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Ezetimibe Tablets IP | Each flimcoated tablet contains |
| Ezetimibe 10 mg |
| Permitted Color Used |
| |
| Famotidine Tablets IP 20 mg | Each film coated tablet contains : |
| Famotidine IP 20 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Famotidine Tablets IP 40 mg | Each film coated tablet contains : |
| Famotidine IP 40 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / |
| Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| |
| Faropenem Sodium (ER) Tablets | Each film coated Extended Release tablet contains : |
| Faropenem Sodium JP |
| Eq. to Faropenem 300 mg |
| Approved coloured used |
| |
| Faropenem Sodium Tablets JP | Each film coated tablet contains : |
| Faropenem Sodium JP |
| Eq. to Faropenem 200 mg |
| Approved coloured used |
| |
| Febuxostat Tablets IP | Each filmcoated tablet contains : |
| Febuxostat IP 80 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/ |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Apple Green/Iron oxide red, Iron oxide Yellow |
| |
| Febuxostate Tablets | Each filmcoated tablet contains : |
| Febuxostate IP 40 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron Oxide red,Iron oxide Yellow |
| |
| Fenofibrate Tablets IP 160 mg | Each film coated tablets contains : |
| Fenofibrate IP 160 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Fenofibrate Tablets IP 200 mg | Each film coated tablets contains : |
| Fenofibrate IP 200 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| FERRIC AMMONIUM CITRATE, CYANOCOBALAMIN WITH | Each 15 ml contains : |
| Ferric Ammonium Citrate IP 160 mg |
| (equivalent to Elemental Iron 32 mg) |
| Vitamin B 12 IP 7.5 mcg |
| Folic Acid IP 1 mg |
| Approved Colour used in Flavoured Syrupy Base |
| |
| Ferric Ammonium Citrate, Cyanocobalamin With | Each 15 ml contains : |
| Ferric Ammonium Citrate IP 160 mg |
| (equivalent to Elemental Iron 32 mg) |
| Cyanocobalmin IP 7.5 mcg |
| Folic Acid IP 0.5 mg |
| Approved Colour used inFlavoured Syrupy Base |
| |
| Ferric Ammonium Citrate, Cyanocobalamin, Folic Acid | Each 15 ml contains : |
| Ferric Ammonium Citrate IP 160 mg |
| (equivalent to Elemental Iron 32 mg) |
| Cyanocobalamin IP 7.5 mcg |
| Folic Acid IP 0.5 mg |
| Cupric Sulphate IP 30 mcg |
| Manganese Sulphate IP 30 mcg |
| Approved Colour used inFlavoured Syrupy Base |
| |
| Ferrous Ascorbate & Folic Acid Tablets | Each film coated tablet contains: |
| Ferrous Ascorbate IP 100mg |
| Eq. to elemental Iron |
| Folic Acid IP 1.5mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Ferrous Ascorbate, Folic Acid and Zinc Tablets | Each film coated tablet contains : |
| Ferrous Ascorbate |
| Eq. to elemental Iron 100 mg |
| Folic acid IP 1.5 mg |
| Zinc Sulphate Monohydrate IP |
| Eq. to Zinc 22.5 mg |
| Approved colour to be use |
| |
| Ferrous Ascorbate, Folic Acid, Zinc and Methylcobalamin Tablets | Each film coated tablet contains: |
| Ferrous Ascorbate |
| Eq. to elemental Iron 100 mg |
| Folic acid IP 1 mg |
| Zinc Sulphate Monohydrate IP |
| Eq. to Zinc 10 mg |
| Methylcobalamin IP 500 mcg |
| Approved colour to be use |
| |
| Ferrous Fumarate, Folic Acid and Zinc Tablets | Each film coated tablets contains |
| Ferrous Fumarate IP 152 mg |
| Eq. to Elemental Iron 49.5 mg |
| Folic Acod IP 750 mcg |
| Zinc Sulphate Monohydrate IP 61.8 mg |
| Eq. to Elemental Zinc 22.5 mg |
| Approved color to be use |
| |
| FERROUS FUMARATE, L-LYSINE, FOLIC ACID, CYANOCOBALAMIN | Each hard gelatin capsule contains |
| Ferrous Fumarate IP 350 mg |
| L-Lysine Hydrochloride IP 150 mg |
| Folic Acid IP 1.5 mg |
| Cyanocobalamin IP 15 mcg |
| Zinc Sulphate IP |
| Eq. to Elemental Zinc 66 mg |
| Copper Sulphate IP |
| Eq. to Elemental Copper 80 mcg |
| Manganese Sulphate USP 250 mg |
| Approved colour used in empty capsule shell |
| |
| FERROUS FUMERATE WITH FOLIC ACID CAPSULES | Each hard gelatin capsule contains |
| Ferrous Fumerate IP 200 mg |
| Folic Acid IP 1500 mcg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| FERROUS FUMERATE, VITAMIN B12 WITH | Each 5 ml contains : |
| Ferrous Fumerate IP 100 mg |
| Eq, to Ferrous Iron IP 32.5 mg |
| Vitamin B12 IP 5 mcg |
| Folic Acid IP 0.5 mg |
| Zinc Sulphate |
| Eq. to Zinc 10 mg |
| Approved colour used in flavoured syrupy base |
| |
| Ferrous Gluconate, Folic Acid Cyanocobalamin with | Each 15 ml contains : |
| Ferrous Gluconate IP 129.5 mg |
| (equivalent to Elemental Iron 15 mg) |
| Cyanocobalmin IP 1.3 mcg |
| Folic Acid IP 0.25 mg |
| Calcium Lactate IP 75 mg |
| Approved Colour used inFlavoured Syrupy Base |
| |
| Ferrous Sulphate and Folic Acid Tablets IP | Each film coated tablet contains : |
| Ferrous Sulphate IP 300 mg |
| Eq. to elemental Iron 60 mg |
| Folic acid IP 0 .25 mg |
| Approved colour to be use |
| |
| Ferrous Sulphate Tablets | Each film coated tablet contains : |
| Ferrous Sulphate IP 300 mg |
| Eq. to elemental Iron 60 mg |
| Approved colour to be use |
| |
| Ferrous Sulphate Tablets IP | Each film coated tablet contains : |
| Dried Ferrous Sulphate IP 200 mg |
| Eq. to Ferrous Iron 60 mg |
| Approved colour use |
| |
| Ferrous Sulphate, and Folic Acid Tablets | Each Sugar coated tablet contains : |
| Dried Ferrous Sulphate IP 200 mg |
| Eq. to Elemental Iron 60 mg |
| Folic acid IP 1 mg |
| Approved colour to be use |
| |
| Ferrous Sulphate, Folic Acid and Zinc Tablets | Each film coated tablet contains : |
| Ferrous Sulphate IP 300 mg |
| Eq. to elemental Iron 60 mg |
| Folic acid IP 1.5 mg |
| Zinc Sulphate Monohydrate IP |
| Eq. to Zinc 22.5 mg |
| Approved colour to be use |
| |
| Fexofenadine & Montelukast Suspension | Each 5 ml. contains |
| Fexofenadine Hydrochloride IP 30 mg |
| Montelukast Sodium IP |
| Jeq. to Montelukast 4 mg |
| Colour : Erythrosine / Tartrazine / Sunset Yellow |
| Ponceau-4R or Carmosine |
| In flavoured syrupy base |
| |
| Fexofenadine & Montelukast Tablets | Each film / uncoated tablet contains : |
| Fexofenadine Hydrochloride IP 120 mg |
| Montelukast Sodium IP |
| eq. to Montelukast 10 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow/ Runsel yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellon |
| |
| Fexofenadine and Montelukast Chewable Tablets | Each uncoated chewable tablet contains: |
| Fexofenadine Hydrochloride IP 120 mg |
| Montelukast Sodium IP |
| eq. to Montelukast 10 mg |
| Approved color to be use |
| |
| Fexofenadine and Montelukast Suspension | Each 5 ml contains : |
| Fexofenadine IP 60 mg |
| Montelukast Sodium IP |
| eq. to Montelukast 4 mg |
| Approved colour used in flavoured syrupy base |
| |
| Fexofenadine Hydrochloride Tablets | Each uncoated tablet contains : |
| Fexofenadine Hydrochloride IP 30 mg |
| |
| Fexofenadine Suspension For paediatric use | Each 5 ml. contains |
| Fexofenadine Hydrochloride IP 30 mg. |
| Colour: Erythrosine / Tartrazine / Sunset Yellow |
| Ponceau-4R or Carmosine |
| in flavoured syrupy base |
| |
| Fexofenadine Tablets IP | Each film / uncoated tablet contains : |
| Fexofenadine Hydrochloride IP 120 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/ |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Fexofenadine Tablets IP | Each film / uncoated tablet contains : |
| Fexofenadine Hydrochloride IP 180 mg |
| Colour: Erythrosine / Tartrazine/ |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Fexofenadine, Montelukast and Acebrophylline Tablets | Each film coated tablet contains : |
| Fexofenadine Hydrochloride IP 120 mg |
| Montelukast sodium IP |
| Eq. to Montelukast 10 mg |
| Acebrophylline 200 mg |
| Approved coloured used |
| |
| Flavoxate Hydrochloride 100 mg | Each film coated tablets contains : |
| Flavoxate Hydrochloride IP 100 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Flibanserin Tablets 100 mg | Each film coated tablet contains |
| Flibanserin 100 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| FLUCONAZOLE CAPSULES IP | Each hard gelatin capsule contains |
| Fluconazole IP 150 mg |
| Approved colour used in empty capsule shell |
| |
| Fluconazole Tablets IP 150 mg | Each uncoated tablet contains : |
| Fluconazole IP 150 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Fluconazole Tablets IP 150 mg. | Each uncoated tablet contains : |
| Fluconazole USP 150 mg |
| Excipients q.s. |
| |
| Fluconazole Tablets IP 200 mg. | Each uncoated tablet contains |
| Fluconazole IP 200 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Flunarizine Dihydrochloride Capsules | Each hard gelatin capsule contains |
| Flunarizine Dihydrochloride IP |
| Eq. to Flunarizine 5 mg |
| Approved colour use in empty capsule shell |
| |
| Flunarizine Dihydrochloride Capsules | Each hard gelatin capsule contains |
| Flunarizine Dihydrochloride IP 10 mg |
| Eq. to Flunarizine |
| Approved colour use in empty capsule shell |
| |
| Flunarizine Dihydrochloride Tablets IP | Each uncoated tablet contains |
| Flunarizine Dihydrochloride IP 10 mg |
| |
| Flunarizine Dihydrochloride, Domperidone Paracetamol Tablets | Each uncoated tablet contains |
| Flunarizine Dihydrochloride IP 5 mg |
| Domperidone IP 10 mg |
| Paracetamol IP 325 mg |
| Colour: Brilliant Blue / Erythrosine /Tartrazine |
| or Titanium Dioxide IP / Ferric Oxide Yellow |
| |
| Flunarizine Tablets IP | Each uncoated tablet contains : |
| Flunarizine Dihydrochloride IP |
| Eq. to Flunarizine 5 mg |
| |
| Fluoxetine Capsules IP 10 mg | Each hard gelatin capsule contains |
| Fluoxetine Hydrochloride IP |
| Eq.to Fluxetine 10 mg |
| Approved colour use in empty capsule shell |
| |
| Fluoxetine Capsules IP 20 mg | Each hard gelatin capsule contains |
| Fluoxetine Hydrochloride IP |
| Eq.to Fluxetine 20 mg |
| Approved colour use in empty capsule shell |
| |
| Fluoxetine Hydrochloride Tablets | Each film coated tablet contains |
| Fluoxetine Hydrochloride BP |
| eq. to Fluoxetine 20 mg |
| Colour: Brilliant Blue / Erythrosine Tartrazine |
| or Titanium Dioxide IP / Ferric Oxide Yellow |
| |
| Fluoxetine Oral Solution | Each 5 ml contains : |
| Fluoxetine Hydrochloride IP 20 mg |
| Eq.to Fluxetine |
| Approved colour used in flavoured syrupy base |
| |
| Flupentixol and Melitracen Tablets | Each film coated tablets contains: |
| Flupentixol Hydrochloride BP |
| Eq. to Flupentixol 0.5 mg |
| Melitracen Hydrochloride |
| Eq. to Melitracen 10 mg |
| Approved colour to be used |
| |
| Flupentixol Dihydrochloride Tablets | Each film coated tablet contains |
| Flupentixol Dihydrochloride BP |
| eq. to Flupentixol 0.5 mg |
| Colour: Brilliant Blue / Erythrosine /Tartrazine |
| or Titanium Dioxide IP / Ferric Oxide Yellow |
| |
| Flupirtine Maleate & Paracetamol Tablets | Each Uncoated bilayered coated tablets contains: |
| Flupirtine Maleate 100 mg |
| Paracetamol IP 325 mg |
| Excipients q.s. |
| |
| Flurazepam HCI Capsules | Each hard gelatin capsules contains : |
| Flurazepam HCI IP |
| Eq. to Flurazepam 15.0 mg |
| Excipients q.s. |
| |
| Flurazepam HCI Capsules | Each hard gelatin capsules contains : |
| Flurazepam HCI IP |
| Eq. to Flurazepam 5 mg |
| Excipients q.s. |
| |
| Flurazepam HCI Capsules | Each hard gelatin capsules contains : |
| Flurazepam HCI IP |
| Eq. to Flurazepam 10 mg |
| Excipients q.s. |
| |
| Flurazepam HCI Capsules | Each hard gelatin capsules contains : |
| Flurazepam HCI IP |
| Eq. to Flurazepam 15 mg |
| Excipients q.s. |
| |
| Fluvoxamine Maleate Tablets IP | Each film coated tablet contains: |
| Fluvoxamine Maleate IP 50 mg |
| Approved colour to used |
| |
| Fluvoxamine Maleate Tablets IP | Each film coated tablet contains: |
| Fluvoxamine Maleate IP 100 mg |
| Approved colour to used |
| |
| Folic Acid Tablets | Each uncoated tablet contains: |
| Folic Acid IP 2 mg |
| Excipients q.s |
| |
| Folic Acid Tablets | Each uncoated tablet contains: |
| Folic Acid IP 3 mg |
| Excipients q.s |
| |
| Folic Acid Tablets IP | Each uncoated tablet contains : |
| Folic Acid IP 100 mcg |
| Excipients q.s. |
| |
| Folic Acid Tablets IP | Each uncoated tablet contains : |
| Folic Acid IP 5 mg |
| Excipients q.s. |
| |
| Folic Acid Tablets IP | Each uncoated tablet contains: |
| Folic Acid IP 1 mg |
| Excipients q.s |
| |
| Folic Acid Tablets IP | Each uncoated tablet contains: |
| Folic Acid IP 10 mg |
| Excipients q.s |
| |
| Frusemide Tablets IP 40 mg | Each uncoated tablet contains : |
| Frusemide IP 40 mg |
| |
| FUNGAL DIASTASE & PEPSIN SYRUPS | Each 5 ml contains : |
| Fungal Diastase(1:1200) IP 50 mg |
| From Aspergillus Oryzae |
| (Digest Not less than 60gms of cooked starch) |
| Pepsin(1:3000) IP 10 mg |
| (Digest Not less than 30gms of cogulated egg albumin) |
| Approved colour used in flavoured syrupy base |
| |
| FUNGAL DIASTASE & PEPSIN SYRUPS | Each 15 ml contains : |
| Fungal Diastase (1:1200) IP 50 mg |
| (Digest not less than 60 gm of cooked starch) |
| Pepsin (1:3000) IP 10 mg |
| (Digest not less than 30 gm of coagulated ezz albumnen) |
| Approved colour used in flavoured syrupy base |
| |
| Fungal Diastase, Papain , Simethicone & Niacinamide | Each film coated tablet contains : |
| Fungal Diastase (1:800) IP 50 mg |
| Papain IP 40 mg |
| Simethicone IP 50 mg |
| Niacinamide 25 mg |
| Thiamine Mononitrate IP 2.5 mg |
| Vitamin B2 IP 2.5 mg |
| Excipients q.s. |
| Colour – Black Oxide of Iron |
| |
| Fungal Diastase, Papain With Activated Charcoal Tablets | Each film coated tablet contains : |
| Fungal Diastase (1:800) IP 50 mg |
| Papain IP 40 mg |
| Activated Charcoal IP 75 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| FURAZOLIDONE & METRONIDAZOLE | Each 5 ml contains : |
| Furazalidone IP 30 mg |
| Metronidazole Benzoate IP |
| Equivalent to Metronidazole IP 100 mg |
| Approved colour used in flavoured syrupy base |
| |
| Furazolidone , Metronidazole & Dicyclomine Hydrochloride Tablets | Each uncoated tablet contains : |
| Furazolidone IP 50 mg |
| Metronidazole IP 200 mg |
| Dicyclomine Hydrochloride IP 10 mg |
| |
| Furazolidone and Metronidazole Tablets | Each uncoated tablet contains |
| Furazolidone IP 50 mg |
| Metronidazole IP 100 mg |
| Excipients q.s. |
| |
| FURAZOLIDONE SUSPENSION IP | Each 5 ml contains : |
| Furazalidone IP 25 mg |
| Approved colour used in flavoured syrupy base |
| |
| Furazolidone Tablets IP | Each uncoated tablet contains : |
| Furazolidone IP 100 mg |
| |
| Gabapentin and Methylcobalamin Tablets | Each film coated tablet contains : |
| Gabapentin IP 100 mg |
| Methylcobalamin IP 500 mcg |
| Approved colour to be use q.s. |
| |
| Gabapentin and Nortriptyline Tablets | Each film coated tablet contains: |
| Gabapentin IP 400 mg |
| Nortriptyline Hydrochloride IP |
| Eq. to Nortriptyline 10 mg |
| | Approved coloured used |
| |
| Gabapentin and Nortriptyline Tablets | Each film coated tablet contains: |
| Gabapentin IP 300 mg |
| Nortriptyline Hydrochloride IP |
| Eq. to Nortriptyline 10 mg |
| Approved coloured used |
| |
| Gabapentin and Nortriptyline Tablets | Each film coated tablet contains: |
| Gabapentin IP 100 mg |
| Nortriptyline Hydrochloride IP |
| Eq. to Nortriptyline 10 mg |
| Approved colour to be used |
| |
| Gabapentin and Nortriptyline Tablets | Each film coated tablets contains : |
| Gabapentin IP 200 mg |
| Nortriptyline Hydrochloride IP |
| Eq. to Nortriptyline 10 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Gabapentin Tablets IP | Each film coated tablet contains : |
| Gabapentin IP 100 mg |
| Approved coloured used |
| |
| Gabapentin Tablets IP | Each film coated tablet contains : |
| Gabapentin IP 300 mg |
| Approved coloured used |
| |
| Gabapentin Tablets IP | Each uncoated tablet contains |
| Gabapentin IP 100 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Gabapentin with Methylcobalamin | Each film coated tablet contains |
| Gabapentin IP 100 mg |
| Methylcobalamin 1500 mcg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine/ |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Gatifloxacin Tablets | Each film coated tablet contains |
| Gatifloxacin 400 mg |
| Approved colour to used |
| |
| Ginseng with Multi Vitamin, Calcium Panthothenate,Vitamin C, Zinc Sulphate, Niacinamide, Ferrous Fumarate and Folic acid | Each hard gelatin capsule contains : |
| Ginseng Extract IP 45 mg |
| Vitamin A Palmetate IP 2500 IU |
| Vitamin D3 (As Cholecalciferol) IP 200 IU |
| Vitamin E Acetate IP 10 mg |
| Vitamin B1 Mono IP 2 mg |
| Vitamin B2 IP 3 mg |
| Vitamin B6 HCI IP 1 mg |
| Vitamin B12 IP 1 mcg |
| Calcium Panthothenate IP 5 mg |
| Vitamin C (Coated) IP 50 mg |
| Zinc Sulphate IP |
| Equivalent to elemental zinc 1mg |
| Niacinamide IP 25 mg |
| Ferrous Fumarate IP 200 mg |
| Folic Acid IP 300 mcg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Glibenclamide and Metformin HCl Sustained Release Tablets | Each uncoated tablet contains : |
| Glibenclamide IP 5 mg |
| Metformin HCl (As Sustained Release) IP 500 mg |
| Approved colour used |
| |
| Glibenclamide and Metformin HCl Sustained Release Tablets | Each uncoated tablet contains : |
| Glibenclamide IP 2.5 mg |
| Metformin HCl (As Sustained Release) IP 500 mg |
| Approved colour used |
| |
| Glibenclamide and Metformin HCl Tablets IP | Each uncoated tablet contains : |
| Glibenclamide IP 5 mg |
| Metformin HCl IP 500 mg |
| Approved colour used |
| |
| Glibenclamide and Metformin HCl Tablets IP | Each uncoated tablet contains : |
| Glibenclamide IP 2.5 mg |
| Metformin HCl IP 400 mg |
| Approved colour used |
| |
| Glibenclamide Tablets IP | Each uncoated tablet contains |
| Glibenclamide IP 5 mg |
| |
| Glibenclamide, Pioglitazone and Metformin HCI Tablets | Each uncoated tablet contains : |
| Glibenclamide IP 5 mg |
| Pioglitazone Hydrochloride IP |
| Eq. to Pioglitazone 15 mg |
| Metformin Hydrochloride IP 500 mg |
| Approved colour to be used |
| |
| Glicazide Extended Release Tablets | Each uncoated extend release tablet contains |
| Glicazide IP 30 mg |
| |
| Glicazide Tablets IP | Each uncoated tablet contains |
| Glicazide IP 80 mg |
| |
| Gliclazide and Rosiglitazone with Metformin HCl Tablets | Each uncoated tablet contains : |
| Gliclazide IP 40 mg |
| Rosiglitazone Maleate |
| Eq. to Rosiglitazone 2 mg |
| Metformin HCl IP 500 mg |
| Approved colour to used |
| |
| Gliclazide and Rosiglitazone with Metformin HCl Tablets | Each uncoated tablet contains : |
| Gliclazide IP 80 mg |
| Rosiglitazone Maleate |
| Eq. to Rosiglitazone 2 mg |
| Metformin HCl IP 500 mg |
| Approved colour to used |
| |
| Gliclazide, Metformin HCl and Pioglitzone Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 500 mg |
| Gliclazide IP 80 mg |
| Pioglitazone Hydrochloride IP |
| Eq. to Pioglitazone 15 mg |
| Excipients q.s. |
| Approved coloured used |
| |
| Glimepiride and Metformin HCl Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 500 mg |
| Glimepiride IP 1 mg |
| Approved coloured used |
| |
| Glimepiride and Metformin HCl Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 500 mg |
| Glimepiride IP 2 mg |
| Approved coloured used |
| |
| Glimepiride Tablets IP 0.5 mg | Each film coated tablets contains : |
| Glimepiride IP 0.5 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Glimepiride, Metformin HC (SR) and Voglibose Tablets | Each uncoated bilayered tablet contains |
| Metformin Hydrochloride IP 500 mg |
| (As sustained release) |
| Glimepiride IP 2 mg |
| Voglibose IP 0.3 mg |
| Approved coloured used |
| |
| Glimepiride, Metformin HCI (SR) and Voglibose Tablets | Each uncoated bilayered tablet contains |
| Metformin Hydrochloride IP 500 mg |
| (As sustained release) |
| Glimepiride IP 2 mg |
| Voglibose IP 0.2 mg |
| Approved coloured used |
| |
| Glimepiride, Metformin HCI (SR) and Voglibose Tablets | Each uncoated bilayered tablet contains |
| Metformin Hydrochloride IP 500 mg |
| (As sustained release) |
| Glimepiride IP 1 mg |
| Voglibose IP 0.2 mg |
| Approved coloured used |
| |
| Glimepiride, Metformin HCI (SR) and Voglibose Tablets | Each uncoated bilayered tablet contains |
| Metformin Hydrochloride IP 500 mg |
| (As sustained release) |
| Glimepiride IP 1 mg |
| Voglibose IP 0.3 mg |
| Approved coloured used |
| |
| Glimepiride, Metformin HCI (SR) and Voglibose Tablets | Each uncoated bilayered tablet contains |
| Metformin Hydrochloride IP 1000 mg |
| (As sustained release) |
| Glimepiride IP 3 mg |
| Voglibose IP 0.2 mg |
| Approved colour to be used |
| |
| Glimepiride, Metformin HCl (SR) and Voglibose Tablets | Each uncoated bilayered tablet contains |
| Metformin Hydrochloride IP 500 mg |
| (As sustained release) |
| Glimepiride IP 3 mg |
| Voglibose IP 0.3 mg |
| Approved coloured used |
| |
| Glimepiride, Metformin HCl (SR) and Voglibose Tablets | Each uncoated bilayered tablet contains |
| Metformin Hydrochloride IP 1000 mg |
| (As sustained release) |
| Glimepiride IP 3 mg |
| Voglibose IP .03 mg |
| Approved coloured used |
| |
| Glimepiride, Metformin HCl (SR) and Voglibose Tablets | Each uncoated bilayered tablet contains |
| Metformin Hydrochloride IP 1000 mg |
| (As sustained release) |
| Glimepiride IP 2 mg |
| Voglibose IP 0.2 mg |
| Approved coloured used |
| |
| Glimepiride, Metformin HCl (SR) and Voglibose Tablets | Each uncoated bilayered tablet contains |
| Metformin Hydrochloride IP 1000 mg |
| (As sustained release) |
| Glimepiride IP 1 mg |
| Voglibose IP 0.2 mg |
| Approved coloured used |
| |
| Glimepride Tablets IP | Each uncoated tablet contains |
| Glimepride IP 1 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Glimepride Tablets IP | Each uncoated tablet contains |
| Glimepride IP 2 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Glimepride Tablets IP | Each uncoated tablet contains |
| Glimepride IP 3 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Glimepride Tablets IP | Each uncoated tablet contains |
| Glimepride IP 4 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Glipizide Tablets 10 mg | Each uncoated tablet contains : |
| Glipizide IP 10 mg |
| |
| Glipizide Tablets IP 5 mg | Each uncoated tablet contains : |
| Glipizide IP 5 mg |
| |
| Glucosamine, Methylcobalamin Methyl sulphonyl Methane | Each film coated tablet contains |
| Glucosamine Sulphate Potassium Chloride IP 750 mg |
| Methylcobalamin 750 mcg |
| Methyl sulphonyl Methane USP 250 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Glutathione Tablets | Each uncoated tablet contains : |
| Glutathione 600 mg |
| Exciplents q.s. |
| |
| Glyceryl Trinitrate Tablets IP | Each uncoated tablet contains |
| Glyceryl Trinitrate IP 500 mcg |
| |
| Griseofulvin & Cetirizine Hydrochloride Tablets | Each uncoated tablet contains : |
| Griseofulvin IP 250 mg |
| Cetirizine Hydrochloride IP 5 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Griseofulvin Tablets IP | Each uncoated tablet contains : |
| Griseofulvin IP 125 mg |
| Excipients q.s. |
| |
| Griseofulvin Tablets IP | Each uncoated tablet contains : |
| Griseofulvin IP 250 mg |
| Excipients q.s. |
| |
| Guaiphenesin, Bromhexine Hcl, and Chlorpheniramine | Each uncoated tablet contains : |
| Guaiphenesin IP 50 mg |
| Bromhexine HCl IP 4 mg |
| Chlorpheniramine maleate IP 2 mg |
| Approved colour to used |
| |
| Haloperidol Tablet IP | Each uncoated tablet contains |
| Haloperidol IP 0.5 mg |
| Excipients q.s. |
| |
| Haloperidol Tablet IP | Each uncoated tablet contains |
| Haloperidol IP 1 mg |
| Excipients q.s. |
| |
| Haloperidol Tablet IP | Each uncoated tablet contains |
| Haloperidol IP 1.5 mg |
| Excipients q.s. |
| |
| Haloperidol Tablet IP | Each uncoated tablet contains |
| Haloperidol IP 2 mg |
| Excipients q.s. |
| |
| Haloperidol Tablet IP | Each uncoated tablet contains |
| Haloperidol IP 5 mg |
| Excipients q.s. |
| |
| Haloperidol Tablet IP | Each uncoated tablet contains |
| Haloperidol IP 10 mg |
| Excipients q.s. |
| |
| Haloperidol Tablets | Each uncoated tablet contains : |
| Haloperidol IP 0.5 mg |
| Approved colour to used |
| |
| Haloperidol Tablets IP | Each uncoated tablet contains : |
| Haloperidol IP 1.5 mg |
| Approved colour to used |
| |
| Haloperidol Tablets IP | Each uncoated tablet contains : |
| Haloperidol IP 5 mg |
| Approved colour to used |
| |
| Haloperidol Tablets IP | Each uncoated tablet contains : |
| Haloperidol IP 10 mg |
| Approved colour to used |
| |
| Hydralazine Hydrochloride Tablets 25 mg | Each uncoated tablets contains : |
| Hydralazine Hydrochloride BP 25 mg |
| Approved colour to be used |
| |
| |
| Hydralazine Hydrochloride Tablets 50 mg | Each uncoated tablets contains : |
| Hydralazine Hydrochloride BP 50 mg |
| Approved colour to be used |
| |
| |
| Hydrochlorothiazide Tablets IP | Each uncoated tablet contains : |
| Hydrochlorothiazide IP 12.5 mg |
| |
| Hydrochlorothiazide Tablets IP | Each uncoated tablet contains : |
| Hydrochlorothiazide IP 25 mg |
| |
| Hydrocortisone Tablets USP 10 mg | Each Uncoated tablet contains: |
| Hydrocortisone IP 10 mg |
| |
| |
| Hydrocortisone Tablets USP 20 mg | Each Uncoated tablet contains: |
| Hydrocortisone IP 20 mg |
| |
| |
| Hydrocortisone Tablets USP 5 mg | Each Uncoated tablet contains: |
| Hydrocortisone IP 5 mg |
| |
| |
| Hydroxychloroquine Tablets IP | Each film coated tablet contains : |
| Hydroxychloroquine Sulphate IP 100 mg |
| Approved colour to be use |
| |
| Hydroxychloroquine Tablets IP | Each film coated tablet contains : |
| Hydroxychloroquine Sulphate IP 200 mg |
| Approved colour to be use |
| |
| Hydroxychloroquine Tablets IP | Each film coated tablet contains : |
| Hydroxychloroquine Sulphate IP 300 mg |
| Approved colour to be use |
| |
| Hydroxychloroquine Tablets IP | Each film coated tablet contains : |
| Hydroxychloroquine Sulphate IP 400 mg |
| Approved colour to be use |
| |
| Hydroxyzine Hydrochloride Oral Suspension IP | Each 5 ml contains : |
| Hydroxyzine Hydrochloride IP 10 mg |
| Approved colour used in flavoured syrupy base |
| |
| Hydroxyzine Hydrochloride Tablets IP | Each film coated tablet contains : |
| Hydroxyzine Hydrochloride IP 25 mg |
| Approved colour to used |
| |
| Hydroxyzine Hydrochloride Tablets IP | Each film coated tablet contains : |
| Hydroxyzine Hydrochloride IP 10 mg |
| Excipients q.s. |
| Approved colour to used |
| |
| Ibuprofen & Paracetamol Dispersible Tablets | Each uncoated dispersible tablet contains |
| Ibuprofen IP 100 mg |
| Paracetamol IP 125 mg |
| Colour: Brilliant Blue / Erythrosine/ Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP IApple Green / Iran oxide red,Iron oxide Yellow |
| |
| IBUPROFEN & PARACETAMOL ORAL SUSPENSION IP | Each 5 ml contains : |
| Ibuprofen IP 100 mg |
| Paracetamol IP 125 mg |
| Approved colour used in flavoured syrupy base |
| |
| IBUPROFEN & PARACETAMOL ORAL SUSPENSION IP | Each 5 ml contains : |
| Ibuprofen IP 100 mg |
| Paracetamol IP 162.5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Ibuprofen & Paracetamol Tablets | Each uncoated tablet contains : |
| Ibuprofen IP 200 mg |
| Paracetamol IP 325 mg |
| |
| Ibuprofen & Paracetamol Tablets | Each uncoated tablet contains : |
| Ibuprofen IP 400 mg |
| Paracetamol IP 325 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / |
| Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Ibuprofen Tablets IP 200 mg | Each film coated tablet contains : |
| Ibuprofen IP 200 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Ibuprofen Tablets IP 400 mg | Each film coated tablet contains : |
| Ibuprofen IP 400 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Ibuprofen Tablets IP 600 mg | Each film coated tablet contains : |
| Ibuprofen IP 600 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Imipramine Hydrochloride Tablets IP 10 mg | Each film coated tablet contains : |
| Imipramine Hydrochloride IP 10 mg |
| Approved colour to used |
| |
| Imipramine Hydrochloride Tablets IP 25 mg | Each film coated tablet contains : |
| Imipramine Hydrochloride IP 25 mg |
| Approved colour to used |
| |
| Indapamide (Sustained Release) and Nebivolol Hydrochloride Tablets | Each uncoated bilayered tablet contains : |
| Indapamide IP 1.5 mg |
| (As sustained release) |
| Nebivolol Hydrochloride IP |
| Eq. to Nebivolol 2.5 mg |
| Approved colour to used |
| |
| Indapamide (Sustained Release) and Nebivolol Hydrochloride Tablets | Each uncoated bilayered tablet contains : |
| Indapamide IP 1.5 mg |
| (As sustained release) |
| Nebivolol Hydrochloride IP |
| Eq. to Nebivolol 5 mg |
| Approved colour to be used |
| |
| Indomethacin (SR) & Omeprazole Capsules | Each hard gelatin capsule contains |
| Indomethacin IP 75 mg |
| (As per sustain Release pellets) |
| Omeprazole IP 20 mg |
| (As per enteric coated pellets) |
| Approved colour used in empty capsule shell |
| |
| Indomethacin (SR) Capsules | Each hard gelatin capsule contains |
| Indomethacin IP 75 mg |
| (As per sustain Release pellets) |
| Approved colour used in empty capsule shell |
| |
| INDOMETHACIN CAPSULE IP | Each hard gelatin capsule contains |
| Indomethacin IP 25 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Irbesartan and Hydrochlorothiazide Tablets IP | Each uncoated tablet contains : |
| Irbesartan IP 150 mg |
| Hydrochlorothiazide IP 12.5 mg |
| Approved colour to used |
| |
| Irbesartan and Hydrochlorothiazide Tablets IP | Each uncoated tablet contains : |
| Irbesartan IP 300 mg |
| Hydrochlorothiazide IP 12.5 mg |
| Approved colour to used |
| |
| Irbesartan Tablets 75 mg | Each uncoated tablet contains : |
| Irbesartan IP 75 mg |
| Approved colour to used |
| |
| Irbesartan Tablets IP 150 mg | Each uncoated tablet contains : |
| Irbesartan IP 150 mg |
| Approved colour to used |
| |
| Irbesartan Tablets IP 300 mg | Each uncoated tablet contains : |
| Irbesartan IP 300 mg |
| Approved colour to used |
| |
| IRON & FOLIC ACID SYRUPS For Therapeutic Use | Each 5 ml contains : |
| Iron (III) Hydroxide Polymaltose Complex |
| Eq. to Elemental Iron IP 50 mg |
| Folic Acid IP 500 mcg |
| Approved colour used in flavoured syrupy base |
| |
| Iron & Folic Acid Tablets IP | Each film coated tablet contains: |
| Ferrous Sulphate IP |
| Eq. to elemental Iron 100 mg |
| Folic Acid IP 1.5 mg |
| Permitted Color Used |
| |
| Iron (III) Polymaltose, Folic acid Syrup | Each 15 ml contains : |
| Iron (III) Hydroxide Polymaltose |
| Complex Eq. to Elemental Iron 50 mg |
| Folic acid IP 0.5 mg |
| Approved coloured use in a flavoured syrup base |
| |
| IRON, CYANOCOBALAMIN wITH FOLIC ACID SYRUPS | Each 15 ml contains |
| Ferric Ammonium Citrate IP 160 mg |
| (equivalent to Elemental Iron 32 mg) |
| Folic Acid IP 1500 mcg |
| Cyanocobalamin IP 15 mcg |
| Approved Colour used in Flavoured Syrupy Base |
| |
| Iron, Cyanocobalamin, Zinc Folic Acid, and Pyridoxine Hcl | Each 15 ml contains : |
| Ferric Ammonium Citrate IP 200 mg |
| (Equivalent to Elemental Iron 41 mg) |
| Folic Acid IP 0.5 mg |
| Cyanocobalamin IP 7.5 mcg |
| Zinc Sulphate IP 7 mg |
| Pyridoxine Hcl IP 1.5 mg |
| Sorbitol solution 70 % q.s. |
| Approved Colour used inFlavoured Syrupy Base |
| |
| Iron, Folic acid and Cyanocobalamin Syrup | Each 5 ml contains : |
| Ferric Amonium Citrate IP 110 mg |
| Eq. to Elemental Iron 22.5 mg |
| Folic acid IP 1.5 mg |
| Cyanocobalamin IP 15 mcg |
| Sorbitol solution (70%) Non crystalling q.s. |
| Approved coloured use in a flavoured syrup base |
| |
| IRON, FOLIC ACID WITH ZINC SYRUPS | Each 15 ml contains: |
| Iron (III) Hydroxide Polymaltose Complex |
| Eq. to Elemental Iron IP 100 mg |
| Folic Acid IP 1500 mcg |
| Zinc Sulphate IP |
| Eq.to Elemental Zinc 10 mg |
| Approved Colour used inFlavoured Syrupy Base |
| |
| IRON, FOLIC ACID, WITH CYANOCOBALAMIN & ZINC SYRUPS | Each 15 ml contains: |
| Elemental Iron (As Carbonyl Iron USP) 75 mg |
| Folic Acid IP 1500 mcg |
| Cyanocobalamin IP 5 mcg |
| Zinc Sulphate Monohydrate IP |
| Elemental Zinc 20 mg |
| Approved colour used in flavoured syrupy base |
| |
| IRON, L-LYSIN HYDROCHLORIDE WITH FOLIC ACID SYRUP | Each 5 ml contains : |
| Iron (III) Hydroxide Polymaltose Complex |
| eq. to Elemental Iron IP 50 mg |
| L-Lysine Hydrochloride USP 10 mg |
| Cyanocobalamin IP 5 mcg |
| Folic Acid IP 1 mg |
| Approved colour used in flavoured syrupy base |
| |
| IRON,MULTIVITAMIN &MULTIMINERAL SYRUPS | Each 15 ml contains: |
| Iron Choline Citrate IP 200 mg |
| L-Lysine Hydrochloride USP 100 mg |
| Nicotinamide IP 45 mg |
| Thiamine Mononitrate IP 5 mg |
| Riboflavine (As Riboflavine Sodium Phosphate) IP 5 mg |
| D Panthenol IP 5 mg |
| Pyridoxine HCL IP 1.5 mg |
| Zinc Sulphate Monohydrate IP 10 mg |
| Cyanocobalamin IP 7.5 mcg |
| Choline Dihydrogen Citrate 30 mg |
| Glutamic Acid USP 10 mg |
| Approved colour used in flavoured syrupy base |
| |
| Isoniazid Tablets IP 100 mg | Each filmcoated tablet contains : |
| Isoniazid IP 100 mg |
| Approved colour to used |
| |
| Isoniazid Tablets IP 300 mg | Each filmcoated tablet contains : |
| Isoniazid IP 300 mg |
| Approved colour to used |
| |
| Isoniazid Tablets IP 50 mg | Each filmcoated tablet contains : |
| Isoniazid IP 50 mg |
| Approved colour to used |
| |
| Isosorbibe Dinitrate and Hydralazine Hydrochloride Tablets | Each film coated tablets contains : |
| Diluted Isosorbibe Dinitrate IP |
| Eq. to Isosorbibedrinate 20 mg |
| Hydralazine Hydrochloride IP 37.5 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Isosorbide Mononitrate Tablets IP | Each uncoated tablet contains |
| Isosorbide Mononitrate IP 10 mg |
| |
| Isosorbide Mononitrate Tablets IP | Each uncoated tablet contains |
| Isosorbide Mononitrate IP 20 mg |
| |
| Isosorbide Mononitrate Tablets IP | Each uncoated tablet contains |
| Isosorbide Mononitrate IP 30 mg |
| |
| Isotretinoin Capsules IP | Each hard gelatin capsule contains: |
| Isotretinoin IP 5 mg |
| Excipients q.s. |
| Approved colour use in empty capsule shells |
| |
| Isotretinoin Capsules IP | Each hard gelatin capsule contains: |
| Isotretinoin IP 10 mg |
| Excipients q.s. |
| Approved colour use in empty capsule shells |
| |
| Isotretinoin Capsules IP | Each hard gelatin capsule contains: |
| Isotretinoin IP 20 mg |
| Excipients q.s. |
| Approved colour use in empty capsule shells |
| |
| Isotretinoin Capsules IP | Each hard gelatin capsule contains: |
| Isotretinoin IP 30 mg |
| Excipients q.s. |
| Approved colour use in empty capsule shells |
| |
| Isotretinoin Capsules IP | Each hard gelatin capsule contains: |
| Isotretinoin IP 40 mg |
| Excipients q.s. |
| Approved colour use in empty capsule shells |
| |
| Isotretinoin Tablets | Each Uncoated tablet contains: |
| Isotretinoin IP 10 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Isotretinoin Tablets | Each Uncoated tablet contains: |
| Isotretinoin IP 20 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Itopride HCI (SR) Capsules | Each hard gelatin capsule contains |
| Itopride Hydrochloride IP 150 mg |
| (As sustained release pellets) |
| Approved colour use in empty capsule shell |
| |
| Itopride Hydrochloride Tablets IP | Each film coated tablet contains: |
| Itopride Hydrochloride IP 50mg |
| Approved colour use |
| |
| Itraconazole Capsules | Each hard gelatin capsule contains |
| Itraconazole (As pellets) BP 100 mg |
| Approved colour used in empty capsule shell |
| |
| Itraconazole Capsules | Each hard gelatin capsule contains |
| Itraconazole (As pellets) BP 200 mg |
| Approved colour used in empty capsule shell |
| |
| Itraconazole IR Pellets 20.00 % W/W | Each 1 gm coated pellets contains |
| Itraconazole 200 mg |
| Approved colour to be use |
| |
| |
| Itraconazole IR Pellets 22.00 % W/W | Each 1 gm coated pellets contains |
| Itraconazole 220 mg |
| Approved colour to be use |
| |
| |
| Itraconazole IR Pellets 35.00 % w/w | Each 1 gm coated pellets contains |
| Itraconazole 350 mg |
| Approved colour to be use |
| |
| |
| Itraconazole Sustained Release Tablets | Each film coated (SR) tablet contains : |
| Itraconazole USP 200 mg |
| Approved coloured used |
| |
| Ivermectin Tablets | Each uncoated tablet contains : |
| Ivermectin IP 6 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / tron oxide red iron oxide Yellow |
| |
| Ivermectin Tablets | Each uncoated tablet contains |
| Ivermectin IP 10 mg |
| Colour : Erythrosine |
| |
| Ivermectin Tablets For Veterinary Use | Each uncoated tablet contains |
| Ivermectin IP 100 mg |
| Colour : Sunset Yellow |
| |
| Ivermectin Tablets USP | Each uncoated tablet contains |
| Ivermectin IP 12 mg |
| Approved colour to be used |
| |
| Ketoconazole Tablets IP | Each uncoated tablet contains |
| Ketoconazole IP 200 mg |
| |
| Ketoprofen & Paracetamol Bolus For Veterinary Use | Each uncoated bolus contains |
| Ketoprofen USP 1500 mg |
| Paracetamol IP 1500 Mg |
| |
| Ketoprofen & Thiocolchicoside Tablets | Each uncoated tablet contains |
| Ketoprofen 50 mg |
| Thiocolchicoside 4 mg |
| |
| Ketorolac Tromethamine Tablets IP 10 mg | Each Uncoated tablet contains: |
| Ketorolac Tromethamine IP 10 mg |
| Excipients q.s. |
| |
| |
| Lacosamide Tablets | Each film coated tablet contains : |
| Lacosamide 50 mg |
| Excipients q.s. |
| Approved colour used |
| |
| Lacosamide Tablets | Each film coated tablet contains : |
| Lacosamide 100 mg |
| Excipients q.s. |
| Approved colour used |
| |
| Lacosamide Tablets | Each film coated tablet contains : |
| Lacosamide 150 mg |
| Excipients q.s. |
| Approved colour used |
| |
| Lacosamide Tablets | Each film coated tablet contains : |
| Lacosamide 200 mg |
| Excipients q.s. |
| Approved colour used |
| |
| Lactic Acid Bacillus Capsules | Each hard gelatin capsule contains |
| Lactic Acid Bacillus IP 1000 mill.Spor |
| Approved colour used in empty capsule shell |
| |
| Lactic acid Bacillus tablet | Each uncoated tablet contains : |
| Lactic acid Bacillus 60 mil. spo. |
| Approved colour to be use |
| |
| Lactic acid Bacillus tablet | Each uncoated tablet contains : |
| Lactic acid Bacillus 120 mil. spo. |
| Approved colour to be use |
| |
| Lactic acid basillus, Vitamin B12 and Folic acid Dispersible Tablets | Each Uncoated Dispersible tablet contains: |
| Lactic acid basillus 120 mill. Spore |
| Vitamin B 12 IP 5 mcg |
| Folic acid IP 1500 mcg |
| Excipients q.s. |
| Approved colour to be used |
| |
| LACTIC ACID, THIAMINE (MONO), RIBOFLAVINE, NICOTINAMIDE,Pyridoxine HCL, D panthenol and Folic acid | Each hard gelatin capsule contains |
| Lactic Acid Bacillus 40 mill.Sp |
| Thiamine Monoitrate IP 2 mg |
| Riboflavine IP 2.5 mg |
| Nicotinamide IP 22.5 mg |
| Pyridoxine Hydrochloride IP 0.75 mg |
| D-Panthenol IP 2.5 mg |
| Folic Acid IP 300 mcg |
| Approved colour used in empty capsule shell |
| |
| Lactulose Oral Solution USP | Each 15 ml. contains : |
| Lactulose Concentrate USP |
| eq. to Lactulose 10 g |
| Approved colour used in flavoured syrupy base |
| |
| Lamotrigine Dispersible Tablets IP | Each uncoated dispersible tablet contains: |
| Lamotrigine IP 25 mg |
| Approved colour to be used |
| |
| Lamotrigine Dispersible Tablets IP | Each uncoated dispersible tablet contains: |
| Lamotrigine IP 50 mg |
| Approved colour to be used |
| |
| Lamotrigine Dispersible Tablets IP | Each uncoated dispersible tablet contains: |
| Lamotrigine IP 100 mg |
| Approved colour to be used |
| |
| Lamotrigine Sustained-release Tablets IP | Each uncoated sustained release tablet contains: |
| Lamotrigine IP 50 mg |
| Approved colour to be used |
| |
| Lamotrigine Sustained-release Tablets IP | Each uncoated sustained release tablet contains: |
| Lamotrigine IP 100 mg |
| Approved colour to be used |
| |
| Lamotrigine Sustained-release Tablets IP | Each uncoated sustained release tablet contains: |
| Lamotrigine IP 200 mg |
| Approved colour to be used |
| |
| LANSOPRAZOLE & DOMPERIDONE CAPSULES | Each hard gelatin capsule contains |
| Lansoprazole (As enteric coated pellets) IP 30 mg |
| Domperidon (As coated pellets) IP 10 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| LANSOPRAZOLE CAPSULES IP | Each hard gelatin capsule contains |
| Lansoprazole (As enteric coated pellets) IP 30 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| LANSOPRAZOLE EC PELLETS 10.0 % W/W | Each 1 gm enteric coated pellets contains |
| Lansoprazole 100mg |
| Approved colour to be use |
| |
| LANSOPRAZOLE EC PELLETS 11.20 % W/W | Each 1 gm enteric coated pellets contains |
| Lansoprazole 112mg |
| Approved colour to be use |
| |
| LANSOPRAZOLE EC PELLETS 8.5 % w/w | Each 1 gm enteric coated pellets contains |
| Lansoprazole 85 mg |
| Approved colour to be use |
| |
| LANSOPRAZOLE EC PELLETS 9.25 % W/W | Each 1 gm enteric coated pellets contains |
| Lansoprazole 92.5 mg |
| Approved colour to be use |
| |
| Lansoprazole Orally Disintegrating Tablets | Each orally disintegrating tablet contains |
| Lansoprazole IP 15 mg |
| Approved coloured used |
| |
| Lenalidomide Capsules IP | Each hard gelatin capsule contains: |
| Lenalidomide IP 5 mg |
| Excipients q.s. |
| Approved colour use in empty capsule shells |
| |
| Lenalidomide Capsules IP | Each hard gelatin capsule contains: |
| Lenalidomide IP 10 mg |
| Excipients q.s. |
| Approved colour use in empty capsule shells |
| |
| Lenalidomide Capsules IP | Each hard gelatin capsule contains: |
| Lenalidomide IP 15 mg |
| Excipients q.s. |
| Approved colour use in empty capsule shells |
| |
| Lenalidomide Capsules IP | Each hard gelatin capsule contains: |
| Lenalidomide IP 25 mg |
| Excipients q.s. |
| Approved colour use in empty capsule shells |
| |
| Lenvatinib Capsules IP | Each hard gelatin capsule contains: |
| Lenvatinib Mesylate IP |
| Eq. to Lenvatinib 4 mg |
| Excipients q.s. |
| Approved colour use in empty capsule shells |
| |
| Lenvatinib Capsules IP | Each hard gelatin capsule contains: |
| Lenvatinib Mesylate IP |
| Eq. to Lenvatinib 8 mg |
| Excipients q.s. |
| Approved colour use in empty capsule shells |
| |
| Lenvatinib Capsules IP | Each hard gelatin capsule contains: |
| Lenvatinib Mesylate IP |
| Eq. to Lenvatinib 10 mg |
| Excipients q.s. |
| Approved colour use in empty capsule shells |
| |
| Letrozole Tablets IP | Each film coated tablets contains : |
| Letrozole IP 2.5 mg |
| Approved colour to be used |
| |
| Levamisole Hydrochloride & Albendazole Tablets | Each film coated tablets contains : |
| Levamisole Hydrochloride IP |
| Eq. to Levamisole 50 mg |
| Albendazole IP 400 mg |
| Approved colour to be used |
| |
| Levamisole Hydrochloride Tablets IP | Each uncoated tablets contains |
| Levamisole Hydrochloride IP |
| Eq. to Levamisole 50 mg |
| Approved colour to be used |
| |
| Levamisole Hydrochloride Tablets IP | Each uncoated tablets contains |
| Levamisole Hydrochloride IP |
| Eq. to Levamisole 150 mg |
| Approved colour to be used |
| |
| Levetiracetam (PR) Tablets IP | Each uncoated tablet contains : |
| Levetiractam IP 500 mg |
| (Prolonged released) |
| Excipients q.s. |
| |
| Levetiracetam Tablets IP | Each uncoated tablet contains |
| Levetiracetam 250 mg |
| |
| Levetiracetam Tablets IP | Each uncoated tablet contains |
| Levetiracetam 500 mg |
| |
| Levetiracetam Tablets IP | Each uncoated tablet contains |
| Levetiracetam 750 mg |
| |
| Levetiracetam Tablets IP | Each uncoated tablet contains : |
| Levetiractam IP 1000 mg |
| Excipients q.s. |
| |
| Levetiracetam Tablets IP | Each film coated tablet contains : |
| Levetiractam IP 500 mg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Levocetirizine Hcl & Ambroxol Hcl Syrup | Each 5 ml contains : |
| Levocetirizine HCl IP 5 mg |
| Ambroxol Hcl IP 30 mg |
| Approved colour used in flavoured syrupy base |
| |
| Levocetirizine Hcl & Ambroxol Hcl Syrup | Each 5 ml contains : |
| Levocetirizine HCl IP 2.5 mg |
| Ambroxol Hcl IP 30 mg |
| Approved colour used in flavoured syrupy base |
| |
| LEVOCETIRIZINE HYDROCHLORIDE & AMBROXOL HYDROCHLORIDE | Each 5 ml contains : |
| Levocetirizine Hydrochloride IP 2.5 mg |
| Ambroxol Hydrochloride IP 15 mg |
| Approved colour used in flavoured syrupy base |
| |
| |
| LEVOCETIRIZINE HYDROCHLORIDE & MONTELUKAST SUSPENSION | Each 5 ml contains : |
| Levocetirizine Hydrochloride IP 2.5 mg |
| Montelukast Sodium IP |
| eq. to Montelukast 4 mg |
| Approved colour used in flavoured syrupy base |
| |
| Levocetirizine Hydrochloride and Montelukast dispersible Tablets | Each uncoated dispersible tablet contains : |
| Levocetirizine Hydrochloride IP 2.5 mg |
| Montelukast Sodium IP |
| Eq. to Montelukast 5 mg |
| Approved colour used |
| |
| Levocetirizine Hydrochloride and Montelukast Tablets | Each uncoated tablet contains : |
| Levocetirizine Hydrochloride IP 2.5 mg |
| Montelukast Sodium IP |
| Eq. to Montelikast 5 mg |
| Approved colour used |
| |
| Levocetirizine Hydrochloride Phenylephrine Hydrochloride & | Each uncoated tablet contains |
| Levocetirizine Hydrochloride IP 5 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Paracetamol IP 325 mg |
| Colour: Brilliant Blue / Erythrosine /Tartrazine |
| or Titanium Dioxide IP/Ferric Oxide Yellow |
| |
| Levocetirizine Hydrochloride Phenylephrine Hydrochloride & | Each uncoated tablet contains |
| Levocetirizine Hydrochloride IP 5 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Paracetamol IP 500 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| LEVOCETIRIZINE HYDROCHLORIDE SYRUP IP | Each 5 ml contains : |
| Levocetirizine Hydrochloride IP 2.5 mg |
| Approved colour used in flavoured syrupy base |
| |
| |
| Levocetirizine Hydrochloride Tablets IP | Each film coated tablet contains: |
| Levocetirizine Hydrochloride IP 5 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Survet yellow |
| |
| Levocetirizine Hydrochloride Tablets | Each film coated tablet contains : |
| Levocetirizine Hydrochloride IP 10 mg |
| Approved colour used |
| |
| Levocetirizine Hydrochloride With Ambroxol Hdrochloride Tablets | Each film coated tablet contains : |
| Levocetirizine Hydrochloride IP 5 mg |
| Ambroxol Hdrochloride IP 60 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Levocetirizine Hydrochloride, Phenylephrine Hydrochloride,Ambroxol HCL and Paracetamol | Each uncoated tablet contains : |
| Levocetirizine Hydrochloride IP 5 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Ambroxol Hydrochloride IP 30 mg |
| Paracetmol IP 325 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| |
| LEVOCETIRIZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE and Paracetamol | Each 5 ml contains : |
| Levocetirizine Hydrochloride IP 2.5 mg |
| Paracetamol IP 250 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Levocetirizine With Dispersible Tablets | Each uncoated dispersible tablet contains : |
| Levocetirizine Hydrochloride IP 2.5 mg |
| Montelukast Sodium IP |
| eq. to Montelukast 4 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Senset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Levocetirizine With Montelukast Tablets | Each film coated tablet contains : |
| Levocetirizine Hydrochloride IP 5 mg |
| Montelukast Sodium IP |
| Eq. to Montelukast 10 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Levocetirizine, Montelukast & Ambroxol Tablets | Each uncoated tablet contains |
| Levocetirizine Hydrochloride IP 5 mg |
| Montelukast Sodium IP |
| eq. to Montelukast 10 mg |
| Ambroxol Hydrochloride IP 75 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine |
| |
| Levocetirizine, Montelukast and Ambroxol HCI (SR) tablets | Each uncoated bilayered tablet contains |
| Levocetirizine Hydrochloride IP 5 mg |
| Montelukast sodium IP |
| Eq. to Montelukast 10 mg |
| Ambroxol Hydrochloride 75 mg |
| (As Sustained Release form) |
| Approved coloured used |
| |
| Levodopa and Carbidopa Tablets IP | Each uncoated tablet contains: |
| Levodopa IP 100 mg |
| Carbidopa IP |
| Eq. to Anhydrous Carbidopa 10 mg |
| Excipients q.s. |
| |
| Levodopa and Carbidopa Tablets IP | Each uncoated tablet contains: |
| Levodopa IP 100 mg |
| Carbidopa IP |
| Eq. to Anhydrous Carbidopa 25 mg |
| Excipients q.s. |
| |
| Levodopa and Carbidopa Tablets IP | Each uncoated tablet contains: |
| Levodopa IP 250 mg |
| Carbidopa IP |
| Eq. to Anhydrous Carbidopa 25 mg |
| Excipients q.s. |
| |
| Levodopa Capsules IP | Each hard gelatin capsule contains |
| Levodopa IP 125 mg |
| Excipients q.s. |
| Approved colour use in empty capsule shell |
| |
| Levodopa Capsules IP | Each hard gelatin capsule contains |
| Levodopa IP 250 mg |
| Excipients q.s. |
| Approved colour use in empty capsule shell |
| |
| Levodopa Capsules IP | Each hard gelatin capsule contains |
| Levodopa IP 500 mg |
| Excipients q.s. |
| Approved colour use in empty capsule shell |
| |
| Levodopa Tablets IP | Each uncoated tablet contains : |
| Levodopa IP 250 mg |
| Excipients |
| |
| Levodopa Tablets IP | Each uncoated tablet contains : |
| Levodopa IP 500 mg |
| Excipients |
| |
| Levodropropizine and Chlorpheniramine Maleate Syrup | Each 5 ml contains : |
| Levodropropizine IP 30 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Approved colour used in flavoured syrupy base |
| |
| Levofloxacin and Ornidazole Tablets | Each film coated tablet contains : |
| Levofloxacin Hemihydrate IP |
| Eq. to Levofloxacin 250 mg |
| Ornidazole IP 500 mg |
| Excipients q.s. |
| Approved coloured used |
| |
| Levofloxacin Oral Solution IP | Each 5 ml contains: |
| Levofloxacin Hemihydrate IP |
| eq. to Levofloxacin 125 mg |
| Approved colour used in flavoured syrupy base |
| |
| Levofloxacin Tablets IP 250 mg | Each film coated tablet contains : |
| Levofloxacin Hemihydrate IP |
| Equivalent to Levofloxacin 250 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yelloy / Sunset yellow |
| or Tanium Dioxide IP /Apple Green / Iron oxide red, Iron Oxide Yeller |
| |
| Levofloxacin Tablets IP 500 mg | Each film coated tablet contains : |
| Levofloxacin Hemihydrate IP |
| Equivalent to Levofloxacin 500 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron Oxide red, Iron oxide Yellow |
| |
| Levofloxacin Tablets IP 750 mg | Each film coated tablet contains : |
| Levofloxacin Hemihydrate IP |
| Equivalent to Levofloxacin 750 mg |
| Approved colour to be used |
| |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride | Each 5 ml contains : |
| Levosalbutamol Sulphate IP |
| Eq. to Levosalbutamol 0.5 mg |
| Ambroxol Hydrochloride IP 15 mg |
| Guaiphenesin IP 25 mg |
| Approved colour used in flavoured syrupy base |
| |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride | Each ml contains : |
| Levosalbutamol Sulphate IP |
| eq. to Levosalbutamol 0.25 mg |
| Ambroxol Hydrochloride IP 7.5 mg |
| Guaiphenesin IP 12.5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride | Each 5 ml contains : |
| Levosalbutamol Sulphate IP |
| eq. to Levosalbutamol 1 mg |
| Ambroxol Hydrochloride IP 15 mg |
| Guaiphenesin IP 50 mg |
| Approved colour used in flavoured syrupy base |
| |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride & | Each 5 ml. contains |
| Levosalbutamol Sulphate |
| eq. to Levosalbutamol IP 1 mg |
| Ambroxol Hydrochloride IP 30 mg |
| Guaiphenesin IP 50 mg |
| Colour: Erythrosine / Tartrazine / Sunset Yellow |
| Ponceau-4R or Carmosine |
| In flavoured syrupy base |
| |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride & | Each 5 ml. contains |
| Levosalbutamol Sulphate |
| eq. to Levosalbutamol IP 1 mg |
| Ambroxol Hydrochloride IP 30 mg |
| Guaiphenesin IP 50 mg |
| Colour: Erythrosine / Tartrazine / Sunset Yellow |
| Ponceau-4R or Carmosine |
| In flavoured syrupy base |
| |
| LEVOSALBUTAMOL SULPHATE, BROMHEXINE HYDROCHLORIDE,Guaiphenesin and Menthol | Each 10 ml contains : |
| Levosalbutamol Sulphate IP |
| Equivalent to Levosalbutamol 2 mg |
| Bromhexine Hydrochloride IP 4 mg |
| Guaiphenesin IP 100 mg |
| Menthol qs |
| Approved colour used in flavoured syrupy base |
| |
| Levosulpiride Sustained Released Tablets | Each uncoated Sustained Released tablet contains : |
| Levosulpiride 75 mg |
| |
| Levosulpiride Sustained Released Tablets | Each uncoated Sustained Released tablet contains : |
| Levosulpiride 150 mg |
| |
| Levosulpiride Sustained Released Tablets | Each uncoated Sustained Released tablet contains : |
| Levosulpiride 200 mg |
| |
| Levosulpiride Tablets | Each uncoated tablet contains : |
| Levosulpiride 25 mg |
| |
| Levothyroxine Sodium Tablets IP | Each uncoated tablet contains |
| Levothyroxine Sodium IP |
| eq.to Thyroxine Sodium 175 mcg |
| |
| Levothyroxine Sodium Tablets IP | Each uncoated tablet contains |
| Levothyroxine Sodium IP |
| eq.to Thyroxine Sodium 350 mcg |
| |
| Levothyroxine Sodium Tablets IP | Each uncoated tablet contains |
| Levothyroxine Sodium IP |
| eq.to Thyroxine Sodium 700 mcg |
| |
| Linagliptin Tablets | Each uncoated tablet contains |
| Linagliptin IP 400 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Linagliptin Tablets | Each uncoated tablet contains |
| Linagliptin IP 5 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Linezolid Oral Suspension Paediatric used | Each 5 ml contains: |
| Linezolid IP 100 mg |
| Approved colour used in flavoured syrupy base |
| |
| Linezolide Tablets | Each film coated tablet contains |
| Linezolide IP 600 mg |
| |
| LIQUOR BISMUTH, AMMONIUM CHLORIDE | Each 5 ml contains : |
| Liquor Bismuth |
| Ammonium Citrate BP 2.50 ml |
| (Equivalent to Bi2 O3 140 mg) |
| Belladonna Dry Extract IP 9 mg |
| Thymol IP 0.15 mg |
| Menthol IP qs |
| Approved colour used in flavoured syrupy base |
| |
| Lisinopril Tablets IP | Each uncoated tablet contains : |
| Lisinopril IP 5 mg |
| |
| Lithium Carbonate Capsules | Each hard gelatin capsule contains |
| Lithium Carbonate IP 250 mg |
| Approved colour used in empty capsule shell q.s. |
| |
| Lithium Carbonate Capsules | Each hard gelatin capsule contains |
| Lithium Carbonate IP 300 mg |
| Approved colour used in empty capsule shell q.s. |
| |
| Lithium Carbonate Prolonged-release | Each uncoated Prolonged released tablet contains |
| Lithium Carbonate IP 300 mg |
| (As Prolonged release) |
| |
| Lithium Carbonate Prolonged-release | Each uncoated Prolonged released tablet contains |
| Lithium Carbonate IP 400 mg |
| (As Prolonged release) |
| |
| Lithium Carbonate Prolonged-release | Each uncoated Prolonged released tablet contains |
| Lithium Carbonate IP 450 mg |
| (As Prolonged release) |
| Excipients q.s. |
| Lithium Carbonate Tablets IP 300 mg | Each uncoated tablet contains |
| Lithium Carbonate IP 300 mg |
| |
| llaprazole & Domperidone (SR) | Each hard gelatin capsule contains |
| llprazole IP 10 mg |
| (As per enteric coated pellets) |
| Domperidone 30 mg |
| (As per sustain Release pellets) |
| Approved colour used in empty capsule shell |
| |
| LOPERAMIDE HYDROCHLORIDE CAPSULE IP | Each hard gelatin capsule contains |
| Loperamide Hydrochloride IP 2 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Loperamide Hydrochloride Tablets IP | Each uncoated tablet contains : |
| Loperamide Hydrochloride IP 2 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Loratadine and Ambroxol HCI Tablets | Each film coated tablet contains : |
| Loratadine IP 5 mg |
| Ambroxol Hydrochloride IP 60 mg |
| Approved coloured used |
| |
| Loratadine Tablets IP | Each uncoated tablet contains : |
| Loratadine IP 5 mg |
| |
| Loratadine Tablets IP | Each uncoated tablet contains : |
| Loratadine IP 10 mg |
| |
| Lorazepam Tablets IP | Each Uncoated tablet contains : |
| Lorazepam IP 1 mg |
| Excipients q.s. |
| |
| Lorazepam Tablets IP | Each Uncoated tablet contains : |
| Lorazepam IP 2.0 mg |
| Excipients q.s. |
| |
| L-Ornithine – L-Aspartate, Silymarin with Mutil-Vitamins Tablets | Each film coated tablet contains: |
| L-Ornithine – L-Aspartate 250 mg |
| Silymarin 140 mg |
| Calcium D Pantothenate IP 10 mg |
| Thiamine Mononitrate IP 5 mg |
| Riboflavine IP 5 mg |
| Pyridoxine Hydrochloride IP 3 mg |
| Methylcobalamin IP 20 mcg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Lornoxicam & Paracetmol Tablets | Each film coated tablet contains : |
| Lornoxicam IP 8 mg |
| Paracetmol IP 325 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Lornoxicam & Thiocolchicoside Tablets | Each film coated tablet contains : |
| Lornoxicam IP 4 mg |
| Thiocolchicoside 4 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/ |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Lornoxicam & Thiocolchicoside Tablets | Each film coated tablet contains : |
| Lornoxicam IP 8 mg |
| Thiocolchicoside 4 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/ |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Lornoxicam Tablets IP 8mg | Each film coated tablet contains: |
| Lornoxicam 8mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Losartan & Hydrochlorothiazide Tablets | Each film coated tablet contains : |
| Losartan Potassium IP 50 mg |
| Hydrochlorothiazide IP 12.5 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Losartan Potassium & Atenolol Tablets | Each uncoated tablet contains : |
| Losartan Potassium IP 50 mg |
| Atenolol IP 5 mg |
| Approved color to be use |
| |
| Losartan Potassium and Amlodipine Tablets IP | Each film coated tablet contains : |
| Losartan Potassium IP 50 mg |
| Amlodipine besylate IP |
| Eq. to Amlodipine 5 mg |
| Approved colour to used |
| |
| Losartan Potassium and Hydrochlorothiazide Tablets IP | Each uncoated tablet contains : |
| Losartan Potassium IP 25 mg |
| Hydrochlorothiazide IP 5 mg |
| |
| Losartan Potassium and Hydrochlorothiazide Tablets IP | Each film coated tablet contains : |
| Losartan Potassium IP 25 mg |
| Hydrochlorothiazide IP 12.5 mg |
| Approved colour to used |
| |
| Losartan Potassium Tablets | Each film coated tablets contains |
| Losartan Potassium IP 100 mg |
| Approved colour to be use |
| |
| Losartan Tablets | Each film coated tablet contains : |
| Losartan Potassium IP 25 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Losartan Tablets | Each film coated tablet contains : |
| Losartan Potassium IP 50 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| |
| Loxapine Capsules USP | Each hard gelatin capsule contains |
| Loxapine Succinate USP |
| Eq. to Loxapine 5 mg |
| Approved colour to used |
| |
| Loxapine Capsules USP | Each hard gelatin capsule contains |
| Loxapine Succinate USP |
| Eq. to Loxapine 10 mg |
| Approved colour to used |
| |
| Loxapine Capsules USP | Each hard gelatin capsule contains |
| Loxapine Succinate USP |
| Eq. to Loxapine 20 mg |
| Approved colour to used |
| |
| Loxapine Capsules USP | Each hard gelatin capsule contains |
| Loxapine Succinate USP |
| Eq. to Loxapine 50 mg |
| Approved colour to used |
| |
| Lurasidone Hydrochloride Tablets | Each film coated tablet contains : |
| Lurasidone Hydrochloride 40 mg |
| Approved colour to used |
| |
| Lurasidone Hydrochloride Tablets | Each film coated tablet contains : |
| Lurasidone Hydrochloride 80 mg |
| Approved colour to used |
| |
| LYCOPENE WITH MULTIVITAMIN & MULTIMINERAL SYRUPS | Each 5 ml contains : |
| Lycopene 6% USP 1000 mcg |
| Zinc Sulphate Monohydrate USP 7.5 mg |
| Sodium Selenite USP |
| eq. to Selenite 35 mcg |
| Manganese Gluconate USP 2.75 mg |
| Potassiu lodid IP |
| eq. to Elemental lodine 75 mcg |
| Copper Sulphate IP |
| eq. to elemental Copper 1.1 mg |
| Approved colour used in flavoured syrupy base |
| |
| Lycopene, Protine, Amino Acids With Multivitamins | Each 100 g contains : |
| Lycopene 6% USP 6000 mcg |
| Protine (Whey Protine 20% ) 40 g |
| Carbohydrate 60 g |
| Fat (Less than ) 2 g |
| Glutamic Acid 10 mg |
| Vitamin A 3000 IU |
| Vitamin D3 (As Cholecalciferol) 300 IU |
| Thiamine Monoitrate IP 3 mg |
| Riboflavine IP 3 mg |
| Pyridoxine Hydrochloride IP 2 mg |
| Methylocabalamine IP 50 mcg |
| Vitamin C IP 50 mg |
| Vitamin E IP 5 mg |
| Folic Acid IP 1 mg |
| Calcium Pantothenate IP 3 mg |
| Naicinamide IP 30 mg |
| Calcium 1000 mg |
| Phosphorous 425 mg |
| Magnesium Sulphate IP 12 mg |
| Manganese (As Sulphate) USP 50 mcg |
| Zinc (As Zinc Sulphate) USP 10.0mg |
| Carbonyl Iron IP 20 mg |
| Magnesium Oxide IP 4 mg |
| Copper 2.5 mg |
| Chromium (As Sulphate) IP 75 mcg |
| Selenium Dioxide Monohydrate USP 60 mcg |
| lodine ( As Potassium lodide ) IP 0.1 mg |
| Excipients q.s. |
| |
| Magaldrate and Simethicone Oral Suspension IP | Each 5 ml contains: |
| Magaldrate IP 400 mg |
| Simethicone IP 60 mg |
| Approved colour used in flavoured syrupy base |
| |
| MAGALDRATE WITH ACTIVATED DIMETHICONE | Each 5 ml contains : |
| Magaldrate IP 400 mg |
| Activated Dimethicone IP 52.5 mg |
| Approved colour used in flavoured syrupy base |
| |
| MAGALDRATE WITH ACTIVATED DIMETHICONE & | Each 5 ml contains : |
| Magaldrate IP 400 mg |
| Activated Dimethicone IP 52.5 mg |
| Oxythacaine 5 mg |
| Approved colour used in flavoured syrupy base |
| |
| MAGALDRATE WITH ACTIVATED DIMETHICONE SUSPENSION | Each 5 ml contains : |
| Magaldrate IP 450 mg |
| Activated Dimethicone IP 20 mg |
| Approved colour used in flavoured syrupy base |
| |
| Magaldrate with Simethicone Suspension | Each 5 ml contains: |
| Magaldrate IP 480 mg |
| Simethicone IP 20 mg |
| Approved colour used in flavoured syrupy base |
| |
| MAGALDRATE, ACTIVATED DIMETHICONE | Each 5 ml contains : |
| Magaldrate IP 400 mg |
| Activated Dimethicone IP 52.5 mg |
| Benzocaine IP 5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Magaldrate, Alginic Acid and Activated Dimethicone | Each 5 ml contains: |
| Magaldrate IP 540 mg |
| Alginic Acid IP 50 mg |
| Activated Dimethicone IP 50 mg |
| Approved colour used in flavoured syrupy base |
| |
| Magaldrate, Oxetacaine and Activated Dimethicone Suspension | Each 5 ml contains |
| Magaldrate IP 540 mg |
| Oxetacaine BP 10 mg |
| Activated Dimethicone IP 50 mg |
| Approved colour used in flavoured syrupy base |
| |
| Magaldrate, Oxetacaine and Simethicone Suspension | Each 5 ml contains : |
| Magaldrate IP 480 mg |
| Oxetacaine BP 10 mg |
| Simethicone IP 20 mg |
| Approved coloured use in a flavoured syrup base |
| |
| Magaldrate, Simethicone and Oxetacaine Suspension | Each 5 ml contains : |
| Magaldrate IP 540 mg |
| Simethicone IP 20 mg |
| Oxetacaine BP 10 mg |
| Approved colour used in flavoured syrupy base |
| |
| Magnesium Hydroxide, Dried Aluminium Hydroxide With | Each uncoated chewable tablet contains : |
| Magnesium Hydroxide IP 250 mg |
| Dried Aluminium Hydroxide Gel IP 250 mg |
| Simethicone IP 25 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / |
| Sunset yellow or |
| Titanium Dioxide IP /Apple Green/Iron oxide red, Iron Oxide Yollow |
| |
| Magnesium Hydroxide, Dried Aluminium Hydroxide With Simethicone ( Actvated Dimethicone) | Each Uncoated chewable tablet contains: |
| Magnesium Hydroxide IP 250 mg |
| Dried Aluminium Hydroxide Gel IP 250 mg |
| Simethicone (Activated Dimethicone) IP 50 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Magnesium Trisilicate & Dried Aluminium Hydroxide | Each chewable tablet contains : |
| Magnesium Trisilicate IP 250 mg |
| Dried Aluminium Hydroxide Gel IP 120 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron Oxide Yellow |
| |
| Magnesium Trisilicate Chewable Tablets | Each uncoated chewable tablet contains : |
| Magnesium Trisilicate IP 250 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine/Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| |
| Mebendazole Tablets IP | Each uncoated tablet contains : |
| Mebendazole IP 100 mg |
| |
| Mebeverine Hydrochloride and Chlordiazepoxide Tablets | Each uncoated tablet contains : |
| Mebeverine Hydrochloride IP 135 mg |
| Chlordiazepoxide IP 5 mg |
| Excipients q.s |
| Approved colour to be used |
| |
| Mebeverine Hydrochloride and Chlordiazepoxide Tablets | Each film coated tablet contains: |
| Mebeverine Hydrochloride IP 135 mg |
| Chlordiazepoxide IP 5 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Meclizine HCL (SR) with Folic Acid Tablets | Each film coated Sustain release tablets contains |
| Meclizine Hydrochloride IP 50 mg |
| Eq. to Meclizine |
| (As sustain release) |
| Folic acid IP 5 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Mecobalamin & Epalrestat Tablets | Each Uncoated tablet contains: |
| Mecobalamin IP 500 mcg |
| Epalrestat 50 mg |
| Approved colour to be used |
| |
| Mecobalamin, Benfotiamine and Pyridoxine HCI Capsules | Each hard gelatin capsule contains |
| Mecobalamin IP 0.5 mg |
| Benfotiamine 100 mg |
| Pyridoxine HCI IP 50 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Mecobalamin, Folic Acid, Benfotiamine, Alpha Lipoic Acid and Chromium | Each film coated tablet contains : |
| Mecobalamin IP 1500 mcg |
| Folic acid IP 1.5 mg |
| Benfotiamine IP 200 mg |
| Alpha Lipoic Acid IP 100 mg |
| Chromium Polynicotinate 200 mcg |
| Myo Inositol 10 mg |
| Pyridoxine HCl IP 20 mg |
| Approved colour to be use |
| |
| Mecobalamin, Pyridoxine and Nicotinamide Tablets | Each film coated tablet contains : |
| Mecobalamin IP 750 mcg |
| Pyridoxine Hydrochloride IP 1.5 mg |
| Nicotinamide IP 45 mg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Mecobalamin, Pyridoxine HCI Alpha Lipoic Acid and Benfotiamine | Each film coated tablet contains: |
| Mecobalamin IP 0.5 mg |
| Pyridoxine Hydrochloride IP 50 mg |
| Benfotiamine 100 mg |
| Alpha Lipoic Acid IP 100 mg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Mecobalamin,Alpha Lipoic Acid, Thiamine, Pyridoxine HCI,Calcium Pantothenate and Folic acid | Each hard gelatin capsule contains |
| Mecobalamin IP 1500 mcg |
| Alpha Lipoic Acid USP 100 mg |
| Thiamine IP 10 mg |
| Pyridoxine Hydrochloride IP 3 mg |
| Calcium Pantothenate IP 5 mg |
| Folic acid IP 1.5 mg |
| Approved colour use in empty capsule shell |
| |
| Mecobalamine, Alfacacidol, Riboflavin, Thiamine, Pyridoxine, Nicotinamide,Calcium D Pantothenate and Zinc Sulphate | Each 5 ml contains : |
| Mecobalamine IP 1 mcg |
| Alfacalcidol IP 0.25 mcg |
| Thiamine mononitrate IP 1 mg |
| Riboflavin IP 1.1 mg |
| Pyridoxine hydrochloride IP 0.80 mg |
| Nicotinamide IP 15 mg |
| Calcium D Pantothenate IP 3 mg |
| Zinc sulphate monohydrate IP |
| Eq. to elemntal Zinc 1.82 mg |
| Approved coloured used in flavoured syrupy base |
| |
| Mecobalamine, Foilc Acid, Riboflavin, Pyridoxine, Naicinamide | Each film coated tablet contains: |
| Mecobalamine IP 1000 mcg |
| Foilc Acid, IP 1 mg |
| Riboflavin IP 10 mg |
| Pyridoxine Hydrochloride IP 3 mg |
| Naicinamide IP 45 mg |
| Calcium Panthothenate IP 50 mg |
| Excipients q.s. |
| Permitted Color Used |
| |
| Mefenaimic Acid Suspension | Each 5 ml contains : |
| Mefenamic acid IP 100 mg |
| Approved colour used in flavoured syrupy base |
| |
| MEFENAMIC ACID & DICYCLOMINE HYDROCHLORIDE CAPSULES | Each hard gelatin capsule contains |
| Dicyclomine Hydrochloride IP 10 mg |
| Mefenamic Acid IP 250 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Mefenamic Acid & Dicyclomine Hydrochloride Tablets | Each uncoated tablet contains : |
| Mefenamic Acid IP 250 mg |
| Dicyclomine Hydrochloride IP 10 mg |
| |
| Mefenamic Acid & Dicyclomine Hydrocloride Tablets | Each uncoated tablet contains |
| Mefenamic Acid IP 250 mg |
| Dicyclomine Hydrochloride IP 20 mg |
| |
| Mefenamic Acid & Paracetamol Suspension | Each 5 ml. contains: |
| Mefenamic Acid IP 100 mg |
| Paracetamol IP 250 mg |
| Approved colour used in flavoured syrupy base |
| |
| MEFENAMIC ACID & PARACETAMOL SUSPENSION | Each 5 ml contains : |
| Mefenamic Acid IP 50 mg |
| Paracetamol IP 125 mg |
| Approved colour used in flavoured syrupy base |
| |
| Mefenamic Acid & Paracetamol Tablets | Each uncoated tablet contains : |
| Mefenamic Acid IP 250 mg |
| Paracetamol IP 325 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green/Iron oxide red, Iron Oxide Yellow |
| |
| Mefenamic Acid and Dicyclomine HCI Tablets | Each uncoated tablet contains : |
| Mefenamic acid IP 125 mg |
| Dicyclomine Hydrochloride IP 10 mg |
| Excipients q.s. |
| Approved coloured to be used |
| |
| Mefenamic acid and Tizanidine Tablets | Each unCoated tablet contains : |
| Mefenamic acid IP 500 mg |
| Tizanidine Hydrochloride IP |
| Equivalent to Tizanidine 6 mg |
| Excipients q.s. |
| Approved color to be use |
| |
| Mefenamic Acid Dispersible Tablets | Each Uncoated Dispersible tablet contains: |
| Mefenamic Acid IP 100 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Mefenamic Acid Tablets IP | Each uncoated tablet contains : |
| Mefenamic Acid IP 250 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / |
| Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| |
| Mefenamic Acid, Paracetamol and Dicyclomine Tablets | Each uncoated tablet contains: |
| Mefenamic Acid IP 250 mg |
| Paracetamol IP 325 mg |
| Dicyclomine Hydrochloride IP 10 mg |
| Approved colour to be used |
| |
| Meloloprol Succinate & Amlodipine Tablets IP | Each uncoated tablet contains : |
| Metoloprol Succinate IP 47.5 mg |
| Amlodipine Besiylate IP |
| Eq. to Amlodipine 5 mg |
| |
| Meloxicam Tablets | Each uncoated tablet contains : |
| Meloxicam IP 7.5 mg |
| Approved colour to used |
| |
| Meloxicam Tablets | Each uncoated tablet contains : |
| Meloxicam IP 15 mg |
| Approved colour to used |
| |
| Memantine HCI Tablets IP | Each film coated tablet contains : |
| Memantine Hydrochloride IP 10 mg |
| Excipients q.s. |
| Approved coloured used |
| |
| Memantine HCI Tablets IP | Each film coated tablet contains : |
| Memantine Hydrochloride IP 5 mg |
| Approved coloured used |
| |
| Metformin & Glibenclamide Pioglitazone Tablets | Each film coated tablet contains |
| Metformin Hydrochloride IP 500 mg |
| Glibenclamide IP 5 mg |
| Pioglitazone IP 15 mg |
| Permitted Color Used |
| |
| Metformin & Gliclazide with Pioglitazone Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 500 mg |
| Gliclazide IP 40 mg |
| Pioglitazone IP 15 mg |
| Permitted Color Used |
| |
| Metformin & Gliclazide with Pioglitazone Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 500 mg |
| Gliclazide IP 80 mg |
| Pioglitazone IP 15 mg |
| Permitted Color Used |
| |
| Metformin (SR) & Glimepiride Tablets | Each uncoated sustain release tablet contains |
| Metformin HCl (as sustain release) IP 1000 mg |
| Glimepiride IP 1 mg |
| Colour : Erythrosine /Tartrazine / Sunset yellow / Titanium Dioxide IP |
| |
| Metformin (SR) & Glimepiride Tablets | Each uncoated sustain release tablet contains |
| Metformin HCl (as sustain release) IP 1000 mg |
| Glimepiride IP 2 mg |
| Colour : Erythrosine /Tartrazine / Sunset yellow / Titanium Dioxide IP |
| |
| Metformin (SR) & Glimepride Tablets IP | Each film coated tablet contains |
| Metformin Hydrochloride (as sustain release) IP 500 Mg |
| Glimepride IP 1 mg |
| Permitted Color Used |
| |
| Metformin (SR) & Glimepride Tablets IP | Each film coated tablet contains |
| Metformin Hydrochloride (as sustain release) IP 500 mg |
| Glimepride IP 2 mg |
| Permitted Color Used |
| |
| Metformin (SR) & Voglibose Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride (SR) IP 500 mg |
| Voglibose IP 0.20 mg |
| Permitted Color Used |
| |
| Metformin (SR), Gliclazide Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 500 mg |
| (As sustained release ) |
| Gliclazide IP 80 mg |
| Excipients q.s. |
| Approved coloured to be used |
| |
| Metformin (SR), Glimepride Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 500 mg |
| (As sustained release form) |
| Glimepride IP 2 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Metformin (SR), Glimepride Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride (As sustained rel IP 500 mg |
| (As sustained release form) |
| Glimepride IP 1 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Metformin (sustained released) and Voglibose Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 1000 mg |
| (As sustained release) |
| Voglibose IP 0.2 mg |
| Excipients q.s. |
| Approved coloured to be used |
| |
| Metformin (sustained released) and Voglibose Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 1000 mg |
| (As sustained release) |
| Voglibose IP 0.3 mg |
| Excipients q.s. |
| Approved coloured to be used |
| |
| Metformin HCI (SR) and Glimepiride Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 500 mg |
| (As sustained release) |
| Glimepiride IP 4 mg |
| Excipients q.s. |
| Approved coloured to be used |
| |
| Metformin HCI (SR) and Glimepiride Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 500 mg |
| (As sustained release) |
| Glimepiride IP 3 mg |
| Excipients q.s. |
| Approved coloured to be used |
| |
| Metformin HCI (SR) and Glimepiride Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 1000 mg |
| (As sustained release) |
| Glimepiride IP 3 mg |
| Excipients q.s. |
| Approved coloured used |
| |
| Metformin HCI (SR) and Glimepiride Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 1000 mg |
| (As sustained release) |
| Glimepiride IP 4 mg |
| Excipients q.s. |
| Approved coloured to be used |
| |
| Metformin HCI (SR) Gliclazide (SR) & Pioglitazone | Each uncoated bilayered tablet contains |
| Metformin Hydrochloride IP 1000 mg |
| (As sustained release) |
| Gliclazide (As sustained release) IP 30 mg |
| Pioglitazone Hydrochloride IP |
| Eq. to Pioglitazone 15 mg |
| Approved colour to be used |
| |
| Metformin HCl and Glimepiride Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 750 mg |
| Glimepiride IP 0.5 mg |
| |
| Metformin HCl and Glimepiride Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 750 mg |
| Glimepiride IP 1 mg |
| |
| Metformin HCl and Glimepiride Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 750 mg |
| Glimepiride IP 2 mg |
| |
| Metformin HCl and Glimepiride Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 500 mg |
| Glimepiride IP 3 mg |
| Excipients q.s. |
| Approved coloured to be used |
| |
| Metformin HCl and Glimepiride Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 500 mg |
| Glimepiride IP 4 mg |
| Excipients q.s. |
| Approved coloured to be used |
| |
| Metformin HCl and Glimepiride Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 1000 mg |
| Glimepiride IP 3 mg |
| Excipients q.s. |
| Approved coloured to be used |
| |
| Metformin HCl and Glimepiride Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 1000 mg |
| Glimepiride IP 4 mg |
| Excipients q.s. |
| Approved coloured to be used |
| |
| Metformin Hydrochloride & Repaglinide Tablets | Each uncoated bilayered-tablet contains |
| Metformin Hydrochloride IP 500 mg |
| Repaglinide IP 2 mg |
| Excipients q.s. |
| Approved coloured used |
| |
| Metformin Hydrochloride (ER). Teneligliptin Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 500 mg |
| (as extaned release form) |
| Tenengliptin Hydrobromide Hydrate IP |
| eq. to Teneligliptin 20 mg |
| Approved colour to used |
| |
| Metformin Hydrochloride (ER). Teneligliptin Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 1000 mg |
| (as extaned release form) |
| Tenengliptin Hydrobromide Hydrate IP |
| eq. to Teneligliptin 20 mg |
| Approved colour to used |
| |
| Metformin Hydrochloride (SR) and Dapagliflozin tablets | Each uncoated bilayered tablet contains : |
| Metformin Hydrochloride IP 500 mg |
| (As sustained release) |
| Dapagliflozin propanediol Monohydrate |
| Equivalent to Dapagliflozin IP 10 mg |
| Approved colour to be used |
| |
| Metformin Hydrochloride (SR) and Dapagliflozin tablets | Each uncoated bilayered tablet contains : |
| Metformin Hydrochloride IP 1000 mg |
| (As sustained release) |
| Dapagliflozin propanediol Monohydrate |
| Equivalent to Dapagliflozin IP 10 mg |
| Approved colour to be used |
| |
| Metformin Hydrochloride (SR) and Glimepiride tablets | Each uncoated bilayered tablet contains : |
| Metformin Hydrochloride IP 750 mg |
| (As sustained release) |
| Glimepiride IP 0.5 mg |
| Approved colour to used |
| |
| Metformin Hydrochloride (SR) and Glimepiride tablets | Each uncoated bilayered tablet contains : |
| Metformin Hydrochloride IP 750 mg |
| (As sustained release) |
| Glimepiride IP 1 mg |
| Approved colour to used |
| |
| Metformin Hydrochloride (SR) and Glimepiride tablets | Each uncoated bilayered tablet contains : |
| Metformin Hydrochloride IP 750 mg |
| (As sustained release) |
| Glimepiride IP 2 mg |
| Approved colour to used |
| |
| Metformin Hydrochloride (SR) and Glimepiride Tablets | Each uncoated bilayred tablet contains : |
| Metformin Hydrochloride IP 850 mg |
| (As sustained release) |
| Glimepiride IP 1 mg |
| Approved colour to used |
| |
| Metformin Hydrochloride (SR) and Glimepiride Tablets | Each uncoated bilayred tablet contains : |
| Metformin Hydrochloride IP 850 mg |
| (As sustained release) |
| Glimepiride IP 2 mg |
| Approved colour to used |
| |
| Metformin Hydrochloride (SR) and Glimepiride Tablets | Each uncoated bilayred tablet contains : |
| Metformin Hydrochloride IP 850 mg |
| (As sustained release) |
| Glimepiride IP 3 mg |
| Approved colour to used |
| |
| Metformin Hydrochloride (SR) tablets | Each uncoated bilayred tablet contains : |
| Metformin Hydrochloride IP 850 mg |
| (As sustained release) |
| |
| Metformin Hydrochloride (SR) tablets | Each uncoated bilayred tablet contains : |
| Metformin Hydrochloride IP 750 mg |
| (As sustained release) |
| |
| Metformin Hydrochloride (SR) Tablets | Each uncoated sustain release tablet contains |
| Metformin HCI IP 850 mg |
| |
| Metformin Hydrochloride (SR) Tablets | Each uncoated sustain release tablet contains |
| Metformin HCI IP 500 mg |
| Colour: Brilliant Blue / Erythrosine /Tartrazine / |
| Sunset yellow or Apple Green / Titanium Dioxide IP |
| |
| Metformin Hydrochloride (SR) Tablets | Each uncoated sustain release tablet contains |
| Metformin HCI IP 1000 mg |
| Colour: Brilliant Blue / Erythrosine /Tartrazine / |
| Sunset yellow or Apple Green / Titanium Dioxide IP |
| |
| Metformin Hydrochloride (SR), Glimepride Tablets | Each uncoated bilayered tablet contains |
| Metformin Hydrochloride IP 500 mg |
| (As sustained release form) |
| Glimepride IP 0.5 mg |
| Approved colour to used |
| |
| Metformin Hydrochloride Prolonged release and glimepiride Tablets | Each Uncoated bilayered tablet contains: |
| Metformin Hydrochloride IP 1000 mg |
| ( As prolonged release form |
| Glimepiride IP 0.5 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Metformin Hydrochloride Tablets | Each uncoated tablet contains |
| Metformin HCI IP 1000 mg |
| Colour: Brilliant Blue / Erythrosine Tartrazine / |
| Sunset yellow or Apple Green / Titanium Dioxide IP |
| Metformin Hydrochloride Tablets IP | Each uncoated tablet contains |
| Metformin HCI IP 850 mg |
| |
| Metformin Hydrochloride Tablets IP | Each uncoated tablet contains : |
| Metformin Hydrochloride IP 500 mg |
| |
| Metformin Hydrochloride Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 750 mg |
| |
| Metformin Hydrochloride Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 850 mg |
| |
| Metformin Hydrochloride With Gliclazide Tablets | Each uncoated tablet contains : |
| Metformin Hydrochloride IP 500 mg |
| Gliclazide BP 80 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine/Quinoline Yellow / |
| Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Metformin Hydrochloride With Gliclazide Tablets | Each uncoated tablet contains: |
| Metformin Hydrochloride IP 500 mg |
| Gliclazide BP 80 mg |
| Approved colour to be used |
| |
| Metformin Sustain Release Tablets IP | Each film coated sustain release tablet contains |
| Metformin Hydrochloride IP 500 mg |
| Permitted Color Used |
| |
| Metformin Sustain Release Tablets IP | Each film coated sustain release tablet contains |
| Metformin Hydrochloride IP 1000 mg |
| Permitted Color Used |
| |
| Metformin Tablets IP | Each uncoated tablet contains |
| Metformin Hydrochloride IP 250 mg |
| |
| Metformin, Gliclazide and Voglibose Tablets | Each uncoated tablet contains : |
| Metformin Hydrochloride IP 500 mg |
| Gliclazide IP 80 mg |
| Voglibose IP 0.2 mg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Metformin, Gliclazide and Voglibose Tablets | Each uncoated tablet contains : |
| Metformin Hydrochloride IP 500 mg |
| Gliclazide IP 80 mg |
| Voglibose IP 0.3 mg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Methylcobalamin & Pregabaline Tablets | Each film coated tablet contains : |
| Methylcobalamin IP 750 mcg |
| Pregabaline IP 75 mg |
| Approved colour to be use |
| |
| Methylcobalamin and Gabapentine Tablets | Each film coated tablet contains : |
| Methylcobalamin IP 500 mcg |
| Gabapentine IP 300 mg |
| Approved colour to be use q.s. |
| |
| Methylcobalamin Tablets | Each film coated tablet contains : |
| Methylcobalamin IP 1500 mcg |
| Approved colour to be use |
| |
| Methylcobalamin Tablets | Each film coated tablet contains : |
| Methylcobalamin IP 500 mcg |
| Approved colour to be use |
| |
| Methylcobalamin, Alpha Lipoic Acid, Pyridoxine HCl and Folic Acid | Each hard gelatin capsule contains |
| Methylcobalamin IP 1500 mcg |
| Alpha Lipoic acid IP 100 mg |
| Pyridoxine HCI IP 3 mg |
| Folic Acid IP 1.5 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Methylcobalamin, Biotin with Pyridoxine Hydrochloride | Each film coated tablet contains |
| Methylcobalamin 1500 mcg |
| Biotin IP 5 mg |
| Pyridoxine Hydrochloride IP 10 mg |
| Folic Acid IP 5 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| IApple Green / Iron oxide red,Iron oxide Yellow |
| |
| Methylcobalamin, Folic acid and L-Carnitine Tartrate Tablets | Each film cooted tablet contains : |
| Methylcobalamin IP 1500 mcg |
| Folic Acid IP 1.5 mg |
| L-Carnitine L-Tartrate IP |
| Eq. L-Carnitine 500 mg |
| Approved colour to be use |
| |
| Methylcobalamin, Glutamic Acid and Folic Acid Tablets | Each film coated tablet contains : |
| Methylcobalamin IP 1500 mcg |
| Glutamic Acid IP 100 mg |
| Folic acid IP 1 mg |
| Approved colour to be use q.s. |
| |
| Methylcobalamin, Nortriptyline Pregabalin Capsules | Each hard gelatin capsule : |
| Methylcobalamin IP 1500 mcg |
| Nortriptyline Hydrochloride IP |
| Eq. to Nortriptyline 10 mg |
| Pregabalin IP 75 mg |
| Approved colour used in empty capsule shell |
| |
| Methylcobalamin, Pregabalin, Alpha Lipoic Acid, Pyridoxine HCI | Each hard gelatin capsule contains |
| Methylcobalamin IP 1500 mcg |
| Alpha Lipoic acid IP 200 mg |
| Pregabalin IP 75 mg |
| Pyridoxine HCI IP 5 mg |
| Folic Acid IP 2.5 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Methylcobalamin, Pregabalin, Pyridoxine HCI, Benfotiamine | Each hard gelatin capsule contains |
| Methylcobalamin IP 750 mcg |
| Pregabalin IP 75 mg |
| Pyridoxine HCI IP 2 mg |
| Benfotiamine 7.5 mg |
| Folic Acid IP 0.75 mg |
| Excipients q.s. |
| Approved colour use in empty capsule shell |
| |
| Methylcobalamin, Pregabaline & Nortriptyline Tablets | Each film coated tablet contains : |
| Methylcobalamin IP 1500 mcg |
| Pregabaline IP 75 mg |
| Nortriptyline HCl IP |
| Eq. to Nortriptyline 10 mg |
| Approved colour to be use q.s. |
| |
| Methylcobalamin, Pyridoxine & Folic Acid Tablets | Each film coated tablet contains |
| Methylcobalamin 500 mcg |
| Pyridoxine Hydrochloride IP 5 mg |
| Folic Acid IP 5 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/ |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green/Iron oxide red,Iron oxide Yellow |
| |
| Methylcobalamin, Pyridoxine Hydrochloride,Vit D3 and Folic Acid Tablets | Each uncoated mouth dissolving tablets contains |
| Methylcobalamin IP 1500 mcg |
| Pyridoxine Hydrochloride IP 3 mg |
| Vitamin d3 IP 1000 IU |
| Folic Acid IP 5 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Methylcobalmin , Pyridoxine Hcl With | Each hard gelatin capsule contains |
| Methylcobalmin 1500 mcg |
| Pyridoxine Hydrochloride IP 1.5 mg |
| Alpha Lipoic Acid IP 100 mg |
| Approved colour used in empty capsule shell |
| |
| Methylcobalmin, & Pregabalin | Each hard gelatin capsule contains |
| Methylcobalmin 1500 mcg |
| Pregabalin IP 75 mg |
| Approved colour used in empty capsule shell |
| |
| Methylcobalmin, & Pregabalin | Each hard gelatin capsule contains |
| Methylcobalmin 750 mcg |
| Pregabalin IP 75 mg |
| Approved colour used in empty capsule shell |
| |
| Methylcobalmin, Alpha Lipoic Acid,Glucosamine Sulphate and Chondrotine Sulphate | Each hard gelatin capsule contains |
| Methylcobalmin 500 mcg |
| Alpha Lipoic Acid 100 mg |
| Glucosamine Sulphate IP 500 mg |
| Chondrotine Sulphate 400 mg |
| Approved colour used in empty capsule shell |
| |
| Methylcobalmin, Alpha Lipoic Acid,Glucosamine Sulphate and Chondrotine Sulphate | Each hard gelatin capsule contains |
| Methylcobalmin 1500 mcg |
| Alpha Lipoic Acid 200 mg |
| Pregabalin IP 75 mg |
| Folic Acid IP 1500 mcg |
| Approved colour used in empty capsule shell |
| |
| Methylcobalmine, Alpha Lipoic Acid, Biotin | Each hard gelatin capsule contains |
| Methylcobalmine IP 1500 mcg |
| Alpha Lipoic Acid 200 mg |
| Biotin IP 200 mcg |
| Folic Acid IP 1500 mcg |
| Pyridoxine HCl IP 3 mg |
| Vitamin D3 IP 1000 IU |
| |
| Methyldopa Tablets IP | Each film coated tablet contains : |
| Methyldopa IP |
| Eq. to Anhydrous Methyldopa 125 mg |
| Approved coloured used |
| |
| Methyldopa Tablets IP | Each film coated tablet contains : |
| Methyldopa IP |
| Eq. to Anhydrous Methyldopa 250 mg |
| Approved coloured used |
| |
| Methylergomatrine Maleate Tablets IP | Each uncoated tablet contains : |
| Methylergomatrine Maleate IP 0.125 mg |
| |
| |
| Methylprednisolone Tablets IP 16 mg. | Each uncoated tablet contains : |
| Methylprednisolone IP 16 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Methylprednisolone Tablets IP 4 mg. | Each uncoated tablet contains : |
| Methylprednisolone IP 4 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Methylprednisolone Tablets IP 8 mg. | Each uncoated tablet contains : |
| Methylprednisolone IP 8 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| METOCLOPRAMIDE HYDROCHLORIDE SYRUP IP | Each 5 ml contains : |
| Metoclopramide Hydrochloride |
| Eq.to Anhydrous Metoclopramide Hydrochloride IP 5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Metoclopramide Hydrochloride Tablets IP | Each uncoated tablet contains : |
| Metoclopramide Hydrochloride IP 10 mg |
| Eq. to Anhydrous Metoclopramide Hydrochloride |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunsel yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Metoloprol Succinate with Amlodipine Tablets | Each uncoated tablet contains : |
| Metoloprol Succinate IP 50 mg |
| Amlodipine Besiylate IP |
| Eq. to Amlodipine 5 mg |
| |
| Metoloprol Succinate with Amlodipine Tablets IP | Each uncoated tablet contains : |
| Metoloprol Succinate IP 23.7 mg |
| Amlodipine Besiylate IP |
| Eq. to Amlodipine 5 mg |
| |
| METRONIDAZOLE & FURAZOLIDONE Tablets | Each uncoated tablet contains : |
| Metronidazole IP 200 mg |
| Furazolidone IP 100 mg |
| |
| METRONIDAZOLE BENZOATE SUSPENSION IP | Each 5 ml contains : |
| Metronidazole Benzoate IP |
| Equivalent to Metronidazole 100 mg |
| Approved colour used in flavoured syrupy base |
| |
| Metronidazole Tablets IP 200 MG. | Each film coated tablet contains : |
| Metronidazole IP 200 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| |
| Metronidazole Tablets IP 400 MG. | Each film coated tablet contains : |
| Metronidazole IP 400 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| |
| Midodrine Hydrochloride Tablets USP 2.5 mg | Each film coated tablets contains : |
| Midodrine Hydrochloride USP 2.5 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Midodrine Hydrochloride Tablets USP 5 mg | Each film coated tablets contains : |
| Midodrine Hydrochloride USP 5 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Mirtazipine Tablets | Each uncoated tablet contains |
| Mirtazipine IP 15 mg |
| Colour: Tartrazine / Sunset Yellow |
| |
| Mirtazipine Tablets | Each uncoated tablet contains |
| Mirtazipine IP 30 mg |
| Colour: Tartrazine / Sunset Yellow |
| |
| Misoprostol Tablets IP | Each uncoated tablet contains : |
| Misoprostol IP 200 mcg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide P /Apple Green/Iron oxide red Iron oxide Yellow |
| |
| Modafinil Tablets IP | Each uncoated tablet contains : |
| Modafinil IP 100 mg |
| Approved colour to be used |
| |
| Modafinil Tablets IP | Each uncoated tablet contains : |
| Modafinil IP 200 mg |
| Approved colour to be used |
| |
| Montelukast sodium and Hydroxyzine Tablets | Each film coated tablet contains: |
| Montelukast Sodium IP |
| eq. to Montelukast 10 mg |
| Hydroxyzine Hydrochloride IP 25 mg |
| Approved colour to be used |
| |
| Montelukast Tablets IP | Each film coated tablet contains : |
| Montelukast Sodium IP |
| Eq. Montelukast 10 mg |
| Approved coloured used |
| |
| Montelukast Tablets IP | Each film coated tablet contains : |
| Montelukast Sodium IP |
| Eq. Montelukast 5 mg |
| Approved coloured used |
| |
| Montelukast, Acebrophylline and Levocetirizine HCI Tablets | Each uncoated tablet contains : |
| Montelukast Sodium IP |
| Eq. to Montelukast 10 mg |
| Acebrophylline 200 mg |
| (As prolonged release) |
| Levocetirizine Hydrochloride IP 5 mg |
| Approved colour to used |
| |
| Moxifloxacin Tablets | Each film coated tablet contains |
| Moxifloxacin Hydrochloride IP |
| eq. to Moxifloxacin 400 mg |
| Colour: Brilliant Blue / Erythrosine /Tartrazine / |
| Sunset yellow or Apple Green / Titanium Dioxide IP |
| |
| Moxonidine Tablets | Each film coated tablet contains : |
| Moxonidine BP 0.2 mg |
| Excipients q.s. |
| Approved colour used |
| |
| Moxonidine Tablets | Each film coated tablet contains : |
| Moxonidine BP 0.3 mg |
| Excipients q.s. |
| Approved colour used |
| |
| Moxonidine Tablets | Each film coated tablet contains : |
| Moxonidine BP 0.4 mg |
| Excipients q.s. |
| Approved colour used |
| |
| MULTIVITAMIN & MULTIMINERAL SYRUP | Each 5 ml contains : |
| Ferrous Gluconate IP 100 mg |
| Cyanocobalamin IP 1 mcg |
| Folic Acid IP 0.25 mg |
| L-Lysine Hydrochloride USP 25 mg |
| Pyridoxine Hydrochloride IP 0.5 mg |
| D Panthenol IP 1.25 mg |
| Nicotinamide IP 15 mg |
| Approved colour used in flavoured syrupy base |
| |
| MULTIVITAMIN & MULTIMINERAL SYRUPS | Each 10 ml contains : |
| Lycopene 6% USP 2000 mcg |
| Nicotinamide IP 25 mg |
| Pyridoxine Hydrochloride IP 1.5 mg |
| Cyanocobalamin IP 1 mcg |
| Sodium Selenite USP |
| eq. to Selenite 35 mcg |
| Zinc Gluconate USP |
| eq.to Zinc 3 mg |
| Manganese Gluconate |
| eq. to Manganese 2.00 mg |
| Potassium lodide IP |
| eq. to Elemental lodine 100 mcg |
| Cupric Sulphte Pentahydrate |
| eq.to Copper USP 500 mcg |
| Approved colour used in flavoured syrupy base |
| |
| MULTIVITAMIN & MULTIMINERAL WITH L-LYSINE HYROCHLORIDE SYRUP | Each 5 ml contains : |
| Pyridoxine Hydrochloride IP 0.5 mg |
| Cholecalciferol (Vitamin D3 ) IP 100 IU |
| Nicotinamide IP 15 mg |
| Cyanocobalamin IP 0.5 mcg |
| Folic Acid IP 300 mcg |
| Copper Sulphate USP 100 mcg |
| D Panthenol IP 1.25 mg |
| Zinc Sulphate Monohydrate IP 22.5 mg |
| Chromium (As Chromium Chloride) IP 1 mcg |
| Manganese Chloride IP 3 mcg |
| L-Lysine HCL USP 5 mg |
| Approved colour used in flavoured syrupy base |
| |
| MULTIVITAMIN CAPSULES For Prophylactic Use | Each hard gelatin capsule contains |
| Thiamine Mononitrate IP 1 mg |
| Riboflavine IP 1 mg |
| Pyridoxine Hydrochloride IP 0.5 mg |
| Vitamin A Concentrate ( As Palmitate) |
| Eq. to Vitamin A IP 2000 IU |
| Vitamin D, (As Cholecalciferol) IP 100 IU |
| Niacinamide IP 15 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| MULTIVITAMIN CAPSULES For Prophylactic Use | Each hard gelatin capsule contains |
| Thiamine Mononitrate IP 1 mg |
| Riboflavine IP 1 mg |
| Pyridoxine Hydrochloride IP 0.5 mg |
| Cyanocobalamin IP 1 mcg |
| Niacinamide IP 15 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| MULTIVITAMIN DROPS For infants less then 1 year | Each ml contains : |
| Vitamin A Concentrate(Oily Form as Palmitate) IP 2500 IU |
| Vitamin D3 (As Cholecalciferol) IP 200 IU |
| Thiamin Hcl IP 1 mg |
| Vitamin B2 Sodium Phosphate IP |
| Eq. to Vitamin B2 0.5 mg |
| Naicinamide IP 5 mg |
| Vitamin B6 HCI IP 0.5 mg |
| D-Panthenol IP 1.5 mg |
| Vitamin E Acetate IP 2.5 IU |
| Approved colour used in flavoured syrupy base |
| MULTIVITAMIN DROPS For infants less then 1 year | Each ml contains : |
| Vitamin A Concentrate(Oily Form as Palmitate) IP 3000 IU |
| Vitamin D3 (As Cholecalciferol) IP 400 IU |
| Thiamin Hcl IP 1 mg |
| Vitamin B2 Sodium Phosphate IP |
| Eq. to Vitamin B2 1 mg |
| Naicinamide IP 5 mg |
| Vitamin B6 HCI IP 1 mg |
| D-Panthenol IP 3 mg |
| Vitamin E Acetate IP 5 I.U |
| Approved colour used in flavoured syrupy base |
| |
| Multivitamin Drops For paediatric use | Each ml contains : |
| Thiamine Mononitrate IP 1 mg |
| Riboflavine IP 1.5 mg |
| Pyridoxine HCL IP 1.5 mg |
| Cyanocobalamin IP 3 mcg |
| Nicotinamide IP 15 mg |
| Cholecalciferol (Vitamin D3) IP 400 IU |
| Zinc Sulphate Monohydrate IP |
| Eq. to elemantel Zinc 2.50 mg |
| Vitamin A (As Palmetate) IP 2000 IU |
| Omega 3 30 mg |
| Selenium Dioxide IP 15 mcg |
| Approved colour used in flavoured syrupy base |
| |
| MULTIVITAMIN DROPS For Paediatric Use | Each ml contains : |
| Vitamin A Concentrate(Oily Form as Palmil IP 4000 IU |
| Vitamin D3 (As Cholecalciferol) IP 400 IU |
| Thiamin HCl IP 1 mg |
| Vitamin B2 Sodium Phosphate IP 1 mg |
| Eq. to Vitamin B2 |
| Vitamin B6 HCI 1 mg |
| Vitamin B12 IP 3 mcg |
| Naicinamide IP 10 mg |
| L-Lysine hydrochloride IP 10 mg |
| D-Panthenol IP 3 mg |
| Approved colour used in flavoured syrupy base |
| |
| MULTIVITAMIN SYRUP For Therapeutic Use | Each 5 ml contains : |
| Thiamine Mononitrate IP 5 mg |
| Riboflavine Us Riboflavine Sodium Phosphate) IP 5 mg |
| Nicotinamide IP 45 mg |
| Pyridoxine Hydrochloride IP 1.5 mg |
| Cyanocobalamin IP 7.5 mcg |
| Approved colour used in flavoured syrupy base |
| |
| MULTIVITAMIN SYRUPS For Prophylactic Use | Each 5 ml contains : |
| Vitamin B1 Hcl IP 1 mg |
| Vitamin B2 IP 1 mg |
| Vitamin B12 IP 1 mcg |
| Naicinamide IP 15 mg |
| D-Panthenol IP 2.5 mg |
| Approved colour used in flavoured syrupy base |
| |
| MULTIVITAMIN SYRUPS For Prophylactic Use | Each 5 ml contains : |
| Vitamin B1 IP 1 mg |
| Vitamin B2 IP 1 mg |
| Vitamin B6 IP 0.5 mg |
| Vitamin B12 IP 1 mcg |
| Naicinamide IP 15 mg |
| D-Panthenol IP 2.5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Multivitamin Syrups For Prophylatic use | Each 5 ml contains : |
| Thiamine Mononitrate IP 2 mg |
| Riboflavine IP 2 mg |
| Pyridoxine HCL IP 1.0 mg |
| Cyanocobalamin IP 3 mcg |
| Nicotinamide IP 25 mg |
| Cholecalciferol (Vitamin D3) IP 400 IU |
| Zinc Sulphate Monohydrate IP |
| Eq. to elemantel Zinc IP 5 mg |
| Vitamin A (As Palmetate) IP 3000 IU |
| Selenium Dioxide IP 25 mcg |
| Approved colour used in flavoured syrupy base |
| |
| Multivitamin With Cyproheptadine Syrup | Each 5 ml contains : |
| Thiamine Mononitrate IP 1 mg |
| Pyridoxine HCL IP 1.5 mg |
| Cyanocobalamin IP 1 mcg |
| Nicotinamide IP 15 mg |
| D-Panthenol IP 5 mg |
| Zinc Sulphate Monohydrate IP |
| Eq. to elemantel Zinc 1.82 mg |
| Cyproheptadine Hydrochloride IP 2 mg |
| Approved colour used in flavoured syrupy base |
| |
| MULTIVITAMIN WITH L-LYSINE, ZINC SULPHATE CAPSULES | Each Capsule Contains |
| Vitamin A Acetate IP 5000 IU |
| Vitamin D3 (As Cholecalciferol) IP 500 IU |
| Vitamin E Acetate IP 15 mg |
| Vitamin B1 Mono IP 10 mg |
| Vitamin B2 IP 10 mg |
| Vitamin B6 HCI IP 3 mg |
| L-Lysine Mono HCI IP 50 mg |
| Vitamin B12 IP 10 mcg |
| Calcium Panthothenate IP 25 mg |
| Vitamin C (Coated) IP 75 mg |
| Zinc Sulphate IP 20 mg |
| Equivalent to elemental zinc 4.50 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| MULTIVITAMIN, FOLIC ACID WITH CALCIUM PANTHOTHENATE CAPSULES | Each hard gelatin capsule contains |
| Thiamine Mononitrate IP 1 mg |
| Riboflavine IP 1 mg |
| Pyridoxine Hydrochloride IP 0.5 mg |
| Cyanocobalamin IP 1 mcg |
| Calcium Panthothenate IP 1 mg |
| Folic Acid IP 100 mcg |
| Niacinamide IP 20 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| MULTIVITAMIN, FOLIC ACID, ZINC SULPHATE | Each hard gelatin capsule contains |
| Thiamine Mononitrate IP 5 mg |
| Riboflavine IP 5 mg |
| Pyridoxine Hydrochloride IP 1.5 mg |
| Cyanocobalamin IP 5 mcg |
| Calcium Panthothenate IP 5 mg |
| Folic Acid IP 1000 mcg |
| Niacinamide IP 45 mg |
| Zinc Sulphate IP 20 mg |
| Eq. to elemental Zinc 4.5 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Multivitamin, Mineral with Lycopene Syrup | Each 15 ml contains : |
| Lycopene 10% 1000 mcg |
| Niacitamide IP 25 mg |
| Pyridoxine HCl IP 1.5 mg |
| Cyanocobalamin IP 1 mg |
| Folic acid IP 100 mcg |
| Selenium (As sodium seleneate) 35 mcg |
| Zinc (As Zinc Glucotate) BP 3 mg |
| lodine (As Potassium lodide) IP 100 mcg |
| Copper (As Copper Sulphate) BP 500 mcg |
| Biotine BP 100 mcg |
| Magnesium Gluconate BP 100 mcg |
| Approved coloured use in a flavoured syrup base |
| |
| Multi-Vitamin, Multi-Mineral with Lycopene & Methylcobalamin | Each 5 ml contains : |
| Methylcobalamin IP 500 mcg |
| Lycopene 6% USP 1500 mcg |
| L-Lysine Hydrochloride 60 mg |
| Vitamin A (As Palmetate) IP 5000 IU |
| Vitamin E IP 15 IU |
| Vitamin D3 IP 400 IU |
| Thiamine Mononitrate IP 5 mg |
| Riboflavine (As Sodium Phosphate) IP 5 mg |
| Sodium Selenite USP |
| eq. to Selenite 20 mcg |
| Zinc Gluconate USP |
| eq.to Zinc 2 mg |
| Mangnesium Chloride IP 2 mg |
| Potassium lodide IP |
| eq. to Elemental lodine 100 mcg |
| Chromium Chloride IP 16 mcg |
| Approved colour used in flavoured syrupy base |
| |
| Multi-Vitamin, Multi-Mineral with Lycopene & Methylcobalamin | Each 5 ml contains : |
| Methylcobalamin IP 500 mcg |
| Lycopene 6% USP 1500 mcg |
| L-Lysine Hydrochloride 60 mg |
| Vitamin A (As Palmetate) IP 5000 IU |
| Vitamin E IP 15 IU |
| Thiamine Mononitrate IP 5 mg |
| Riboflavine (As Sodium Phosphate) IP 5 mg |
| Sodium Selenite USP |
| eq. to Selenite 20 mcg |
| Zinc Gluconate USP |
| eq.to Zinc 2 mg |
| Mangnesium Chloride IP 2 mg |
| Potassium lodide IP |
| eq. to Elemental lodine 100 mcg |
| Chromium Chloride IP 16 mcg |
| Approved colour used in flavoured syrupy base |
| |
| Multivitamins, Multiminerals With Ginseng Tablets | Each film coated tablet contains : |
| Vitamin A IP 250 mcg |
| Vitamin B 1 Mononitrate IP 1 mg |
| Vitamin B 2 IP 1.5 mg |
| Vitamin B3 IP 10 mg |
| Vitamin B6 IP 1 mg |
| Vitamin B 12 IP 1 mcg |
| Vitamin D3 (As Cholecalciferol) IP 5 IU |
| Vitamin E IP 1.25 mg |
| Folic Acid IP 0.15 mg |
| Biotin 30 mcg |
| Zinc ( As Zinc Sulphate) USP 15 mg |
| lodine (As Potassium lodide) IP 0.15 mg |
| Carbonyl Iron 30 mg |
| Maganesium Sulphate IP 100 mg |
| Manganese USP 2.5 mg |
| Copper USP 2 mg |
| Calcium IP 250 mg |
| Phosphorous 125 mg |
| Potassium 40 mg |
| Chloride IP 36.3 mg |
| Selenium USP 30 mcg |
| Nickel IP 5 mcg |
| Silicon USP 2 mg |
| Vanadium IP 10 mcg |
| Boron IP 150 mcg |
| Chromium 25 mcg |
| Tin 10 mcg |
| Ginseng extract powder 21.25 mg |
| Excipients q.s. |
| |
| Multivitamins, Mutiminerals Calcium, Iron & Zinc Powder | Each 30 g contains : |
| Pyridoxine Hydrochloride IP 0.5 mg |
| Cyanocobalamin IP 1mcg |
| Vitamin D3 As Cholecalciferol) IP 100 I.U |
| Folic Acid IP 300 mcg |
| Naicinamide IP 15 mg |
| Calcium ( As Dibasic Calcium Phosphate Dihydrate IP 200 mg |
| Manganese (As Sulphate) USP 1.5 mcg |
| Zinc (As Zinc Sulphate) USP 1.5 mg |
| Iron (Ferric Ammonium Citrate ) IP 10 mg |
| Magnesium Oxide IP 4 mg |
| Cupperic Sulphate USP 2.5 mg |
| Chromium (As Chromium Chloride) IP 25 mg |
| Selenium Dioxide Monohydrate USP 20 mcg |
| Potassium Chloride IP 5 mg |
| Sodium Chloride IP 33 mg |
| lodine ( As Potassium lodide ) IP 100 mcg |
| Excipients q.s. |
| |
| Mycophenolate Mofetil Capsules IP 250 mg | Each hard gelatin capsule contains |
| Mycophenolate Mofetil IP 250 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Mycophenolate Mofetil Capsules IP 500 mg | Each hard gelatin capsule contains |
| Mycophenolate Mofetil IP 500 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Mycophenolate Mofetil Suspension | Each ml contains : |
| Mycophenolate Mofetil IP 200 mg |
| Approved colour used in flavoured syrupy base |
| |
| Mycophenolate Mofetil Tablets IP 250 mg | Each film coated tablets contains |
| Mycophenolate Mofetil IP 250 mg |
| Approved colour to be used |
| |
| Mycophenolate Mofetil Tablets IP 360 mg | Each film coated tablets contains |
| Mycophenolate Mofetil IP 360 mg |
| Approved colour to be used |
| |
| Mycophenolate Mofetil Tablets IP 500 mg | Each film coated tablets contains |
| Mycophenolate Mofetil IP 500 mg |
| Approved colour to be used |
| |
| Mycophenolate Mofetil Tablets IP 750 mg | Each film coated tablets contains |
| Mycophenolate Mofetil IP 750 mg |
| Approved colour to be used |
| |
| Myo-Inositol and Metformin HCI (SR) Tablets | Each uncoated bilayer tablet contains |
| Myo-Inositol IP 600 mg |
| Metformin Hydrochloride IP 250 mg |
| (As sustained release form) |
| Approved colour to be used |
| |
| Myo-Inositol and Metformin HCI Tablets | Each film coated tablet contains |
| Myo-lnositol IP 600 mg |
| Metformin Hydrochloride IP 250 mg |
| Approved colour to be use |
| |
| N-Acetylsteine Tablet | Each Film coated tablet contains : |
| N-Acetylsteine USP 600 mg |
| Excipients q.s. |
| Approved coloured used |
| |
| Naltrexone Hydrochloride Tablets IP 50 mg | Each uncoated tablets contains: |
| Naltrexone Hydrochloride IP 50 mg |
| Approved colour to be use |
| |
| Naproxen and Domperidone Tablet | Each uncoated tablet contains : |
| Naproxen IP 250 mg |
| Domperidone IP 10 mg |
| Excipients q.s. |
| |
| Naproxen Sodium & Domperidone Tablets | Each film coated tablet contains: |
| Naproxen Sodium IP 500 mg |
| Domperidone Maleate IP |
| Eq. to Domperidone 10 mg |
| Approved colour to be used |
| |
| Naproxen Tablets IP | Each uncoated tablet contains : |
| Naproxen IP 250 mg |
| Excipients q.s. |
| Approved coloured to be used |
| |
| Naproxen Tablets IP | Each uncoated tablet contains : |
| Naproxen IP 500 mg |
| Excipients q.s. |
| Approved coloured to be used |
| |
| Nebivolol and Telmisartan Tablets | Each film coated tablets contains |
| Nebivolol Hydrochloride IP |
| Eq. to Nebivolol 5 mg |
| Telmisartan IP 40 mg |
| Approved color to be use |
| |
| Nebivolol and Valsartan Capsules | Each hard gelatin capsule contains |
| Valsartan IP 80 mg |
| Nebivolol Hydrochloride IP |
| Eq. to Nebivolol 5 mg |
| Approved colour use in empty capsule shell |
| |
| Nebivolol Hcl Tablets IP | Each uncoated tablet contains : |
| Nebivolol Hydrochloride IP |
| Eq. to Nebivolol 5 mg |
| Approved colour to be use |
| |
| Nebivolol Hcl Tablets IP | Each uncoated tablet contains : |
| Nebivolol Hydrochloride IP |
| Eq. to Nebivolol 10 mg |
| Approved colour to be use |
| |
| Nebivolol Hydrochloride and Hydrochlorothiazide Tablets | Each uncoated tablet contains : |
| Nebivolol Hydrochloride IP |
| Eq. to Nebivolol 5 mg |
| Hydrochlorothiazide IP 12.5 mg |
| Approved colour to used |
| |
| Nicorandil Prolonged Release Tablets IP 10 mg | Each uncoated Prolonged-release tablet contains : |
| Nicorandil IP 10 mg |
| Excipient q.s |
| |
| Nicorandil Prolonged Release Tablets IP 20 mg | Each uncoated Prolonged-release tablet contains : |
| Nicorandil IP 20 mg |
| Excipient q.s |
| |
| Nicorandil Tablets 5 mg | Each uncoated tablet contains : |
| Nicorandil IP 5 mg |
| Approved colour to used |
| |
| Nicorandil Tablets IP 10 mg | Each uncoated tablet contains : |
| Nicorandil IP 10 mg |
| Approved colour to used |
| |
| Nicorandil Tablets IP 20 mg | Each uncoated tablet contains : |
| Nicorandil IP 20 mg |
| Approved colour to used |
| |
| Nicoumalone Tablets IP 1 mg | Each uncoated tablet contains : |
| Nicoumalone IP 1 mg |
| Approved colour to used |
| |
| Nicoumalone Tablets IP 2 mg | Each uncoated tablet contains : |
| Nicoumalone IP 2 mg |
| Approved colour to used |
| |
| Nicoumalone Tablets IP 2 mg. | Each Uncoated tablet contains : |
| Nicoumalone BP 2 mg |
| |
| Nicoumalone Tablets IP 3 mg | Each uncoated tablet contains : |
| Nicoumalone IP 3 mg |
| Approved colour to used |
| |
| Nicoumalone Tablets IP 4 mg | Each uncoated tablet contains : |
| Nicoumalone IP 4 mg |
| Approved colour to used |
| |
| Nicoumalone Tablets IP | Each uncoated tablet corntains |
| Nicoumalone IP 0.5 mg |
| Excipients q.s. |
| |
| Nicoumalone Tablets IP | Each uncoated tablet corntains |
| Nicoumalone IP 5 mg |
| Excipients q.s. |
| |
| Nicoumalone Tablets IP | Each uncoated tablet corntains |
| Nicoumalone IP 6 mg |
| Excipients q.s. |
| |
| Nifedipine Prolonged-release Tablets IP | Each prolonged-release tablet contains |
| Nifedipin IP 20 mg |
| |
| Nimesulide & Dicyclomine Hydrochloride Tablets | Each uncoated tablet contains : |
| Nimesulide IP 100 mg |
| Dicyclomine Hydrochloride IP 10 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / |
| Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Nimesulide & Paracetamol Tablets | Each uncoated tablet contains : |
| Nimesulide BP 100 mg |
| Paracetamol IP 325 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow/Sunset yellow |
| for Titanium Dioxide IP /Apple Green / Iron Oxide red,Iron oxide Yellow |
| |
| Nimesulide & Serratiopeptidase Tablets | Each film coated tablet contains : |
| Nimesulide BP 100 mg |
| Serratiopeptidase IP 10 mg |
| (20,000 Uints of Serratiopeptidase As Enteric Coated) |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Nimesulide & Tizanidine Hydrochloride Tablets IP | Each uncoated tablet contains : |
| Nimesulide BP 100 mg |
| Tizanidine Hydrochloride IP |
| Eq. to Tizanidine 2 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Nimesulide Dispersible Tablets | Each uncoated dispersible tablet contains : |
| Nimesulide BP 100 mg |
| |
| |
| Nimesulide Orally Disintegrating Tablets | Each orally disintegrating tablet contains : |
| Nimesulide BP 100 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Nimesulide Tablets | Each uncoated tablet contains |
| Nimesulide BP 200 mg |
| |
| Nimesulide Tablets BP | Each uncoated tablet contains : |
| Nimesulide BP 100 mg |
| |
| |
| Nimesulide, Cetirizine Hydrochloride With Phenylephrine Hydrochloride | Each uncoated tablet contains : |
| Nimesulide IP 100 mg |
| Cetirizine Hydrochloride IP 5 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide ip /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Nimesulide, Paracetamol & Tizanidine Hydrochloride Tablets | Each uncoated tablet contains : |
| Nimesulide BP 100 mg |
| Paracetamol IP 325 mg |
| Tizanidine Hydrochloride IP |
| Eq. to Tizanidine 2 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide iP /Apple Green / Iron Oxide red,Iron oxide Yellow |
| |
| Nimesulide, Paracetamol and Serratiopeptidase Tablets | Each film coated tablet contains : |
| Nimesulide BP 100 mg |
| Paracetamol IP 325 mg |
| Serratiopeptidase(As enteric coat IP 15 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Nimetazepam Tablets | Each Uncoated tablet contains : |
| Nimetazepam 5.0 mg |
| Excipients q.s. |
| |
| Nitazoxanide Suspension | Each 5 ml contains : |
| Nitazoxanide 100 mg |
| Approved coloured use in a flavoured syrup base |
| |
| Nitazoxanide Tablets | Each film coated tablet contains |
| Nitazoxanide 500 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Nitrazepam Tablets IP | Each uncoated tablet contains : |
| Nitrazepam IP 10 mg |
| |
| Nitroglycerin Controlled Release Tablets IP | Each uncoated CR tablet contains : |
| Diluted Nitroglycerin IP |
| eq. to Nitroglycerin 2.6 mg |
| Colour: Sunset yellow FCF |
| |
| Nitroglycerin Controlled Release Tablets IP | Each uncoated CR tablet contains : |
| Diluted Nitroglycerin IP |
| eq. to Nitroglycerin 6.4 mg |
| Colour: Sunset yellow FCF |
| |
| Norethisterone Acetate Controlled released Tablets | Each film coated controlled released tablet contains : |
| Norethisterone Acetate BP 10 mg |
| Approved colour to be use |
| |
| Norethisterone Tablets IP | Each uncoated tablet contains : |
| Norethisterone IP 5 mg |
| Excipients q.s. |
| |
| NORFLOXACIN & METRONIDAZOLE | Each 5 ml contains : |
| Norfloxacin IP 100 mg |
| Metronidazole Benzoate IP |
| Equivalent to Metronidazole 120 mg |
| Approved colour used in flavoured syrupy base |
| |
| Norfloxacin & Ornidazole Tablets | Each film coated tablet contains : |
| Norfloxacin IP 400 mg |
| Ornidazole IP 500 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Norfloxacin & Tinidazole (With Betacyclodextrin) Tablets | Each uncoated tablet contains : |
| Norfloxacin IP 400 mg |
| Tinidazole IP 600 mg |
| ( With Betacyclodextrin) |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / |
| Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Norfloxacin , Tinidazole With Betacyclodextrin Tablets | Each film coated tablet contains : |
| Norfloxacin IP 400 mg |
| Tinidazole IP 600 mg |
| Betacyclodextrin USP 50 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / |
| Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Norfloxacin , Tinidazole With Betadex Tablets | Each film coated tablet contains : |
| Norfloxacin IP 400 mg |
| Tinidazole IP 600 mg |
| Betadex (Anhydrous) USP 10 mg |
| Approved colour to used |
| |
| Norfloxacin and Tinidazole Tablets | Each film coated tablet contains : |
| Norfloxacin IP 200 mg |
| Tinidazole IP 300 mg |
| Approved colour to used |
| |
| Norfloxacin Tablets IP | Each film coated tablet contains : |
| Norfloxacin IP 400 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| |
| Norfloxacin With Betacyclodextrin Tablets | Each film coated tablet contains : |
| Norfloxacin IP 400 mg |
| Betacyclodextrin USP 50 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / |
| Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Norfloxacin With Lactic Acid Bacillus Tablets | Each film coated tablet contains : |
| Norfloxacin IP 400 mg |
| Lactic Acid Bacillus 90 ms. |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| NORFLOXACIN WITH METRONIDAZOLE ORAL SUSPENSION | Each 5 ml contains : |
| Norfloxacin IP 100 mg |
| Metronidazole Benzoate IP |
| Equivalent to Metronidazole 100 mg |
| Approved colour used in flavoured syrupy base |
| |
| NORFLOXACIN, METRONIDAZOLE & FURAZOLIDONE ORAL SUSPENSION | Each 5 ml contains : |
| Norfloxacin IP 100 mg |
| Metronidazole Benzoate IP |
| Equivalent to Metronidazole 100 mg |
| Furazolidone IP 20 mg |
| Approved colour used in flavoured syrupy base |
| |
| Nortriptyline Tablets IP | Each film coated tablet contains : |
| Nortriptyline IP 10 mg |
| Permitted Color Used |
| |
| Nortriptyline Tablets IP | Each film coated tablet contains : |
| Nortriptyline IP 25 mg |
| Permitted Color Used |
| |
| Ofloxacin & Metronidazole Oral Suspension | Each 5 ml contains : |
| Ofloxacin IP 100 mg |
| Metronidazole Benzoate IP |
| Equivalent to Metronidazole 200 mg |
| Approved colour used in flavoured syrupy base |
| |
| OFLOXACIN & METRONIDAZOLE ORAL SUSPENSION | Each 5 ml contains : |
| Ofloxacin IP 50 mg |
| Metronidazole Benzoate IP |
| Equivalent to Metronidazole 100 mg |
| Approved colour used in flavoured syrupy base |
| |
| Ofloxacin & Ornidazole Tablets | Each film coated tablet contains : |
| Ofloxacin IP 200 mg |
| Ornidazole IP 500 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / |
| Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Ofloxacin & Tinidazole Tablets | Each film coated tablet contains : |
| Ofloxacin IP 200 mg |
| Tinidazole IP 600 mg |
| Colour: Brilliant Blue/Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron Oxide red, Iron oxide Yellow |
| |
| Ofloxacin Dispersible Tablets | Each dispersible tablet contains : |
| Ofloxacin IP 100 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| OFLOXACIN ORAL SUSPENSION IP | Each 5 ml contains : |
| Ofloxacin IP 50 mg |
| Approved colour used in flavoured syrupy base |
| |
| |
| Ofloxacin Tablets IP 200 mg | Each film coated tablet contains : |
| Ofloxacin IP 200 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron Oxide red,Iron oxide Yellow |
| |
| Ofloxacin Tablets IP 400 mg | Each film coated tablet contains : |
| Ofloxacin IP 400 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron Oxide red,Iron oxide Yellow |
| |
| Ofloxacin With Cefixime Tablets | Each flim coated tablet contains |
| Ofloxacin IP 200 mg |
| Cefixime Trihydrate IP |
| eq. to Cefixime 200 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Ofloxacin With Lactic Acid Bacillus Tablets | Each film coated tablet contains : |
| Ofloxacin IP 200 mg |
| Lactic Acid Bacillus IP 60 ml s.p. |
| Approved Color to be use in Tablet |
| |
| OFLOXACIN WITH ORNIDAZOLE ORAL SUSPENSION | Each 5 ml contains : |
| Ofloxacin IP 50 mg |
| Ornidazole IP 125 mg |
| Approved colour used in flavoured syrupy base |
| |
| Olanzapine Tablets IP | Each film coated tablet contains: |
| Olanzapine IP 2.5 mg |
| Approved colour to used |
| |
| Olanzapine Tablets IP | Each film coated tablet contains: |
| Olanzapine IP 5 mg |
| Approved colour to used |
| |
| Olanzapine Tablets IP | Each film coated tablet contains: |
| Olanzapine IP 7.5 mg |
| Approved colour to used |
| |
| Olanzapine Tablets IP | Each film coated tablet contains: |
| Olanzapine IP 10 mg |
| Approved colour to used |
| |
| Olanzapine Tablets | Each film coated tablet contains: |
| Olanzapine IP 15 mg |
| Approved colour to used |
| |
| Olmesartan Medoxomil & Hydrochlorothiazide Tablets | Each uncoated tablet contains : |
| Olmesartan Medoxomil IP 40 mg |
| Hydrochlorothiazide IP 12.5 mg |
| |
| Olmesartan Medoxomil & Hydrochlorothiazide Tablets | Each film coated tablet contains: |
| Olmesartan Medoxomil IP 20 mg |
| Hydrochlorothiazide IP 12.5 mg |
| Colour: Brilliant Blue/ Erythrosine/ Tartraz ine / Quinoline Yellow/ Sunset yelow |
| or Titanium Dioxide IP IApple Green /Iron oxide red,Iron oxide Yellow |
| |
| Olmesartan Medoxomil & Hydrochlorothiazide With | Each uncoated tablet contains : |
| Olmesartan Medoxomil IP 40 mg |
| Hydrochlorothiazide IP 12.5 mg |
| Amlodipine Besiylate IP |
| Eq. to Amlodipine 5 mg |
| |
| Olmesartan Medoxomil Hydrochlorothiazide with | Each uncoated tablet contains |
| Olmesartan Medoxomil IP 40 mg |
| Hydrochlorothiazide IP 25 mg |
| Amlodipine Besiylate IP |
| Eq.to Amlodipine 10 mg |
| |
| Olmesartan Medoxomil Hydrochlorothiazide with | Each uncoated tablet contains: |
| Olmesartan Medoxomil IP 20 mg |
| Hydrochlorothiazide IP 12.5 mg |
| Amlodipine Besiylate IP |
| Eq. to Amlodipine 5 mg |
| |
| Olmesartan Medoxomil Hydrochlorothiazide with | Each uncoated tablet contains: |
| Olmesartan Medoxomil IP 5 mg |
| Hydrochlorothiazide IP 12.5 mg |
| Amlodipine Besiylate IP |
| Eq. to Amlodipine 2. 5 mg |
| |
| Olmesartan Medoxomil Hydrochlorothiazide with | Each uncoated tablet contains: |
| Olmesartan Medoxomil IP 40 mg |
| Hydrochlorothiazide IP 25 mg |
| Amlodipine Besiylate IP |
| Eq. to Amlodipine 5 mg |
| Olmesartan Medoxomil Tablets IP | Each film coated tablet contains : |
| Olmesartan Medoxomil IP 20 mg |
| Permitted Color Used |
| |
| Olmesartan Medoxomil Tablets IP | Each film coated tablet contains : |
| Olmesartan Medoxomil IP 10 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Olmesartan Medoxomil Tablets IP | Each film coated tablet contains : |
| Olmesartan Medoxomil IP 40 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Olmesartan Medoxomil Tablets IP | Each film coated tablet contains: |
| Olmesartan Medoxomil IP 20 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/Quinoline Yellow/Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| |
| Olmesartan Medoxomil, Chlorothiazide Tablets | Each uncoated tablet contains |
| Olmesartan Medoxomil IP 20 mg |
| Chlorothiazide IP 12.5 mg |
| |
| Olmesartan Medoxomil, Chlorothiazide Tablets | Each uncoated tablet contains |
| Olmesartan Medoxomil IP 40 mg |
| Chlorothiazide IP 12.5 mg |
| |
| Olmesartan, Cilnidipine with Chlorthalidone Tablets | Each film coated tablet contains |
| Olmisartan Medoxomil IP 40 mg |
| Cilnidipine IP 10 mg |
| Chlorthalidone IP 12.5 mg |
| Permitted Color Used |
| |
| OMEPRAZOLE & DOMPERIDONE CAPSULES | Each hard gelatin capsule contains |
| Omeprazole (As enteric coated pellets) IP 20 mg |
| Domperidon (As coated pellets) IP 10 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Omeprazole (EC) and Cinitapride (ER) Capsules | Each hard gelatin capsule contains |
| Omeprazole IP 20 mg |
| (As Gastro-resistant pellets) |
| Cinitapride Hydrogen Tartrate |
| Eq. to Cinitapride 3 mg |
| (As extended release pellets) |
| Approved colour use in empty capsule shell |
| |
| OMEPRAZOLE CAPSULES | Each hard gelatin capsule contains |
| Omeprazole (As enteric coated pellets IP 40 mg |
| Approved colour used in empty capsule shell |
| |
| OMEPRAZOLE CAPSULES IP | Each hard gelatin capsule contains |
| Omeprazole (As enteric coated pellets) IP 20 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| OMEPRAZOLE EC PELLETS 10.00 % w/w | Each 1 gm enteric coated pellets contains |
| Omeprazole 100 mg |
| Approved colour to be use |
| |
| OMEPRAZOLE EC PELLETS 12.5 % w/w | Each 1 gm enteric coated pellets contains |
| Omeprazole 125 mg |
| Approved colour to be use |
| |
| OMEPRAZOLE EC PELLETS 25.0 % w/w | Each 1 gm enteric coated pellets contains |
| Omeprazole 250 mg |
| Approved colour to be use |
| |
| OMEPRAZOLE EC PELLETS 7.50 % w/w | Each 1 gm enteric coated pellets contains |
| Omeprazole 75 mg |
| Approved colour to be use |
| |
| OMEPRAZOLE EC PELLETS 8.50 % w/w | Each 1 gm enteric coated pellets contains |
| Omeprazole 85 mg |
| Approved colour to be use |
| |
| Ondansetron Hydrochloride Tablets IP | Each uncoated tablet contains : |
| Ondansetron Hydrochloride IP |
| eq. to Ondansetron 4 mg |
| Colour: Brilliant Blue/Erythrosine/Tartrazine/Quinoline Yellow/Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Ondansetron Hydrochloride Tablets IP | Each uncoated tablet contains: |
| Ondansetron Hydrochloride IP |
| eq. to Ondansetron 8 mg |
| Approved colour to be used |
| |
| ONDANSETRON ORAL SOLUTION IP | Each 5 ml contains : |
| Ondansetron Hydrochloride IP |
| Eq. to Ondansetron 2 mg |
| Approved colour used in flavoured syrupy base |
| |
| Ondansetron Oral Solution IP | Each 5 ml contains: |
| Ondansetron Hydrochloride IP |
| Eq. to Ondansetron 4 mg |
| Approved colour used in flavoured syrupy base |
| |
| Ondansetron Orally Disintegrating Tablets IP | Each orally disintegrating tablets contains : |
| Ondansetron Hydrochloride IP |
| eq. to Ondansetron 4 mg |
| Colour: Brilliant Blue/Erythrosine/Tartrazine/Quinoline Yellow/Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Ondansetron Orally Disintegrating Tablets IP | Each orally disintegrating tablet contains: |
| Ondansetron Hydrochloride IP |
| eq. to Ondansetron 8 mg |
| Approved colour to be used |
| |
| Oral Rehydration Salts IP | Each sachet 21g contains |
| Sodium chloride IP 2.60 g |
| Dextrose anhydrose IP 13.5 g |
| Potassium Chloride IP 1.50 g |
| Sodium Carate IP 2.90 g |
| Excipients q.s. |
| |
| Oral Rehydration Salts Solution | Each 200 ml. contains |
| Sodium Chloride IP 0.52 g |
| Dextrose Monohydrate IP 2.97 g |
| Potassium Chloride IP 0.30 g |
| Sodium Citrate IP 0.58 g |
| Approved colour in flavoured syrupy base |
| |
| Orinidazole Tablets | Each Film coated tablet contains : |
| Orinidazole IP 500 mg |
| Excipients q.s. |
| Approved coloured used |
| |
| Orlistat Capsules USP | Each hard gelatin capsule contains |
| Orlistat USP 120 mg |
| Approved colour used in flavoured syrupy base |
| |
| Orlistat Capsules USP | Each hard gelatin capsule : |
| Orlistat (As Pellets) USP 60 mg |
| Approved colour used in empty capsule shell |
| |
| Oseltamivir Phosphate Capsules IP | Each hard gelatin capsule contains |
| Oseltamivir Phosphate IP 75 mg |
| Eq. to Oseltamivir |
| Excipients q.s. |
| Approved colour use in empty capsule shell |
| |
| Oseltamivir Phosphate Capsules IP | Each hard gelatin capsule contains |
| Oseltamivir Phosphate IP 45 mg |
| Eq. to Oseltamivir |
| Excipients q.s. |
| Approved colour use in empty capsule shell |
| |
| Oseltamivir Phosphate Capsules IP | Each hard gelatin capsule contains |
| Oseltamivir Phosphate IP 30 mg |
| Eq. to Oseltamivir |
| Excipients q.s. |
| Approved colour use in empty capsule shell |
| |
| Oseltamivir Phosphate Oral Suspension IP | Each ml of Reconstituted Suspension contains : |
| Oseltamivir Phosphate IP |
| Eq. to Oseltamivi 15 mg |
| Approved colour used in flavoured syrupy base |
| |
| Oseltamivir Phosphate Oral Suspension IP | Each ml of Reconstituted Suspension contains : |
| Oseltamivir Phosphate IP |
| Eq. to Oseltamivi 12 mg |
| Approved colour used in flavoured syrupy base |
| |
| Oxazepam Tablets IP | Each Uncoated tablet contains : |
| Oxezepam IP 10.0 mg |
| Excipients q.s. |
| |
| Oxazepam Tablets IP | Each Uncoated tablet contains : |
| Oxezepam IP 15.0 mg |
| Excipients q.s. |
| |
| Oxazepam Tablets IP | Each Uncoated tablet contains : |
| Oxezepam IP 30.0 mg |
| Excipients q.s. |
| |
| Oxcarbazepine Extended Release Tablets | Each film coated extended release tablet contains: |
| Oxcarbazepine IP 300 mg |
| Approved colour to be used |
| |
| Oxcarbazepine Extended Release Tablets | Each film coated extended release tablet contains: |
| Oxcarbazepine IP 600 mg |
| Approved colour to be used |
| |
| Oxcarbazepine Tablets IP 150 mg | Each film coated tablet contains : |
| Oxcarbazepine IP 150 mg |
| Excipients q.s |
| Approved colour to used |
| |
| Oxcarbazepine Tablets IP 300 mg | Each film coated tablet contains : |
| Oxcarbazepine IP 300 mg |
| Excipients q.s |
| Approved colour to used |
| |
| Oxcarbazepine Tablets IP 450 mg | Each film coated tablet contains : |
| Oxcarbazepine IP 450 mg |
| Excipients q.s |
| Approved colour to used |
| |
| Oxcarbazepine Tablets IP 600 mg | Each film coated tablet contains : |
| Oxcarbazepine IP 600 mg |
| Excipients q.s |
| Approved colour to used |
| |
| Oxfendazole Bolus For Veterinary Use | Each uncoated bolus contains |
| Oxfendazole IP 150 mg |
| Colour : Sunset Yellow FCF |
| |
| Oxfendazole E Bolus For Veterinary Use | Each uncoated bolus contains |
| Oxfendazole IP 2200 mg |
| Colour: Sunset Yellow FCF |
| |
| Oxyphenbutazone Tablets IP | Each film coated tablet contains : |
| Oxyphenbutazone IP 100 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Oxytetracycline Bolus For Veterinary Use | Each uncoated bolus contains |
| Oxytetracycline Hcl IP 500 mg |
| |
| |
| OXYTETRACYCLINE HYDROCHLORIDE CAPSULES IP | Each hard gelatin capsule contains |
| Oxytetracycline Hydrochloride IP 250 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Pantoprazole & Domperidone Tablets | Each enteric coated tablet contains : |
| Pantoprazole Sodium Sesquihydrate IP |
| Eq. to Pantoprazole 40mg |
| Domperidone IP 10 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron Oxide red, iron oxide kllow |
| |
| Pantoprazole & Domperidone Tablets | Each enteric coated tablet contains: |
| Pantoprazole Sodium Sesquihydrate IP |
| Eq. lo Pantoprazole 20 mg |
| Domperidone IP 10 mg |
| Approved colour to used |
| |
| Pantoprazole (EC) and Levosulpiride (SR) Capsules | Each hard gelatin capsule contains |
| Pamotprazole Sodium IP |
| Eq.to Pantoprazole 40 mg |
| (As enteric coated pellets) |
| Levosulpiride 75 mg |
| (As sustained release pellets) |
| Approved colour use in empty capsule shell |
| |
| Pantoprazole Dual-release gastro-resistant Tablets | Each Dual-release gastro-resistant tablet contains : |
| Pantoprazole Sodium IP 80 mg |
| Eq.to Pantoprazole |
| Approved colour to be used |
| |
| PANTOPRAZOLE SODIUM & DOMPERIDONE (SR) CAPSULES | Each hard gelatin capsule contains |
| Pantoprazole Sodium Sesquihydrate IP |
| Eq. to Pantoprazole (As enteric coated pellets) 20 mg |
| Domperidon (As sustained release pellets) IP 10 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| PANTOPRAZOLE SODIUM & DOMPERIDONE (SR) CAPSULES | Each hard gelatin capsule contains |
| Pantoprazole Sodium Sesquihydrate IP |
| Eq. to Pantoprazole (As enteric coated pellets) 40 mg |
| Domperidon (As sustained release pellets) IP 30 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| PANTOPRAZOLE SODIUM & DOMPERIDONE (SR) CAPSULES | Each hard gelatin capsule contains |
| Pantoprazole Sodium eq. to IP |
| Pantoprazole 40 mg |
| Domperidone IP 10 mg |
| Approved colour used in emply capsule shell |
| |
| Pantoprazole Sodium (EC) and Cinitapride (SR) Capsules | Each hard gelatin capsule contains |
| Pantoprazole Sodium IP |
| Eq.to Pantoprazole 40 mg |
| (As Gastro-resistant pellets) |
| Cinitapride Hydrogen Tartrate |
| Eq. to Cinitapride 3 mg |
| (As extended release pellets) |
| Approved colour use in empty capsule shell |
| |
| Pantoprazole Sodium (EC) and Itopride HCI (SR) Capsules | Each hard gelatin capsule contains |
| Pantoprazole Sodium IP |
| Eq.to Pantoprazole 40 mg |
| (As enteric coated pellets) |
| Itopride Hydrochloride IP 150 mg |
| (As sustained release pellets) |
| Approved colour use in empty capsule shell |
| |
| PANTOPRAZOLE SODIUM EC PELLETS 15.0 % W/W | Each 1 gm enteric coated pellets contains |
| Pantoprazole sodium 150 mg |
| Approved colour to be use |
| |
| PANTOPRAZOLE SODIUM EC PELLETS 20.0 % W/W | Each 1 gm enteric coated pellets contains |
| Pantoprazole sodium 200 mg |
| Approved colour to be use |
| |
| PANTOPRAZOLE SODIUM EC PELLETS 22.50% W/W | Each 1 gm enteric coated pellets contains |
| Pantoprazole sodium 225 mg |
| Approved colour to be use |
| |
| |
| PANTOPRAZOLE SODIUM EC PELLETS 8.50 % W/W | Each 1 gm enteric coated pellets contains |
| Pantoprazole sodium 85 mg |
| Approved colour to be use |
| |
| Pantoprazole Sodium Gastro-Resistant Tablets IP 20 mg | Each enteric coated tablet contains : |
| Pantoprazole Sodium IP |
| Eq. to Pantoprazole 20 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Pantoprazole Tablets | Each enteric coated tablet contains : |
| Pantoprazole Sodium Sesquihydrate IP |
| Eq. to Pantoprazole 40 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Paracetamol & Caffeine Tablets | Each uncoated tablet contains : |
| Paracetamol IP 325 mg |
| Caffeine (Anhydrous) IP 30 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| Jor Titanium Dioxide IP /Apple Green/Iron oxide red iron oxide Yellow |
| |
| Paracetamol & Caffeine Tablets | Each Uncoated tablet contains: |
| Paracetamol IP 325 mg |
| Caffeine (Anhydros) IP 10 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Paracetamol & Chlorpheniramine Maleate Tablets | Each uncoated tablet contains : |
| Paracetamol IP 325 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Colour: Brilliant Blue/Erythrosine/Tartrazine/Quinoline Yellow/Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Paracetamol & Chlorzoxazone Tablets | Each uncoated tablet contains : |
| Paracetamol IP 325 mg |
| Chlorzoxazone USP 250 mg |
| |
| Paracetamol & Diclofenac Potassium Tablets | Each sugar-coated tablet contains : |
| Paracetamol IP 250 mg |
| Diclofenac Potassium IP 50 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Paracetamol & Diclofenac Potassium Tablets | Each uncoated tablet contains : |
| Paracetamol IP 325 mg |
| Diclofenac Potassium IP 50 mg |
| Colour: Brilliant Blue/Erythrosine/Tartrazine/Quinoline Yellow/Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Paracetamol & Domperidone Tablets | Each film coated tablet contains : |
| Paracetamol IP 325 mg |
| Domperidone IP 10 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline ellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green/Iron oxide red, Iron Oxide Yellow |
| |
| Paracetamol & Metoclopramide Hydrochloride Tablets | Each uncoated tablet contains : |
| Paracetamol 325mg |
| Metoclopramide Hydrochloride IP 10 mg |
| Eq. to Anhydrous Metoclopramide Hydrochloride |
| Excipients qs |
| |
| Paracetamol & Phenylephrine Hydrochloride Tablets | Each uncoated tablet contains : |
| Paracetamol IP 325 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green /tron oxide red,Iron oxide Yellow |
| |
| PARACETAMOL & PROMETHAZINE HYDROCHLORIDE SUSPENSION | Each 5 ml contains : |
| Paracetamol IP 125 mg |
| Promethazine Hydrochloride IP 5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Paracetamol & Tolperisone Tablets | Each film coated tablet contains : |
| Paracetamol IP 500 mg |
| Tolperisone Hydrochloride JP 150 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Paracetamol & Tolperisone Tablets | Each film coated tablet contains : |
| Paracetamol IP 325 mg |
| Tolperisone Hydrochloride JP 150 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Paracetamol , Caffeine & Chlorpheniramine Maleate Tablets | Each uncoated tablet contains : |
| Paracetamol IP 300 mg |
| Caffeine (Anhydrous) IP 20 mg |
| Chlorpheniramine Maleate IP 4 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide ip /Apple Green / Iron oxide red, Iron Oxide Yelloy |
| |
| Paracetamol , Nimesulide & Chlorzoxazone Bolus | Each uncoated bolus contains |
| Paracetamol IP 1500 mg |
| Nimesulide BP 400 mg |
| Chlorzoxazone USP 1000 mg |
| Colour : Quinoline Yellow |
| |
| Paracetamol , Phenylephrine Hcl & Chlorpheniramine Maleate and Caffeine | Each uncoated tablet contains : |
| Paracetamol IP 325 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Chlorpheniramine Maleate IP 4 mg |
| Caffeine (Anhydrous) IP 20 mg |
| Approved colour to be used |
| |
| Paracetamol , Phenylephrine Hydrochloride & Chlorpheniramine Maleate | Each Uncoated tablet contains: |
| Paracetamol IP 500 mg |
| Phenylephrine Hydrochloride IP 10 mg |
| Chlorpheniramine Maleate IP 4 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Paracetamol and Caffeine Tablets IP | Each uncoated tablet contains : |
| Paracetamol IP 500 mg |
| Caffeine (Anhydrosu) IP 25 mg |
| Excipients q.s. |
| Approved coloured used |
| |
| Paracetamol and Caffeine Tablets IP | Each uncoated tablet contains : |
| Paracetamol IP 650 mg |
| Caffeine (Anhydrosu) IP 50 mg |
| Excipients q.s. |
| Approved coloured used |
| |
| Paracetamol and Domperidone Suspension | Each 5 ml contains : |
| Paracetamol IP 250 mg |
| Domperidone IP 5 mg |
| Approved coloured use in a flavoured syrup base |
| |
| Paracetamol and Domperidone Tablets | Each uncoated tablet contains |
| Paracetamol IP 325 mg |
| Domperidone IP 10 mg |
| Excipients q.s. |
| Approved coloured used |
| |
| Paracetamol and Domperidone Tablets | Each uncoated tablet contains |
| Paracetamol IP 500 mg |
| Domperidone IP 20 mg |
| Excipients q.s. |
| Approved coloured used |
| |
| Paracetamol and Zaltoprofen Tablets | Each film coated tablet contains: |
| Paracetamol IP 325 mg |
| Zaltoprofen JP 80 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Paracetamol Dispersible Tablets | Each uncoated dispersible tablet contains : |
| Paracetamol BP 125 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Paracetamol Effervescent Tablets | Each uncoated Effervescent tablet contains : |
| Paracetamol IP 500 mg |
| Approved coloured used |
| |
| Paracetamol Effervescent Tablets | Each uncoated Effervescent tablet contains : |
| Paracetamol IP 1000 mg |
| Approved coloured used |
| |
| Paracetamol Oral Suspension IP | Each ml. contains |
| Paracetamol IP 100 mg |
| Colour: Erythrosine / Tartrazine / Sunset Yellow |
| Ponceau-4R or Carmosine |
| In flavoured syrupy base |
| |
| Paracetamol Paediatric Oral Suspension IP | Each ml contains : |
| Paracetamol IP 150 mg |
| Approved colour used in flavoured syrupy base |
| |
| Paracetamol Phenylephrine Hydrochloride & | Each uncoated tablet contains |
| Paracetamol IP 250 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Colour : Erythrosine /Tartrazine / Sunset yellow / Titanium Dioxide IP |
| |
| PARACETAMOL SUSPENSION IP | Each 5 ml contains : |
| Paracetamol IP 125 mg |
| Approved colour used in flavoured syrupy base |
| |
| |
| PARACETAMOL SUSPENSION IP For paediatric use | Each 5 ml contains : |
| Paracetamol IP 250 mg |
| Approved colour used in flavoured syrupy base |
| |
| Paracetamol Suspension | Each 5 ml contains : |
| Paracetamol IP 240 mg |
| Approved colour used in flavoured syrupy base |
| |
| Paracetamol Suspension | Each 5 ml contains : |
| Paracetamol IP 120 mg |
| Approved colour used in flavoured syrupy base |
| |
| PARACETAMOL SYRUP IP | Each 5 ml contains : |
| Paracetamol IP 125 mg |
| Approved colour used in flavoured syrupy base |
| |
| Paracetamol Tablets IP | Each uncoated tablet contains : |
| Paracetamol IP 500 mg |
| |
| Paracetamol Tablets IP | Each uncoated tablet contains : |
| Paracetamol IP 650 mg |
| |
| Paracetamol Tablets IP 300 mg | Each uncoated tablet contains : |
| Paracetamol IP 300 mg |
| |
| Paracetamol, Ambroxol HCI, Guaiphenesin, Cetirizine Hcl & | Each uncoated tablet contains: |
| Paracetamol IP 325 mg |
| Ambroxol Hydrochloride IP 15 mg |
| Guaiphenesin IP 50 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Cetirizine Hydrochloride IP 5mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| PARACETAMOL, AMBROXOL Hcl, PHENYLEPHRINE HYDROCHLORIDE and Chlorpheniramine Maleate | Each 5 ml contains : |
| Paracetamol IP 125 mg |
| Ambroxol Hydrochloride IP 15 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Approved colour used in flavoured syrupy base |
| |
| PARACETAMOL, AMBROXOL Hcl, PHENYLEPHRINE HYDROCHLORIDE and Chlorpheniramine Maleate | Each ml contains : |
| Paracetamol IP 100 mg |
| Ambroxol Hydrochloride IP 7.5 mg |
| Phenylephrine Hydrochloride IP 2.5 mg |
| Chlorpheniramine Maleate IP 1 mg |
| Approved colour used in flavoured syrupy base |
| |
| Paracetamol, Caffeine & Chlorpheniramine Maleate Tablets | Each uncoated tablet contains : |
| Paracetamol IP 325 mg |
| Caffeine (Anhydrous) IP 10 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / |
| Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Paracetamol, Caffeine, Phenylephrine HCL, and Chlorpheniramine maleate | Each uncoated tablet contains |
| Paracetamol IP 500 mg |
| Caffeine (Anhydrous) IP 30 mg |
| Phenylephrine Hydrochloride IP 10 mg |
| Chlorpheniramine maleate IP 4 mg |
| Excipients q.s. |
| |
| Paracetamol, Cetirizine Hydrochloride | Each 5 ml contains : |
| Paracetamol IP 250 mg |
| Cetirizine HCl IP 5 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Paracetamol, Guaiphenesin Chlorpheniramine Maleate,Phenylephrine HCL and Bromhexine HCL | Each uncoated tablet contains : |
| Paracetamol IP 450 mg |
| Guaiphenesin IP 50 mg |
| Chlorpheniramine Maleate IP 4 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Bromhexine Hydrochloride IP 4 mg |
| Approved colour to used |
| |
| Paracetamol, Guaiphenesin, Chlorpheniramine maleate and Bromhexine Hydrochloride | Each uncoated tablet contains : |
| Paracetamol IP 325 mg |
| Guaiphenesin IP 100 mg |
| Bromhexine Hydrochloride IP 8 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Approved colour to used |
| |
| Paracetamol, Nimesulide & Chlorzoxazone Tablets | Each uncoated tablet contains : |
| Paracetamol IP 325 mg |
| Nimesulide BP 100 mg |
| Chlorzoxazone USP 375 mg |
| Colour: Brilliant Blue / Crythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron Oxide red, Iron oxide Yellow |
| |
| Paracetamol, Phenylephrine HCL & Chlorpheniramine Maleate Tablets | Each Uncoated tablet contains: |
| Paracetamol IP 500 mg |
| Phenylephrine Hydrochloride IP 10 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Paracetamol, Phenylephrine HCl and Chlorpheniramine Maleate Tablets | Each uncoated tablet contains : |
| Paracetamol IP 325 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Approved colour to used |
| |
| Paracetamol, Phenylephrine Hcl, Chlorpheniramine Maleate and Sodium Citrate | Each 5 ml contains : |
| Paracetamol IP 125 mg |
| Chlorpheniramine Maleate IP 1 mg |
| Phenylephrine Hcl IP 5 mg |
| Sodium Citrate IP 60 mg |
| Menthol qs |
| Approved colour used in flavoured syrupy base |
| |
| Paracetamol, Phenylephrine Hcl, Chlorpheniramine Maleate and Sodium Citrate | Each 5 ml contains : |
| Paracetamol IP 250 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Phenylephrine Hcl IP 5 mg |
| Sodium Citrate IP 60 mg |
| Menthol qs |
| Approved colour used in flavoured syrupy base |
| |
| Paracetamol, Phenylephrine Hcl, Chlorpheniramine Maleate Drops | Each ml contains : |
| Paracetamol IP 125 mg |
| Chlorpheniramine Maleate IP 1 mg |
| Phenylephrine Hcl IP 5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Paracetamol, Phenylephrine Hcl, Chlorpheniramine Maleate and Menthol | Each 5 ml contains : |
| Paracetamol IP 125 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Phenylephrine Hcl IP 2.5 mg |
| Menthol IP |
| Approved colour used in flavoured syrupy base |
| |
| Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate | Each Uncoated tablet contains: |
| Paracetamol IP 500 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate Tablets | Each uncoated tablets contains |
| Paracetamol IP 325 mg |
| Phenylephrine Hydrochloride IP 10 mg |
| Chlorpheniramine Maleate IP 4 mg |
| Approved colour to be used |
| |
| Paracetamol, Phenylephrine, Bromhexine, Gualphenesin and Chlorpheniramine maleate | Each uncoated tablet contains: |
| Paracetamol IP 500 mg |
| Phenylephrine HCI IP 5 mg |
| Bromhexine Hydrochloride IP 4 mg |
| Gualphenesin IP 50 mg |
| Chlorpheniramine maleate IP 4 mg |
| Approved colour to used |
| |
| Paracetamol, Phenylephrine, Caffeine & | Each uncoated tablet contains : |
| Paracetamol IP 500 mg |
| Caffeine (Anhydrous) IP 30 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Diphenhydramine Hydrochloride IP 25 mg |
| Approved colour to used |
| |
| Paracetamol, Phenylephrine, Caffeine & Diphenhydramine Tablets | Each uncoated tablet contains : |
| Paracetamol IP 325 mg |
| Caffeine (Anhydrous) IP 30 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Diphenhydramine Hydrochloride IP 25 mg |
| Permitted Color Used |
| |
| Paracetamol, Phenylephrine, Caffeine and Chlorpheniramine | Each uncoated tablet contains: |
| Paracetamol IP 325 mg |
| Phenylephrine HCI IP 10 mg |
| Caffeine (Anhydrous) IP 30 mg |
| Chlorpheniramine maleate IP 4 mg |
| Approved colour to used |
| |
| Paracetamol, Phenylephrine, Cetirizine and Ambroxol Tablets | Each uncoated tablet contains : |
| Paracetamol IP 325 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Cetirizine Hydrochloride IP 5 mg |
| Ambroxol Hydrochloride IP 30 mg |
| Approved colour to used |
| |
| Parácetamol, Phenylephrine, Cetirizine HCI Tablets | Each uncoated tablet contains: |
| Paracetamol IP 500 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Cetirizine Hydrochloride IP 5 mg |
| Excipients q.s. |
| |
| Parácetamol, Phenylephrine, Cetirizine HCI Tablets | Each uncoated tablet contains: |
| Paracetamol IP 500 mg |
| Phenylephrine Hydrochloride IP 10 mg |
| Cetirizine Hydrochloride IP 5 mg |
| Excipients q.s. |
| |
| Paracetamol, Phenylephrine,Caffeine and Diphenhydramine Tablets | Each uncoated bilayered tablets contains |
| Paracetamol IP 500 mg |
| Caffeine (Anhydrous) IP 30 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Diphenhydramine Hydrochloride IP 25 mg |
| Approved colour to be used |
| |
| Paracetmol , Chlorpheniramine Maleate Caffeine Tablets | Each uncoated tablet contains: |
| Paracetmol IP 325 mg |
| Chlorpheniramine Maleate IP 4 mg |
| Caffeine (Anhydrous) IP 20 mg |
| Colour Brillow Blue/Frythrosine/Tartrazine/Quinoline Yellow/Suret yellow |
| Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| |
| Paracetmol , Phenylephrine Hydrochloride With | Each uncoated tablet contains: |
| Paracetmol IP 325 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Chlorpheniramine Maleate IP 4 mg |
| Colour Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunsel yellow |
| or Titanium Dioxide ip /Apple Green / Iron Oxide red,Iron oxide Yellow |
| |
| Paracetmol , Phenylephrine Hydrochloride With | Each uncoated tablet contains : |
| Paracetmol IP 325 mg |
| Phenylephrine Hydrochloride IP 5 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Caffeine (Anhydrous) IP 30 mg |
| Colour: Brilliant Blue/Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| |
| Paroxetine Hydrochloride Tablets | Each film coated tablet contains : |
| Paroxetine Hydrochloride IP |
| Eq. to Paroxetine 40 mg |
| Approved colour to be use |
| |
| Paroxetine Prolonged Release Tablets | Each Enteric coated tablet contains : |
| Paroxetine Hydrochloride IP |
| Eq. to Paroxetine 12.5 mg |
| Approved colour to be use |
| |
| Paroxetine Prolonged Release Tablets | Each Enteric coated tablet contains : |
| Paroxetine Hydrochloride IP |
| Eq. to Paroxetine 25 mg |
| Approved colour to be use |
| |
| Paroxetine Prolonged Release Tablets | Each Enteric coated tablet contains : |
| Paroxetine Hydrochloride IP |
| Eq. to Paroxetine 37.5 mg |
| Approved colour to be use |
| |
| Paroxetine Tablets IP 10 mg | Each film coated tablet contains : |
| Paroxetine Hydrochloride IP |
| eq. to Paroxetine 10 mg |
| Approved colour to used |
| |
| Paroxetine Tablets IP 20 mg | Each film coated tablet contains : |
| Paroxetine Hydrochloride IP |
| eq. to Paroxetine 20 mg |
| Approved colour to used |
| |
| Paroxetine Tablets IP 30 mg | Each film coated tablet contains : |
| Paroxetine Hydrochloride IP |
| eq. to Paroxetine 30 mg |
| Approved colour to used |
| |
| Pentoxifylline Extended release Tablets IP 400 mg | Each film coated Extended release tablets contains : |
| pentoxifylline IP 400 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Pheniramine Maleate Syrups | Each 5 ml Contains : |
| Pheniramine Maleate IP 15 mg |
| Approved colour used in flavoured syrupy base |
| |
| Pheniramine Maleate Syrups | Each 5 ml Contains : |
| Pheniramine Maleate IP 30 mg |
| Approved colour used in flavoured syrupy base |
| |
| Pheniramine Maleate Tablets IP 25 mg | Each uncoated tablet contains : |
| Pheniramine Maleate IP 25 mg |
| |
| |
| Phenobarbitone Syrup | Each 5 ml Contains : |
| Phenobarbitone Sodium IP |
| Eq. to Phenobarbitone 20 mg |
| Approved colour used in flavoured syrupy base |
| |
| Phenobarbitone Tablets IP 30 mg | Each uncoated tablet contains : |
| Phenobarbitone IP 30 mg |
| Approved colour to used |
| |
| Phenobarbitone Tablets IP 60 mg | Each uncoated tablet contains : |
| Phenobarbitone IP 60 mg |
| Approved colour to used |
| |
| Phenolphthaleine, Senna Powder & Myrobalan With Lactose Tablets | Each uncoated tablet contains : |
| Phenolphthaleine IP 85 IP 129.60 mg |
| Senna Powder IP 66 IP 16.20 mg |
| Myrobalan Powder IP 66 IP 16.20 mg |
| Lactose IP qs. |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / |
| Sunset yellow or |
| Titanium Dioxide IP /Apple Green/Iron oxide red,Iron oxide Yellow |
| |
| Phentermine Hydrochloride Capsules USP | Each hard gelatin capsule contains |
| Phentermine Hydrochloride USP 37.5 mg |
| Approved colour used in empty capsule shell |
| |
| Phenylbutazone Tablets IP | Each sugar coated tablet contains : |
| Phenylbutazone IP 100 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunser yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| |
| Phenylbutazone Tablets IP 07 | Each sugar coated tablet contains : |
| Phenylbutazone IP07 200 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunser yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| |
| Phenylbutazone Tablets IP | Each film coated tablets contains : |
| Phenylbutazone IP07 100 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Phenylbutazone Tablets IP | Each film coated tablets contains : |
| Phenylbutazone IP07 200 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| PHENYLEPHERINE HYDROCHLORIDE, CHLORPHENRAMINE MALEATE SYRUP | Each 5 ml contains : |
| Phenylephrine Hydrochloride IP 5 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Approved colour used in flavoured syrupy base |
| |
| Phenylephrine Hydrochloride & Chlorpheniramine Maleate | Each uncoated tablet çontains: |
| Phenylephrine Hydrochloride IP 5 mg |
| Chlorpheniramine Maleate IP 4 mg |
| Excipients q.s. |
| Approved color to be use |
| |
| PHENYLEPHRINE HYDROCHLORIDE & CHLORPHENIRAMINE MALEATE CAPSULES | Each hard gelatin capsule contains |
| Phenylephrine Hydrochloride IP 5 mg |
| Chlorpheniramine Maleate IP 4 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Phenylephrine Hydrochloride & Chlorpheniramine Maleate Tablets | Each uncoated tablet contains |
| Phenylephrine Hydrochloride IP 10 mg |
| Chlorpheniramine Maleate IP 4 mg |
| Approved Color to be use in Tablet |
| |
| PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENRAMINE MALEATE SYRUP | Each 5 ml contains : |
| Phenylephrine Hydrochloride IP 2.5 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Approved colour used in flavoured syrupy base |
| |
| PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL,Chlorpheniramine Maleate | Each 5 ml contains : |
| Phenylephrine Hydrochloride IP 5 mg |
| Paracetamol IP 250 mg |
| Chlorpheniramine Maleate IP 2 mg |
| Approved colour used in flavoured syrupy base |
| |
| PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL,Chlorpheniramine Maleate | Each 5 ml contains : |
| Phenylephrine Hydrochloride IP 5 mg |
| Paracetamol IP 125 mg |
| Chlorpheniramine Maleate IP 1 mg |
| Approved colour used in flavoured syrupy base |
| |
| |
| PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL,Chlorpheniramine Maleate | Each 5 ml contains : |
| Phenylephrine Hydrochloride IP 2.5 mg |
| Paracetamol IP 125 mg |
| Chlorpheniramine Maleate IP 1 mg |
| Approved colour used in flavoured syrupy base |
| |
| |
| Phenytoin Sodium Tablets IP | Each film coated contains |
| Phenytoin Sodium IP 50 mg |
| Approved coloured used |
| |
| Phenytoin Sodium Tablets IP | Each film coated contains |
| Phenytoin Sodium IP 100 mg |
| Approved coloured used |
| |
| Flunarizine Tablets IP |
| Pioglitazone & Metformin Hydrochloride (ER) | Each uncoated tablet contains |
| Pioglitazone Hydrochloride IP 15 mg |
| Eq. to Pioglitazone |
| Metformin HCI IP 500 mg |
| As extand release |
| |
| Pioglitazone & Metformin Hydrochloride (ER) | Each uncoated tablet contains |
| Pioglitazone Hydrochloride IP 30 mg |
| Eq. to Pioglitazone |
| Metformin HCI IP 500 mg |
| As extand release |
| |
| Pioglitazone & Metformin Hydrochloride (ER) | Each uncoated tablet contains |
| Pioglitazone Hydrochloride IP |
| Eq. to Pioglitazone 15 mg |
| Metformin HCI IP 1000 mg |
| As extand release |
| |
| Pioglitazone & Metformin Hydrochloride , and Glimepride | Each uncoated tablet contains |
| Pioglitazone Hydrochloride IP |
| Eq. to Ploglitazone 15 mg |
| Metformin HCI IP 500 mg |
| Glimepride IP 1 mg |
| |
| Pioglitazone & Metformin Hydrochloride , and Glimepride | Each uncoated tablet contains |
| Pioglitazone Hydrochloride IP |
| Eq. to Ploglitazone 15 mg |
| Metformin HCI IP 500 mg |
| Glimepride IP 2 mg |
| |
| Pioglitazone Tablets IP | Each uncoated tablet contains |
| Pioglitazone Hydrochloride IP |
| Eq. to Pioglitazone 7.5 mg |
| |
| Pioglitazone Tablets IP | Each uncoated tablet contains |
| Pioglitazone Hydrochloride IP |
| Eq. to Pioglitazone 15 mg |
| |
| Pioglitazone Tablets IP | Each uncoated tablet contains |
| Pioglitazone Hydrochloride IP |
| Eq. to Pioglitazone 30 mg |
| |
| Pioglitazone, Metformin HCI (SR) and Gliclazide (SR) Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 500 mg |
| (As sustained release) |
| Gliclazide (As sustained release) IP 60 mg |
| Pioglitazone Hydrochloride IP |
| Eq. to Pioglitazone 15 mg |
| Excipients q.s. |
| Approved coloured to be used |
| |
| Pioglitazone, Metformin HCI (SR) and Gliclazide (SR) Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 500 mg |
| (As sustained release) |
| Gliclazide (As sustained release) IP 30 mg |
| Pioglitazone Hydrochloride IP |
| Eq. to Pioglitazone 15 mg |
| Excipients q.s. |
| Approved coloured to be used |
| |
| Pioglitazone, Metformin HCI (SR) and Glimepiride Tablets | Each uncoated bilayred tablet contains : |
| Metformin Hydrochloride IP 500 mg |
| (As sustained release) |
| Glimepiride IP 1 mg |
| Pioglitazone Hydrochloride IP |
| Eq. to Pioglitazone 7.5 mg |
| Approved coloured used |
| |
| Pioglitazone, Metformin HCI (SR) and Glimepiride Tablets | Each uncoated bilayred tablet contains : |
| Metformin Hydrochloride IP 500 mg |
| Glimepiride IP 1 mg |
| Pioglitazone Hydrochloride IP |
| Eq. to Pioglitazone 7.5 mg |
| |
| Pioglitazone, Metformin HCI (SR) and Glimepiride Tablets | Each uncoated bilayred tablet contains : |
| Metformin Hydrochloride IP 500 mg |
| (As sustained release) |
| Glimepiride IP 2 mg |
| Pioglitazone Hydrochloride IP |
| Eq. to Pioglitazone 7.5 mg |
| Approved coloured used |
| |
| Pioglitazone, Metformin HCI (SR) and Glimepiride Tablets | Each uncoated bilayred tablet contains : |
| Metformin Hydrochloride IP 500 mg |
| Glimepiride IP 2 mg |
| Pioglitazone Hydrochloride IP |
| Eq. to Pioglitazone 7.5 mg |
| |
| Pioglitazone, Metformin HCI (SR) and Glimepiride Tablets | Each uncoated bilayred tablet contains : |
| Metformin Hydrochloride IP 500 mg |
| (As sustained release) |
| Glimepiride IP 1 mg |
| Pioglitazone Hydrochloride IP |
| Eq. to Pioglitazone 15 mg |
| Approved coloured used |
| |
| Pioglitazone, Metformin HCI (SR) and Glimepiride Tablets | Each uncoated bilayred tablet contains : |
| Metformin Hydrochloride IP 500 mg |
| (As sustained release) |
| Glimepiride IP 2 mg |
| Pioglitazone Hydrochloride IP |
| Eq. to Pioglitazone 15 mg |
| Approved coloured used |
| |
| Pioglitazone, Metformin HCI and Gliclazide Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 500 mg |
| Gliclazide IP 60 mg |
| Pioglitazone Hydrochloride IP |
| Eq. to Pioglitazone 15 mg |
| Excipients q.s. |
| Approved coloured to be used |
| |
| Pioglitazone, Metformin HCI and Gliclazide Tablets | Each uncoated tablet contains |
| Metformin Hydrochloride IP 500 mg |
| Gliclazide IP 30 mg |
| Pioglitazone Hydrochloride IP |
| Eq. to Pioglitazone 15 mg |
| Excipients q.s. |
| Approved coloured to be used |
| |
| PIPERAZINE CITRATE & DIETHYL CARBAMAZINE CITRATE SYRUP | Each 5 ml contains : |
| Piperazine Citrate IP |
| eq. to Piperazine Hydrate 500 mg |
| Diethyl Carbamazine Citrate IP 25 mg |
| Approved colour used in flavoured syrupy base |
| |
| PIPERAZINE CITRATE SYRUP IP | Each 5 ml contains : |
| Piperazine Citrate IP |
| Equivalent to Piperazine Hydrate 750 mg |
| Approved colour used in flavoured syrupy base |
| PIPERAZINE CITRATE SYRUP IP For paediatric use | Each 5 ml contains : |
| Piperazine Citrate IP |
| Eq. to Piperazine Hydrate 500 mg |
| Approved colour used in flavoured syrupy base |
| |
| Piracetam Tablets | Each uncoated tablet contains |
| Piracetam IP 800 mg |
| |
| Piracetam Tablets | Each film coated tablet contains : |
| Piracetam IP 800 mg |
| Excipients q.s. |
| Approved colour to used |
| |
| Pirfenidone Tablets IP 400 mg | Each film coated tablet contains : |
| Pirfenidone IP 400 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Pirfonidone Tablets IP | Each film coated tablet contains |
| Pirfenidone IP 200 mg |
| Approved colour to used |
| |
| Piroxicam and Betacyclodextrin Dispersible Tablets | Each uncoated dispersible tablet contains: |
| Piroxicam IP 20mg |
| Betacyclodextrin IP 50mg |
| Approved colour to used |
| |
| Piroxicam and Paracetamol Tablets | Each uncoated tablet contains : |
| Piroxicam IP 20 mg |
| Paracetamol IP 500 mg |
| Excipients q.s. |
| |
| Piroxicam and Paracetamol Tablets | Each uncoated tablet contains : |
| Piroxicam IP 20 mg |
| Paracetamol IP 325 mg |
| Excipients q.s. |
| |
| PIROXICAM CAPSULE IP 10 mg. | Each hard gelatin capsule contains |
| Piroxicam IP 10 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| PIROXICAM CAPSULE IP 20 mg. | Each hard gelatin capsule contains |
| Piroxicam IP 20 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Piroxicam Dispersible Tablets | Each uncoated dispersible tablet contains: |
| Piroxicam IP 20mg |
| Approved colour to used |
| |
| Piroxicam Dispersible Tablets | Each dispersible tablet contains : |
| Piroxicam IP 20 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunsel yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| |
| Piroxicam Tablets IP | Each uncoated tablet contains : |
| Piroxicam IP 20 mg |
| Approved colour to used |
| |
| Ploglitazone & Glimepride Tablets | Each uncoated tablet contains |
| Ploglitazone Hydrochloride IP |
| Eq. to Pioglitazone 15 mg |
| Glimepride IP 1 mg |
| |
| Ploglitazone & Glimepride Tablets | Each uncoated tablet contains |
| Ploglitazone Hydrochloride IP |
| Eq. to Pioglitazone 15 mg |
| Glimepride IP 2 mg |
| |
| Ploglitazone & Metformin Hydrochloride (ER) | Each uncoated tablet contains |
| Ploglitazone Hydrochloride IP |
| Eq. to Ploglitazone 30 mg |
| Metformin HCI IP 1000 mg |
| As extand release |
| |
| Posaconazole Oral Suspension | Each ml contains : |
| Posaconazole 40 mg |
| Approved colour used in flavoured syrupy base |
| |
| POTASSIUM CITRATE & MAGNESIUM CITRATE SYRUP | Each 5 ml contains : |
| Potassium Citrate IP 1100 mg |
| Magnesium Citrate USP 375 mg |
| Approved colour used in flavoured syrupy base |
| |
| Prasugrel Tablets IP 10 mg | Each film coated tablet contains : |
| Prasugrel Hydrochloride IP |
| Eq. to Prasugrel 10 mg |
| Approved colour to used |
| |
| Prasugrel Tablets IP 5 mg | Each film coated tablet contains : |
| Prasugrel Hydrochloride IP |
| Eq. to Prasugrel 5 mg |
| Approved colour to used |
| |
| Praziquantel Tablets IP 600mg | Each film coated tablets contains : |
| Praziquantel IP 600 mg |
| Approved colour to be used |
| |
| Prebiotic & Probiotic Capsules | Each hard gelatin capsule contains |
| Streptococcus faecalis 30 million |
| Clostridium Butyricum 2 million |
| Bacillus Mesentericus IP 1 million |
| Lactic Acid Bacillus IP 50 million |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Ponceau 4R or Titanium Dioxide IP / Sunset Yellow |
| |
| Prednisolone Sodium Phosphate Syrup | Each 5 ml contains : |
| Prednisolone Sodium Phosphate IP |
| Eq. to Prednisolone 5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Prednisolone Syrup USP | Each 5 ml Contains : |
| Prednisolone IP 5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Prednisolone Tablets IP | Each uncoated tablet contains : |
| Prednisolone IP 5 mg |
| Excipients q.s. |
| |
| Prednisolone Tablets IP | Each uncoated tablet contains : |
| Prednisolone IP 10 mg |
| Excipients q.s. |
| |
| Prednisolone Tablets IP | Each uncoated tablet contains |
| Prednisolone IP 20 mg |
| |
| Pregabalin and Nortriptyline Tablets | Each film coated tablet contains: |
| Pregabalin IP 75 mg |
| Nortriptyline Hydrochloride IP |
| Eq. to Nortriptyline 10 mg |
| | Approved coloured used |
| |
| Pregabalin Capsules IP 100 mg | Each hard gelatin capsule contains |
| Pregabalin IP 100 mg |
| Approved colour use in empty capsule shell |
| |
| Pregabalin Capsules IP 150 mg | Each hard gelatin capsule contains |
| Pregabalin IP 150 mg |
| Approved colour use in empty capsule shell |
| |
| Pregabalin Capsules IP 225 mg | Each hard gelatin capsule contains |
| Pregabalin IP 225 mg |
| Approved colour use in empty capsule shell |
| |
| Pregabalin Capsules IP 25 mg | Each hard gelatin capsule contains |
| Pregabalin IP 25 mg |
| Approved colour use in empty capsule shell |
| |
| Pregabalin Capsules IP 300 mg | Each hard gelatin capsule contains |
| Pregabalin IP 300 mg |
| Approved colour use in empty capsule shell |
| |
| Pregabalin Capsules IP 50 mg | Each hard gelatin capsule contains |
| Pregabalin IP 50 mg |
| Approved colour use in empty capsule shell |
| |
| Pregabalin Capsules IP 75 mg | Each hard gelatin capsule contains |
| Pregabalin IP 75 mg |
| Approved colour use in empty capsule shell |
| |
| Pregabalin Sustained Release Tablets | Each uncoated tablet contains : |
| Pregabaline IP 75 mg |
| Approved colour to be use q.s |
| |
| Pregabalin Sustained Release Tablets | Each uncoated tablet contains : |
| Pregabaline IP 150 mg |
| Approved colour to be use |
| |
| Pregabalin Sustained Release Tablets | Each uncoated tablet contains : |
| Pregabaline IP 300 mg |
| Approved colour to be use |
| |
| Pregabaline & Nortriptyline Tablets | Each film coated tablet contains : |
| Pregabaline IP 75 mg |
| Nortriptyline HCI IP |
| Eq. to Nortriptyline 10 mg |
| Approved colour to be use q.s. |
| |
| Pregabaline and Nortriptyline Tablets | Each film coated tablet contains: |
| Pregabaline IP 75 mg |
| Nortriptyline Hydrochloride IP |
| Eq. to Nortriptyline 10 mg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Pregabaline and Nortriptyline Tablets | Each film coated tablet contains: |
| Pregabaline IP 50 mg |
| Nortriptyline Hydrochloride IP |
| Eq. to Nortriptyline 10 mg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Pregabaline and Nortriptyline Tablets | Each film coated tablet contains: |
| Pregabaline IP 37.5 mg |
| Nortriptyline Hydrochloride IP |
| Eq. to Nortriptyline 10 mg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Primaquine Tablets IP 15 mg | Each film coated tablets contains : |
| Primaquine Phosphate IP 26 mg |
| Eq. to Primaquine 15mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Primaquine Tablets IP 7.5 mg | Each film coated tablets contains : |
| Primaquine Phosphate IP 13 mg |
| Eq. to Primaquine 7.5 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Prochlorperazine Maleate Orally Disintegrating Tablets | Each orally disintegrating tablet contains : |
| Prochlorperazine Maleate IP 5 mg |
| Excipients q.s. |
| |
| Prochlorperazine Maleate Orally Disintegrating Tablets | Each orally disintegrating tablet contains : |
| Prochlorperazine Maleate IP 10 mg |
| Excipients q.s. |
| |
| Prochlorperazine Maleate Tablets IP | Each uncoated tablet contains : |
| Prochlorperazine Maleate IP 10 mg |
| |
| |
| Prochlorperazine Maleate Tablets IP | Each uncoated tablet contains : |
| Prochlorperazine Maleate IP 5 mg |
| |
| Procyclidine Tablets IP | Each uncoated tablet contains: |
| Procyclidine Hydrochloride IP 2.5 mg |
| Approved colour to used |
| |
| Procyclidine Tablets IP | Each uncoated tablet contains: |
| Procyclidine Hydrochloride IP 5 mg |
| Approved colour to used |
| |
| PROMETHAZINE HYDROCHLORIDE SYRUP IP | Each 5 ml contains : |
| Promethazine Hydrochloride IP 5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Promethazine Hydrochloride Tablets IP | Each film coated tablet contains : |
| Promethazine Hydrochloride IP 10 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron Oxide red iron oxide Yellow |
| |
| Propranolol HCl and Flunarizine Tablets | Each uncoated tablet contains : |
| Propranolol HCI IP 40 mg |
| Flunarizine Dlhydrochloride IP |
| Eq. to Flunarizine 10 mg |
| Approved colour to used |
| |
| Propranolol HCl and Flunarizine Tablets | Each uncoated tablet contains : |
| Propranolol HCI IP 40 mg |
| Flunarizine Dihydrochloride IP |
| Eq. to Flunarizine 5 mg |
| Approved colour to be used |
| |
| Propranolol HCl and Flunarizine Tablets | Each uncoated tablet contains : |
| Propranolol HCI IP 40 mg |
| Flunarizine Dlhydrochloride IP |
| Eq. to Flunarizine 5 mg |
| Approved colour to used |
| |
| Propranolol Hydrochloride & Etizolam Tablets | Each uncoated tablet contains |
| Propranolol Hydrochloride IP 10 mg |
| Etizolam 0.25 mg |
| Colour: Brilliant Blue / Erythrosine /Tartrazine |
| or Titanium Dioxide IP |
| |
| Propranolol Hydrochloride & Flunarizine Di hydrochloride | Each hard gelatine capsule contains |
| Propranolol Hydrochloride IP 40 mg |
| Flunarizine Di hydrochloride 10 mg |
| Approved colour used in empty capsule shell |
| |
| Propranolol Hydrochloride and Benodrofluazide Capsules | Each hard gelatin capsule contains |
| Propranolol Hydrochloride IP 80 mg |
| Benodrofluazide IP 2.5 mg |
| Approved colour used in empty capsule shell |
| |
| Propranolol Hydrochloride Sustained release Capsules | Each hard gelatin capsule contains |
| Propranolol Hydrochloride IP 80 mg |
| (As Sustained release Pellets) |
| Approved colour used in empty capsule shell |
| |
| Propranolol Hydrochloride Tablets | Each uncoated tablet contains |
| Propranolol Hydrochloride IP 10 mg |
| |
| Propranolol Hydrochloride Tablets | Each uncoated tablet contains |
| Propranolol Hydrochloride IP 20 mg |
| |
| Propranolol Hydrochloride Tablets IP | Each uncoated tablet contains : |
| Propranolol Hydrochloride IP 40 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green /tron oxide red, Iron Oxide Yellow |
| |
| Propranolol Sustained Release Tabiets 160 mg | Each uncoated sustained release tablet contains : |
| Propranolol Hydrochloride IP 160 mg |
| Approved colour to be used |
| |
| Propranolol Sustained Release Tabiets 20 mg | Each uncoated sustained release tablet contains : |
| Propranolol Hydrochloride IP 20 mg |
| Approved colour to be used |
| |
| Propranolol Sustained Release Tabiets 80 mg | Each uncoated sustained release tablet contains : |
| Propranolol Hydrochloride IP 80 mg |
| Approved colour to be used |
| |
| Propyphenazone, Paracetamol With Caffeine Tablets | Each uncoated tablet contains : |
| Propyphenazone IP 150 mg |
| Paracetamol IP 250 mg |
| Caffeine (Anhydrous) IP 50 mg |
| |
| Protein , Multivitamins, Calcium , Iron | Each 30 g contains : |
| Protein Hydrolysate 20% 5 mg |
| Elemental Calcium 225 mg |
| Elemental Phosphorus 174 mg |
| (As Dibasic Calcium Phosphate Dihydrate IP) |
| Pyridoxine Hydrochloride IP 0.5 mg |
| Cyanocobalamin IP 1 mcg |
| Vitamin D3 (As Cholecalciferol) IP 100 I.U. |
| Niacinamide IP 15 mg |
| Zinc (As Zinc Sulphate) USP 1.5 mg |
| Iron (As Ferric Ammonium Citrate IP) |
| Manganese (As Sulphate) USP 1.5 mcg |
| Excipients q.s. |
| |
| PROTEIN WITH MULTIVITAMIN SYRUPS | Each 15 ml contains: |
| Protein Hydrolysate (100 %) IP 500 mg |
| (Elemental Nitrogen 112 mg.) |
| L-Lysine Monohydrochloride USP 70 mg |
| Folic Acid IP 0.5 mg |
| Vitamin B6 IP 1.5 mg |
| Naicinamide IP 25 mg |
| D-Panthenol IP 5 mg |
| Vitamin B 12 IP 1 mcg |
| Approved colour used in flavoured syrupy base |
| |
| PROTIN & MULTIVITAMIN SYRUP | Each 5 ml contains : |
| Why Protein 20% 800 mg |
| Ferric Ammonium Citrate IP 160 mg |
| L-Lysine Hydrochloride USP 20 mg |
| Cyanocobalamin IP 1 mcg |
| Zinc Sulphate IP |
| Eq. to Elemental Zinc 22 mg |
| Pyridoxine Hydrochloride IP 1 mg |
| Naicinamide IP 15 mg |
| D-Panthenol IP 2.5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Protine With Multivitamins, Multiminerals &Lycoene Powder | Each 30 g contains : |
| Protine (Whey Protine 20% ) 5 g |
| Calcium Phosphorous ( Derived from IP 225 mg |
| Dibasic Calcium Phosphate Dihydrate) 174 mg |
| Lycoene 6 % USP 2000 mcg |
| Pyridoxine Hydrochloride IP 0.5 mg |
| Cyanocobalamin IP 1 mcg |
| Vitamin D3 (As Cholecalciferol) IP 100 IU |
| Folic Acid IP 0.3 mg |
| Naicinamide IP 15 mg |
| Manganese (As Sulphate) USP 1.5 mcg |
| Zinc (As Zinc Sulphate) USP 5 mg |
| Iron (Ferric Ammonium Citrate ) IP 7.5 mg |
| Magnesium Oxide IP 4 mg |
| Cupperic Sulphate USP 2.5 mg |
| Chromium (As Chromium Chloride) IP 25 mg |
| Selenium Dioxide Monohydrate USP 20 mcg |
| Potassium Chloride IP 5 mg |
| Sodium Chloride IP 33 mg |
| lodine (As Potassium lodide) IP 100 mcg |
| Excipients q.s. |
| |
| Protine, Calcium, Multivitamins, DHA, Iron & Zinc Powder | Each 30 g contains : |
| Protine (Whey Protine 20% ) 5 g |
| DHA 10 % 25 mg |
| Pyridoxine Hydrochloride IP 0.5 mg |
| Cyanocobalamin IP 1 mcg |
| Vitamin D3 (As Cholecalciferol) IP 100 IU |
| Folic Acid IP 300 mcg |
| Naicinamide IP 15 mg |
| Calcium (As Dibasic Calcium Phosphate Dihydrate) IP 200 mg |
| Manganese (As Sulphate) USP 1.5 mcg |
| Zinc ( As Zinc Sulphate) USP 1.5 mg |
| Iron (Ferric Ammonium Citrate ) IP 10 mg |
| Magnesium Oxide IP 4 mg |
| Cupperic Sulphate USP 2.5 mg |
| Chromium (As Chromium Chloride) IP 25 mg |
| Selenium Dioxide Monohydrate USP 20 mcg |
| Potassium Chloride IP 5 mg |
| Sodium Chloride IP 33 mg |
| lodine (As Potassium lodide) IP 100 mcg |
| Excipients q.s. |
| |
| Prulifloxacin Tablets | Each film coated tablet contains |
| Prulifloxacin Hydrochloride IP |
| eq. to Prulifloxacin 600 mg |
| |
| Prulifloxacin Tablets | Each film coated tablets contains: |
| Prulifloxacin HCl 600 mg |
| Approved color to be use |
| |
| Pyrazinamide Tablets | Each uncoated tablet contains : |
| Pyrazinamide IP 750 mg |
| |
| Pyridoxine Hcl, Nicotinamide, Cyanocobalamin and Lysine Hcl | Each 5 ml contains : |
| Pyridoxine Hydrochloride IP 0.75 mg |
| Nicotinamide IP 15 mg |
| Cyanocobalamin IP 2 mcg |
| Lysine Hcl USP 37.5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Pyridoxine Hydrochloride Tablets IP | Each uncoated tablet contains : |
| Pyridoxine Hydrochloride IP 10 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Pyridoxine, Nicotinamide, Mecobalamine, L-Lysine Syrup | Each 5 ml contains : |
| Pyridoxine hydrochloride IP 0.75 mcg |
| Nicotinamide IP 15 mg |
| Mecobalamine IP 2 mg |
| L-Lysine Hydrochloride IP 37.5 mg |
| Sorbitol Solution (70%) IP q.s |
| (Non Crystallizing) |
| Approved coloured used in flavoured syrupy base |
| |
| Quetiapine Fumarate Tablets IP | Each film coated tablet contains: |
| Quetiapine Fumarate IP 25 mg |
| Eq. to Quetiapine |
| Approved colour to used |
| |
| Quetiapine Fumarate Tablets IP | Each film coated tablet contains: |
| Quetiapine Fumarate IP 50 mg |
| Eq. to Quetiapine |
| Approved colour to used |
| |
| Quetiapine Fumarate Tablets IP | Each film coated tablet contains: |
| Quetiapine Fumarate IP 100 mg |
| Eq. to Quetiapine |
| Approved colour to used |
| |
| Quetiapine Fumarate Tablets IP | Each film coated tablet contains: |
| Quetiapine Fumarate IP 200 mg |
| Eq. to Quetiapine |
| Approved colour to used |
| |
| Quetiapine Fumarate Tablets IP | Each film coated tablet contains: |
| Quetiapine Fumarate IP 300 mg |
| Eq. to Quetiapine |
| Approved colour to used |
| |
| Quetiapine Sustained release Tablets | Each film coated Sustained released tablet contains: |
| Quetiapine Fumarate IP |
| Eq. to Quetiapine 50 mg |
| Approved colour to be used |
| |
| Quetiapine Sustained release Tablets | Each film coated Sustained released tablet contains: |
| Quetiapine Fumarate IP |
| Eq. to Quetiapine 200 mg |
| Approved colour to be used |
| |
| Quetiapine Sustained release Tablets | Each film coated Sustained released tablet contains: |
| Quetiapine Fumarate IP |
| Eq. to Quetiapine 300 mg |
| Approved colour to be used |
| |
| Quetiapine Sustained release Tablets | Each film coated Sustained released tablet contains: |
| Quetiapine Fumarate IP |
| Eq. to Quetiapine 400 mg |
| Approved colour to be used |
| |
| Quiniodochlor Tablets IP | Each uncoated tablet contains : |
| Quiniodochlor IP 250 mg |
| |
| RABEPRAZOLE SODIUM & DOMPERIDONE (SR) CAPSULES | Each hard gelatin capsule contains |
| Rabeprazole Sodium (As enteric coated pellets) IP 20 mg |
| Domperidon (As sustained release pellets) IP 10 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Rabeprazole Sodium & Domperidone Tablets IP | Each enteric-coated tablet contains: |
| Rabeprazole Sodium IP 20 mg |
| Domperidone IP 10 mg |
| Colour: Brilliant Blue / Erythrosine/ Tartraz ine/ Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP IApple Green / Iron oxide red,Iron oxide Yellow |
| |
| Rabeprazole Sodium & Levosulpiride | Each hard gelatin capsule contains |
| Rabeprazole Sodium IP 20 mg |
| (As per enteric coated pellets) |
| Levosulpiride 75 mg |
| (As per sustain Release pellets) |
| Approved colour used in empty capsule shell |
| |
| Rabeprazole Sodium & Levosulpiride | Each hard gelatin capsule contains |
| Rabeprazole Sodium IP 20 mg |
| (As per enteric coated pellets) |
| Levosulpiride 20 mg |
| (As per sustain Release pellets) |
| Approved colour used in empty capsule shell |
| |
| RABEPRAZOLE SODIUM (EC) & DOMPERIDONE (SR) CAPSULES | Each hard gelatin capsule contains |
| Rabeprazole Sodium (As enteric coated pellets) IP 20 mg |
| Domperidon (As sustained release pellets) IP 30 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| RABEPRAZOLE SODIUM (EC) & ITOPRIDE HYDROCHLORIDE (SR) CAPSULES | Each hard gelatin capsule contains |
| Rabeprazole Sodium (As enteric coated pellets) IP 20 mg |
| Itopride Hydrochloride (As sustained release pellets) IP 150 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| RABEPRAZOLE SODIUM CAPSULES | Each hard gelatin capsule contains |
| Rabeprazole Sodium (As enteric coated pellets) IP 20 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| RABEPRAZOLE SODIUM EC PELLETS 11.2 % W/W | Each 1 gm enteric coated pellets contains |
| Rabeprazole Sodium 112mg |
| Approved colour to be use |
| |
| RABEPRAZOLE SODIUM EC PELLETS 15.0 % W/W | Each 1 gm enteric coated pellets contains |
| Rabeprazole Sodium 150mg |
| Approved colour to be use |
| |
| RABEPRAZOLE SODIUM EC PELLETS 8.50% W/W | Each 1 gm enteric coated pellets contains |
| Rabeprazole Sodium 85mg |
| Approved colour to be use |
| |
| Rabeprazole Sodium Tablets IP | Each enteric-coated tablet contains |
| Rabeprazole Sodium IP 20 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP IApple Green / Iron oxide red, ron oxide Yellow |
| |
| Racecadotril Dispersible Tablets | Each uncoated dispersible tablet contains : |
| Racecadotril IP 10 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Racecadotril Dispersible Tablets | Each uncoated dispersible tablet contains : |
| Racecadotril IP 30 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Racecadotril Suspension | Each 5 ml contains : |
| Racecadotril IP 10 mg |
| Approved colour used in flavoured syrupy base |
| |
| Ramipiril and Amlodipine tablet | Each uncoated tablet contains : |
| Ramipril IP 2.5mg |
| Amlodipine Besylate IP |
| Eq. to Amlodipine 5 mg |
| Approved colour to be use |
| |
| Ramipiril and Amlodipine tablet | Each uncoated tablet contains : |
| Ramipril IP 5mg |
| Amlodipine Besylate IP |
| Eq. to Amlodipine 5 mg |
| Approved colour to be use |
| |
| Ramipiril and Amlodipine tablet | Each uncoated tablet contains : |
| Ramipril IP 10mg |
| Amlodipine Besylate IP |
| Eq. to Amlodipine 5 mg |
| Approved colour to be use |
| |
| Ramipril Tablets IP | Each filmcoated tablet contains : |
| Ramipril IP 2.5 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Ramipril Tablets IP | Each filmcoated tablet contains : |
| Ramipril IP 5 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Ramipril Tablets IP | Each filmcoated tablet contains : |
| Ramipril IP 10 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Ramipril Tablets IP | Each uncoated tablets contains : |
| Ramipril IP 5 mg |
| |
| Ramipril With Hydrochlorothiazide Tablets | Each filmcoated tablet contains : |
| Ramipril IP 2.5 mg |
| Hydrochlorothiazide IP 12.5 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP/ |
| Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Ramosetron Hydrochloride Tablets | Each uncoated tablet contains: |
| Ramosetron Hydrochloride 2.5 mcg |
| Approved colour to used |
| |
| Ramosetron Hydrochloride Tablets | Each uncoated tablet contains: |
| Ramosetron Hydrochloride 5 mcg |
| Approved colour to used |
| |
| Ramosetron Hydrochloride Tablets | Each uncoated tablet contains: |
| Ramosetron Hydrochloride 0.1 mg |
| Approved colour to used |
| |
| Ramosetron Hydrochloride Tablets | Each uncoated tablets contains |
| Ramosetron Hydrochloride 100 mcg |
| Approved colour to be used |
| |
| Ranitidine Hydrochloride & Domperidone Tablets | Each film coated tablet contains : |
| Ranitidine Hydrochloride IP |
| Eq. to Ranitidine 150 mg |
| Domperidone IP 10 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron Oxide red Iron oxide Yellow |
| |
| Ranitidine Hydrochloride Tablets IP | Each film coated tablet contains : |
| Ranitidine Hydrochloride IP |
| Eq. to Ranitidine 150 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Ranitidine Hydrochloride Tablets IP | Each film coated tablet contains : |
| Ranitidine Hydrochloride IP |
| Eq. to Ranitidine 300 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Ranitidine Hydrochloride, Dicyclomine Hydrochloride & | Each film coated tablet contains : |
| Ranitidine Hydrochloride IP |
| Eq. to Ranitidine 150 mg |
| Dicyclomine Hydrochloride IP 10 mg |
| Simethicone IP 20 mg |
| Excipients qs |
| Approved colour to be used |
| |
| Ranitidine Hydrochloride, Dicyclomine Hydrochloride & Simethicone Tablets | Each film coated tablets contains : |
| Ranitidine Hydrochloride IP |
| Eq. to Ranitidine 150 mg |
| Dicyclomine Hydrochloride IP 10 mg |
| Simethicone IP 20 mg |
| |
| Ranitidine Hydrochloride, Domperidone & | Each film coated tablet contains : |
| Ranitidine Hydrochloride IP |
| Eq. to Ranitidine 150 mg |
| Domperidone IP 10 mg |
| Simethicone IP 20 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / |
| Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Ranitidine Oral Solution IP | Each 5 ml contains : |
| Ranitidine Hydrochloride IP |
| Eq. to Ranitidine 75 mg |
| Approved colour used in flavoured syrupy base |
| |
| Ranolazine Extend Release Tablets | Each film coated Sustained release tablets contains : |
| Ranolazine 500 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Ranolazine Sustained Release Tablets | Each uncoated Sustained Release tablet contains |
| Ranolazine 750 mg |
| Excipients q.s. |
| |
| Ranolazine Sustained Release Tablets | Each uncoated Sustained Release tablet contains |
| Ranolazine 500 mg |
| Excipients q.s. |
| |
| Ranolazine Sustained Release Tablets | Each uncoated Sustained Release tablet contains |
| Ranolazine 1000 mg |
| Excipients q.s. |
| |
| Ranolazine Sustained Release Tablets | Each film coated Extended release tablets contains : |
| Ranolazine 500 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Rebamipide Tablets | Each film coated tablet contains |
| Rebamipide IP 100 mg |
| Excipients q.s. |
| |
| Rececadotril Dispersible Capsule | Each uncoated dispersible Capsule contains : |
| Rececadotril IP 100 mg |
| Excipients q.s. |
| |
| Rececadotril Tablets | Each uncoated tablet contains : |
| Rececadotril IP 100 mg |
| Excipients q.s. |
| |
| Repaglinide and Voglibose Tablets | Each uncoated tablet contains |
| Repaglinide IP 0.5 mg |
| Voglibose IP 0.2 mg |
| Excipients q.s. |
| |
| Repaglinide and Voglibose Tablets | Each uncoated tablet contains |
| Repaglinide IP 1 mg |
| Voglibose IP 0.2 mg |
| Excipients q.s. |
| |
| Repaglinide and Voglibose Tablets | Each uncoated tablet contains |
| Repaglinide IP 0.5 mg |
| Voglibose IP 0.3 mg |
| Excipients q.s. |
| |
| Repaglinide and Voglibose Tablets | Each uncoated tablet contains |
| Repaglinide IP 1 mg |
| Voglibose IP 0.3 mg |
| Excipients q.s. |
| |
| Riboflavin Tablets IP For Therapeutic Use | Each uncoated tablet contains : |
| Riboflavin IP 10 mg |
| Excipients q.s. |
| |
| Riboflavin, Folic Acid, Niacinamide and Lactic acid Bacillus Tablets | Each uncoated tablet contains : |
| Riboflavin IP 10 mg |
| Foilc Acid IP 1.5 mg |
| Niacinamide IP 100 mg |
| Lactic acid Bacillus 60 mil.spo |
| Approved colour to be use |
| |
| Riboflavin, Pyridoxine HCI Nicotinamide, Cyanocobalamin,Calcium Pantothenate and Folic Acid | Each hard gelatine capsule contains: |
| Riboflavin IP 5 mg |
| Pyridoxine Hydrochloride IP 1.5 mg |
| Cyanocobalamin IP 10 mcg |
| Nicotinamide IP 15 mg |
| Calcium Pantothenate IP 5 mg |
| Folic Acid IP 100 mcg |
| Approved colour use |
| |
| Riboflavin, Pyridoxine HCI Nicotinamide, Cyanocobalamin,Calcium Pantothenate and Folic Acid | Each hard gelatine capsule contains: |
| Riboflavin IP 2 mg |
| Pyridoxine Hydrochloride IP 0.5 mg |
| Cyanocobalamin IP 10 mcg |
| Nicotinamide IP 15 mg |
| Calcium Pantothenate IP 5 mg |
| Folic Acid IP 100 mcg |
| Approved colour use |
| |
| Rifampicin & Isoniazid Tablets | Each filmcoated tablet contains : |
| Rifampicin IP 450 mg |
| Isoniazid IP 300 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow/Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Rifaximin Dispersible Tablets | Each uncoated dispersible tablets contains |
| Rafaximin BP 200 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Rifaximin Oral Suspension | Each 5 ml contains : |
| Rifaximin BP 100 mg |
| Approved colour used in flavoured syrupy base |
| |
| Rifaximin Tablets | Each Film coated tablet contains : |
| Rifaximin Eur. 200 mg |
| Excipients q.s. |
| Approved coloured used |
| |
| Rifaximin Tablets | Each Film coated tablet contains : |
| Rifaximin Eur. 400 mg |
| Excipients q.s. |
| Approved coloured used |
| |
| Rifaximin Tablets | Each Film coated tablet contains : |
| Rifaximin Eur. 550 mg |
| Excipients q.s. |
| Approved coloured used |
| |
| Risperidone and Trihexyphenidyl Tablets | Each uncoated tablet contains : |
| Risperidone IP 2 mg |
| Trihexyphenidyl Hydrochloride IP 2 mg |
| Approved colour to be used |
| |
| Risperidone and Trihexyphenidyl Tablets | Each uncoated tablet contains : |
| Risperidone IP 4 mg |
| Trihexyphenidyl Hydrochloride IP 2 mg |
| Approved colour to be used |
| |
| Risperidone Tablets IP | Each uncoated tablet contains : |
| Risperidone IP 2 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Risperidone Tablets IP | Each uncoated tablets contains |
| Risperidone IP 0.5 mg |
| Approved color to be use |
| |
| Risperidone Tablets IP | Each uncoated tablets contains |
| Risperidone IP 1 mg |
| Approved color to be use |
| |
| Risperidone Tablets IP | Each uncoated tablets contains |
| Risperidone IP 3 mg |
| Approved color to be use |
| |
| Risperidone Tablets IP | Each uncoated tablets contains |
| Risperidone IP 4 mg |
| Approved color to be use |
| |
| Rivaroxaban Tablets | Each film coated tablet contains : |
| Rivaroxaban 10 mg |
| Approved colour to used |
| |
| Rivaroxaban Tablets | Each film coated tablet contains : |
| Rivaroxaban 20 mg |
| Approved colour to used |
| |
| Rivaroxaban Tablets | Each film coated tablet contains : |
| Rivaroxaban 15 mg |
| Approved colour to used |
| |
| Roflumilast Tablets 500 mcg | Each uncoated tablet contains : |
| Roflumilast IP 500 mcg |
| |
| Rosiglitazone and Glimepiride Tablets | Each flim coated tablet contains : |
| Glimepiride IP 1 mg |
| Rosiglitazone Maleate |
| Eq. to Rosiglitazone 2 mg |
| Approved colour to used |
| |
| Rosiglitazone and Metformin HCI Tablets | Each uncoated tablet contains: |
| Metformin HCI IP 500 mg |
| Rosiglitazone Maleate |
| Eq. to Rosiglitazone 2 mg |
| Approved colour to used |
| |
| Rosiglitazone and Metformin HCI Tablets | Each uncoated tablet contains: |
| Metformin HCI IP 500 mg |
| Rosiglitazone Maleate |
| Eq. to Rosiglitazone 4 mg |
| Approved colour to used |
| |
| Rosiglitazone and Metformin HCI Tablets | Each uncoated tablet contains: |
| Metformin HCI IP 1000 mg |
| (As Sustained Release) |
| Rosiglitazone Maleate |
| Eq. to Rosiglitazone 2 mg |
| Approved colour to used |
| |
| Rosiglitazone and Metformin HCI Tablets | Each uncoated tablet contains: |
| Metformin HCI IP 1000 mg |
| (As Sustained Release) |
| Rosiglitazone Maleate |
| Eq. to Rosiglitazone 4 mg |
| Approved colour to used |
| |
| Rosiglitazone and Metformin HCI Tablets | Each uncoated tablet contains: |
| Metformin HCI IP 500 mg |
| (As Sustained Release) |
| Rosiglitazone Maleate |
| Eq. to Rosiglitazone 4 mg |
| Approved colour to used |
| |
| Rosiglitazone and Metformin HCI Tablets | Each uncoated tablet contains: |
| Metformin HCI IP 500 mg |
| (As Sustained Release) |
| Rosiglitazone Maleate |
| Eq. to Rosiglitazone 2 mg |
| Approved colour to used |
| |
| Rosiglitazone and Metformin HCl Tablets | Each uncoated tablet contains : |
| Metformin HCl IP 500 mg |
| Rosiglitazone Maleate |
| Eq. to Rosiglitazone 1 mg |
| Approved colour to used |
| |
| Rosiglitazone Maleate Tablets | Each uncoated tablet contains : |
| Rosiglitazone Maleate |
| Eq. to Rosiglitazone 1 mg |
| Approved colour to used |
| |
| Rosiglitazone Maleate Tablets | Each uncoated tablet contains : |
| Rosiglitazone Maleate |
| Eq. to Rosiglitazone 2 mg |
| Approved colour to used |
| |
| Rosiglitazone Maleate Tablets | Each uncoated tablet contains : |
| Rosiglitazone Maleate |
| Eq. to Rosiglitazone 4 mg |
| Approved colour to used |
| |
| Rosiglitazone Maleate Tablets | Each uncoated tablet contains : |
| Rosiglitazone Maleate |
| Eq. to Rosiglitazone 8 mg |
| Approved colour to used |
| |
| Rosuvastatin & Aspirin Capsules | Each hard gelatin capsule : |
| Rosuvastatin Calcium IP |
| eq. to Rosuvastatin 5 mg |
| Aspirin IP 75 mg |
| |
| Rosuvastatin & Aspirin Capsules | Each hard gelatin capsule : |
| Rosuvastatin Calcium IP |
| eq. to Rosuvastatin 10 mg |
| Aspirin IP 75 mg |
| |
| Rosuvastatin & Aspirin Capsules | Each hard gelatin capsule : |
| Rosuvastatin Calcium IP |
| eq. to Rosuvastatin 10 mg |
| Aspirin IP 150 mg |
| |
| Rosuvastatin & Clopidogrel Aspirin Capsules | Each hard gelatin capsule : |
| Rosuvastatin Calcium IP |
| eq. to Rosuvastatin 10 mg |
| Clopidogrel Bisulphate IP |
| eq. to Clopidogrel 75 mg |
| Aspirin IP 75 mg |
| Approved colour used in empty capsule shell |
| |
| Rosuvastatin & Clopidogrel Aspirin Capsules | Each hard gelatin capsule : |
| Rosuvastatin Calcium IP |
| eq. to Rosuvastatin 20 mg |
| Clopidogrel Bisulphate IP |
| eq. to Clopidogrel 75 mg |
| Aspirin IP 75 mg |
| Approved colour used in empty capsule shell |
| |
| Rosuvastatin & Clopidogrel Aspirin Capsules | Each hard gelatin capsule : |
| Rosuvastatin Calcium IP |
| eq. to Rosuvastatin 20 mg |
| Clopidogrel Bisulphate IP |
| eq. to Clopidogrel 75 mg |
| Aspirin IP 150 mg |
| Approved colour used in empty capsule shell |
| |
| Rosuvastatin & Clopidogrel Tablets | Each filmcoated tablet contains : |
| Rosuvastatin Calcium IP 20 mg |
| eq. to Rosuvastatin |
| Clopidogrel Bisulphate BP |
| Eq. to Clopidogrel 75 mg |
| |
| Rosuvastatin & Clopidogrel Tablets | Each film coated tablet contains : |
| Rosuvastatin Calcium IP |
| eq. to Rosuvastatin 40 mg |
| Clopidogrel Bisulphate BP |
| Eq. to Clopidogrel 75 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Rosuvastatin & Fenofibrate Tablets | Each filmcoated tablet contains : |
| Rosuvastatin Calcium IP 10 mg |
| eq. to Rosuvastatin |
| Clopidogrel Bisulphate BP |
| Eq. to Clopidogrel 75 mg |
| |
| Rosuvastatin & Fenofibrate Tablets IP | Each film coated tablet contains: |
| Rosuvastatin Calcium IP |
| eq. to Rosuvastatin 10 mg |
| Fenofibrale IP 160 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/ |
| |
| Rosuvastatin and Aspirin Capsules | Each hard gelatin capsule contains |
| Rosuvastatin Calcium IP |
| Eq. to Rosuvastatin (As pellets) 20 mg |
| Aspirin IP 75 mg |
| (As Enteric coated pellets) |
| Approved coloured used in empty capsule shell |
| |
| Rosuvastatin and Aspirin Capsules | Each hard gelatin capsule contains |
| Rosuvastatin Calcium IP |
| Eq. to Rosuvastatin (As pellets) 20 mg |
| Aspirin IP 150 mg |
| (As Enteric coated pellets) |
| Approved coloured used in empty capsule shell |
| |
| Rosuvastatin and Aspirin Tablets | Each film coated tablet contains : |
| Rosuvastatin Calcium IP |
| Eq. to Rosuvastatin 20 mg |
| Aspirin IP 75 mg |
| Approved colour to be used |
| |
| Rosuvastatin and Aspirin Tablets | Each film coated tablet contains : |
| Rosuvastatin Calcium IP |
| Eq. to Rosuvastatin 10 mg |
| Aspirin IP 75 mg |
| Approved colour to be used |
| |
| Rosuvastatin and Clopidogrel Capsules | Each hard gelatin capsule contains |
| Rosuvastatin Calcium IP |
| Eq. to Rosuvastatin (As pellets) 20 mg |
| Clopidogrel Bisulphate IP |
| Eq. Clopidogrel (As pellets) 75 mg |
| Excipients q.s. |
| Approved coloured used in empty capsule shell |
| |
| Rosuvastatin and Ezetimibe Tablets IP | Each film coated tablet contains : |
| Ezetimibe IP 10 mg |
| Rosuvastatin Calcium IP |
| Eq. to Rosuvastatin 5 mg |
| Approved coloured used |
| |
| Rosuvastatin and Ezetimibe Tablets IP | Each film coated tablet contains : |
| Ezetimibe IP 10 mg |
| Rosuvastatin Calcium IP |
| Eq. to Rosuvastatin 20 mg |
| Approved coloured used |
| |
| Rosuvastatin and Ezetimibe Tablets IP | Each film coated tablet contains : |
| Ezetimibe IP 10 mg |
| Rosuvastatin Calcium IP |
| Eq. to Rosuvastatin 40 mg |
| Approved coloured used |
| |
| Rosuvastatin and Fenofibrate Tablets | Each film coated tablet contains : |
| Rosuvastatin Calcium IP |
| Eq. to Rosuvastatin 20 mg |
| Fenofibrate IP 160 mg |
| Approved colour to be use |
| |
| Rosuvastatin and Fenofibrate Tablets IP | Each film coated tablet contains : |
| Fenofibrate IP 160 mg |
| Rosuvastatin Calcium IP |
| Eq. to Rosuvastatin 5 mg |
| Approved coloured used |
| |
| Rosuvastatin and Fenofibrate Tablets IP | Each film coated tablet contains : |
| Fenofibrate IP 80 mg |
| Rosuvastatin Calcium IP |
| Eq. to Rosuvastatin 10 mg |
| Approved coloured used |
| |
| Rosuvastatin and Fenofibrate Tablets IP | Each film coated tablet contains : |
| Fenofibrate IP 145 mg |
| Rosuvastatin Calcium IP |
| Eq. to Rosuvastatin 10 mg |
| Approved coloured used |
| |
| Rosuvastatin and Fenofibrate Tablets IP | Each film coated tablet contains : |
| Fenofibrate IP 145 mg |
| Rosuvastatin Calcium IP |
| Eq. to Rosuvastatin 20 mg |
| Approved coloured used |
| |
| Rosuvastatin and Fenofibrate Tablets IP | Each film coated tablet contains : |
| Fenofibrate IP 67.5 mg |
| Rosuvastatin Calcium IP |
| Eq. to Rosuvastatin 10 mg |
| Approved coloured used |
| |
| Rosuvastatin and Fenofibrate Tablets IP | Each film coated tablet contains : |
| Fenofibrate IP 67.5 mg |
| Rosuvastatin Calcium IP |
| Eq. to Rosuvastatin 20 mg |
| Approved coloured used |
| |
| Rosuvastatin and Teneligliptin Tablets | Each film coated tablets contains : |
| Rosuvastatin Calcium IP |
| Eq. to Rosuvastatin 20 mg |
| Teneligliptin Hydrobromide hydrat IP |
| Eq. to Teneligliptin 5 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Rosuvastatin and Teneligliptin Tablets | Each film coated tablets contains : |
| Rosuvastatin Calcium IP |
| Eq. to Rosuvastatin 20 mg |
| Teneligliptin Hydrobromide hydrat IP |
| Eq. to Teneligliptin 10 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Rosuvastatin and Teneligliptin Tablets | Each film coated tablets contains : |
| Rosuvastatin Calcium IP |
| Eq. to Rosuvastatin 20 mg |
| Teneligliptin Hydrobromide hydrat IP |
| Eq. to Teneligliptin 20 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Rosuvastatin Tablets IP | Each film coated tablet contains : |
| Rosuvastatin Calcium IP |
| eq. to Rosuvastatin 20 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine/Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Rosuvastatin Tablets IP | Each film coated tablet contains : |
| Rosuvastatin Calcium IP |
| eq. to Rosuvastatin 5 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/ |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green/Iron oxide red, Iron oxide Yellow |
| |
| Rosuvastatin Tablets IP | Each film coated tablet contains : |
| Rosuvastatin Calcium IP |
| eq. lo Rosuvastatin 10 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/ |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green/Iron oxide red, Iron oxide Yellow |
| |
| Rosuvastatin Tablets IP | Each film coated tablet contains : |
| Rosuvastatin Calcium IP |
| eq. lo Rosuvastatin 40 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/ |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green/Iron oxide red, Iron oxide Yellow |
| |
| Roxithromycin and Ambroxol Hel Tablets | Each film coated tablet contains : |
| Roxithromycin IP 150 mg |
| Ambroxol Hydrochloride IP 60 mg |
| Approved colour to be us |
| |
| Roxithromycin Dispersible Tablets IP | Each ucoated dispersible tablet contains : |
| Roxithromycin IP 50 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green/Iron oxide red,Iron oxide Yellow |
| |
| ROXITHROMYCIN SUSPENSION IP For Paediatric Use | Each 5 ml contains : |
| Roxithromycin BP 50 mg |
| Approved colour used in flavoured syrupy base |
| |
| Roxithromycin Tablets IP | Each film coated tablet contains : |
| Roxithromycin IP 150 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Roxithromycin, Ambroxol Mcl and Lactic Acid Basillus Tablets | Each film coated tablet contains : |
| Roxithromycin IP 150 mg |
| Ambroxol Hydrochloride IP 30 mg |
| Lactic Acid Basillus IP 30 mil.Sp. |
| Approved colour to be use |
| |
| Sacubitril and Valsartan Tablets | Each film coated tablets contains |
| Sacubutril 24 mg |
| Valsartan IP 26 mg |
| Approved colour to be used |
| |
| Sacubitril and Valsartan Tablets | Each film coated tablets contains |
| Sacubutril 49 mg |
| Valsartan IP 51 mg |
| Approved colour to be used |
| |
| Sacubutril and Valsartan Tablets | Each film coated tablets contains |
| Sacubutril 97 mg |
| Valsartan IP 103 mg |
| Approved colour to be used |
| |
| Salbutamol Sulphate & Bromhexine Hydrochloride Tablets | Each uncoated tablet contains : |
| Salbutamol Sulphate IP |
| Equivalent to Salbutamol 2 mg |
| Bromhexine Hydrochloride IP 8 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine/Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron Oxide Yellow |
| |
| Salbutamol Sulphate & Bromhexine Hydrochloride Tablets | Each uncoated tablet contains : |
| Salbutamol Sulphate IP |
| Equivalent Salbutamol 2 mg |
| Bromhexine Hydrochloride IP 4 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| |
| SALBUTAMOL SULPHATE SYRUP IP | Each 5 ml contains : |
| Salbutamol Sulphate IP |
| Equivalent to Salbutamol 2 mg |
| Approved colour used in flavoured syrupy base |
| |
| Salbutamol Sulphate Tablets IP 2 mg. | Each uncoated tablet contains : |
| Salbutamol Sulphate IP |
| Eq. to Salbutamol 2 mg |
| |
| Salbutamol Sulphate Tablets IP 2 mg. | Each uncoated tablet contains : |
| Salbutamol Sulphate IP |
| Eq. to Salbutamol 4 mg |
| |
| SALBUTAMOL SULPHATE, BROMHEXINE | Each 5 ml contains : |
| Salbutamol Sulphate IP |
| Equivalent to Salbutamol 2 mg |
| Bromhexine Hydrochloride IP 4 mg |
| Menthol IP qs |
| Approved colour used in flavoured syrupy base |
| |
| SALBUTAMOL SULPHATE, BROMHEXINE HYDROCHLORIDE,Guaiphenesin and Menthol | Each 10 ml contains : |
| Salbutamol Sulphate IP |
| Equivalent to Salbutamol 2 mg |
| Bromhexine Hydrochloride IP 4 mg |
| Guaiphenesin IP 100 mg |
| Menthol IP qs |
| Approved colour used in flavoured syrupy base |
| |
| Sartraline Tablets IP | Each film coated tablet contains : |
| Sartraline Hydrochloride IP |
| Eg. to Sartraline 25 mg |
| Approved colour to be used |
| |
| Sartraline Tablets IP | Each film coated tablet contains : |
| Sartraline Hydrochloride IP |
| Eg. to Sartraline 50 mg |
| Approved colour to be used |
| |
| Sartraline Tablets IP | Each film coated tablet contains : |
| Sartraline Hydrochloride IP |
| Eg. to Sartraline 100 mg |
| Approved colour to be used |
| |
| Saxagliptin and Metformin HCI Extended Release Tablets | Each film coated tablet contains |
| Metformin Hydrochloride IP 1000 mg |
| (As extended release) |
| Saxagliptin Hydrochloride |
| Eq. to Saxagliptin 5 mg |
| Approved coloured used |
| |
| Serratiopeptidase Tablets | Each enteric coated tablet contains : |
| Serratiopeptidase (20,000 Serratiopeptidase Units) IP 10 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Sertraline Tablets IP | Each film coated tablet contains : |
| Sertraline Hydrochloride IP |
| Eq. to Paroxetine 25 mg |
| Excipients q.s |
| |
| Sertraline Tablets IP | Each film coated tablet contains : |
| Sertraline Hydrochloride IP |
| Eq. to Paroxetine 50 mg |
| Excipients q.s |
| |
| Sertraline Tablets IP | Each uncoated tablet contains : |
| Sertraline Hydrochloride IP |
| Eq. to Paroxetine 100 mg |
| Excipients q.s |
| |
| Sildenafil Chewable Tablets | Each uncoated chewable tablet contains : |
| Sildenafil Citrate IP |
| Eq. to Sildenfil 100 mg |
| Approved colour to be used |
| |
| Sildenafil Citrate & Dapoxetine Hcl Tablets | Each film coated tablet contains : |
| Sildenafil Citrate IP |
| Eq. to Sildenafil 50 mg |
| Dapoxetine Hydrochloride IP |
| Eq. to Dapoxetine 30 mg |
| Approved colour to used |
| |
| Sildenafil Citrate & Dapoxetine HCl Tablets | Each film coated tablet contains : |
| Sildenafil Citrate IP |
| Eq. to Sildenafil 100 mg |
| Dapoxetine Hydrochloride IP |
| Eq. to Dapoxetine 60 mg |
| Excipients q.s. |
| Approved colour to used |
| |
| Sildenafil Citrate & Dapoxetine HCl Tablets | Each film coated tablet contains : |
| Sildenafil Citrate IP |
| Eq. to Sildenafil 100 mg |
| Dapoxetine Hydrochloride IP |
| Eq. to Dapoxetine 30 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Sildenafil Citrate Capsules | Each hard gelatin capsule contains : |
| Sildenafil Citrate IP |
| Eq. to Sildenafil 25 mg |
| Approved colour use in empty capsule shell |
| |
| Sildenafil Citrate Capsules | Each hard gelatin capsule contains : |
| Sildenafil Citrate IP |
| Eq. to Sildenafil 50 mg |
| Approved colour use in empty capsule shell |
| |
| Sildenafil Citrate Capsules | Each hard gelatin capsule contains : |
| Sildenafil Citrate IP |
| Eq. to Sildenafil 100 mg |
| Approved colour use in empty capsule shell |
| |
| Sildenafil Citrate Orally Disintegrating Tablets | Each orally disintegrating tablet contains : |
| Sildenafil Citrate IP |
| Equivalent to Sildenafil 100 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / |
| Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| SILDENAFIL CITRATE ORALLY DISINTEGRATING TABLETS | Each orally disintegrating tablet contains : |
| Sildenafil Citrate IP |
| Equivalent to Sildenafil 25 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| SILDENAFIL CITRATE ORALLY DISINTEGRATING TABLETS | Each orally disintegrating tablet contains : |
| Sildenafil Citrate IP |
| Equivalent to Sildenafil 50 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Sildenafil Citrate Tablets IP | Each film coated tablet contains : |
| Sildenafil Citrate IP |
| Equivalent to Sildenafil 25 mg |
| Permitted Color Used |
| |
| Sildenafil Citrate Tablets IP 100 mg | Each film coated tablet contains : |
| Sildenafil Citrate IP |
| Equivalent to Sildenafil 100 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide ip /Apple Green / Iron oxide red, Iron Oxide Yellow |
| |
| Sildenafil Citrate Tablets IP 50 mg | Each film coated tablet contains : |
| Sildenafil Citrate IP |
| Equivalent to Sildenafil 50 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide ip /Apple Green / Iron oxide red, Iron Oxide Yellow |
| |
| Sildenafil Citrate tablets | Each film coated tablet contains : |
| Sildenafil Citrate IP |
| Eq. to Sildenafil 150 mg |
| Approved coloured used |
| |
| Sildenafil Citrate tablets | Each film coated tablet contains : |
| Sildenafil Citrate IP |
| Eq. to Sildenafil 200 mg |
| Approved coloured used |
| |
| Sildenafil Oral Suspension | Each ml contains : |
| Sildenafil Citrate IP |
| Eq. to Sildenfil 10 mg |
| Approved colour used in flavoured syrupy q.s. |
| |
| Sildenafil Oral Suspension | Each ml contains : |
| Sildenafil Citrate IP |
| Eq. to Sildenfil 5 mg |
| Approved colour used in flavoured syrupy q.s. |
| |
| Sildenafil, Dapoxetine Hcl, Diclofenac sodium and Pyridoxine Hydrochloride | Each hard gelatin capsule contains : |
| Sildenafil Citrate IP |
| Eq. to Sildenafil 100 mg |
| Dapoxetine Hydrochloride IP |
| Eq. to Dapoxetine 30 mg |
| Diclofenac sodium IP 50 mg |
| Pyridoxine Hydrochloride IP 10 mg |
| Approved colour used in empty capsule shell |
| |
| Silymarin, L-Onithine L-Aspartate, Pancreatin, Lecithin, Pyridoxine and Folic acid | Each film coated tablet contains : |
| Silymarin 140 mg |
| L-Onithine L-Aspartate 150 mg |
| Pancreatin IP 100 mg |
| Lecithin 125 mg |
| Pyridoxine Hcl IP 2 mg |
| Folic acid IP 1.5 mcg |
| Approved colour to be use |
| |
| Simethicone, Dill Oil with Fennel Oil Drops | Each ml contains : |
| Simethicone IP 40 mg |
| Dill Seed Oil IP 0.005 ml |
| Fennel Oil IP 0.0007 ml |
| Approved Colour used inFlavoured Syrupy Base |
| |
| Sitagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains |
| Sitagliptin (As Phosphate) IP 50 mg |
| Metformin Hydrochloride IP 500 mg |
| Colur: Titanium Dioxide |
| |
| Sitagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains |
| Sitagliptin IP 50 mg |
| Metformin Hydrochloride IP 1000 mg |
| Colur: Titanium Dioxide |
| |
| Sitagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains |
| Sitagliptin IP 50 mg |
| Metformin Hydrochloride IP 850 mg |
| Colur: Titanium Dioxide |
| |
| Sitagliptin Tablets IP | Each film coated tablet contains |
| Sitagliptin (As Phosphate IP 25 mg |
| Colur: Titanium Dioxide |
| |
| Sitagliptin Tablets IP | Each film coated tablet contains |
| Sitagliptin (As Phosphate IP 50 mg |
| Colur: Titanium Dioxide |
| |
| Sitagliptin Tablets IP | Each film coated tablet contains |
| Sitagliptin (As Phosphate IP 100 mg |
| Colur: Titanium Dioxide |
| |
| Sodium Alginate. Sodium bicarbonate and Calcium Carbonate Suspension | Each 5 ml contains : |
| Sodium Alginate IP 250 mg |
| Sodium bicarbonate IP 133.5 mg |
| Calcium carbonate IP 80 mg |
| Excipients q.s. |
| Approved colour used in flavoured syrupy base |
| |
| Sodium Plcosulphate Oral Solution BP | Each 5 ml contains |
| Sodium Picosulphate BP 5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Sodium Valproate and Valproic Acid Controlled release Tablets | Each film coated controlled release tablets contains : |
| Sodium Valproate IP 133.5 mg |
| Valproic Acid IP 58 mg |
| ( Both together corresponds to sodium Valproate IP 200 mg ) |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Sodium Valproate Tablets IP | Each uncoated tablet contains |
| Sodium Valproate IP 100 mg |
| |
| Sodium Valproate Tablets IP | Each uncoated tablet contains |
| Sodium Valproate IP 200 mg |
| |
| Sodium Valproate Tablets IP | Each uncoated tablet contains |
| Sodium Valproate IP 300 mg |
| |
| Sodium Valproate Tablets IP | Each uncoated tablet contains |
| Sodium Valproate IP 500 mg |
| |
| Sparfloxacin Tablets | Each film coated tablet contains : |
| Sparfloxacin 200 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / tron oxide red, Iron Oxide Yellow |
| |
| Spiramycin Tablets | Each film coated tablets contains |
| Spiramycin IP 8000000 IU |
| Excipients q.s. |
| Approved colour to be used |
| |
| Spironolactone Tablets IP | Each uncoated tablet contains |
| Spironolactone IP 25 mg |
| |
| Spironolactone Tablets IP | Each uncoated tablet contains |
| Spironolactone IP 50 mg |
| |
| Spironolactone Tablets IP | Each uncoated tablet contains |
| Spironolactone IP 100 mg |
| |
| SUCRALFATE & BENZOCAINE SUSPENSION | Each 5 ml contains : |
| Sucaralfate USP 1 gm |
| Benzocaine IP 5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Sucralfate and Oxetacaine Suspension | Each 5 ml contains : |
| Sucralfate IP 500 mg |
| Oxetacaine BP 10 mg |
| Approved coloured use in a flavoured syrup base |
| |
| Sucralfate and Oxetacaine Suspension | Each 10 ml contains : |
| Sucralfate IP 1000 mg |
| Oxetacaine IP 20 mg |
| Approved coloured used in a flavoured syrup base |
| |
| Sucralfate and Oxetacaine Suspension | Each 5 ml contains : |
| Sucralfate IP 1000 mg |
| Oxetacaine IP 10 mg |
| Approved coloured used in a flavoured syrup base |
| |
| SUCRALFATE SUSPENSION | Each 5 ml contains : |
| Sucaralfate USP 1 gm |
| Approved colour used in flavoured syrupy base |
| |
| Sucralfate Suspension | Each 5 ml contains : |
| Sucralfate IP 500 mg |
| Approved colour used in flavoured syrupy base |
| |
| Sucralfate Tablet IP | Each uncoated tablet contains |
| Sucralfate IP 1000 mg |
| |
| Sucralfate Tablets | Each uncoated tablet contains : |
| Sucralfate IP 500 mg |
| Approved colour to used |
| |
| Sulpdimidine Bolus For Veterinary Use | Each uncoated bolus contains |
| Sulpdimidine IP 5000 mg |
| |
| |
| Sulphaguanidine Tablets IP | Each uncoated tablet contains : |
| Sulphaguanidine IP66 500 mg |
| |
| Sulpiride Capsules | Each hard gelatin capsule contains |
| Sulpiride IP 50 mg |
| Approved colour use in empty capsule shell |
| |
| Sulpiride Capsules | Each hard gelatin capsule contains |
| Sulpiride IP 200 mg |
| Approved colour use in empty capsule shell |
| |
| Sulpiride Tablets IP 100 mg | Each uncoated tablet contains : |
| Sulpiride IP 100 mg |
| Approved colour to used |
| |
| Sulpiride Tablets IP 200 mg | Each uncoated tablet contains : |
| Sulpiride IP 200 mg |
| Approved colour to used |
| |
| Sulpiride Tablets IP 400 mg | Each uncoated tablet contains : |
| Sulpiride IP 400 mg |
| Approved colour to used |
| |
| Sumatriptan & Naproxen Tablets | Each film coated tablet contains : |
| Sumatriptan IP 85 mg |
| Naproxen IP 500 mg |
| Approved colour to be used |
| |
| Sumatriptan & Naproxen Tablets | Each film coated tablet contains : |
| Sumatriptan IP 50 mg |
| Naproxen IP 275 mg |
| Approved colour to be used |
| |
| Tadalafil Orally Tablets Disintegrating Tablets | Each orally disintegrating tablet contains : |
| Tadalafil IP 20 mg |
| Approved colour lo used |
| |
| Tadalafil Tablets | Each film coated tablel contains |
| Tadalafil IP 2.5 mg |
| Approved colour to used |
| |
| Tadalafil Tablets | Each film coated tablel contains |
| Tadalafil IP 5 mg |
| Approved colour to used |
| |
| Tadalafil Tablets | Each film coated tablel contains |
| Tadalafil IP 10 mg |
| Approved colour to used |
| |
| Tadalafil Tablets USP | Each film coated tablet contains : |
| Tadalafil Citrate IP |
| Equivalent to Tadalafil 20 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron Oxide yellow |
| |
| Tadalafil With Dapoxetine Tablets | Each film coated tablet contains : |
| Tadalafil Citrate IP |
| Equivalent to Tadalafil 20 mg |
| Dapoxetine Hydrochloride IP |
| eq. to Dapoxetine 30 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Tadalafil With Dapoxetine Tablets | Each film coated tablet contains : |
| Tadalafil IP 10 mg |
| Dapoxetine Hydrochloride IP |
| eq. to Dapoxetine 30 mg |
| Approved colour to used |
| |
| Tamsulosin Hydrochloride (MR) Tablets | Each film coated tablet contains: |
| Tamsulosin hydrochloride IP 0.4 mg |
| (As Modified Release) |
| Excipients q.s. |
| Approved colour to be used |
| |
| Tamsulosin Hydrochloride Tablets | Each film coated tablet contains: |
| Tamsulosin hydrochloride IP 0.4 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Tapentadol and Carisoprodol Capsules | Each hard gelatin capsule contains |
| Tapentadol HCI IP |
| Eq. to Tapentadol 70 mg |
| Carisoprodol IP 50 mg |
| Approved colour use in empty capsule shell |
| |
| Tapentadol Capsules | Each hard gelatin capsule : |
| Tapentadol Hydrochloride IP 75 mg |
| |
| Tapentadol Capsules | Each hard gelatin capsule : |
| Tapentadol Hydrochloride IP 50 mg |
| |
| Tapentadol Hydrochloride and Carisoprodol Tablets | Each uncoated tablet contains |
| Tapentadol Hydrochloride IP |
| Eq. to Tapentadol 125 mg |
| Carisoprodol IP 100 mg |
| Excipients q.s. |
| |
| Tapentadol Hydrochloride and Carisoprodol Tablets | Each film coated tablet contains |
| Tapentadol Hydrochloride IP |
| Eq. to Tapentadol 100 mg |
| Carisoprodol IP 350 mg |
| Approved color to be use |
| |
| Tapentadol Hydrochloride Capsules | Each hard gelatin capsule contains |
| Tapentadol Hydrochloride IP |
| Eq. to Tapentadol 25 mg |
| Approved colour use in empty capsule shell |
| |
| Tapentadol Hydrochloride Capsules | Each hard gelatin capsule contains |
| Tapentadol Hydrochloride IP |
| Eq. to Tapentadol 100 mg |
| Approved colour use in empty capsule shell |
| |
| Tapentadol Hydrochloride Sustain Release Tablet | Each film coated sustain realease tablet contains |
| Tapentadol Hydrochloride IP |
| Eq. to Tapentadol 100 mg |
| Approved colour to used |
| |
| Tapentadol Hydrochloride Sustain Release Tablets | Each film coated sualain realease tablet contains |
| Tapentadol Hydrochloride IP |
| Eq. to Tapentadol 50 mg |
| Excipients q.s. |
| Approved colour to used |
| |
| Tapentadol Hydrochloride Tablet | Each film coated tablet contains |
| Tapentadol Hydrochloride IP |
| Eq. to Tapentadol 100 mg |
| Approved colour lo used |
| |
| Tapentadol Hydrochloride Tablets | Each film coated contains |
| Tapentadol Hydrochloride IP |
| Eq. to Tapentado 25 mg |
| Approved coloured used |
| |
| Tapentadol Tablets | Each film coated tablets contains : |
| Tapentadol Hydrochloride IP 75 mg |
| Permitted Color Used |
| |
| Tapentadol Tablets | Each film coated tablets contains : |
| Tapentadol Hydrochloride IP 50 mg |
| Permitted Color Used |
| |
| Telmisartan & Hydrochlorothiazide Tablets | Each uncoated tablet contains : |
| Telmisartan IP 80 mg |
| Hydrochlorothiazide IP 12.5 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Telmisartan and Amlodioine Tablets IP | Each uncoated tablet contains : |
| Telmisartan IP 80 mg |
| Amlodipine Besylate IP |
| Eq. to Amlodipine 10 mg |
| |
| Telmisartan and Ramipiril Tablets | Each uncoated tablet contains : |
| Telmisartan IP 40 mg |
| Ramipril IP 5 mg |
| Approved colour to used |
| |
| Telmisartan and Ramipiril Tablets | Each uncoated tablet contains : |
| Telmisartan IP 40 mg |
| Ramipril IP 2.5 mg |
| Approved colour to used |
| |
| Telmisartan Tablets IP | Each uncoated tablet contains : |
| Telmisartan IP 40 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Telmisartan Tablets IP | Each uncoated tablet contains : |
| Telmisartan IP 80 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Telmisartan With Amlodipine Besylate Tablets | Each uncoated tablet contains : |
| Telmisartan IP 40 mg |
| Amlodipine Besylate BP |
| Eq. to Amlodipine 5 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Telmisartan with Chlorthalidone Tablets | Each film coated tablet contains |
| Telmisartan IP 40 mg |
| Chlorthalidone IP 6.25 mg |
| Permitted Color Used |
| |
| Telmisartan with Chlorthalidone Tablets | Each film coated tablet contains |
| Telmisartan IP 40 mg |
| Chlorthalidone IP 12.5 mg |
| Permitted Color Used |
| |
| Telmisartan with Chlorthalidone Tablets | Each film coated tablet contains |
| Telmisartan IP 80 mg |
| Chlorthalidone IP 6.25 mg |
| Permitted Color Used |
| |
| Telmisartan with Hydrochlorothazide | Each film coated tablet contains |
| Telmisartan IP 40 mg |
| Hydrochlorothazide IP 12.5 mg |
| Permitted Color Used |
| |
| Telmisartan With Hydrochlorothiazide Tablets IP | Each uncoated bilayered tablet contains: |
| Telmisartan IP 80 mg |
| Hydrochlorothiazide IP 25 mg |
| Excipients q . s. |
| Approved colour to used |
| |
| Telmisartan With Hydrochlorothiazide Tablets IP | Each uncoated bilayered tablet contains: |
| Telmisartan IP 80 mg |
| Hydrochlorothiazide IP 12.5 mg |
| Excipients q . s. |
| Approved colour to used |
| |
| Telmisartan, Amlodioine and Hydrochlorothiazide Tablets | Each uncoated tablet contains: |
| Telmisartan IP 20 mg |
| Amlodipine Besylate IP |
| Eq. to Amlodipine 2.5 mg |
| Hydrochlorothiazide IP 6.25 mg |
| |
| Telmisartan, Chlorthalidone and Metoprolol (ER) Tablets | Each film coated tablet contains |
| Telmisartan IP 40 mg |
| Chlorthalidone IP 12.5 mg |
| Metoprolol Succinate IP 47.5 mg |
| Eq.to Metoprolol Tartrate 50 mg |
| Approved colour to be used |
| |
| Telmisartan, Chlorthalidone and Metoprolol Tablets | Each film coated tablet contains |
| Telmisartan IP 40 mg |
| Chlorthalidone IP 12.5 mg |
| Metoprolol Succinate IP 23.75 mg |
| Eq.to Metoprolol Tartrate 25 mg |
| Approved colour to be used |
| |
| Telmisartan, Hydrochlorothiazide and Amlodipine Tablets | Each film coated tablets contains |
| Telmisartan IP 40 mg |
| Hydrochlorothiazide IP 12.5 mg |
| Amlodipine Besylate IP |
| Eq.to Amlodipine 5 mg |
| Approved colour to be used |
| |
| Temazepam Tablets | Each Uncoated tablet contains : |
| Temazepam IP 10 mg |
| |
| Temazepam Tablets | Each Uncoated tablet contains : |
| Temazepam BP 20 mg |
| Excipients q.s. |
| |
| Temazepam Tablets | Each Uncoated tablet contains : |
| Temazepam BP 10 mg |
| Excipients q.s. |
| |
| Temazepam Tablets | Each Uncoated tablet contains : |
| Temazepam BP 20 mg |
| Excipients q.s. |
| |
| Teneligliptin and Pioglitazone Hydrochloride Tablets | Each film coated tablets contains : |
| Teneligliptin Hydrobromide Hydrate IP |
| Eq. to Teneligliptin 20 mg |
| Pioglitazone Hydrochloride IP |
| Eq. to Pioglitazone 15 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Teneligliptin Tablets 20 mg. | Each film coated tablets contains : |
| Teneligliptin Hydromide Hydrate |
| eq. to Teneligliptin 20 mg |
| Permitted Color Used |
| |
| Terbinafine Hydrochloride Tablets IP | Each uncoated tablet contains : |
| Terbinafine Hydrochloride IP |
| Eq. to Terbinafine 250 mg |
| Approved colour to used |
| |
| Terbinafine Hydrochloride Tablets USP | Each uncoated tablet contains |
| Terbenafine Hydrochloride USP 250 mg |
| |
| Terbutaline Sulphate & Bromhexine Hcl Tablets | Each uncoated tablet contains |
| Terbutaline Sulphate IP 2.5 mg |
| Bromhexine Hydrochloride IP 8 mg |
| Approved colour to be used |
| |
| Terbutaline Sulphate & Bromhexine Hydrochloride Tablets | Each uncoated tablet contains : |
| Terbutaline Sulphate IP 2.50 mg |
| Bromhexine Hydrochloride IP 16 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/Quinoline Yellow / |
| Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Terbutaline Sulphate , Guaiphensin & Bromhexine Hydrochloride Tablets | Each uncoated tablet contains : |
| Terbutaline Sulphate IP 1.25 mg |
| Guaiphensin IP 50 mg |
| Bromhexine Hydrochloride IP 4 mg |
| Colour: Brilliant Blue/Erytheosine / Tartrazine/Quinoline Yellow / Sunsel yellow |
| or Thanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Terbutaline Sulphate With Bromhexine Hydrochloride Tablets | Each uncoated tablet contains : |
| Terbutaline Sulphate IP 1.25 mg |
| Bromhexine Hydrochloride IP 4 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine/Quinoline Yellow/Sunset |
| yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Terbutaline Sulphate, Acebrophylline with | Each 5 ml contains : |
| Terbutaline Sulphate IP 1.25 mg |
| Acebrophylline IP 50 mg |
| Guaiphenesin IP 50 mg |
| Approved colour used in flavoured syrupy base |
| |
| Terbutaline Sulphate, Ambroxol Hydrochloride | Each 5 ml contains : |
| Terbutaline Sulphate IP 0.63 mg |
| Ambroxol Hydrochloride IP 10 mg |
| Guaiphenesin IP 25 mg |
| Approved colour used in flavoured syrupy base |
| |
| Terbutaline Sulphate, Ambroxol Hydrochloride | Each ml contains : |
| Terbutaline Sulphate IP 0.25 mg |
| Ambroxol Hydrochloride IP 7.5 mg |
| Guaiphenesin IP 12.5 mg |
| Approved colour used in flavoured syrupy base |
| |
| TERBUTALINE SULPHATE, AMBROXOL HYDROCHLORIDE,and Guaiphenesin | Each 10 ml contains : |
| Terbutaline Sulphate IP 2.5 mg |
| Ambroxol Hydrochloride IP 30 mg |
| Guaiphenesin IP 100 mg |
| Menthol qs |
| Approved colour used in flavoured syrupy base |
| |
| TERBUTALINE SULPHATE, AMBROXOL HYDROCHLORIDE,and Guaiphenesin | Each 5 ml contains : |
| Terbutaline Sulphate IP 1.25 mg |
| Ambroxol Hydrochloride IP 15 mg |
| Guaiphenesin IP 50 mg |
| Ammonium chloride IP 100 mg |
| Menthol qs |
| Approved colour used in flavoured syrupy base |
| |
| Terbutaline Sulphate, Bromhexine HCl Guaiphenesin With Menthol Syrup | Each 5 ml contains : |
| Terbutaline Sulphate IP 1.25 mg |
| Bromhexine Hydrochloride IP 2 mg |
| Guaiphenesin IP 50 mg |
| Menthol IP q.s. |
| Approved colour used in flavoured syrupy base |
| |
| TERBUTALINE SULPHATE, BROMHEXINE HYDROCHLORIDE, Guaiphenesin and Menthol | Each 10 ml contains : |
| Terbutaline Sulphate IP 2.5 mg |
| Bromhexine Hydrochloride IP 8 mg |
| Guaiphenesin IP 100 mg |
| Menthol IP qs |
| Approved colour used in flavoured syrupy base |
| |
| Tetrabenazine Tablets 25 mg | Each Uncoated tablet contains: |
| Tetrabenazine 25 mg |
| Excipients q.s. |
| |
| |
| TETRACYCLINE HYDROCHLORIDE CAPSULES IP | Each hard gelatin capsule contains |
| Tetracycline Hydrochloride IP 250 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| TETRACYCLINE HYDROCHLORIDE CAPSULES IP | Each hard gelatin capsule contains |
| Tetracycline Hydrochloride IP 500 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| THEOPHYLLINE & ETOFYLLINE SYRUPS | Each 5 ml contains : |
| Theophylline IP 14 mg |
| Etofylline IP 46.5 mg |
| Approved colour used in flavoured syrupy base |
| |
| Thiamine (Mono), Riboflavin Pyridoxine Hydrochloride | Each film coated tablet contains : |
| Thiamine Mononitrate IP 10 mg |
| Riboflavin IP 10 mg |
| Pyridoxine Hydrochloride IP 3 mg |
| Cyanocobalamin IP 15 mcg |
| Naicinamide IP 45 mg |
| Calcium Panthothenate IP 50 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| THIAMINE (Mono), Riboflavin With Cyanocobalamin Tablets | Each film coated tablet contains : |
| Thiamine Mononitrate IP 1 mg |
| Riboflavin IP 1 mg |
| Cyanocobalamin IP 1 mcg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green/Iron oxide red, Iron oxide Yellow |
| |
| Thiamine (Mono), Riboflavine , Nicotinamide & Pyridoxine Hcl,Calcium Pantothenate and Cyanocobalamin | Each film coated tablet contains : |
| Thiamine Monoitrate IP 5 mg |
| Riboflavine IP 5 mg |
| Nicotinamide IP 50 mg |
| Pyridoxine Hydrochloride IP 1.5 mg |
| Calcium Pantothenate IP 10 mg |
| Cyanocobalamin IP 5 mcg |
| Foilc Acid IP 1000 mcg |
| Approved Color to be use in Tablet |
| |
| Thiamine (Mono), Riboflavine , Nicotinamide & Pyridoxine Hcl,Calcium Pantothenate and Cyanocobalamin | Each film coated tablet contains : |
| Thiamine Monoitrate IP 10 mg |
| Riboflavine IP 5 mg |
| Nicotinamide IP 100 mg |
| Pyridoxine Hydrochloride IP 3 mg |
| Calcium Pantothenate IP 50 mg |
| Cyanocobalamin IP 15 mcg |
| Excipients q.s. |
| Approved Color to be use in Tablet |
| |
| Thiamine (Mono), Riboflavine Pyridoxine Hydrochloride | Each film coated tablet contains : |
| Thiamine Monoitrate IP 4.5 mg |
| Riboflavine IP 5 mg |
| Nicotinamide IP 45 mg |
| Pyridoxine Hydrochloride IP 1.5 mg |
| Calcium Pantothenate IP 5 mg |
| Cyanocobalamin IP 5 mcg |
| Folic Acid IP 1 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Thiamine (Mono), Riboflavine Pyridoxine Hydrochloride | Each film coated tablet contains : |
| Thiamine Monoitrate IP 1 mg |
| Riboflavine IP 1 mg |
| Pyridoxine Hydrochloride IP 0.5 mg |
| Cyanocobalamin IP 0.5 mcg |
| Naicinamide IP 5 mg |
| Folic Acid IP 0.3 mg |
| Calcium Panthothenate IP 2 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Thiamine (Mono), Riboflavine Pyridoxine Hydrochloride,Naicinamide and Calcium Panthothenate | Each film coated tablet contains : |
| Vitamin B 1 Mononitrate IP 2 mg |
| Vitamin B 2 IP 2 mg |
| Vitamin B6 IP 1 mg |
| Vitamin B 12 IP 1 mcg |
| Naicinamide IP 15 mg |
| Calcium Panthothenate IP 5 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| THIAMINE (MONO), RIBOFLAVINE, CYANOCOBALAMIN and Pyridoxine Hydrochloride | Each hard gelatin capsule contains |
| Thiamine Mononitrate IP 1 mg |
| Riboflavine IP 1 mg |
| Cyanocobalamin IP 0.5 mcg |
| Pyridoxine Hydrochloride IP 0.5 mg |
| Approved colour used in empty capsule shell |
| |
| THIAMINE (MONO), RIBOFLAVINE, NICOTINAMIDE, PYRIDOXINE HCL,Calcium Hydrochloride,Cyanocobalmin,Folic Acid and Vitamin C | Each hard gelatin capsule contains |
| Thiamine Monoitrale IP 10 mg |
| Riboflavine IP 10 mg |
| Nicotinamide IP 50 mg |
| Pyridoxine Hydrochloride IP 3 mg |
| Calcium Pantothenate IP 12.5 mg |
| Cyanocobalamin IP 5 mcg |
| Folic Acid IP 1 mg |
| Vitamin C IP 100 mg |
| Approved colour used in empty capsule shell |
| |
| THIAMINE (MONO), RIBOFLAVINE, PYRIDOXINE HCL, NICOTINAMIDE, Cyanocobalamin and Zinc Sulphate | Each 5 ml contains : |
| Thiamine Monoitrate IP 1.5 mg |
| Riboflavine IP 1.5 mg |
| Pyridoxine Hydrochloride IP 1 mg |
| Nicotinamide IP 15 mg |
| Cyanocobalamin IP 1 mcg |
| Zinc Sulphate IP |
| eq. to Elemental Zinc 7 mg |
| L-Lysine Hydrochloride IP 70 mg |
| Excipients q.s |
| Approved colour used in flavoured syrupy base |
| |
| Thiamine Hydrochloride Tablets | Each film coated tablets contains : |
| Thiamine Hydrochloride IP 100 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Thiamine, Riboflavin, Pyridoxine Niacinamide, Calcium Pantothenate | Each hard gelatin capsule contains |
| Thiamine Mononitrate IP 10 mg |
| Riboflavin IP 5 mg |
| Pyridoxine Hydrochloride IP 1.5 mg |
| Niacinamide IP 45 mg |
| Calcium Pantothenate IP 5 mg |
| Cyanocobalamin IP 5 mcg |
| Approved colour use in empty capsule shell |
| |
| Thyroxine Sodium Tablets IP | Each uncoated tablet contains |
| Thyroxine Sodium IP 25 mcg |
| |
| Thyroxine Sodium Tablets IP | Each uncoated tablet contains |
| Thyroxine Sodium IP 50 mcg |
| |
| Thyroxine Sodium Tablets IP | Each uncoated tablet contains |
| Thyroxine Sodium IP 75 mcg |
| |
| Thyroxine Sodium Tablets IP | Each uncoated tablet contains |
| Thyroxine Sodium IP 100 mcg |
| |
| Thyroxine Sodium Tablets IP | Each uncoated tablet contains |
| Thyroxine Sodium IP 125 mcg |
| |
| Tianeptine Sodium Tablets | Each sugar coated tablet contains : |
| Tianeptine sodium BP 12.5 mg |
| Approved colour to used |
| |
| Ticagrelor Tablets IP 90 mg | Each film coated tablet contains : |
| Ticagrelor IP 90 mg |
| Approved colour to used |
| |
| Tinidazole Tablets IP 300 mg | Each film coated tablet contains : |
| Tinidazole IP 300 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| |
| Tinidazole Tablets IP 500 mg | Each film coated tablet contains : |
| Tinidazole IP 500 mg |
| Approved colour to used |
| |
| Tinidazole Tablets IP 600 mg | Each film coated tablet contains : |
| Tinidazole IP 600 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or |
| Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| |
| Tizanidine Tablets IP | Each uncoated tablet contains: |
| Tizanidine Hydrochloride IP |
| Equivalent to Tizanidine 2 mg |
| Excipients q.s. |
| Approved color to be use |
| |
| Tizanidine Tablets IP | Each uncoated tablet contains: |
| Tizanidine Hydrochloride IP |
| Equivalent to Tizanidine 4 mg |
| Excipients q.s. |
| Approved color to be use |
| |
| Tizanidine Tablets IP | Each uncoated tablet contains: |
| Tizanidine Hydrochloride IP 6 mg |
| Equivalent to Tizanidine |
| Excipients q.s. |
| Approved color to be use |
| |
| Tofacitinib Tablets | Each film coated tablet contains |
| Tofacitinb Citrate |
| Eq. to Tofacitinib 5 mg |
| Approved colour to be used |
| |
| Tofisolam Tablets | Each uncoated tablet contains : |
| Tofisoalm JP 100 mg |
| |
| Tofisolam Tablets | Each uncoated tablet contains : |
| Tofisoalm JP 50 mg |
| |
| Tofisopam Tablets 100 mg | Each uncoated / film coated tablets contains : |
| Tofisopam JP 100 mg |
| Excipients q.s. |
| |
| |
| Tofisopam Tablets 50 mg | Each uncoated / film coated tablets contains : |
| Tofisopam JP 50 mg |
| Excipients q.s. |
| |
| |
| Tolperisone Hydrochloride and Diclofenac sodium Tablets | Each film coated tablet contains: |
| Tolperisone Hydrochloride JP 150 mg |
| Diclofenac Sodium IP 50 mg |
| Excipients q . s. |
| Approved colour to used |
| |
| Tolperisone Hydrochloride and Diclofenac sodium Tablets | Each sustained released tablet contains: |
| Tolperisone Hydrochloride JP 450 mg |
| Diclofenac Sodium IP 100 mg |
| Excipients q . s. |
| Approved colour to used |
| |
| Tolperisone Hydrochloride Sustained Release Tablets | Each Sustained Release tablet contains : |
| Tolperisone Hydrochloride JP 450 mg |
| Excipients q.s. |
| Approved colour to used |
| |
| Tolperisone Hydrochloride Tablets 100 mg | Each film coated tablet contains : |
| Tolperisone Hydrochloride JP 100 mg |
| Excipients q.s |
| Approved colour to used |
| |
| Tolperisone Hydrochloride Tablets 150 mg | Each film coated tablet contains : |
| Tolperisone Hydrochloride JP 150 mg |
| Excipients q.s |
| Approved colour to used |
| |
| Tolperisone Hydrochloride Tablets 50 mg | Each film coated tablet contains : |
| Tolperisone Hydrochloride JP 50 mg |
| Excipients q.s |
| Approved colour to used |
| |
| Tolperisone Sustained Release Tablets | Each Sustained Release tablet contains : |
| Tolperisone Hydrochloride JP 450 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Tolperisone Sustained Release Tablets | Each Sustained Release tablet contains : |
| Tolperisone Hydrochloride JP 150 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Tolperisone Sustained Release Tablets | Each Prolonged Release tablet contains : |
| Tolperisone Hydrochloride JP 450 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Tolperisone Tablets | Each film coated tablet contains : |
| Tolperisone Hydrochloride JP 150 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Topiramate Tablets IP | Each film coated tablet contains: |
| Topiramate IP 25 mg |
| Approved colour to be used |
| |
| Topiramate Tablets IP | Each film coated tablet contains: |
| Topiramate IP 50 mg |
| Approved colour to be used |
| |
| Topiramate Tablets IP | Each film coated tablet contains: |
| Topiramate IP 100 mg |
| Approved colour to be used |
| |
| Topiramate Tablets IP | Each film coated tablet contains: |
| Topiramate IP 200 mg |
| Approved colour to be used |
| |
| Topiramate Tablets IP | Each film coated tablet contains: |
| Topiramate IP 300 mg |
| Approved colour to be used |
| |
| Topiramate Tablets IP | Each film coated tablet contains: |
| Topiramate IP 400 mg |
| Approved colour to be used |
| |
| Topotecan Hydrochloride IP Capsules | Each hard gelatin capsule contains: |
| Topotecan Hydrochloride IP 1 mg |
| Eq. to Topotecan |
| Excipients q.s. |
| Approved colour use in empty capsule shells |
| |
| Torsemide and Amiloride Tablets | Each uncoated tablet contains : |
| Torsemide IP 10 mg |
| Amiloride Hydrochloride IP |
| Eq. to Anhydrous Amiloride Hcl 5 mg |
| Excipients q.s. |
| Approved colour used |
| |
| Torsemide and Spironolactone Tabiets | Each uncoated tablet contains : |
| Torsemide IP 10 mg |
| Spironolactone IP 25 mg |
| Excipients q.s. |
| Approved colour used |
| |
| Torsemide and Spironolactone Tabiets | Each uncoated tablet contains : |
| Torsemide IP 10 mg |
| Spironolactone IP 50 mg |
| Excipients q.s. |
| Approved colour used |
| |
| Torsemide tablets IP | Each uncoated tablet contains : |
| Torsemide IP 5 mg |
| |
| Torsemide tablets IP | Each uncoated tablet contains : |
| Torsemide IP 10 mg |
| |
| Torsemide tablets IP | Each uncoated tablet contains : |
| Torsemide IP 20 mg |
| |
| Torsemide tablets IP | Each uncoated tablet contains : |
| Torsemide IP 100 mg |
| |
| Tramadol HCl Tablets | Each film coated tablet contains : |
| Tramadol Hydrochloride IP 100 mg |
| Approved colour to used |
| |
| Tramadol Hydrochloride & Aceclofenac Tablets | Each film coated tablet contains |
| Aceclofenac IP 100 mg |
| Tramadol Hydrochloride IP 50 mg |
| Excipients q.s. |
| |
| Tramadol Hydrochloride & Paracetamol Tablets | Each uncoated bilayered tablet contains : |
| Tramadol Hydrochloride IP 37.5 mg |
| Paracetamol IP 325 mg |
| Excipients q.s. |
| Approved colour to used |
| |
| Tramadol Hydrochloride & Paracetmol Sustained Release Tablet | Each Film coated sustained release tablet contains: |
| Tramadol Hydrochloride IP 37.5 mg |
| Paracetmol IP 325 mg |
| Approved colour to be used |
| |
| Tramadol Hydrochloride & Paracetmol Tablets | Each film coated tablet contains : |
| Tramadol Hydrochloride IP 37.5 mg |
| Paracetmol IP 325 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine/Quinoline Yellow / Sunset yellow or |
| Titanium Dioxide ir /Apple Green / Iron oxide red iron oxide Yellow |
| |
| Tramadol Hydrochloride & Paracetmol Tablets | Each film coated tablet contains : |
| Tramadol Hydrochloride IP 50 mg |
| Paracetmol IP 325 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine/Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide ir /Apple Green / Iron oxide red iron oxide Yellow |
| |
| TRAMADOL HYDROCHLORIDE CAPSULES IP | Each hard gelatin capsule contains |
| Tramadol Hydrochloride IP 50 mg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Tramadol Hydrochloride Sustained Release Tablet | Each sustained release tablet contains |
| Tramadol Hydrochloride IP 100 mg |
| Approved colour to used |
| |
| Tramadol Hydrochloride Tablets | Each uncoated tablet contains : |
| Tramadol Hydrochloride IP 50 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or |
| Titanium Dioxide IP /Apple Green / tron oxide red,Iron oxide Yellow |
| |
| Tramadol Hydrochloride Tablets | Each film coated tablet contains : |
| Tramadol Hydrochloride IP 100 mg |
| Approved colour to be used |
| |
| Tranexamic Acid & Mefenamic Acid Tablets | Each uncoated tablet contains |
| Tranexamic Acid BP 500 mg |
| Mefenamic Acid IP 250 mg |
| |
| Tranexamic acid and Etamsylate Tablets | Each film coated tablet contains: |
| Tranexamic Acid IP 250 mg |
| Etamsylate BP 250 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Tranexamic Acid Tablets | Each uncoated tablet contains |
| Tranexamic Acid BP 500 mg |
| |
| Triazolam Tablets | Each Uncoated tablet contains : |
| Triazolam USP 0.25 mg |
| Excipients q.s. |
| |
| TRICHOLINE CITRATE SYRUP | Each 5 ml contains : |
| Tricholine citrate 275 mg |
| Approved colour used in flavoured syrupy base |
| |
| TRICHOLINE CITRATE WITH SORBITOL 70% SYRUP | Each 10 ml contains : |
| Tricholine citrate 0.55 gm |
| Sorbitol Soluion (Non crystallizing 70%) IP 7.15 gm |
| Approved colour used in flavoured syrupy base |
| |
| Tricholine Citrate, Thiamine HCl Riboflavin, Cyanocobalamin | Each 5 ml contains : |
| Tricholine Citrate 250 mg |
| Thiamine Hydrochloride IP 2.5 mg |
| Riboflavin IP 2.5 mcg |
| Cyanocobalmin IP 5.0 mcg |
| Pyridoxine Hydrochloride IP 0.75 mg |
| Approved Colour used inFlavoured Syrupy Base |
| |
| Triclofos Oral Solution IP 02.09.2023 | Each 5 ml contains: |
| Triclofos Sodium IP 500 mg |
| Approved colour used in flavoured syrupy base |
| |
| Trifluoperazine Hydrochloride Tablets IP | Each film coated tablet contains : |
| Trifluoperazine Hydrochloride IP |
| Eq. to Trifluoperazine 1 mg |
| |
| Trihexyphenidyl Hydrochloride Dispersible Tablets IP 2 mg | Each Uncoated dispersible tablet contains: |
| Trihexyphenidyl Hydrochloride IP 2 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Trihexyphenidyl Hydrochloride Tablets IP 2 mg | Each Uncoated tablet contains: |
| Trihexyphenidyl Hydrochloride IP 2 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Trihexyphenidyl Hydrochloride Tablets IP 5 mg | Each Uncoated tablet contains: |
| Trihexyphenidyl Hydrochloride IP 5 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| |
| Trimetazidine HCI (SR) Tablets | Each Sustained release film coated tablet contains : |
| Trimetazidine Hydrochloride IP 60 mg |
| Approved colour to be used |
| |
| Trimetazidine HCL (SR) Tablets | Each modified release film coated tablet contains : |
| Trimetazidine Hydrochloride IP 35 mg |
| Approved colour to be used |
| |
| Trimetazidine Hydrochlorde Modified release tablets | Each modified release film coated tablet contains : |
| Trimetazidine Hydrochlorde IP 35 mg |
| Approved colour to be used |
| |
| Trimetazidine Hydrochlorde Tablets IP 20 mg | Each uncoated tablets contains |
| Trimetazidine Hydrochlorde IP 20 mg |
| |
| Trimetazidine Hydrochloride Tablets | Each uncoated tablet contains |
| Trimetazidine Hydrochloride IP 20 mg |
| |
| Trimetazidine Hydrochloride Tablets | Each uncoated tablet contains |
| Trimetazidine Hydrochloride IP 35 mg |
| |
| Trimetazidine Tablets IP 20mg | Each film coated tablet contains : |
| Trimetazidine Hydrochloride IP 20 mg |
| Approved colour to be used |
| |
| Trimetazidine Tablets | Each uncoated tablet contains : |
| Trimetazidine Hydrochloride IP 3 mg |
| Approved colour to be used |
| |
| Trimethoprim & Sulphamethoxazole Bolus | Each uncoated bolus contains |
| Trimethoprim IP 400 mg |
| Sulphamethoxazole IP 2000 mg |
| |
| |
| Triplodine Hcl & Pseudoephedrine Hcl Tablets | Each uncoated tablet contains |
| Pseudoephedrine Hydrochloride IP 60 mg |
| Triplodine Hydrochloride IP 2.5 mg |
| Approved colour to be used |
| |
| Triprolidine Hydrochloride and Codeine Phosphate Syrup | Each 5 ml contains : |
| Codeine Phosphate IP 10 mg |
| Triprolidine Hydrochloride IP 1.25 mg |
| Approved colour used in flavoured syrupy base |
| |
| Trizolam Tablets | Each Uncoated tablet contains : |
| Triazolam USP 0.25 mg |
| Excipients q.s. |
| |
| Trypsin, Bromelain with Rotoside Trihydrate Tablets | Each film coated tablet contains |
| Trypsin IP 48 mg |
| Bromelain 90 mg |
| Rotoside Trihydrate USP 100 mg |
| Colour: Brilliant Blue / Erythrosine / Tartrazine/ |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Apple Green/Iron oxide red, Iron oxide Yellow |
| |
| Trypsin, Bromelain, Papain and Rotoside Trihydrate Tablets | Each film coated tablet contains : |
| Trypsin BP 96 mg |
| Bromelain 180 mg |
| Rotoside Trihydrate BP 200 mg |
| Papain IP 120 mg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Ubiquinol Capsules | Each hard gelatin capsule contains |
| Ubiquinol 100 mg |
| Approved colour use in empty capsule shell |
| |
| Udenafil & Dapoxetine Hcl Tab?ets | Each film coated tablet contains : |
| Udenafil IP 100 Mg |
| Dapoxetine Hydrochloride IP |
| Eq. to Dapoxetine 60 mg |
| Excipients q.s. |
| Approved colour to be used |
| |
| Udenafil Tablets 100 mg | Each film coated tablet contains : |
| Udenafil IP 100 mg |
| Approved colour to used |
| |
| Udenafil Tablets 200 mg | Each film coated tablet contains : |
| Udenafil IP 200 mg |
| Approved colour to used |
| |
| Ursodeoxycholic Acid (SR) Tablets IP | Each sustain release coated tablet contains |
| Ursodeoxycholic Acid IP 450 mg |
| |
| Ursodeoxycholic Acid Oral Suspension | Each 5 ml contains : |
| Ursodeoxycholic Acid IP 125 mg |
| Approved coloured use in a flavoured syrup base |
| |
| Ursodeoxycholic Acid Oral Suspension | Each 5 ml contains : |
| Ursodeoxycholic Acid IP 250 mg |
| Approved coloured use in a flavoured syrup base |
| Ursodeoxycholic Acid Tablet IP 150 mg | Each film coated tablet contains |
| Ursodeoxycholic Acid IP 150 mg |
| Approved coloured used |
| |
| Ursodeoxycholic Acid Tablet IP 300 mg | Each film coated tablet contains |
| Ursodeoxycholic Acid IP 300 mg |
| Approved coloured used |
| |
| Valsartan Capsules | Each hard gelatin capsule contains |
| Valsartan IP 80 mg |
| Approved coloured used in empty capsule shell |
| |
| Valsartan Capsules | Each hard gelatin capsule contains |
| Valsartan IP 160 mg |
| Approved coloured used in empty capsule shell |
| |
| Valsartan Tablets IP | Each film coated tablet contains : |
| Valsartan IP 40 mg |
| Approved colour to be used |
| |
| Valsartan Tablets IP | Each film coated tablet contains : |
| Valsartan IP 80 mg |
| Approved colour to be used |
| |
| Valsartan Tablets IP | Each film coated tablet contains : |
| Valsartan IP 160 mg |
| Approved colour to used |
| |
| Valsartan Tablets IP | Each film coated tablet contains : |
| Valsartan IP 320 mg |
| Approved colour to used |
| |
| Vardenafil & Dapoxetine HCI Tablets | Each film coated tablet contains : |
| Vardenafil Hydrochloride |
| Eq. to Vardenafil 20 mg |
| Dapoxetine Hydrochloride IP |
| Eq. to Dapoxetine 60 mg |
| Approved colour to be used |
| |
| Vardenafil Chewable Tablets | Each uncoated chewable tablet contains : |
| Vardenafil Hydrochloride |
| Eq. to Vardenafil 20 mg |
| Approved colour to be used |
| |
| Vardenafil Tablets 10 mg | Each film coated tablet contains : |
| Vardenafil Hydrochloride |
| Eq. to Vardenafil 10 mg |
| Approved colour to be used |
| |
| Vardenafil Tablets 20 mg | Each film coated tablet contains : |
| Vardenafil Hydrochloride |
| Eq. to Vardenafil 20 mg |
| Approved colour to be used |
| |
| Vardenafil Tablets 40 mg | Each film coated tablet contains : |
| Vardenafil Hydrochloride |
| Eq. to Vardenafil 40 mg |
| Approved colour to be used |
| |
| Venlafaxine Prolonged-release Tablets IP | Each uncoated Prolonged-release tablet contains : |
| VenlafaxineHydrochloride IP |
| Eq. to Venlafaxine 25 mg |
| Excipients q.s |
| |
| Venlafaxine Prolonged-release Tablets IP | Each uncoated Prolonged-release tablet contains : |
| VenlafaxineHydrochloride IP |
| Eq. to Venlafaxine 37.5 mg |
| Excipients q.s |
| |
| Venlafaxine Prolonged-release Tablets IP | Each uncoated Prolonged-release tablet contains : |
| VenlafaxineHydrochloride IP |
| Eq. to Venlafaxine 75 mg |
| Excipients q.s |
| |
| Venlafaxine Prolonged-release Tablets IP | Each uncoated Prolonged-release tablet contains : |
| VenlafaxineHydrochloride IP |
| Eq. to Venlafaxine 150 mg |
| Excipients q.s |
| |
| Vildagliptin and Metformin Hydrochloride Tablets | Each uncoated tablet contains |
| Vildagliptin 50 mg |
| Metformin Hydrochloride IP 500 mg |
| |
| Vildagliptin and Metformin Hydrochloride Tablets | Each uncoated tablet contains |
| Vildagliptin 50 mg |
| Metformin Hydrochloride IP 850 mg |
| |
| Vildagliptin and Metformin Hydrochloride Tablets | Each uncoated tablet contains |
| Vildagliptin 50 mg |
| Metformin Hydrochloride IP 1000 mg |
| |
| Vildagliptin tablets IP | Each uncoated tablet contains : |
| Vildagliptin IP 50 mg |
| Excipients q.s. |
| |
| Vildagliptin tablets IP | Each uncoated tablet contains : |
| Vildagliptin IP 100 mg |
| Excipients q.s. |
| |
| Vitamin A & Vitamin D Chewable Tablets | Each uncoated chewable tablet contains : |
| Vitamin A IP 1000 IU |
| Vitamin D3 IP 400 IU |
| Approved colour to be used |
| |
| Vitamin A & Vitamin D Chewable Tablets | Each uncoated chewable tablet contains : |
| Vitamin A IP 10000 IU |
| Vitamin D3 IP 1000 IU |
| Approved colour to be used |
| |
| Vitamin A Acetate, Vitamin D 3 Thiamine, Riboflavin and Naicinamide | Each film coated tablet contains : |
| Vitamin A Acetate IP 750 mcg |
| Vitamin D 3 IP 200 IU |
| Thiamine Monanitrate IP 0.5 mg |
| Riboflavin IP 0.5 mg |
| Naicinamide IP 5 mg |
| Excipients q.s. |
| Permitted Color Used |
| |
| Vitamin A Chewable Tablets | Each uncoated chewable tablet contains : |
| Vitamin A IP 1000 IU |
| Approved colour to be used |
| |
| Vitamin A Chewable Tablets | Each uncoated chewable tablet contains : |
| Vitamin A IP 5000 IU |
| Approved colour to be used |
| |
| Vitamin A Chewable Tablets | Each uncoated chewable tablet contains : |
| Vitamin A IP 50000 IU |
| Approved colour to be used |
| |
| VITAMIN A DROPS | Each ml contains : |
| Vitamin A (As Palmitate) IP 100000 IU |
| Approved colour used in flavoured syrupy base |
| |
| Vitamin A Drops For paediatric use | Each ml contains : |
| Vitamin A (As Palmetate) IP 1500 IU |
| Approved colour used in flavoured syrupy base |
| |
| Vitamin A Drops For paediatric use | Each ml contains : |
| Vitamin A (As Palmetate) IP 2500 IU |
| Approved colour used in flavoured syrupy base |
| |
| Vitamin B-Complex Capsules | Each hard gelatin capsule contains |
| Thiamine Mononitrate IP 1 mg |
| Riboflavin IP 1 mg |
| Pyridoxine Hydrochloride IP 0.5 mg |
| Niacinamide IP 15 mg |
| Lactic Acid Bacillus IP 1000 mill.spor |
| Approved colour used in empty capsule shell |
| |
| VITAMIN B-COMPLEX CAPSULES For Prophylactic Use | Each hard gelatin capsule contains |
| Thiamine Mononitrate IP 1 mg |
| Riboflavine IP 1 mg |
| Cyanocobalamin IP 0.5 mcg |
| Excipients q.s. |
| Approved colour used in empty capsule shell |
| |
| Vitamin B-Complex Tablets For Prophylactic Use | Each film coated tablet contains : |
| Vitamin B1 IP 2 mg |
| Vitamin B2 IP 2 mg |
| Vitamin B6 IP 0.50 mg |
| Naicinamide IP 25 mg |
| Calcium Panthothenate IP 1 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Vitamin B-Complex Tablets | Each film coated tablet contains |
| Thiamine Mononitrate IP 2 mg |
| Riboflavin IP 2 mg |
| Pyridoxine Hydrochloride IP 1 mg |
| Niacinamide IP 15 mg |
| Calcium Pantothenate IP 5 mg |
| Colour: Brilliant Blue / Erythrosine/Tartrazine / |
| Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| /Apple Green / Iron oxide red,Iron oxide Yellow |
| |
| Vitamin C & Zinc Tablets | Each uncoated chewable tablet contains : |
| Vitamin C IP 1000 mg |
| Zinc Sulphate IP |
| eq. to elemental Zinc 20 mg |
| Approved colour to be used |
| |
| Vitamin C & Zinc Tablets | Each uncoated chewable tablet contains : |
| Vitamin C IP 1000 mg |
| Zinc Sulphate IP |
| eq. to elemental Zinc 50 mg |
| Approved colour to be used |
| |
| Vitamin C & Zinc Tablets | Each uncoated chewable tablet contains : |
| Vitamin C IP 500 mg |
| Zinc Sulphate IP |
| eq. to elemental Zinc 20 mg |
| Approved colour to be used |
| |
| Vitamin C & Zinc Tablets | Each uncoated chewable tablet contains : |
| Vitamin C IP 500 mg |
| Zinc Sulphate IP |
| eq. to elemental Zinc 50 mg |
| Approved colour to be used |
| |
| Vitamin C Chewable Tablets IP | Each uncoated chewable tablet contains : |
| Vitamin C IP 100 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Vitamin C Chewable Tablets IP | Each uncoated chewable tablet contains : |
| Ascorbic Acid IP 500 mg |
| Excipients q.s. |
| Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow |
| or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| |
| Vitamin D3, Calcium, L-Methylfolate & Boron with | Each film coated chewable tablet contains : |
| Vitamin D3 IP 1000 IU |
| Caclium Citrate Maleate IP 1180 mg |
| Eq. to Calcium 250 mg |
| L-Methylfolate 468 mg |
| Boron 1.5 mg |
| Methylcobalamin IP 1500 mcg |
| Excipients q.s. |
| Approved colour to be use |
| |
| Vitamin K 2-7, Calcium Citrate, Calcitriol, Zinc Sulphate and Folic acid | Each film coated tablet contains: |
| Vitamin K 2-7 50 mcg |
| Calcium Citrate Maleate |
| eq. to Elemental Calcium 250 mg |
| Calcitriol IP 0.25 mcg |
| Zinc Sulphate IP 7.5 mg |
| Folic Acid IP 100 mcg |
| Excipients q.s. |
| Permitted Color Used |
| |
| Vitamin K2-7, Calcium Carbonate, Calcitriol, Zinc Sulphate,L-Methyl Folate , Methylcobalamin and Magnesium | Each film coated tablet contains : |
| Vitamin K 2-7 45 mcg |
| Calcium Carbonate IP 1250 mg |
| Calcitriol IP 0.25 mcg |
| Zinc sulphate IP 7.5 mg |
| L-Methyl Folate 800 mcg |
| Methylcobalamin IP 1500 mcg |
| Magnesium IP 50 mg |
| Excipients q.s |
| Approved colour use |
| |
| Voglibose and Metformin Hydrochloride (SR) Tablet | Each uncoated tablet contains |
| Voglibose 0.3 mg |
| Metformin Hydrochloride IP 500 mg |
| (As Sustain Release) |
| |
| Voglibose Tablets IP | Each uncoated tablet contains : |
| Voglibose IP 0.2 mg |
| |
| Voglibose Tablets IP | Each uncoated tablet contains : |
| Voglibose IP 0.3 mg |
| |
| Vonoprazan Tablets | Each film coated tablets contains : |
| Vonoprazan Fumarate |
| Eq. to Vonoprazan 20 mg |
| Approved colour to be used |
| |
| Voriconazole Oral powder for solution | Each ml contains : |
| Voriconazole IP 40 mg |
| Approved colour used in flavoured syrupy base |
| |
| Voriconazole Tablets IP | Each film coated tablets contains : |
| Voriconazole IP 50 mg |
| Approved colour to used |
| |
| Voriconazole Tablets IP | Each film coated tablets contains : |
| Voriconazole IP 200 mg |
| Approved colour to used |
| |
| Warfarin Sodium Tablets 4 mg | Each uncoated tablet contains : |
| Warfarin Sodium IP 4 mg |
| Approved colour to used |
| |
| Warfarin Sodium Tablets IP 1 mg | Each uncoated tablet contains : |
| Warfarin Sodium IP 1 mg |
| Approved colour to used |
| |
| Warfarin Sodium Tablets IP 10 mg | Each uncoated tablet contains : |
| Warfarin Sodium IP 10 mg |
| Approved colour to used |
| |
| Warfarin Sodium Tablets IP 3 mg | Each uncoated tablet contains : |
| Warfarin Sodium IP 3 mg |
| Approved colour to used |
| |
| Warfarin Sodium Tablets IP 5 mg | Each uncoated tablet contains : |
| Warfarin Sodium IP 5 mg |
| Approved colour to used |
| |
| Xylometazoline HCI Nasal Solution IP | Each 5 ml contains : |
| Xylometazoline HCI IP 0.05 % w/v |
| Benzalkonium Chloride (As preservapive) IP 0.02 % w/v |
| Sterile aqueous base q.s. |
| |
| Yeast Tablets B.P.C | Each uncoated tablet contains |
| Dried Yeast Powder BPC 300 mg |
| Excipients q.s. |
| |
| Zaleplon Capsules IP | Each hard gelatin capsule contains |
| Zaleplon IP 5 mg |
| Approved colour use in empty capsule shell |
| |
| Zaleplon Capsules IP | Each hard gelatin capsule contains |
| Zaleplon IP 10 mg |
| Approved colour use in empty capsule shell |
| |
| Zinc Acetate Tablets | Each uncoated tablet contains: |
| Zinc Acetate IP |
| eq. to elemental Zinc 20 mg |
| Approved colour to be used |
| |
| Zinc Acetate Tablets | Each uncoated tablet contains: |
| Zinc Acetate IP |
| eq. to elemental Zinc 50 mg |
| Approved colour to be used |
| |
| Contains : |
| Povidone-lodine IP 5 % w/v |
| Permitted Color Used |
| |
| Zinc Sulphate Dispersible Tablets IP | Each uncoated dispersible tablet contains: |
| Zinc Sulphate Monohydrate IP |
| eq. to elemental Zinc 10 mg |
| Approved colour to be used |
| |
| Zinc Sulphate Dispersible Tablets IP | Each uncoated dispersible tablet contains: |
| Zinc Sulphate Monohydrate IP |
| eq. to elemental Zinc 20 mg |
| Approved colour to be used |
| |
| Zinc Sulphate Syrup For paediatric use | Each 5 ml. contains |
| Zinc Sulphate IP |
| eq. to Zinc 5 mg |
| Colour : Erythrosine / Tartrazine / Sunset Yellow |
| Ponceau-4R or Carmosine |
| In flavoured syrupy base |
| |
| Zinc Sulphate Syrup | Each 5 ml. contains |
| Zinc Sulphate IP |
| eq. to Zinc 10 mg |
| Colour : Erythrosine / Tartrazine / Sunset Yellow |
| Ponceau-4R or Carmosine |
| In flavoured syrupy base |
| |
| Zinc Sulphate Tablets | Each uncoated bless contains |
| Zinc Sulphate Monohydrate IP |
| eq. to Elemental Zinc 5 mg |
| Approved colour to used |
| |
| Zinc Sulphate Tablets | Each uncoated tablet contains : |
| Zinc Sulphate IP |
| eq. to elemental Zinc 10 mg |
| Approved colour to be used |
| |
| Zinc Sulphate Tablets | Each uncoated tablet contains : |
| Zinc Sulphate IP |
| eq. to elemental Zinc 20 mg |
| Approved colour to be used |
| |
| Zinc Sulphate Tablets | Each uncoated tablet contains : |
| Zinc Sulphate IP |
| eq. to elemental Zinc 50 mg |
| Approved colour to be used |
| |
| Zolpidem Tartrate orally Disintegrating Tablets | Each uncoated orally Disintegrating tablet contains : |
| Zolpidem Tartrate IP 5 mg |
| Excipients q.s. |
| |
| Zolpidem Tartrate orally Disintegrating Tablets | Each uncoated orally Disintegrating tablet contains : |
| Zolpidem Tartrate IP 10 mg |
| Excipients q.s. |
| |
| Zolpidem Tartrate Prolonged release Tablets IP | Each Uncoated prolonged release tablet contains : |
| Zolpidem Tartrate IP 6.25 mg |
| Excipients q.s. |
| |
| Zolpidem Tartrate Prolonged release Tablets IP | Each Uncoated prolonged release tablet contains : |
| Zolpidem Tartrate IP 12.50 mg |
| Excipients q.s. |
| |
| Zolpidem Tartrate Tablets IP | Each Uncoated prolonged release tablet contains : |
| Zolpidem Tartrate IP 5.0 mg |
| Excipients q.s. |
| |
| Zolpidem Tartrate Tablets IP | Each Uncoated prolonged release tablet contains : |
| Zolpidem Tartrate IP 10.0 mg |
| Excipients q.s. |
| |
| Zopiclone Tablets IP | Each film coated tablet contains : |
| Zopiclone IP 3.75 mg |
| Approved colour to be used |
| |
| Zopiclone Tablets IP | Each film coated tablet contains : |
| Zopiclone IP 7.5 mg |
| Approved colour to be used |
| |
| Zopiclone Tablets IP | Each film coated tablet contains : |
| Zopiclone IP 10 mg |
| Approved colour to be used |
